id,conversation_id,created_at,date,time,timezone,user_id,username,name,place,tweet,language,mentions,urls,photos,replies_count,retweets_count,likes_count,hashtags,cashtags,link,retweet,quote_url,video,thumbnail,near,geo,source,user_rt_id,user_rt,retweet_id,reply_to,retweet_date,translate,trans_src,trans_dest
1212024150774222849,1212024149335523334,2019-12-31 20:24:10 IST,2019-12-31,20:24:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"5. $SRPT -icons: ‚ÄúIt‚Äôs true, we‚Äôre in it for the money.‚Äù  6. FDA scandal: @SteveFDA hacks @ScottGottliebMD, deletes all tweets.   7. @BagholderQuotes revealed to be burner account of @JMaraganore   8. @adamfeuerstein finally changes that stupid Twitter avatar",en,"[{'screen_name': 'stevefda', 'name': 'dr. stephen m. hahn', 'id': '2904169317'}, {'screen_name': 'scottgottliebmd', 'name': 'scott gottlieb, md', 'id': '40156330'}, {'screen_name': 'bagholderquotes', 'name': 'bag holder', 'id': '3424441204'}, {'screen_name': 'jmaraganore', 'name': 'john maraganore', 'id': '875447213878423552'}, {'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",[],[],4,1,38,[],['srpt'],https://twitter.com/adamfeuerstein/status/1212024150774222849,False,,0,,,,,,,,[],,,,
1209522876371611650,1209522876371611650,2019-12-24 22:45:00 IST,2019-12-24,22:45:00,+0530,44060322,benzinga,Benzinga,,10 Biotech M&amp;A Targets Under The Scanner For 2020 $CRSP $ALNY $AMRN $INCY $GBT $QURE $SRPT $RGNX $SLDB  https://t.co/1jKlmUDGaI,en,[],['https://benzinga.com/z/15034200#.XgIE9-9rBWU.twitter'],[],2,5,16,[],"['crsp', 'alny', 'amrn', 'incy', 'gbt', 'qure', 'srpt', 'rgnx', 'sldb']",https://twitter.com/Benzinga/status/1209522876371611650,False,,0,,,,,,,,[],,,,
1209514728751554560,1159549454858563584,2019-12-24 22:12:37 IST,2019-12-24,22:12:37,+0530,873399943,jacobplieth,Jacob Plieth,,THE BOYS THE BOYS!!! $SRPT  https://t.co/HZAoRCzV9H,en,[],[],['https://pbs.twimg.com/media/EMkPOzNX0AE5z22.jpg'],0,0,6,[],['srpt'],https://twitter.com/JacobPlieth/status/1209514728751554560,False,,1,https://pbs.twimg.com/media/EMkPOzNX0AE5z22.jpg,,,,,,,[],,,,
1209443607024951297,1159549454858563584,2019-12-24 17:30:00 IST,2019-12-24,17:30:00,+0530,873399943,jacobplieth,Jacob Plieth,,"Another $SRPT fan showing concern for ""the boys""  https://t.co/fFRGRowpWH",en,[],[],['https://pbs.twimg.com/media/EMitlbHWwAUfOFN.jpg'],3,0,7,[],['srpt'],https://twitter.com/JacobPlieth/status/1209443607024951297,False,,1,https://pbs.twimg.com/media/EMitlbHWwAUfOFN.jpg,,,,,,,[],,,,
1209121197503471616,1209121197503471616,2019-12-23 20:08:52 IST,2019-12-23,20:08:52,+0530,14115408,jonnajarian,Jon Najarian,,‚è±Ô∏è60 Seconds pre market $JD $SRPT $TSLA üöÄ $UBER üöó $TJX see you live here around noon more @MarketRebels leave questions if you have them  https://t.co/GW1Jbor3e3,en,"[{'screen_name': 'marketrebels', 'name': 'market rebellion', 'id': '817007725666242561'}]",[],[],2,2,17,[],"['jd', 'srpt', 'tsla', 'uber', 'tjx']",https://twitter.com/jonnajarian/status/1209121197503471616,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/1209121038434521088/pu/img/kPZJLxVUQGtFnidf.jpg,,,,,,,[],,,,
1209092869950246912,1209092869950246912,2019-12-23 18:16:18 IST,2019-12-23,18:16:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Sarepta sells international rights to Duchenne gene therapy to Roche  https://t.co/h8D7uS6Ad4 $SRPT $RHHBY,en,[],['https://www.statnews.com/2019/12/23/sarepta-sells-international-rights-duchenne-gene-therapy-roche/'],[],2,11,18,[],"['srpt', 'rhhby']",https://twitter.com/adamfeuerstein/status/1209092869950246912,False,,0,,,,,,,,[],,,,
1209041190148083712,1209041190148083712,2019-12-23 14:50:57 IST,2019-12-23,14:50:57,+0530,873399943,jacobplieth,Jacob Plieth,,All the crackpots who argued in favour of $SRPT Exondys approval today look like geniuses. Congratulations $RHHBY !,en,[],[],[],10,1,15,[],"['srpt', 'rhhby']",https://twitter.com/JacobPlieth/status/1209041190148083712,False,,0,,,,,,,,[],,,,
1208991182526799872,1208991182526799872,2019-12-23 11:32:14 IST,2019-12-23,11:32:14,+0530,274233761,bradloncar,Brad Loncar,,Whoa big news. Roche is licensing $SRPT's micro-dystrophin gene Tx for DMD outside of the United States. $750M upfront to Sarepta and a $400M equity stake.  https://t.co/35zCeqyv2q,en,[],['https://www.globenewswire.com/news-release/2019/12/23/1963846/0/en/Roche-enters-licensing-agreement-with-Sarepta-Therapeutics-to-improve-the-lives-of-patients-living-with-Duchenne-muscular-dystrophy.html'],[],5,52,130,[],['srpt'],https://twitter.com/bradloncar/status/1208991182526799872,False,,0,,,,,,,,[],,,,
1207321154182144001,1207321154182144001,2019-12-18 20:56:08 IST,2019-12-18,20:56:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Let‚Äôs look back at the top M&amp;A candidates from JP Morgan‚Äôs 2019 buyside survey (in order):  $SRPT, $NBIX, $SAGE, $CLVS, $AMRN, $TSRO, $ARGX, $ZGNX, $MDGL, $DVAX  Only one acquired $TSRO",en,[],[],[],5,10,50,[],"['srpt', 'nbix', 'sage', 'clvs', 'amrn', 'tsro', 'argx', 'zgnx', 'mdgl', 'dvax', 'tsro']",https://twitter.com/adamfeuerstein/status/1207321154182144001,False,https://twitter.com/AndyBiotech/status/1207319137128787968,0,,,,,,,,[],,,,
1205474757027733504,1205474757027733504,2019-12-13 18:39:13 IST,2019-12-13,18:39:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,A $SRPT column in which I discuss ‚Äúweaponized patient advocacy.‚Äù See also: $AMRN    https://t.co/vA42nQ7SqU,en,[],['https://www.statnews.com/2019/12/13/the-good-the-bad-and-the-really-really-ugly-behind-sareptas-drug-approval/'],[],18,6,31,[],"['srpt', 'amrn']",https://twitter.com/adamfeuerstein/status/1205474757027733504,False,,0,,,,,,,,[],,,,
1205473362895609857,1205473362895609857,2019-12-13 18:33:40 IST,2019-12-13,18:33:40,+0530,44438256,matthewherper,Matthew Herper,,"Is the FDA spineless, asks @adamfeuerstein?   ""I‚Äôm not sure the FDA has the political will to say no or be the disciplinarian,"" Adam writes on $SRPT. ""That worries me.""    https://t.co/xXSeKxXsbV",en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",['https://www.statnews.com/2019/12/13/the-good-the-bad-and-the-really-really-ugly-behind-sareptas-drug-approval/'],[],3,13,19,[],['srpt'],https://twitter.com/matthewherper/status/1205473362895609857,False,,0,,,,,,,,[],,,,
1205472629991387137,1205472629991387137,2019-12-13 18:30:46 IST,2019-12-13,18:30:46,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"The good, the bad, and the really, really ugly behind $SRPT drug approval  https://t.co/vA42nQ7SqU From me. Includes thoughts on $BIIB aducanumab, too.",en,[],['https://www.statnews.com/2019/12/13/the-good-the-bad-and-the-really-really-ugly-behind-sareptas-drug-approval/'],[],4,14,31,[],"['srpt', 'biib']",https://twitter.com/adamfeuerstein/status/1205472629991387137,False,,0,,,,,,,,[],,,,
1205307181677105152,1205307181677105152,2019-12-13 07:33:20 IST,2019-12-13,07:33:20,+0530,102754598,johncendpts,John Carroll,,"The Sareptamaniacs are having the time of their lives tonight -- and why not, when the FDA seems determined to do their will? Having approved 1 DMD drug without data, why not 2?  $SRPT #goldstandarddontmakemelaugh",en,[],[],[],16,9,24,['goldstandarddontmakemelaugh'],['srpt'],https://twitter.com/JohnCendpts/status/1205307181677105152,False,,0,,,,,,,,[],,,,
1205287652699848705,1205287652699848705,2019-12-13 06:15:44 IST,2019-12-13,06:15:44,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"You want to laugh at Yeezus because of course linking $SRPT and $BIIB is ridiculous. But then this FDA seems incapable of resisting outside pressure and really just wants to approve drugs, regardless of data. So, who knows?  https://t.co/0Y2CaxzCrt",en,[],[],['https://pbs.twimg.com/media/ELoKuOUX0AET4hE.jpg'],10,7,24,[],"['srpt', 'biib']",https://twitter.com/adamfeuerstein/status/1205287652699848705,False,,1,https://pbs.twimg.com/media/ELoKuOUX0AET4hE.jpg,,,,,,,[],,,,
1205274125398360064,1205274125398360064,2019-12-13 05:21:59 IST,2019-12-13,05:21:59,+0530,529704495,damiangarde,Damian Garde,,"$SRPT says its suddenly un-rejected DMD drug will be priced ""at parity"" with the last one, which is dosed upon weight and can cost &gt;$1 million a year  https://t.co/JXkjCPVipA",en,[],['https://www.statnews.com/2019/12/12/fda-changes-course-approves-sarepta-once-rejected-muscular-dystrophy-drug/'],[],2,18,21,[],['srpt'],https://twitter.com/damiangarde/status/1205274125398360064,False,,0,,,,,,,,[],,,,
1205264254955380741,1205264254955380741,2019-12-13 04:42:45 IST,2019-12-13,04:42:45,+0530,102754598,johncendpts,John Carroll,,$SRPT up 23% as Christmas comes early. I think the FDA should throw in an added approval for their next application in advance.,en,[],[],[],4,4,16,[],['srpt'],https://twitter.com/JohnCendpts/status/1205264254955380741,False,,0,,,,,,,,[],,,,
1205263979771301888,1205263979771301888,2019-12-13 04:41:40 IST,2019-12-13,04:41:40,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"On further reflection, the only surprise is that FDA didn‚Äôt approve the NS Pharma drug tonight, as well. More data than $SRPT has ever collected.",en,[],[],[],8,4,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/1205263979771301888,False,https://twitter.com/Sports_bios/status/1205263032957448193,0,,,,,,,,[],,,,
1205263528774504448,1205263528774504448,2019-12-13 04:39:52 IST,2019-12-13,04:39:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚Äî FDA sure seems spineless.  https://t.co/5iyQtJX8YS,en,[],[],['https://pbs.twimg.com/tweet_video_thumb/ELn0vFqXYAU5TWU.jpg'],9,5,34,[],['srpt'],https://twitter.com/adamfeuerstein/status/1205263528774504448,False,,1,https://pbs.twimg.com/tweet_video_thumb/ELn0vFqXYAU5TWU.jpg,,,,,,,[],,,,
1205263473460035584,1205263473460035584,2019-12-13 04:39:39 IST,2019-12-13,04:39:39,+0530,102754598,johncendpts,John Carroll,,Seriously? What? $SRPT gets an OK for golodirsen. Story on the way.   https://t.co/GXe6I3vmRU,en,[],['https://www.prnewswire.com/news-releases/fda-grants-accelerated-approval-to-first-targeted-treatment-for-rare-duchenne-muscular-dystrophy-mutation-300974396.html'],[],6,2,14,[],['srpt'],https://twitter.com/JohnCendpts/status/1205263473460035584,False,,0,,,,,,,,[],,,,
1205241393871900672,1205241393871900672,2019-12-13 03:11:55 IST,2019-12-13,03:11:55,+0530,368158573,rebeccadrobbins,Rebecca Robbins,,"The latest ep of @statnews' podcast is live! On this week's show: üîπ recapping #ASH19  üîπ reflecting on $SRPT, ft. @cngarabedian now of @xontogeny üîπ the alarming rise of young onset CRC, ft. @manjuggm of @COLONTOWN Listen:  https://t.co/IBKHeRbk3M",en,"[{'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}, {'screen_name': 'cngarabedian', 'name': 'chris garabedian', 'id': '1260433608'}, {'screen_name': 'xontogeny', 'name': 'xontogeny, llc', 'id': '3002641203'}, {'screen_name': 'manjuggm', 'name': 'manju george mvsc phd, rectal cancer survivor', 'id': '301419060'}, {'screen_name': 'colontown', 'name': 'colontown', 'id': '1299436313901445120'}]",['https://www.statnews.com/2019/12/12/podcast-future-cart-cancer-sarepta-fda/'],[],0,10,9,['ash19'],['srpt'],https://twitter.com/RebeccaDRobbins/status/1205241393871900672,False,,0,,,,,,,,[],,,,
1203140090668748800,1203140090668748800,2019-12-07 08:02:05 IST,2019-12-07,08:02:05,+0530,102754598,johncendpts,John Carroll,,"Of course, there was the $SRPT thing --  ‚ÄúPeople are hoping of course...that we will find something, but we aren‚Äôt going to approve drugs that aren‚Äôt effective,‚Äù said Janet Woodcock, ""Obviously there is a tremendous need in Alzheimer‚Äôs, and we‚Äôll just have to see about data.‚Äù",en,[],[],[],0,1,14,[],['srpt'],https://twitter.com/JohnCendpts/status/1203140090668748800,False,,0,,,,,,,,[],,,,
1202617844510396416,1202617844510396416,2019-12-05 21:26:52 IST,2019-12-05,21:26:52,+0530,612715576,annemostue,Anne Mostue,,"Thermo Fisher $TMO has spent $93 million on a gene therapy manufacturing center in Lexington, with the plan to work with Sarepta $SRPT on #Duchenne. A review of what‚Äôs ahead:  https://t.co/y7JtftPpxH  https://t.co/DeZlUcQd5R",en,[],['https://www.bloomberg.com/news/audio/2019-12-04/baystate-business-peloton-housing-steve-cohen-audio'],['https://pbs.twimg.com/media/ELCOjIjXsAAAayK.jpg'],1,0,7,['duchenne'],"['tmo', 'srpt']",https://twitter.com/AnneMostue/status/1202617844510396416,False,,1,https://pbs.twimg.com/media/ELCOjIjXsAAAayK.jpg,,,,,,,[],,,,
1199463799813804032,1199463799813804032,2019-11-27 04:33:49 IST,2019-11-27,04:33:49,+0530,16732770,cnbcfastmoney,CNBC's Fast Money,,Here are the traders' top picks for tomorrow morning. $SLB $TIF $HD $SRPT  https://t.co/ggE2t1bLjj,en,[],[],[],3,9,26,[],"['slb', 'tif', 'hd', 'srpt']",https://twitter.com/CNBCFastMoney/status/1199463799813804032,False,,1,https://pbs.twimg.com/media/EKVZ9ycX0AIgBL0.jpg,,,,,,,[],,,,
1197856688302374912,1197806092669063168,2019-11-22 18:07:44 IST,2019-11-22,18:07:44,+0530,873399943,jacobplieth,Jacob Plieth,,I mean can there really be any doubt that $BIIB is going to do a $SRPT with the aducanumab approval process?,en,[],[],[],3,1,8,[],"['biib', 'srpt']",https://twitter.com/JacobPlieth/status/1197856688302374912,False,,0,,,,,,,,[],,,,
1194973855225389056,1194973855225389056,2019-11-14 19:12:23 IST,2019-11-14,19:12:23,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Good snark, but he‚Äôs right. Is there a gene therapy for ADHD, because $SRPT needs one. Can‚Äôt focus.",en,[],[],[],7,1,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/1194973855225389056,False,https://twitter.com/bio_clouseau/status/1194972895975477248,0,,,,,,,,[],,,,
1192575358337536002,1192575358337536002,2019-11-08 04:21:37 IST,2019-11-08,04:21:37,+0530,529704495,damiangarde,Damian Garde,,"Beyond all the other stuff, it's kind of remarkable for the CEO of a drug company to feel the need to say ‚Äúwe want to build a positive relationship‚Äù with the FDA  https://t.co/NVoIKJbqSU $srpt",en,[],['https://www.statnews.com/2019/11/07/sarepta-therapeutics-ceo-fda-duchenne-drug/'],[],3,0,9,[],['srpt'],https://twitter.com/damiangarde/status/1192575358337536002,False,,0,,,,,,,,[],,,,
1192573739143225344,1192573739143225344,2019-11-08 04:15:11 IST,2019-11-08,04:15:11,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Sarepta Therapeutics CEO playing nice with FDA over rejection of Duchenne drug  https://t.co/8ZwvYdFnjb $SRPT,en,[],['https://www.statnews.com/2019/11/07/sarepta-therapeutics-ceo-fda-duchenne-drug/'],[],4,7,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/1192573739143225344,False,,0,,,,,,,,[],,,,
1192557962985910280,1192557962985910280,2019-11-08 03:12:29 IST,2019-11-08,03:12:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT CEO Doug Ingram addressed the FDA rejection of golodirsen, said company was treated fairly by agency, wants to work with agency to resolve remaining issues. But no timeline offered.",en,[],[],[],4,3,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/1192557962985910280,False,,0,,,,,,,,[],,,,
1192551759161544704,1192551759161544704,2019-11-08 02:47:50 IST,2019-11-08,02:47:50,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT earnings PR is a snooze. I hope the call is more informative.,en,[],[],[],0,1,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/1192551759161544704,False,,0,,,,,,,,[],,,,
1190995554169434116,1190995554169434116,2019-11-03 19:44:02 IST,2019-11-03,19:44:02,+0530,15130891,kunal00,Kunal Desai,,Watch list and game plan for tomorrow!   https://t.co/vt6wbdHCLd  $AYX $CRC $SRPT $INMD $SDC $UGAZ  https://t.co/1WQXUJa5Ls,en,[],['http://bit.ly/33a4fyt'],['https://pbs.twimg.com/media/EIdEJPuWoAA8Mgb.png'],0,2,9,[],"['ayx', 'crc', 'srpt', 'inmd', 'sdc', 'ugaz']",https://twitter.com/kunal00/status/1190995554169434116,False,,1,https://pbs.twimg.com/media/EIdEJPuWoAA8Mgb.png,,,,,,,[],,,,
1190637658407608322,1190637658407608322,2019-11-02 20:01:53 IST,2019-11-02,20:01:53,+0530,15130891,kunal00,Kunal Desai,,Trading watch list and game plan for Monday! @szaman    https://t.co/vt6wbdHCLd  $AYX $CRC $SRPT $INMD $SDC $UGAZ  https://t.co/2zVO4jzXwT,en,"[{'screen_name': 'szaman', 'name': 'nyc trader', 'id': '17549691'}]",['http://bit.ly/33a4fyt'],['https://pbs.twimg.com/media/EIX-o9vWwAMxbL7.png'],0,4,8,[],"['ayx', 'crc', 'srpt', 'inmd', 'sdc', 'ugaz']",https://twitter.com/kunal00/status/1190637658407608322,False,,1,https://pbs.twimg.com/media/EIX-o9vWwAMxbL7.png,,,,,,,[],,,,
1186928255946907649,1186928255946907649,2019-10-23 14:22:02 IST,2019-10-23,14:22:02,+0530,873399943,jacobplieth,Jacob Plieth,,"The $SRPT loon Grey Zone is becoming delusional again. I think (s)he meant to say ""thank god dr unger is there to protect my investment and enable me to buy my girlfriend another car""  https://t.co/UBc7JquisL",en,[],[],"['https://pbs.twimg.com/media/EHjQxvpX0AAggFU.jpg', 'https://pbs.twimg.com/media/EHjQyg7X4AAdGz_.jpg']",3,0,6,[],['srpt'],https://twitter.com/JacobPlieth/status/1186928255946907649,False,,1,https://pbs.twimg.com/media/EHjQxvpX0AAggFU.jpg,,,,,,,[],,,,
1184829894812934146,1184829894812934146,2019-10-17 19:23:54 IST,2019-10-17,19:23:54,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,"$NVTA Neurologist shared what he saw in a journal. This is @Invitae 's Detect Program.¬†  Partnership with $BMRN.  Remember Invitae's moat surrounds multiple rare diseases in partnership with 50 biopharma like $BIIB $MRK $SRPT $JAZZ etc.  Final image is from me, not the journal.  https://t.co/mVtSibeKzI",en,"[{'screen_name': 'invitae', 'name': 'invitae', 'id': '476238744'}]",[],"['https://pbs.twimg.com/media/EHFceBZXkAAPxhS.jpg', 'https://pbs.twimg.com/media/EHFceylX0AEIJ1b.jpg', 'https://pbs.twimg.com/media/EHFcgR0W4AEjZLE.jpg']",0,1,18,[],"['nvta', 'bmrn', 'biib', 'mrk', 'srpt', 'jazz']",https://twitter.com/OphirGottlieb/status/1184829894812934146,False,,1,https://pbs.twimg.com/media/EHFceBZXkAAPxhS.jpg,,,,,,,[],,,,
1181255556515975168,1181255556515975168,2019-10-07 22:40:45 IST,2019-10-07,22:40:45,+0530,15971805,investorslive,Nathan Michaud,,$SRPT $7/share fade form short morning shove vs $91 resistance idea  LOOK LEFT to anticipate right!   https://t.co/rTT8dKlAZ3,en,[],['https://www.youtube.com/watch?v=eCKOjDPx2U0'],[],0,1,8,[],['srpt'],https://twitter.com/InvestorsLive/status/1181255556515975168,False,,0,,,,,,,,[],,,,
1180996790432215042,1180996790432215042,2019-10-07 05:32:31 IST,2019-10-07,05:32:31,+0530,15971805,investorslive,Nathan Michaud,,[FREE SCAN] Check out my stock watch list and game plan for tomorrow  https://t.co/fKRqSEj4xp  $MEET $TSG $OSTK $PTON $SES $SDC $SRPT $LABD $ZYXI $REAL and more  https://t.co/4HOW0FfJJb,en,[],['https://www.investorsunderground.com/free-scan-october-7/'],['https://pbs.twimg.com/media/EGO-UltWsAESmD8.jpg'],2,1,15,[],"['meet', 'tsg', 'ostk', 'pton', 'ses', 'sdc', 'srpt', 'labd', 'zyxi', 'real']",https://twitter.com/InvestorsLive/status/1180996790432215042,False,,1,https://pbs.twimg.com/media/EGO-UltWsAESmD8.jpg,,,,,,,[],,,,
1180158378322071557,1180158378322071557,2019-10-04 22:00:58 IST,2019-10-04,22:00:58,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT gene therapy improves muscle function for patients with rare limb-girdle disease  https://t.co/AacI1CE3KH,en,[],['https://www.statnews.com/2019/10/04/sarepta-gene-therapy-limb-girdle-disease/'],[],4,3,17,[],['srpt'],https://twitter.com/adamfeuerstein/status/1180158378322071557,False,,0,,,,,,,,[],,,,
1179675324147208192,1179675324147208192,2019-10-03 14:01:29 IST,2019-10-03,14:01:29,+0530,873399943,jacobplieth,Jacob Plieth,,"Sarepta loons out in force! Here's the script: viltolarsen is toxic, and NS is run by evil scum who stole tech from $SRPT and are shorting its stock",en,[],[],[],8,2,13,[],['srpt'],https://twitter.com/JacobPlieth/status/1179675324147208192,False,,0,,,,,,,,[],,,,
1179455370416332800,1179455370416332800,2019-10-02 23:27:28 IST,2019-10-02,23:27:28,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I believe this answers my $SRPT question from this morning. Lovely group of people.  https://t.co/qNFQ8lwhyx,en,[],[],['https://pbs.twimg.com/media/EF5EaDrWwAApEkD.jpg'],19,1,55,[],['srpt'],https://twitter.com/adamfeuerstein/status/1179455370416332800,False,,1,https://pbs.twimg.com/media/EF5EaDrWwAApEkD.jpg,,,,,,,[],,,,
1179371452539293698,1179371452539293698,2019-10-02 17:54:00 IST,2019-10-02,17:54:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"How many of the $SRPT fans who say they care most about well being of Duchenne kids (more than stock profits) will support, cheer for the approval of NS Pharma‚Äôs drug?",en,[],[],[],16,6,52,[],['srpt'],https://twitter.com/adamfeuerstein/status/1179371452539293698,False,,0,,,,,,,,[],,,,
1179362003011420160,1179362003011420160,2019-10-02 17:16:27 IST,2019-10-02,17:16:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT under new pressure as a competitor files with FDA for Duchenne drug  https://t.co/3AIE26f7wT,en,[],['https://www.statnews.com/2019/10/02/sarepta-under-new-pressure-as-a-competitor-files-with-fda-for-duchenne-drug/'],[],5,7,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/1179362003011420160,False,,0,,,,,,,,[],,,,
1176838489394073600,1176838489394073600,2019-09-25 18:08:55 IST,2019-09-25,18:08:55,+0530,102094857,adamfeuerstein,Adam Feuerstein,,üî• $SRPT questions: Where are eteplirsen confirmatory data?  How are you solving golodirsen rejection? When can you file DMD gene therapy?Can you even make gene thx at commercial scale?  dribbling out some more limb-girdle data... ü§∑üèª‚Äç‚ôÇÔ∏è,en,[],[],[],8,3,25,[],['srpt'],https://twitter.com/adamfeuerstein/status/1176838489394073600,False,https://twitter.com/BioRunUp/status/1176836384113360896,0,,,,,,,,[],,,,
1176457585937068033,1176457585937068033,2019-09-24 16:55:20 IST,2019-09-24,16:55:20,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"RBC analyst Michael Abrahams wants investors to ‚Äúrefocus‚Äù on $SRPT in a + way, starting w/ limb-girdle gene thx update at World Muscle Society. In writing this, Abrahams shows he‚Äôs learned nothing at all from the company‚Äôs recent setbacks.",en,[],[],[],6,0,20,[],['srpt'],https://twitter.com/adamfeuerstein/status/1176457585937068033,False,,0,,,,,,,,[],,,,
1168892191877607429,1168892191877607429,2019-09-03 19:53:10 IST,2019-09-03,19:53:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,The FDA and $SRPT: a window into the real world of drug regulation  https://t.co/X0pjOZM37n via @statnews op-ed,en,"[{'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}]",['https://www.statnews.com/2019/09/03/fda-sarepta-real-world-drug-regulation/'],[],4,13,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/1168892191877607429,False,,0,,,,,,,,[],,,,
1165951012236140546,1165951012236140546,2019-08-26 17:05:58 IST,2019-08-26,17:05:58,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"They rallied around ‚Äòour boys‚Äô as they pushed for a Duchenne cure. Where did that leave girls?  https://t.co/Vmx3w3irMD An important, well-told story by @DrewQJoseph and @sayhitohyacinth , very much worth your time today. #Duchenne $SRPT",en,"[{'screen_name': 'drewqjoseph', 'name': 'andrew joseph', 'id': '359568042'}, {'screen_name': 'sayhitohyacinth', 'name': 'hyacinth empinado', 'id': '302440905'}]",['https://www.statnews.com/2019/08/26/duchenne-muscular-dystrophy-therapy-girls/'],[],1,11,21,['duchenne'],['srpt'],https://twitter.com/adamfeuerstein/status/1165951012236140546,False,,0,,,,,,,,[],,,,
1164534383598014466,1164534383598014466,2019-08-22 19:16:47 IST,2019-08-22,19:16:47,+0530,44438256,matthewherper,Matthew Herper,,"In this morning's Readout, @damiangarde takes a swing at whether $SRPT could reveal the full contents of its CRL.  You should subscribe!   https://t.co/xJAvAJAc1t",en,"[{'screen_name': 'damiangarde', 'name': 'damian garde', 'id': '529704495'}]",['https://mailchi.mp/statnews/tk-595205?e=93333ff6c5'],[],5,6,6,[],['srpt'],https://twitter.com/matthewherper/status/1164534383598014466,False,,0,,,,,,,,[],,,,
1164364727704702976,1144283584410165248,2019-08-22 08:02:38 IST,2019-08-22,08:02:38,+0530,15246621,alphatrends,"Brian Shannon, CMT",,"@MarketSmith once again, biotech stocks are the premiere example of why ""risk management is job #1!"" the Serpent $SRPT crushes investors (again)  https://t.co/fahXkMgTXY",en,[],[],['https://pbs.twimg.com/media/ECinjANUwAAyXgg.jpg'],1,5,23,[],['srpt'],https://twitter.com/alphatrends/status/1164364727704702976,False,,1,https://pbs.twimg.com/media/ECinjANUwAAyXgg.jpg,,,,,,,"[{'screen_name': 'MarketSmith', 'name': 'MarketSmith', 'id': '272125054'}]",,,,
1163845899732299776,1163845899732299776,2019-08-20 21:41:00 IST,2019-08-20,21:41:00,+0530,873399943,jacobplieth,Jacob Plieth,,I‚Äôm happy to report that the water in London is the best in the world $SRPT  https://t.co/BGEbuxnL6q,en,[],[],['https://pbs.twimg.com/tweet_video_thumb/ECbPrA1XkAAn7BM.jpg'],1,0,6,[],['srpt'],https://twitter.com/JacobPlieth/status/1163845899732299776,False,,1,https://pbs.twimg.com/tweet_video_thumb/ECbPrA1XkAAn7BM.jpg,,,,,,,[],,,,
1163813115638665217,1163813115638665217,2019-08-20 19:30:44 IST,2019-08-20,19:30:44,+0530,44438256,matthewherper,Matthew Herper,,One question I'm seeing on $SRPT on which I have an opinion: I do not think this affects other rare disease companies outside the Duchenne space.,en,[],[],[],4,2,13,[],['srpt'],https://twitter.com/matthewherper/status/1163813115638665217,False,,0,,,,,,,,[],,,,
1163798012101058560,1163798012101058560,2019-08-20 18:30:43 IST,2019-08-20,18:30:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"FDA‚Äôs Sarepta rejection is rooted in the past, and will weigh on its future  https://t.co/TXE6cB7nRN My follow-up take on last night‚Äôs big news. $SRPT",en,[],['https://www.statnews.com/2019/08/20/fdas-sarepta-rejection-is-rooted-in-the-past-and-will-weigh-on-its-future/'],[],3,19,32,[],['srpt'],https://twitter.com/adamfeuerstein/status/1163798012101058560,False,,0,,,,,,,,[],,,,
1163785299656433664,1163785299656433664,2019-08-20 17:40:12 IST,2019-08-20,17:40:12,+0530,274233761,bradloncar,Brad Loncar,,Analysts are lowering their $SRPT NPVs to account for Vyondys but the real question is what else potentially does it mean to hold a company that seems to have angered FDA so much that the agency would go to this length today.,en,[],[],[],16,12,55,[],['srpt'],https://twitter.com/bradloncar/status/1163785299656433664,False,,0,,,,,,,,[],,,,
1163762940618711040,1163700871219355650,2019-08-20 16:11:21 IST,2019-08-20,16:11:21,+0530,873399943,jacobplieth,Jacob Plieth,,"@PredatorDiaries That doesn‚Äôt matter. What matters is that the $SRPT loonies made themselves $$$, cracked open the expensive whiskey and bought their girlfriends new cars.",en,[],[],[],2,2,6,[],['srpt'],https://twitter.com/JacobPlieth/status/1163762940618711040,False,,0,,,,,,,,"[{'screen_name': 'PredatorDiaries', 'name': 'Andy Smith', 'id': '225911893'}]",,,,
1163751964125159424,1163751964125159424,2019-08-20 15:27:44 IST,2019-08-20,15:27:44,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I wrote two $SRPT stories before the Vyondys news broke last night. You never know, right? Best to be prepared for all scenarios. I can delete this one from my notes, now.  https://t.co/VRw1gJfUJQ",en,[],[],['https://pbs.twimg.com/media/ECZ6DHlXoAAy0QE.jpg'],3,0,20,[],['srpt'],https://twitter.com/adamfeuerstein/status/1163751964125159424,False,,1,https://pbs.twimg.com/media/ECZ6DHlXoAAy0QE.jpg,,,,,,,[],,,,
1163700871219355650,1163700871219355650,2019-08-20 12:04:42 IST,2019-08-20,12:04:42,+0530,873399943,jacobplieth,Jacob Plieth,,The $SRPT loonies make it into bagholder quotes. Momentous.,en,[],[],[],4,2,27,[],['srpt'],https://twitter.com/JacobPlieth/status/1163700871219355650,False,https://twitter.com/BagholderQuotes/status/1163641221694275585,0,,,,,,,,[],,,,
1163611497064554497,1163611497064554497,2019-08-20 06:09:34 IST,2019-08-20,06:09:34,+0530,274233761,bradloncar,Brad Loncar,,"$SRPT via Credit Suisse:  ""We spoke to the company who indicated SRPT had reached alignment with FDA on post-marketing commitments, had come to agreement on the potential label, and FDA had even reviewed the potential Vyondys 53 approval presser.""",en,[],[],[],13,13,55,[],['srpt'],https://twitter.com/bradloncar/status/1163611497064554497,False,,0,,,,,,,,[],,,,
1163587071409348610,1163587071409348610,2019-08-20 04:32:30 IST,2019-08-20,04:32:30,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"There will be more to say on $SRPT and Vyondys 53 tomorrow and days ahead, but for now, few rational people believe the stated safety issues are real reason for FDA rejection. Have a good night.",en,[],[],[],12,15,61,[],['srpt'],https://twitter.com/adamfeuerstein/status/1163587071409348610,False,https://twitter.com/adamfeuerstein/status/1163573785540345856,0,,,,,,,,[],,,,
1163580780662218752,1163580780662218752,2019-08-20 04:07:31 IST,2019-08-20,04:07:31,+0530,44438256,matthewherper,Matthew Herper,,Holy $SRPT!   https://t.co/ELUuykDd4j   by @adamfeuerstein,en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",['https://www.statnews.com/2019/08/19/fda-rejects-sarepta-duchenne-muscular-dystrophy-drug/'],[],5,9,15,[],['srpt'],https://twitter.com/matthewherper/status/1163580780662218752,False,,0,,,,,,,,[],,,,
1163575991131877376,1163575991131877376,2019-08-20 03:48:29 IST,2019-08-20,03:48:29,+0530,102754598,johncendpts,John Carroll,,"Throughout Twitter, an Orc army is forming. $SRPT",en,[],[],[],2,1,9,[],['srpt'],https://twitter.com/JohnCendpts/status/1163575991131877376,False,,0,,,,,,,,[],,,,
1163573785540345856,1163573785540345856,2019-08-20 03:39:43 IST,2019-08-20,03:39:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT stumbles on FDA rejection of a new drug to treat Duchenne muscular dystrophy  https://t.co/aSO2IkhvKB,en,[],['https://www.statnews.com/2019/08/19/fda-rejects-sarepta-duchenne-muscular-dystrophy-drug/'],[],4,13,22,[],['srpt'],https://twitter.com/adamfeuerstein/status/1163573785540345856,False,,0,,,,,,,,[],,,,
1163568737762643969,1163568737762643969,2019-08-20 03:19:39 IST,2019-08-20,03:19:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT CRL,und,[],[],[],2,5,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/1163568737762643969,False,,0,,,,,,,,[],,,,
1161997335498567680,1161997335498567680,2019-08-15 19:15:28 IST,2019-08-15,19:15:28,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Exondys 51 is $300M a yr drug and no one knows if it works. That‚Äôs odd. Sarepta promised FDA to conduct a trial to confirm Exondys‚Äô treatment benefit but is 3-4 yrs behind schedule. Meantime, $SRPT profits. I wrote about this:   https://t.co/IPM9Z0X0qj",en,[],['https://www.statnews.com/2019/08/15/sarepta-duchenne-drug-questions-exondys-51/'],[],18,23,68,[],['srpt'],https://twitter.com/adamfeuerstein/status/1161997335498567680,False,,0,,,,,,,,[],,,,
1161952037518618625,1161952037518618625,2019-08-15 16:15:28 IST,2019-08-15,16:15:28,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"As $SRPT awaits approval of new Duchenne drug, big questions hang over therapy already on market  https://t.co/IPM9Z0X0qj I wrote about Exondys 51 and the promised (required) confirmatory trial that is 3-4 yrs behind schedule.",en,[],['https://www.statnews.com/2019/08/15/sarepta-duchenne-drug-questions-exondys-51/'],[],8,9,21,[],['srpt'],https://twitter.com/adamfeuerstein/status/1161952037518618625,False,,0,,,,,,,,[],,,,
1161463435185610752,1161463435185610752,2019-08-14 07:53:56 IST,2019-08-14,07:53:56,+0530,44438256,matthewherper,Matthew Herper,,Opinion | This Drug Will Save Children‚Äôs Lives. It Costs $2 Million. $nvs $srpt  https://t.co/iQAAnVCE9i,en,[],['https://www.nytimes.com/2019/08/13/opinion/novartis-drug-cost.html'],[],3,11,25,[],"['nvs', 'srpt']",https://twitter.com/matthewherper/status/1161463435185610752,False,,0,,,,,,,,[],,,,
1160884043468197888,1160884043468197888,2019-08-12 17:31:38 IST,2019-08-12,17:31:38,+0530,44438256,matthewherper,Matthew Herper,,You have $SRPT  questions? @adamfeuerstein has answers.   I'd echo Adam's feeling that $SRPT CEO Doug Ingram has been overconfident. (There's a lot of that going around.)   https://t.co/xBuvvm2ZmR,en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",['https://www.statnews.com/2019/08/12/sareptas-bad-week-raised-questions-about-its-gene-therapy-program-here-are-some-answers/'],[],7,1,3,[],"['srpt', 'srpt']",https://twitter.com/matthewherper/status/1160884043468197888,False,,0,,,,,,,,[],,,,
1159848755912499201,1159848755912499201,2019-08-09 20:57:47 IST,2019-08-09,20:57:47,+0530,274233761,bradloncar,Brad Loncar,,Always nice to talk biotech with @OJRenick on @TDANetwork. Thanks for the discussion. $NKTR $SRPT  https://t.co/I7L90QJhIs  https://t.co/ZfbiikRWkL,en,"[{'screen_name': 'ojrenick', 'name': 'oliver renick', 'id': '1580555131'}, {'screen_name': 'tdanetwork', 'name': 'td ameritrade network', 'id': '872519322077470721'}]",['https://tdameritradenetwork.com/video/rB4AoWxVGWCBbHbdp6YFJA'],['https://pbs.twimg.com/media/EBib1qoXoAEFbv7.jpg'],0,0,16,[],"['nktr', 'srpt']",https://twitter.com/bradloncar/status/1159848755912499201,False,,1,https://pbs.twimg.com/media/EBib1qoXoAEFbv7.jpg,,,,,,,[],,,,
1159805851949051905,1159804051036561408,2019-08-09 18:07:17 IST,2019-08-09,18:07:17,+0530,873399943,jacobplieth,Jacob Plieth,,@AndyBiotech Good luck expecting the $SRPT fans to listen to this advice.,en,[],[],[],3,0,8,[],['srpt'],https://twitter.com/JacobPlieth/status/1159805851949051905,False,,0,,,,,,,,"[{'screen_name': 'AndyBiotech', 'name': 'Andy Biotech', 'id': '632341632'}]",,,,
1159579041139236864,1159579041139236864,2019-08-09 03:06:02 IST,2019-08-09,03:06:02,+0530,44438256,matthewherper,Matthew Herper,,General comment to biotech investors: beware the belief that anyone knows any thing.   $SRPT $AMRN $NKTR,en,[],[],[],7,11,68,[],"['srpt', 'amrn', 'nktr']",https://twitter.com/matthewherper/status/1159579041139236864,False,,0,,,,,,,,[],,,,
1159552613597229058,1159552613597229058,2019-08-09 01:21:01 IST,2019-08-09,01:21:01,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT stock price plummets after an ‚Äòerroneous‚Äô report  https://t.co/ubCakyRXnv via @sheridan_kate,en,"[{'screen_name': 'sheridan_kate', 'name': 'kate sheridan', 'id': '222995559'}]",['https://www.statnews.com/2019/08/08/sareptas-stock-price-plummets-after-an-erroneous-report/'],[],0,5,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/1159552613597229058,False,,0,,,,,,,,[],,,,
1159549852415680515,1159549852415680515,2019-08-09 01:10:02 IST,2019-08-09,01:10:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"My take: $SRPT has been shit-talking safety of $PFE gene thx for weeks to anyone who‚Äôll listen. They‚Äôd have to be monumentally stupid to hide major safety issue in their program.   But also, maybe $SRPT should tone down shit-talking of competitors.",en,[],[],[],11,1,17,[],"['srpt', 'pfe', 'srpt']",https://twitter.com/adamfeuerstein/status/1159549852415680515,False,,0,,,,,,,,[],,,,
1159549454858563584,1159549454858563584,2019-08-09 01:08:28 IST,2019-08-09,01:08:28,+0530,873399943,jacobplieth,Jacob Plieth,,"‚ÄúIt‚Äôs all about the boys, PLEASE THINK ABOUT THE BOYS‚Äù $SRPT",en,[],[],[],4,2,13,[],['srpt'],https://twitter.com/JacobPlieth/status/1159549454858563584,False,https://twitter.com/greyzone513/status/1159543819861463040,0,,,,,,,,[],,,,
1159548357091762176,1159548357091762176,2019-08-09 01:04:06 IST,2019-08-09,01:04:06,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT statement: FAERS report was erroneously submitted; pt was hospitalized for observation &amp; discharged next day; drug safety monitoring board reviewed, recommended study continue uninterrupted  https://t.co/58kbAL5WdJ",en,[],['https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-comments-erroneous-submission-us-fda'],[],1,4,9,[],['srpt'],https://twitter.com/megtirrell/status/1159548357091762176,False,https://twitter.com/megtirrell/status/1159510401672986631,0,,,,,,,,[],,,,
1159541400540766209,1159541400540766209,2019-08-09 00:36:27 IST,2019-08-09,00:36:27,+0530,873399943,jacobplieth,Jacob Plieth,,Remember this rhabdomyolysis-related fake news? $SRPT,en,[],[],[],3,1,10,[],['srpt'],https://twitter.com/JacobPlieth/status/1159541400540766209,False,https://twitter.com/JacobPlieth/status/961931991947104256,0,,,,,,,,[],,,,
1159514417643622400,1159510401672986631,2019-08-08 22:49:14 IST,2019-08-08,22:49:14,+0530,47678782,megtirrell,Meg Tirrell,,"A reminder this FDA side effects database (FAERS) has caused some wacky trades before, in $SRPT as well as others:  https://t.co/ltNamOADQ0  Not to say this is necessarily wacky - we need more info from @Sarepta @douglas_ingram",en,"[{'screen_name': 'sarepta', 'name': 'sarepta therapeutics', 'id': '2216555822'}, {'screen_name': 'douglas_ingram', 'name': 'douglas ingram', 'id': '1584787405'}]",['https://www.cnbc.com/2017/09/29/biotech-stocks-drop-after-fda-makes-drug-side-effects-more-searchable.html'],[],4,9,30,[],['srpt'],https://twitter.com/megtirrell/status/1159514417643622400,False,,0,,,,,,,,[],,,,
1159511106081185792,1159510401672986631,2019-08-08 22:36:05 IST,2019-08-08,22:36:05,+0530,47678782,megtirrell,Meg Tirrell,,Here's the FAERS database info. Waiting for more from $SRPT.  https://t.co/cQ4KYsWx4c,en,[],[],['https://pbs.twimg.com/media/EBdpNHdWwAA-aUr.png'],4,6,7,[],['srpt'],https://twitter.com/megtirrell/status/1159511106081185792,False,,1,https://pbs.twimg.com/media/EBdpNHdWwAA-aUr.png,,,,,,,[],,,,
1159510401672986631,1159510401672986631,2019-08-08 22:33:17 IST,2019-08-08,22:33:17,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT down 13% after Baird reports safety issue on FDA's FAERS database: case of rhabdomyolysis in gene therapy trial for DMD. Pt was hospitalized, event is characterized as ""serious,"" dated Feb 2019. Baird points out rhabdomyolysis is 'known issue in DMD community'",en,[],[],[],5,17,27,[],['srpt'],https://twitter.com/megtirrell/status/1159510401672986631,False,,0,,,,,,,,[],,,,
1159212280069939200,1159212280069939200,2019-08-08 02:48:39 IST,2019-08-08,02:48:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT microdystrophin gene therapy update: Start of the confirmatory clinical trial (using commercial supplements) has been pushed back to 1H 2020, per Evercore ISI‚Äôs Ravi Mehrota, citing the 10Q.   Previous guidance for trial start was Q4 2019.",en,[],[],[],0,4,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/1159212280069939200,False,,0,,,,,,,,[],,,,
1159197271935848450,1159197271935848450,2019-08-08 01:49:01 IST,2019-08-08,01:49:01,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"In its earnings release, $SRPT mentions new R&amp;D effort to develop a gene therapy for multiple sclerosis.",en,[],[],[],6,7,40,[],['srpt'],https://twitter.com/adamfeuerstein/status/1159197271935848450,False,,0,,,,,,,,[],,,,
1158078395621658624,1158078395621658624,2019-08-04 23:43:00 IST,2019-08-04,23:43:00,+0530,274233761,bradloncar,Brad Loncar,,Another big week of earnings.  M: $ARWR $RVNC $XLRN T: $ALNY $EDIT $NVTA $REGN $SAGE W: $ALLO $ARQL $SRPT $TEVA T: $AKBA $NKTR $PBYI $ZIOP F: $IMV $NVO  The full schedule:  https://t.co/X86shzqfJs  https://t.co/eOjGpGBpDj,en,[],['https://www.loncarblog.com/august-5-earnings'],['https://pbs.twimg.com/media/EBHGOf1W4AI4zh5.jpg'],2,16,38,[],"['arwr', 'rvnc', 'xlrn', 'alny', 'edit', 'nvta', 'regn', 'sage', 'allo', 'arql', 'srpt', 'teva', 'akba', 'nktr', 'pbyi', 'ziop', 'imv', 'nvo']",https://twitter.com/bradloncar/status/1158078395621658624,False,,1,https://pbs.twimg.com/media/EBHGOf1W4AI4zh5.jpg,,,,,,,[],,,,
1154052404897173505,1154052404897173505,2019-07-24 21:05:09 IST,2019-07-24,21:05:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Patients, backed by ‚Äòdark money‚Äô group, get ready to debate Duchenne drug prices. It will not be boring  https://t.co/Xqy9cptNm5 @sheridan_kate previews the ICER meeting tomorrow $SRPT $SLDB $PFE",en,"[{'screen_name': 'sheridan_kate', 'name': 'kate sheridan', 'id': '222995559'}]",['https://www.statnews.com/2019/07/24/patients-backed-by-dark-money-group-get-ready-to-debate-duchenne-drug-prices-it-will-not-be-boring/'],[],7,4,12,[],"['srpt', 'sldb', 'pfe']",https://twitter.com/adamfeuerstein/status/1154052404897173505,False,,0,,,,,,,,[],,,,
1150793865718353920,1150793865718353920,2019-07-15 21:16:52 IST,2019-07-15,21:16:52,+0530,24227424,harmongreg,Greg Harmon,,$SRPT Top 10 this week hits @MarketSmith scan as breaks out of a Cup and Handle #IBDPartner.  Target to 188 @InvestorsBusinessDaily @IBDInvestors  https://t.co/7y1Z3ZfZNh,en,"[{'screen_name': 'marketsmith', 'name': 'marketsmith', 'id': '272125054'}, {'screen_name': 'ibdinvestors', 'name': 'investors.com', 'id': '21328656'}]",[],['https://pbs.twimg.com/media/D_hw67_WsAAJvdn.jpg'],0,1,8,['ibdpartner'],['srpt'],https://twitter.com/harmongreg/status/1150793865718353920,False,,1,https://pbs.twimg.com/media/D_hw67_WsAAJvdn.jpg,,,,,,,[],,,,
1149520116482056192,1144283584410165248,2019-07-12 08:55:27 IST,2019-07-12,08:55:27,+0530,15246621,alphatrends,"Brian Shannon, CMT",,$SRPT coiled up and ready to strike again @MarketSmith  https://t.co/IPBpZXxzSS,en,"[{'screen_name': 'marketsmith', 'name': 'marketsmith', 'id': '272125054'}]",[],['https://pbs.twimg.com/media/D_PqaUSUIAU3UH-.jpg'],3,18,30,[],['srpt'],https://twitter.com/alphatrends/status/1149520116482056192,False,,1,https://pbs.twimg.com/media/D_PqaUSUIAU3UH-.jpg,,,,,,,[],,,,
1145816135037853699,1145712503009230848,2019-07-02 03:37:09 IST,2019-07-02,03:37:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@matthewherper @BiotechObserver @phatoftheland10 @SptAdd @Bionerd51 $SRPT is a $12B company already.,en,[],[],[],2,0,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/1145816135037853699,False,,0,,,,,,,,"[{'screen_name': 'matthewherper', 'name': 'Matthew Herper', 'id': '44438256'}, {'screen_name': 'BiotechObserver', 'name': 'BiotechObserver', 'id': '1012298036490506240'}, {'screen_name': 'phatoftheland10', 'name': 'JO-BU', 'id': '120949245'}, {'screen_name': 'SptAdd', 'name': 'Sptadd', 'id': '720675416957132801'}, {'screen_name': 'Bionerd51', 'name': 'Bionerd51', 'id': '531480389'}]",,,,
1145776941183754240,1145774747751342080,2019-07-02 01:01:24 IST,2019-07-02,01:01:24,+0530,44438256,matthewherper,Matthew Herper,,@TheProfessor_85 It's clear $SRPT data look best. The more proper question is how tough would it be to have to take $PFE over nothing? (And what are the odds they are actually similar?),en,[],[],[],1,0,6,[],"['srpt', 'pfe']",https://twitter.com/matthewherper/status/1145776941183754240,False,,0,,,,,,,,"[{'screen_name': 'TheProfessor_85', 'name': 'TheProfessor', 'id': '829403812657983488'}]",,,,
1145712503009230848,1145712503009230848,2019-07-01 20:45:21 IST,2019-07-01,20:45:21,+0530,44438256,matthewherper,Matthew Herper,,"Pfizer, Sarepta, and gene therapy: A race for a better Duchenne treatment  ‚Å¶@adamfeuerstein‚Å© and I talk $pfe and $srpt here. Read a transcript.  https://t.co/slnqCIy2jb",en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",['https://www.statnews.com/2019/07/01/the-race-for-a-better-duchenne-treatment-adam-and-matt-talk-pfizer-sarepta-and-gene-therapy/'],[],4,2,10,[],"['pfe', 'srpt']",https://twitter.com/matthewherper/status/1145712503009230848,False,,0,,,,,,,,[],,,,
1145712313724547077,1145712313724547077,2019-07-01 20:44:36 IST,2019-07-01,20:44:36,+0530,44438256,matthewherper,Matthew Herper,,"Pfizer, Sarepta, and gene therapy: A race for a better Duchenne treatment  Adam and I talk $srpt and $pfe here.  https://t.co/slnqCIy2jb",en,[],['https://www.statnews.com/2019/07/01/the-race-for-a-better-duchenne-treatment-adam-and-matt-talk-pfizer-sarepta-and-gene-therapy/'],[],0,3,8,[],"['srpt', 'pfe']",https://twitter.com/matthewherper/status/1145712313724547077,False,,0,,,,,,,,[],,,,
1144705926642802688,1144705926642802688,2019-06-29 02:05:35 IST,2019-06-29,02:05:35,+0530,15246621,alphatrends,"Brian Shannon, CMT",,VIDEO  https://t.co/ab66bylhMo Stock Market Analysis 6/28/19 $SPY $QQQ $IWM $SMH $IBB $XLF $CBOE $RUN $CSIQ $TAN $SRPT  https://t.co/mkchM4Wpw5,en,[],['http://bit.ly/2NmoJRb'],['https://pbs.twimg.com/media/D-LP9nNUcAAFE3I.jpg'],0,2,9,[],"['spy', 'qqq', 'iwm', 'smh', 'ibb', 'xlf', 'cboe', 'run', 'csiq', 'tan', 'srpt']",https://twitter.com/alphatrends/status/1144705926642802688,False,,1,https://pbs.twimg.com/media/D-LP9nNUcAAFE3I.jpg,,,,,,,[],,,,
1144638965787582464,1144638965787582464,2019-06-28 21:39:30 IST,2019-06-28,21:39:30,+0530,873399943,jacobplieth,Jacob Plieth,,We now have 3 different assays for measuring microdystrophin levels! It's almost as though $PFE $SLDB &amp; $SRPT were deliberately trying to make comparison impossible.,en,[],[],[],1,5,13,[],"['pfe', 'sldb', 'srpt']",https://twitter.com/JacobPlieth/status/1144638965787582464,False,,0,,,,,,,,[],,,,
1144635574269222912,1144635574269222912,2019-06-28 21:26:01 IST,2019-06-28,21:26:01,+0530,44438256,matthewherper,Matthew Herper,,"Suggestion for FDA, $SRPT, $PFE, $BOLD, $SLDB, and whole field: come up with a standard for what ""normal"" dystrophin is that all trialists can agree on. This should have been done pre-competitively.",en,[],[],[],2,3,22,[],"['srpt', 'pfe', 'bold', 'sldb']",https://twitter.com/matthewherper/status/1144635574269222912,False,,0,,,,,,,,[],,,,
1144628289962696705,1144622288819642368,2019-06-28 20:57:05 IST,2019-06-28,20:57:05,+0530,47678782,megtirrell,Meg Tirrell,,Awkward moment from $PFE just now - answered Q about PFE program and accidentally referred to it as $SRPT's. üò≥,en,[],[],[],6,3,21,[],"['pfe', 'srpt']",https://twitter.com/megtirrell/status/1144628289962696705,False,,0,,,,,,,,[],,,,
1144627642357997568,1144622288819642368,2019-06-28 20:54:30 IST,2019-06-28,20:54:30,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT CEO says ""We will fight like mad"" to make sure therapy, if approved, is accessible to all patients.",en,[],[],[],1,2,25,[],['srpt'],https://twitter.com/megtirrell/status/1144627642357997568,False,,0,,,,,,,,[],,,,
1144627560892047360,1144622288819642368,2019-06-28 20:54:11 IST,2019-06-28,20:54:11,+0530,47678782,megtirrell,Meg Tirrell,,"Mom of identical twin girls (very rare for girls to have DMD bc of way it's inherited) asks if cos are thinking of girls, not just boys, for trials and if girls can use the therapy if approved.  $SRPT CEO - We have not thought about girls, and probably unlikely in trials",en,[],[],[],1,0,7,[],['srpt'],https://twitter.com/megtirrell/status/1144627560892047360,False,,0,,,,,,,,[],,,,
1144626731283820546,1144622288819642368,2019-06-28 20:50:53 IST,2019-06-28,20:50:53,+0530,47678782,megtirrell,Meg Tirrell,,"Follow-up from dad: says he hopes clinical trials will still allow his son to enroll at age 9 or 10, even if he's losing ability to walk.  $SRPT CEO: Our goal is to span enough ages that we're confident we're approved and get access for all kids",en,[],[],[],2,0,17,[],['srpt'],https://twitter.com/megtirrell/status/1144626731283820546,False,,0,,,,,,,,[],,,,
1144625508749053955,1144622288819642368,2019-06-28 20:46:02 IST,2019-06-28,20:46:02,+0530,47678782,megtirrell,Meg Tirrell,,"""I'm frankly leaning in the direction of a placebo trial,"" $SRPT CEO says of gene therapy. Also says SRPT therapy well-tolerated, so doesn't expect ""functional unblinding"" because of side effects.",en,[],[],[],0,0,14,[],['srpt'],https://twitter.com/megtirrell/status/1144625508749053955,False,,0,,,,,,,,[],,,,
1144625463609954305,1144625463609954305,2019-06-28 20:45:51 IST,2019-06-28,20:45:51,+0530,14115408,jonnajarian,Jon Najarian,,‚è±Ô∏è60 Seconds from @investitute $SRPT sick call bought  üí• $PRGS $HHC ‚úàÔ∏è $NKE üëü #200 VEGAS üé≤ Have a great weekend if you are going to Chicago's üåà parade..  https://t.co/zAt92WC7Tj,en,"[{'screen_name': 'investitute', 'name': 'investitute', 'id': '1295683179412512768'}]",[],[],1,2,14,[],"['srpt', 'prgs', 'hhc', 'nke']",https://twitter.com/jonnajarian/status/1144625463609954305,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/1144623695505297408/pu/img/G0WypcWqEQ44iBO8.jpg,,,,,,,[],,,,
1144625152765939712,1144622288819642368,2019-06-28 20:44:37 IST,2019-06-28,20:44:37,+0530,47678782,megtirrell,Meg Tirrell,,"Really interesting Q from parent on rationale for placebo-controlled trials. When side effects are so apparent, why does it make sense to maintain placebo?  $SRPT CEO: We have not been able to get Exondys 51 approved in Europe, bc no placebo-controlled trial",en,[],[],[],2,2,22,[],['srpt'],https://twitter.com/megtirrell/status/1144625152765939712,False,,0,,,,,,,,[],,,,
1144624054881660935,1144624054881660935,2019-06-28 20:40:15 IST,2019-06-28,20:40:15,+0530,47678782,megtirrell,Meg Tirrell,,"Wall Street reax coming in on $PFE DMD update.   Baird's @BrianSkorney: ""Is it over for Pfizer? Probably not, but we think it should be.""  $SRPT",en,"[{'screen_name': 'brianskorney', 'name': 'brian skorney', 'id': '285598594'}]",[],[],0,5,35,[],"['pfe', 'srpt']",https://twitter.com/megtirrell/status/1144624054881660935,False,,0,,,,,,,,[],,,,
1144622288819642368,1144622288819642368,2019-06-28 20:33:14 IST,2019-06-28,20:33:14,+0530,47678782,megtirrell,Meg Tirrell,,I wish every clinical trial program was subjected to Qs from patients or parents of patients the way we're hearing at PPMD for Duchenne muscular dystrophy gene therapies from $PFE $SRPT $SLDB now. Much harder to dodge when you're speaking to the people who may take your drug.,en,[],[],[],8,28,117,[],"['pfe', 'srpt', 'sldb']",https://twitter.com/megtirrell/status/1144622288819642368,False,,0,,,,,,,,[],,,,
1144616912384663563,1144609520502616065,2019-06-28 20:11:52 IST,2019-06-28,20:11:52,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT CEO Doug Ingram now up at PPMD. Starts by saying he doesn't see $PFE or $SLDB as competitors, because all are trying to make headway against DMD. But then goes into fact that gene therapy is a one-time option, and lays out factors that go into which gene therapy to try",en,[],[],[],1,1,9,[],"['srpt', 'pfe', 'sldb']",https://twitter.com/megtirrell/status/1144616912384663563,False,,0,,,,,,,,[],,,,
1144615966359220225,1144283584410165248,2019-06-28 20:08:06 IST,2019-06-28,20:08:06,+0530,15246621,alphatrends,"Brian Shannon, CMT",,The Serpent $SRPT has stricken! @Marketsmith  https://t.co/BVxIRVsstx,en,"[{'screen_name': 'marketsmith', 'name': 'marketsmith', 'id': '272125054'}]",[],['https://pbs.twimg.com/media/D-J-CMLUwAEVbJb.jpg'],4,2,17,[],['srpt'],https://twitter.com/alphatrends/status/1144615966359220225,False,,1,https://pbs.twimg.com/media/D-J-CMLUwAEVbJb.jpg,,,,,,,[],,,,
1144614668801122304,1144614668801122304,2019-06-28 20:02:57 IST,2019-06-28,20:02:57,+0530,47678782,megtirrell,Meg Tirrell,,"Great @matthewherper piece on $PFE DMD data and comparisons w $SRPT. Maybe I‚Äôm being naive, but this part struck me. Do drug cos really let Wall Street, rather than science, influence clinical decision-making to this extent?   https://t.co/ZIr4UdL2LI  https://t.co/wiovJt7ybK",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['https://www.statnews.com/2019/06/28/pfizer-with-early-but-hopeful-results-leaps-into-the-race-for-a-duchenne-gene-therapy/'],['https://pbs.twimg.com/media/D-J8-SyX4AA-771.jpg'],10,4,19,[],"['pfe', 'srpt']",https://twitter.com/megtirrell/status/1144614668801122304,False,,1,https://pbs.twimg.com/media/D-J8-SyX4AA-771.jpg,,,,,,,[],,,,
1144612757075087360,1144612757075087360,2019-06-28 19:55:21 IST,2019-06-28,19:55:21,+0530,44438256,matthewherper,Matthew Herper,,"I'd be very careful comparing $SRPT/ $PFE efficacy results. $SRPT optically better, but that may be an optical illusion. (more in story.)   https://t.co/Lbwf4pfBIl",en,[],['https://www.statnews.com/2019/06/28/pfizer-with-early-but-hopeful-results-leaps-into-the-race-for-a-duchenne-gene-therapy/'],[],1,4,10,[],"['srpt', 'pfe', 'srpt']",https://twitter.com/matthewherper/status/1144612757075087360,False,,0,,,,,,,,[],,,,
1144611683517849601,1144611683517849601,2019-06-28 19:51:05 IST,2019-06-28,19:51:05,+0530,102094857,adamfeuerstein,Adam Feuerstein,,. @matthewherper did a great job dissecting the $PFE DMD gene therapy data and adding the $SRPT context. Read here:    https://t.co/rutK7jNIwM,en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['https://www.statnews.com/2019/06/28/pfizer-with-early-but-hopeful-results-leaps-into-the-race-for-a-duchenne-gene-therapy/'],[],1,6,12,[],"['pfe', 'srpt']",https://twitter.com/adamfeuerstein/status/1144611683517849601,False,,0,,,,,,,,[],,,,
1144611095669293062,1144611095669293062,2019-06-28 19:48:45 IST,2019-06-28,19:48:45,+0530,102094857,adamfeuerstein,Adam Feuerstein,,My DMD gene therapy quick take: $PFE not matching $SRPT yet but still competitive. Watch those pivotal study-FDA filing timelines.,en,[],[],[],1,2,9,[],"['pfe', 'srpt']",https://twitter.com/adamfeuerstein/status/1144611095669293062,False,,0,,,,,,,,[],,,,
1144610162503798784,1144610162503798784,2019-06-28 19:45:03 IST,2019-06-28,19:45:03,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"BREAKING: $PFE with early but hopeful results, leaps into the race for a Duchenne gene therapy  https://t.co/rutK7jNIwM via @matthewherper $SRPT",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['https://www.statnews.com/2019/06/28/pfizer-with-early-but-hopeful-results-leaps-into-the-race-for-a-duchenne-gene-therapy/'],[],4,11,17,[],"['pfe', 'srpt']",https://twitter.com/adamfeuerstein/status/1144610162503798784,False,,0,,,,,,,,[],,,,
1144609520502616065,1144609520502616065,2019-06-28 19:42:30 IST,2019-06-28,19:42:30,+0530,47678782,megtirrell,Meg Tirrell,,$PFE presentation at PPMD starting now. $SRPT $SLDB,ro,[],[],[],1,2,6,[],"['pfe', 'srpt', 'sldb']",https://twitter.com/megtirrell/status/1144609520502616065,False,,0,,,,,,,,[],,,,
1144606451404591104,1144606451404591104,2019-06-28 19:30:18 IST,2019-06-28,19:30:18,+0530,44438256,matthewherper,Matthew Herper,,"PPMD webcast here for all the people interested in $PFE, $SRPT, $SLDB, and Duchenne.  https://t.co/03mjQTGPBd",en,[],['https://www.youtube.com/watch?v=U_Xo5C-Yn0M'],[],0,1,7,[],"['pfe', 'srpt', 'sldb']",https://twitter.com/matthewherper/status/1144606451404591104,False,,0,,,,,,,,[],,,,
1144283584410165248,1144283584410165248,2019-06-27 22:07:20 IST,2019-06-27,22:07:20,+0530,15246621,alphatrends,"Brian Shannon, CMT",,the Serpent $SRPT looks ready to move higher  chart from @MarketSmith #IBDPartner  https://t.co/rWw88if1XU,en,"[{'screen_name': 'marketsmith', 'name': 'marketsmith', 'id': '272125054'}]",[],['https://pbs.twimg.com/media/D-FP2S3U8AA1AkZ.jpg'],4,8,37,['ibdpartner'],['srpt'],https://twitter.com/alphatrends/status/1144283584410165248,False,,1,https://pbs.twimg.com/media/D-FP2S3U8AA1AkZ.jpg,,,,,,,[],,,,
1144280488816914433,1144280488816914433,2019-06-27 21:55:02 IST,2019-06-27,21:55:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Reminder: Tomorrow morning, $PFE is presenting first patient data on its Duchenne muscular dystrophy gene therapy at the PPMD conference.    Of course, comparisons to competing $SRPT and $SLDB projects are expected.   @matthewherper will be your STAT guide.",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",[],[],1,22,54,[],"['pfe', 'srpt', 'sldb']",https://twitter.com/adamfeuerstein/status/1144280488816914433,False,,0,,,,,,,,[],,,,
1137009862431453185,1137009862431453185,2019-06-07 20:24:10 IST,2019-06-07,20:24:10,+0530,873399943,jacobplieth,Jacob Plieth,,The $VRTX story: hep C -&gt; cystic fibrosis -&gt; DMD. Via @Vantageanalysis  https://t.co/dv58yfZLvm $SLDB $SRPT $PFE $WVE,en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['http://bit.ly/2JZsZmY'],[],0,5,6,[],"['vrtx', 'sldb', 'srpt', 'pfe', 'wve']",https://twitter.com/JacobPlieth/status/1137009862431453185,False,,0,,,,,,,,[],,,,
1131640183357677568,1131640183357677568,2019-05-24 00:46:59 IST,2019-05-24,00:46:59,+0530,102754598,johncendpts,John Carroll,,"#3 UPDATED: Sarepta‚Äôs Exondys 51 is not cost-effective, nor particularly beneficial for DMD patients ‚Äî ICER @NatalieGrover $SRPT $PTCT  https://t.co/IbTlDZf0dw",en,"[{'screen_name': 'nataliegrover', 'name': 'natalie grover', 'id': '119475889'}]",['https://endpts.com/sareptas-exondys-51-is-not-cost-effective-nor-particularly-beneficial-to-dmd-patients-icer/'],[],8,6,7,[],"['srpt', 'ptct']",https://twitter.com/JohnCendpts/status/1131640183357677568,False,,0,,,,,,,,[],,,,
1128043547347886080,1128043547347886080,2019-05-14 02:35:14 IST,2019-05-14,02:35:14,+0530,102754598,johncendpts,John Carroll,,"Solid Bio‚Äôs higher gene therapy dose for Duchenne MD runs smack into a fresh set of safety issues, renewing fears $SLDB $SRPT $BOLD  https://t.co/RaU9H89iCf",en,[],['https://endpts.com/solid-bios-higher-gene-therapy-dose-for-duchenne-md-runs-smack-into-a-fresh-set-of-safety-issues-renewing-fears/'],[],1,4,13,[],"['sldb', 'srpt', 'bold']",https://twitter.com/JohnCendpts/status/1128043547347886080,False,,0,,,,,,,,[],,,,
1126436037121773576,1126436037121773576,2019-05-09 16:07:34 IST,2019-05-09,16:07:34,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT - @BrianSkorney says $PFE microdystrophin data are going to be a bust when disclosed at DMD meeting late June. (Dosing too high, hints that Western blots may not be presented.)  Skorney's been the axe on $SRPT, making another big bull call this morning.",en,"[{'screen_name': 'brianskorney', 'name': 'brian skorney', 'id': '285598594'}]",[],[],3,12,50,[],"['srpt', 'pfe', 'srpt']",https://twitter.com/adamfeuerstein/status/1126436037121773576,False,,0,,,,,,,,[],,,,
1126217918637903872,1126217918637903872,2019-05-09 01:40:50 IST,2019-05-09,01:40:50,+0530,274233761,bradloncar,Brad Loncar,,$SRPT Exondys 51 sales.  https://t.co/6bQzcmitp1,es,[],[],['https://pbs.twimg.com/media/D6EhOBTWsAAdN8p.jpg'],1,9,29,[],['srpt'],https://twitter.com/bradloncar/status/1126217918637903872,False,,1,https://pbs.twimg.com/media/D6EhOBTWsAAdN8p.jpg,,,,,,,[],,,,
1125372830781247488,1125372830781247488,2019-05-06 17:42:45 IST,2019-05-06,17:42:45,+0530,274233761,bradloncar,Brad Loncar,,"A trip down memory lane.  In 2014, I wrote a rudimentary long thesis on $SRPT for the @SohnConf charity contest (based on eteplirsen only). Stock is up 333% since then. Although much of it was wrong.  https://t.co/2ShDTsonRh  The winner that year was Fiat. Up 250% so not bad.",en,"[{'screen_name': 'sohnconf', 'name': 'sohn conf foundation', 'id': '1219989025'}]",['https://www.loncarblog.com/sarepta-thesis'],[],3,1,30,[],['srpt'],https://twitter.com/bradloncar/status/1125372830781247488,False,,0,,,,,,,,[],,,,
1125085748598730753,1125085748598730753,2019-05-05 22:42:00 IST,2019-05-05,22:42:00,+0530,274233761,bradloncar,Brad Loncar,,There are 248 earnings calls in healthcare this week. NBD  M: $ADAP $BHC $GWPH T: $AGN $ALLO $EDIT $REGN W: $ARNA $ICPT $NKTR $SRPT T: $BPMC $IONS $PBYI F: $IMV $PIRS $PTE  The full list:  https://t.co/ue44m0En8Y  https://t.co/OmoKCsfrwk,en,[],['https://www.loncarblog.com/may-6-earnings'],['https://pbs.twimg.com/media/D5yVQ-6W0AUjXCw.jpg'],2,15,36,[],"['adap', 'bhc', 'gwph', 'agn', 'allo', 'edit', 'regn', 'arna', 'icpt', 'nktr', 'srpt', 'bpmc', 'ions', 'pbyi', 'imv', 'pirs', 'pte']",https://twitter.com/bradloncar/status/1125085748598730753,False,,1,https://pbs.twimg.com/media/D5yVQ-6W0AUjXCw.jpg,,,,,,,[],,,,
1115211509385371648,1115211509385371648,2019-04-08 16:45:18 IST,2019-04-08,16:45:18,+0530,44438256,matthewherper,Matthew Herper,,"$BOLD aims to challenge $SRPT, $PFE in Duchenne muscular dystrophy.  https://t.co/fSTKqLAgl7",en,[],['https://www.statnews.com/2019/04/08/audentes-therapeutics-says-it-will-develop-gene-therapies-for-two-types-of-muscular-dystrophy-including-duchenne/'],[],0,5,13,[],"['bold', 'srpt', 'pfe']",https://twitter.com/matthewherper/status/1115211509385371648,False,,0,,,,,,,,[],,,,
1100868844283924485,1100868844283924485,2019-02-28 02:52:40 IST,2019-02-28,02:52:40,+0530,274233761,bradloncar,Brad Loncar,,$SRPT Exondys 51 sales.  https://t.co/D6yLkR8Wjw,es,[],[],['https://pbs.twimg.com/media/D0cSYAKVsAAm0D2.jpg'],2,7,22,[],['srpt'],https://twitter.com/bradloncar/status/1100868844283924485,False,,1,https://pbs.twimg.com/media/D0cSYAKVsAAm0D2.jpg,,,,,,,[],,,,
1100802275063357443,1100800697421963264,2019-02-27 22:28:08 IST,2019-02-27,22:28:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@bradloncar I wrote my first $SRPT story (then AVI Biopharma) in September 2010:    https://t.co/ULXbbWFO83  Then, in April 2012 when AVI Biopharma presented first eteplirsen data:  https://t.co/BVATPMWnKO",en,[],"['https://www.thestreet.com/story/10861870/1/rodman-rambles-promising-biotechs.html', 'https://www.thestreet.com/story/11479635/1/genetic-fix-from-avi-biopharma-builds-key-muscle-function-protein.html']",[],3,1,12,[],['srpt'],https://twitter.com/adamfeuerstein/status/1100802275063357443,False,,0,,,,,,,,"[{'screen_name': 'bradloncar', 'name': 'Brad Loncar', 'id': '274233761'}]",,,,
1100779244362391554,1100779244362391554,2019-02-27 20:56:38 IST,2019-02-27,20:56:38,+0530,102754598,johncendpts,John Carroll,,"UPDATED: Sarepta posts early, rosy gene therapy data for limb girdle muscular dystrophy ‚Äî fueling $165M buyout of partner @NatalieGrover  $SRPT  +6%  https://t.co/GoXxELXGGi",en,"[{'screen_name': 'nataliegrover', 'name': 'natalie grover', 'id': '119475889'}]",['https://endpts.com/sarepta-posts-early-rosy-gene-therapy-data-for-limb-girdle-muscular-dystrophy-fueling-165m-buyout-of-partner/'],[],0,7,10,[],['srpt'],https://twitter.com/JohnCendpts/status/1100779244362391554,False,,0,,,,,,,,[],,,,
1100755838732509186,1100755838732509186,2019-02-27 19:23:37 IST,2019-02-27,19:23:37,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT will probably always foster heated debate, but no doubt they have matured and progressed from the early, hectic days of the eteplirsen program in 2012.",en,[],[],[],2,6,52,[],['srpt'],https://twitter.com/adamfeuerstein/status/1100755838732509186,False,https://twitter.com/adamfeuerstein/status/1100750026987503616,0,,,,,,,,[],,,,
1100750026987503616,1100750026987503616,2019-02-27 19:00:32 IST,2019-02-27,19:00:32,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"With positive early results, Sarepta appears to have a second gene therapy with potential  https://t.co/EiPVtwx0hr $SRPT",en,[],['https://www.statnews.com/2019/02/27/with-positive-early-results-sarepta-appears-to-have-a-second-gene-therapy-with-potential/'],[],1,13,35,[],['srpt'],https://twitter.com/adamfeuerstein/status/1100750026987503616,False,,0,,,,,,,,[],,,,
1100745967056363521,1100722463124537350,2019-02-27 18:44:24 IST,2019-02-27,18:44:24,+0530,873399943,jacobplieth,Jacob Plieth,,Beta-sarcoglycan expression $SRPT  https://t.co/J6MKjf31nf,en,[],[],['https://pbs.twimg.com/media/D0aino2WkAEkJlD.jpg'],3,4,7,[],['srpt'],https://twitter.com/JacobPlieth/status/1100745967056363521,False,,1,https://pbs.twimg.com/media/D0aino2WkAEkJlD.jpg,,,,,,,[],,,,
1100739315079041025,1100739315079041025,2019-02-27 18:17:58 IST,2019-02-27,18:17:58,+0530,873399943,jacobplieth,Jacob Plieth,,Decent outcome for Myonexus. Seed financing $2.5m in Dec 2017; $SRPT $60m licence fee in May 2018; $165m buyout in Feb 2019,en,[],[],[],1,4,18,[],['srpt'],https://twitter.com/JacobPlieth/status/1100739315079041025,False,,0,,,,,,,,[],,,,
1100735231999574016,1100735231999574016,2019-02-27 18:01:44 IST,2019-02-27,18:01:44,+0530,102094857,adamfeuerstein,Adam Feuerstein,,This is where Limb-Girdle gene therapies were developed. $SRPT had a license for them.,en,[],[],[],0,4,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/1100735231999574016,False,https://twitter.com/BioStocks/status/1100735006895411201,0,,,,,,,,[],,,,
1100734716016279558,1100734716016279558,2019-02-27 17:59:41 IST,2019-02-27,17:59:41,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"For those waiting on $SRPT Limb-Girdle gene therapy results, company spox says data will be revealed on 8 am conference call, ‚Äúlike a medical meeting presentation.‚Äù No press release until after call. I don‚Äôt have embargoed data.",en,[],[],[],3,6,36,[],['srpt'],https://twitter.com/adamfeuerstein/status/1100734716016279558,False,,0,,,,,,,,[],,,,
1100722463124537350,1100722463124537350,2019-02-27 17:11:00 IST,2019-02-27,17:11:00,+0530,873399943,jacobplieth,Jacob Plieth,,Everyone ready for $SRPT 's big event today? Here's what to look for from the limb girdle study  https://t.co/r5cp9YVKri,en,[],['https://twitter.com/JacobPlieth/status/1088109578976403456'],[],3,5,8,[],['srpt'],https://twitter.com/JacobPlieth/status/1100722463124537350,False,https://twitter.com/JacobPlieth/status/1088109578976403456,0,,,,,,,,[],,,,
1099747036201713665,1099747036201713665,2019-02-25 00:35:00 IST,2019-02-25,00:35:00,+0530,274233761,bradloncar,Brad Loncar,,Huge week of mid-cap calls this week.  M: $AERI $ALDR $XNCR T:  $ACAD $BPMC $CLVS W: $AMRN $SRPT $UTHR T: $ICPT $PTCT $PBYI F: $PTLA  The full schedule:  https://t.co/Dy0g0zxLz1  https://t.co/eYw2MdyIE5,en,[],['https://www.loncarblog.com/february-25-earnings'],['https://pbs.twimg.com/media/D0JTHddX4AAOTKY.jpg'],4,18,43,[],"['aeri', 'aldr', 'xncr', 'acad', 'bpmc', 'clvs', 'amrn', 'srpt', 'uthr', 'icpt', 'ptct', 'pbyi', 'ptla']",https://twitter.com/bradloncar/status/1099747036201713665,False,,1,https://pbs.twimg.com/media/D0JTHddX4AAOTKY.jpg,,,,,,,[],,,,
1097817588736897024,1097817588736897024,2019-02-19 16:48:04 IST,2019-02-19,16:48:04,+0530,701464597,cowenresearch,cowenresearch,,"In report today, Ritu Baral looks at $PFE Ph1b trial of its mini-dystrophin gene therapy drug candidate vs. $SRPT solution",en,[],[],[],1,0,8,[],"['pfe', 'srpt']",https://twitter.com/CowenResearch/status/1097817588736897024,False,,0,,,,,,,,[],,,,
1095644790446796801,1095644790446796801,2019-02-13 16:54:08 IST,2019-02-13,16:54:08,+0530,701464597,cowenresearch,cowenresearch,,"Ritu Baral publishes takeaways from her meetings with $SRPT management. Discussion focused on competitive landscape of the DMD gene therapy market, expectations for imminent Ph1/2 LGMD data, as well microdystrophin manufacturing parameters",en,[],[],[],0,0,13,[],['srpt'],https://twitter.com/CowenResearch/status/1095644790446796801,False,,0,,,,,,,,[],,,,
1093559107628531712,1093559107628531712,2019-02-07 22:46:23 IST,2019-02-07,22:46:23,+0530,44438256,matthewherper,Matthew Herper,,"Interesting that $SRPT, which has presented some very good gene therapy data, is down 3%. What are people thinking here?",en,[],[],[],12,2,16,[],['srpt'],https://twitter.com/matthewherper/status/1093559107628531712,False,,0,,,,,,,,[],,,,
1088109578976403456,1088109578976403456,2019-01-23 21:51:54 IST,2019-01-23,21:51:54,+0530,873399943,jacobplieth,Jacob Plieth,,What to look for when $SRPT reports limb-girdle muscular dystrophy data. Via @Vantageanalysis  https://t.co/iFj1LCYid4,en,"[{'screen_name': 'vantageanalysis', 'name': 'evaluate vantage', 'id': '3033767986'}]",['http://bit.ly/2RHJJ6L'],[],3,13,20,[],['srpt'],https://twitter.com/JacobPlieth/status/1088109578976403456,False,,0,,,,,,,,[],,,,
1088054688363225089,1088054688363225089,2019-01-23 18:13:47 IST,2019-01-23,18:13:47,+0530,102754598,johncendpts,John Carroll,,"The other way to look at that is that they gave $SRPT a pass on data, and you only get 1 unproven drug per deadly disease.",en,[],[],[],0,2,8,[],['srpt'],https://twitter.com/JohnCendpts/status/1088054688363225089,False,https://twitter.com/ByJonGardner/status/1088054254311485440,0,,,,,,,,[],,,,
1083737468313223168,1083737468313223168,2019-01-11 20:18:41 IST,2019-01-11,20:18:41,+0530,102094857,adamfeuerstein,Adam Feuerstein,,This reads right. As does the $SRPT addendum offered by @zbiotech,en,"[{'screen_name': 'zbiotech', 'name': 'zach', 'id': '19717430'}]",[],[],0,2,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/1083737468313223168,False,https://twitter.com/zbiotech/status/1083736693545545730,0,,,,,,,,[],,,,
1083494143052124166,1083494143052124166,2019-01-11 04:11:48 IST,2019-01-11,04:11:48,+0530,16732770,cnbcfastmoney,CNBC's Fast Money,,"Biotech's in rally mode, and @GuyAdami is betting on Sarepta for an even bigger breakout $SRPT  https://t.co/Ojp4tzmOVZ",en,"[{'screen_name': 'guyadami', 'name': 'guy adami', 'id': '39264827'}]",[],[],14,21,66,[],['srpt'],https://twitter.com/CNBCFastMoney/status/1083494143052124166,False,,1,https://pbs.twimg.com/media/DwlYLXwX0AExWzV.jpg,,,,,,,[],,,,
1083492846680846336,1083492846680846336,2019-01-11 04:06:39 IST,2019-01-11,04:06:39,+0530,16732770,cnbcfastmoney,CNBC's Fast Money,,POLL: Are you buying @GuyAdami's Fast Pitch on $SRPT?,en,"[{'screen_name': 'guyadami', 'name': 'guy adami', 'id': '39264827'}]",[],[],29,6,12,[],['srpt'],https://twitter.com/CNBCFastMoney/status/1083492846680846336,False,,0,,,,,,,,[],,,,
1082373876707819520,1082373876707819520,2019-01-08 02:00:16 IST,2019-01-08,02:00:16,+0530,102094857,adamfeuerstein,Adam Feuerstein,,It‚Äôs day one at #JPM19. Here‚Äôs what we heard and learned  https://t.co/nOXJaEe0jb includes $SRPT controversy of microdystrophin gene thx regulatory path.,en,[],['https://www.statnews.com/2019/01/07/its-day-one-at-jpm19-here-is-what-we-heard-and-learned/'],[],1,3,9,['jpm19'],['srpt'],https://twitter.com/adamfeuerstein/status/1082373876707819520,False,,0,,,,,,,,[],,,,
1082313385637666816,1082313385637666816,2019-01-07 21:59:54 IST,2019-01-07,21:59:54,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Clarification from $SRPT #JPM19 breakout. FDA taking more conservative stance on mfr of microdystrophin gene therapy, requiring co. to have clinical data using commercial product for filing and approval.",en,[],[],[],6,11,18,['jpm19'],['srpt'],https://twitter.com/adamfeuerstein/status/1082313385637666816,False,,0,,,,,,,,[],,,,
1082310122473320448,1082310122473320448,2019-01-07 21:46:56 IST,2019-01-07,21:46:56,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT CEO Doug Ingram does really good #JPM19 breakout. Story continues to sound great.,en,[],[],[],4,11,58,['jpm19'],['srpt'],https://twitter.com/adamfeuerstein/status/1082310122473320448,False,,0,,,,,,,,[],,,,
1072850697966764032,1072834832001052675,2018-12-12 19:18:33 IST,2018-12-12,19:18:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@grw1177 @douglas_ingram Doug was a strong contender and just missed cut. If $SRPT continues to roll out strong gene thx data in ‚Äò19, he‚Äôs on the list.",en,[],[],[],1,0,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/1072850697966764032,False,,0,,,,,,,,"[{'screen_name': 'grw1177', 'name': ""grw 'Wear a mask and get vaccinated' 1177 üò∑üíâ"", 'id': '2231517818'}, {'screen_name': 'douglas_ingram', 'name': 'Douglas Ingram', 'id': '1584787405'}]",,,,
1068566676709548032,1068566676709548032,2018-11-30 23:35:23 IST,2018-11-30,23:35:23,+0530,44438256,matthewherper,Matthew Herper,,"Here's some of the big moments from the #forbeshealth conference, including my interviews with @JohnArnoldFndtn and CEOs of $CVS, $VRTX, $SRPT, and $ALNY.  With videos and @johndoerr's vintage iPhone!   https://t.co/CXbyaeekjt",en,"[{'screen_name': 'johnarnoldfndtn', 'name': 'john arnold', 'id': '1967275506'}, {'screen_name': 'johndoerr', 'name': 'john doerr', 'id': '22255654'}]",['https://www.forbes.com/sites/matthewherper/2018/11/30/a-billionaire-vs-drug-firms-throwing-pharma-under-the-bus-what-the-first-iphone-means-for-healthcare/#9c91b984f40f'],[],1,13,19,['forbeshealth'],"['cvs', 'vrtx', 'srpt', 'alny']",https://twitter.com/matthewherper/status/1068566676709548032,False,,0,,,,,,,,[],,,,
1064928935216128001,1064922053256667137,2018-11-20 22:40:18 IST,2018-11-20,22:40:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@ByJonGardner The company you dislike and criticize the most ‚Äî $SRPT ‚Äî is the only one on the list that has grown in value. Hugely.,en,[],[],[],2,5,35,[],['srpt'],https://twitter.com/adamfeuerstein/status/1064928935216128001,False,,0,,,,,,,,"[{'screen_name': 'ByJonGardner', 'name': 'Jon Gardner', 'id': '960747870'}]",,,,
1061779539280515072,1061770680977391618,2018-11-12 06:05:43 IST,2018-11-12,06:05:43,+0530,44438256,matthewherper,Matthew Herper,,@AdamSinger @mehrotrasam @Amarincorp I‚Äôm part of a grand conspiracy to try and get people to come to the Forbes Healthcare Summit! $srpt will be there!,en,[],[],[],1,0,28,[],['srpt'],https://twitter.com/matthewherper/status/1061779539280515072,False,,0,,,,,,,,"[{'screen_name': 'AdamSinger', 'name': 'Adam Singer', 'id': '14031032'}, {'screen_name': 'Amarincorp', 'name': 'Amarin', 'id': '2892097336'}]",,,,
1061772744830857216,1061770680977391618,2018-11-12 05:38:43 IST,2018-11-12,05:38:43,+0530,14031032,adamsinger,Adam Singer,,"@mehrotrasam @Amarincorp Are you serious? @matthewherper, who I've met personally isn't part of some grand conspiracy theory on $amrn $srpt or anything else. Please y'all calm down. He's an amazing person and reporter doing his best like everyone else. Markets work out how they do.",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",[],[],3,0,29,[],"['amrn', 'srpt']",https://twitter.com/AdamSinger/status/1061772744830857216,False,,0,,,,,,,,"[{'screen_name': 'Amarincorp', 'name': 'Amarin', 'id': '2892097336'}]",,,,
1055085297220882432,1055085297220882432,2018-10-24 18:45:12 IST,2018-10-24,18:45:12,+0530,292876633,kristen_hallam,Kristen Hallam,,"Lots of healthcare earnings today: Chugai, $ALXN, $BSX, $TMO, $LH have all reported, and $VRTX, $SRPT, $ALGN are yet to come.   The question is: How many cups of coffee will it take me to get through the day?",en,[],[],[],4,2,9,[],"['alxn', 'bsx', 'tmo', 'lh', 'vrtx', 'srpt', 'algn']",https://twitter.com/kristen_hallam/status/1055085297220882432,False,,0,,,,,,,,[],,,,
1054101264596819970,1054101264596819970,2018-10-22 01:35:00 IST,2018-10-22,01:35:00,+0530,274233761,bradloncar,Brad Loncar,,Important week of earnings coming up.  M: $IQV T: $ALKS $BIIB $ILMN W: $ALXN $SRPT $VRTX T: $BMY $CELG $GILD $MRK F: $ZBH  The full schedule:  https://t.co/HUDBDpBplJ  https://t.co/YzL4fSQats,en,[],['https://www.loncarblog.com/october-15-earnings'],['https://pbs.twimg.com/media/Dp7E80kUwAE4G1s.jpg'],1,8,22,[],"['iqv', 'alks', 'biib', 'ilmn', 'alxn', 'srpt', 'vrtx', 'bmy', 'celg', 'gild', 'mrk', 'zbh']",https://twitter.com/bradloncar/status/1054101264596819970,False,,1,https://pbs.twimg.com/media/Dp7E80kUwAE4G1s.jpg,,,,,,,[],,,,
1052739581525643265,1052739581525643265,2018-10-18 07:24:09 IST,2018-10-18,07:24:09,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,"$SRPT is ripping, but *no insiders are selling*, and there's even a tiny bit of buying  See it, for any company --&gt;  https://t.co/ZwEcm7JRnQ   via @cmlviz",en,"[{'screen_name': 'cmlviz', 'name': 'capital market laboratories', 'id': '2796938558'}]",['http://bit.ly/2QX2VbB'],[],0,2,14,[],['srpt'],https://twitter.com/OphirGottlieb/status/1052739581525643265,False,,0,,,,,,,,[],,,,
1050096617943195648,1050096617943195648,2018-10-11 00:21:58 IST,2018-10-11,00:21:58,+0530,44438256,matthewherper,Matthew Herper,,A Preview Of The 2018 Forbes Healthcare Summit   $GSK $VRTX $SRPT $SAGE  $ALNY $CVS $AET   https://t.co/ruAJhMH3P1,en,[],['https://www.forbes.com/sites/matthewherper/2018/10/10/a-preview-of-the-2018-forbes-healthcare-summit/#2e415236674d'],[],3,20,43,[],"['gsk', 'vrtx', 'srpt', 'sage', 'alny', 'cvs', 'aet']",https://twitter.com/matthewherper/status/1050096617943195648,False,,0,,,,,,,,[],,,,
1047843472596770816,1047843472596770816,2018-10-04 19:08:46 IST,2018-10-04,19:08:46,+0530,3290364847,statnews,STAT,,"STAT Plus: In a clinical trial, $SRPT's experimental gene therapy for Duchenne muscular dystrophy produced large increases in a crucial muscle protein normally missing in patients diagnosed with the disease.  https://t.co/RI3DLrAsea",en,[],['https://buff.ly/2ygRdRg'],[],0,5,8,[],['srpt'],https://twitter.com/statnews/status/1047843472596770816,False,,0,,,,,,,,[],,,,
1047613284168478726,1047613284168478726,2018-10-04 03:54:05 IST,2018-10-04,03:54:05,+0530,102754598,johncendpts,John Carroll,,"LOL, as they say  $SRPT Sarepta shares yo-yo in the red on another glimpse of stellar results for Duchenne MD gene therapy ‚Äî what gives?  https://t.co/McFb3l5WGx",en,[],['https://endpts.com/?p=173485&preview=true'],[],0,0,8,[],['srpt'],https://twitter.com/JohnCendpts/status/1047613284168478726,False,,0,,,,,,,,[],,,,
1047602183603179521,1047602183603179521,2018-10-04 03:09:58 IST,2018-10-04,03:09:58,+0530,102754598,johncendpts,John Carroll,,$SRPT -8% on such GREAT news,en,[],[],[],2,1,7,[],['srpt'],https://twitter.com/JohnCendpts/status/1047602183603179521,False,,0,,,,,,,,[],,,,
1047595827227553793,1047595827227553793,2018-10-04 02:44:43 IST,2018-10-04,02:44:43,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,"$SRPT If it can take out $153, it has room to that green dot.  Chart --&gt;   https://t.co/ZgSEKolxRs  via @CMLviz",en,"[{'screen_name': 'cmlviz', 'name': 'capital market laboratories', 'id': '2796938558'}]",['http://bit.ly/2OFMkMd'],[],1,2,4,[],['srpt'],https://twitter.com/OphirGottlieb/status/1047595827227553793,False,,0,,,,,,,,[],,,,
1047594398656225281,1047594398656225281,2018-10-04 02:39:02 IST,2018-10-04,02:39:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"NEWS! Hop, skip, jump. Sarepta‚Äôs Duchenne gene therapy delivers early muscle function improvements  https://t.co/NuoteytFwX $SRPT $SLDB",en,[],['https://www.statnews.com/2018/10/03/hop-skip-jump-sareptas-duchenne-gene-therapy-delivers-early-muscle-function-improvements/'],[],3,30,79,[],"['srpt', 'sldb']",https://twitter.com/adamfeuerstein/status/1047594398656225281,False,,0,,,,,,,,[],,,,
1045656438830436352,1045656438830436352,2018-09-28 18:18:17 IST,2018-09-28,18:18:17,+0530,701464597,cowenresearch,cowenresearch,,"#CowenBiotech team publishes 3,500 page Biotechnology Quarterly today, with specific commentary on nearly 200 biotech companies and views on the next mid-cap stocks poised to become large-caps $AGIO, $ALNY, $BMRN, $BLUE, $INCY, $NBIX, $SAGE, $SRPT, $SGEN, $RARE, more",en,[],[],[],0,1,9,['cowenbiotech'],"['agio', 'alny', 'bmrn', 'blue', 'incy', 'nbix', 'sage', 'srpt', 'sgen', 'rare']",https://twitter.com/CowenResearch/status/1045656438830436352,False,,0,,,,,,,,[],,,,
1044232729120964608,1044232729120964608,2018-09-24 20:00:58 IST,2018-09-24,20:00:58,+0530,102754598,johncendpts,John Carroll,,So $SRPT hold was not lifted in 'record time'. That title is held by Juno -- and it turned into a cautionary tale,en,[],[],[],5,1,11,[],['srpt'],https://twitter.com/JohnCendpts/status/1044232729120964608,False,,0,,,,,,,,[],,,,
1044225404452646912,1044225404452646912,2018-09-24 19:31:51 IST,2018-09-24,19:31:51,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT gene therapy program for Duchenne resumes after clinical trial hold lifted  https://t.co/O6woE0XRwR via @sheridan_kate,en,"[{'screen_name': 'sheridan_kate', 'name': 'kate sheridan', 'id': '222995559'}]",['https://www.statnews.com/2018/09/24/sareptas-gene-therapy-clinical-trial-hold-lifted/'],[],0,3,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/1044225404452646912,False,,0,,,,,,,,[],,,,
1044214404986937346,1044214404986937346,2018-09-24 18:48:09 IST,2018-09-24,18:48:09,+0530,102754598,johncendpts,John Carroll,,"FDA lifts clinical hold on Sarepta‚Äôs Duchenne MD gene therapy, clearing the way to a quick launch of a pivotal trial $SRPT @AmberTongPW   https://t.co/lw2ouHs0yS",en,"[{'screen_name': 'ambertongpw', 'name': 'amber tong', 'id': '746441781588426752'}]",['https://endpts.com/fda-lifts-clinical-hold-on-sareptas-dmd-gene-therapy-clearing-the-way-to-a-quick-launch-of-a-pivotal-trial/'],[],1,4,11,[],['srpt'],https://twitter.com/JohnCendpts/status/1044214404986937346,False,,0,,,,,,,,[],,,,
1044184554834153472,1044184554834153472,2018-09-24 16:49:32 IST,2018-09-24,16:49:32,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT clinical trial hold in DMD gene therapy lifted by FDA:  https://t.co/ngSvDIBR9K,en,[],['http://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-announces-clinical-hold-lifted-its-duchenne-muscular'],[],2,1,14,[],['srpt'],https://twitter.com/megtirrell/status/1044184554834153472,False,,0,,,,,,,,[],,,,
1043087395804073984,1043086762875281408,2018-09-21 16:09:49 IST,2018-09-21,16:09:49,+0530,873399943,jacobplieth,Jacob Plieth,,@tgtxdough Yes. It's scandalous that EU patients are going to be denied access to $SRPT's elegant placebo,en,[],[],[],5,0,14,[],['srpt'],https://twitter.com/JacobPlieth/status/1043087395804073984,False,,0,,,,,,,,[],,,,
1042026583702294529,1042026583702294529,2018-09-18 17:54:32 IST,2018-09-18,17:54:32,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Can patient advocates help make $AKCA the next $SRPT and overcome the FDA‚Äôs rejection?  https://t.co/kjly5TDuwV via @sheridan_kate,en,"[{'screen_name': 'sheridan_kate', 'name': 'kate sheridan', 'id': '222995559'}]",['https://www.statnews.com/2018/09/18/patient-advocacy-drug-approvals/'],[],0,1,7,[],"['akca', 'srpt']",https://twitter.com/adamfeuerstein/status/1042026583702294529,False,,0,,,,,,,,[],,,,
1038146223579049984,1038146223579049984,2018-09-08 00:55:22 IST,2018-09-08,00:55:22,+0530,21778391,cnbcclosingbell,CNBC's Closing Bell,,COMING UP: @megtirrell with an interview with Sarepta CEO Doug Ingram. Tune in! $SRPT  https://t.co/E9mEGhszca,en,"[{'screen_name': 'megtirrell', 'name': 'meg tirrell', 'id': '47678782'}]",[],['https://pbs.twimg.com/media/Dmg8acCX4AARhRN.jpg'],0,4,15,[],['srpt'],https://twitter.com/CNBCClosingBell/status/1038146223579049984,False,,1,https://pbs.twimg.com/media/Dmg8acCX4AARhRN.jpg,,,,,,,[],,,,
1038121989137985536,1038121989137985536,2018-09-07 23:19:04 IST,2018-09-07,23:19:04,+0530,47678782,megtirrell,Meg Tirrell,,This afternoon on @CNBCClosingBell: we interview $SRPT CEO @douglas_ingram. What do you want to know?,en,"[{'screen_name': 'cnbcclosingbell', 'name': ""cnbc's closing bell"", 'id': '21778391'}, {'screen_name': 'douglas_ingram', 'name': 'douglas ingram', 'id': '1584787405'}]",[],[],19,5,34,[],['srpt'],https://twitter.com/megtirrell/status/1038121989137985536,False,,0,,,,,,,,[],,,,
1035226444790738945,1035226444790738945,2018-08-30 23:33:12 IST,2018-08-30,23:33:12,+0530,102094857,adamfeuerstein,Adam Feuerstein,,CRISPR fixed Duchenne muscular dystrophy in beagles. Will this technique overtake an older gene...  https://t.co/aqdkC0AahF via @sxbegle $SRPT $SLDB,en,"[{'screen_name': 'sxbegle', 'name': 'sharon begley', 'id': '346605991'}]",['https://www.statnews.com/2018/08/30/crispr-duchenne-muscular-dystrophy-beagles/'],[],1,6,25,[],"['srpt', 'sldb']",https://twitter.com/adamfeuerstein/status/1035226444790738945,False,,0,,,,,,,,[],,,,
1027293894290169870,1027293894290169870,2018-08-09 02:12:05 IST,2018-08-09,02:12:05,+0530,102754598,johncendpts,John Carroll,,"Sarepta all-in on gene therapy pipeline, adding 3 CNS treatments in $30M Lacerta deal $SRPT +4%  https://t.co/xpgOtE6xSi --",en,[],['https://endpts.com/sarepta-all-in-on-gene-therapy-pipeline-adding-3-cns-treatments-in-30m-lacerta-deal'],[],1,8,16,[],['srpt'],https://twitter.com/JohnCendpts/status/1027293894290169870,False,,0,,,,,,,,[],,,,
1026456640227291136,1026456640227291136,2018-08-06 18:45:08 IST,2018-08-06,18:45:08,+0530,14886375,stocktwits,Stocktwits,,Earnings this week  Mon - $TWLO $ZG $WTW $ETSY $HTZ $PI $HEAR $EDIT Tue - $DIS $DDD $SNAP $MTCH $CARA $BOFI $PZZA $WEN Wed - $YELP $SRPT $ROKU $WB $CVS $BKNG Thu - $FIZZ $OSTK $TTD $APRN Fri - $LN $HAIN $JCP   https://t.co/BrJnctSA18,in,[],['https://stocktwits.com/discover/earnings-calendar'],[],0,19,40,[],"['twlo', 'zg', 'wtw', 'etsy', 'htz', 'pi', 'hear', 'edit', 'dis', 'ddd', 'snap', 'mtch', 'cara', 'bofi', 'pzza', 'wen', 'yelp', 'srpt', 'roku', 'wb', 'cvs', 'bkng', 'fizz', 'ostk', 'ttd', 'aprn', 'ln', 'hain', 'jcp']",https://twitter.com/Stocktwits/status/1026456640227291136,False,,0,,,,,,,,[],,,,
1026154113283715072,1026154113283715072,2018-08-05 22:43:00 IST,2018-08-05,22:43:00,+0530,274233761,bradloncar,Brad Loncar,,200+ healthcare companies report this week. A link to the full schedule below.  M: $EDIT $FATE $XNCR T: $FGEN $IONS $SAGE W: $ACAD $MYL $SRPT T: $XON $OMER $PBYI F: $AEZS $GLYC  Full schedule:  https://t.co/SZQbmFaIrN  https://t.co/xzsDTIAG9H,en,[],['http://www.loncarblog.com/august-6-earnings'],['https://pbs.twimg.com/media/DjxeyVeUYAAEhXW.jpg'],3,34,53,[],"['edit', 'fate', 'xncr', 'fgen', 'ions', 'sage', 'acad', 'myl', 'srpt', 'xon', 'omer', 'pbyi', 'aezs', 'glyc']",https://twitter.com/bradloncar/status/1026154113283715072,False,,1,https://pbs.twimg.com/media/DjxeyVeUYAAEhXW.jpg,,,,,,,[],,,,
1022265696812711937,1022265696812711937,2018-07-26 05:11:49 IST,2018-07-26,05:11:49,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Sarepta halts early-stage gene therapy trial for DMD  https://t.co/G2SENfiC4P via @sheridan_kate $SRPT,en,"[{'screen_name': 'sheridan_kate', 'name': 'kate sheridan', 'id': '222995559'}]",['https://www.statnews.com/2018/07/25/sarepta-clinical-gene-therapy-dmd/'],[],1,8,17,[],['srpt'],https://twitter.com/adamfeuerstein/status/1022265696812711937,False,,0,,,,,,,,[],,,,
1022220202916937737,1022220202916937737,2018-07-26 02:11:02 IST,2018-07-26,02:11:02,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT says DMD gene therapy program put on FDA clinical hold due to manufacturing issue; no safety events observed. Stock -4.7%  https://t.co/EEblgwm4Hi,en,[],['http://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-phase-12a-duchenne-muscular'],[],0,8,8,[],['srpt'],https://twitter.com/megtirrell/status/1022220202916937737,False,,0,,,,,,,,[],,,,
1022220096641617921,1022220096641617921,2018-07-26 02:10:37 IST,2018-07-26,02:10:37,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT - Well-timed bad news dump. Bravo, sirs!",en,[],[],[],1,0,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/1022220096641617921,False,,0,,,,,,,,[],,,,
1022219030831214595,1022219030831214595,2018-07-26 02:06:23 IST,2018-07-26,02:06:23,+0530,274233761,bradloncar,Brad Loncar,,$SRPT clinical hold is due to a bad production lot.  https://t.co/rGAzopZP1C,en,[],['https://www.nasdaq.com/press-release/sarepta-therapeutics-announces-that-phase-12a-duchenne-muscular-dystrophy-dmd-microdystrophin-gene-20180725-01353'],[],1,2,9,[],['srpt'],https://twitter.com/bradloncar/status/1022219030831214595,False,,0,,,,,,,,[],,,,
1014882487959515138,1014876112957132804,2018-07-05 20:13:35 IST,2018-07-05,20:13:35,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@JacobPlieth @SarahKarlin WSJ editorial is correct. During the $SRPT adcomm, Woodcock spoke about the risk of making a Type II error ‚Äî both for the FDA and the company. She was right.",en,[],[],[],5,3,31,[],['srpt'],https://twitter.com/adamfeuerstein/status/1014882487959515138,False,,0,,,,,,,,"[{'screen_name': 'JacobPlieth', 'name': 'Jacob Plieth', 'id': '873399943'}, {'screen_name': 'SarahKarlin', 'name': 'Sarah Karlin-Smith', 'id': '42703163'}]",,,,
1011969475313270784,1011677852775919616,2018-06-27 19:18:19 IST,2018-06-27,19:18:19,+0530,576436187,carolineylchen,Caroline Chen,,"@roncohenshair @Biohazard3737 @LifeSciVC @AppleHelix @JMaraganore @Sarepta That is a really interesting argument re: $SRPT -- then I would ask are we OK as a society approving a drug w/o proven benefit for the hope the company will go on to make a better drug? Maybe we are, but seems like a possible slippery slope.",en,[],[],[],6,1,5,[],['srpt'],https://twitter.com/CarolineYLChen/status/1011969475313270784,False,,0,,,,,,,,"[{'screen_name': 'roncohenshair', 'name': 'Ron Cohen Acorda CEO', 'id': '2420618906'}, {'screen_name': 'Biohazard3737', 'name': 'Sheep of Wall Street', 'id': '2855542157'}, {'screen_name': 'LifeSciVC', 'name': 'Bruce Booth', 'id': '229246832'}, {'screen_name': 'AppleHelix', 'name': 'Jing Liang', 'id': '98707539'}, {'screen_name': 'JMaraganore', 'name': 'John Maraganore', 'id': '875447213878423552'}, {'screen_name': 'Sarepta', 'name': 'Sarepta Therapeutics', 'id': '2216555822'}]",,,,
1011522557906968577,1011522557906968577,2018-06-26 13:42:25 IST,2018-06-26,13:42:25,+0530,873399943,jacobplieth,Jacob Plieth,,This could be the most unhinged tweet of last night's tirade. May god have mercy on my soul for not being more positive about $SRPT !  https://t.co/Fi0NSH7yz8,en,[],[],['https://pbs.twimg.com/media/DgmmNCUX4AE5db5.jpg'],5,0,13,[],['srpt'],https://twitter.com/JacobPlieth/status/1011522557906968577,False,,1,https://pbs.twimg.com/media/DgmmNCUX4AE5db5.jpg,,,,,,,[],,,,
1011258148634742792,1011258148634742792,2018-06-25 20:11:45 IST,2018-06-25,20:11:45,+0530,873399943,jacobplieth,Jacob Plieth,,"You think it's easy for $SRPT &amp; $BMRN to make 1,000,000,000,000,000 AAV vector genomes? Think again. Via @EPVantage  https://t.co/nDRvyDVD0i",en,"[{'screen_name': 'epvantage', 'name': 'vantage', 'id': '841963175729856512'}]",['http://www.epvantage.com/Universal/View.aspx?type=Story&id=798570&isEPVantage=yes'],[],8,25,42,[],"['srpt', 'bmrn']",https://twitter.com/JacobPlieth/status/1011258148634742792,False,,0,,,,,,,,[],,,,
1009743301912743937,1009743301912743937,2018-06-21 15:52:17 IST,2018-06-21,15:52:17,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Mizuho‚Äôs Salim Syed thinks to himself: I want to jazz up my defense of $WVE following $SRPT gene thx data, so let‚Äôs run a buyside survey. Surely, investors agree with me.  https://t.co/r2DWsxooDV",en,[],[],['https://pbs.twimg.com/tweet_video_thumb/DgNUKurVQAAQhfy.jpg'],1,3,17,[],"['wve', 'srpt']",https://twitter.com/adamfeuerstein/status/1009743301912743937,False,,1,https://pbs.twimg.com/tweet_video_thumb/DgNUKurVQAAQhfy.jpg,,,,,,,[],,,,
1009537023542210560,1009521977692966912,2018-06-21 02:12:37 IST,2018-06-21,02:12:37,+0530,25065878,becker_michaeld,Michael D. Becker,,"@JohnCendpts The #RightToTry Act was problematic from day one. No one should be surprised that many companies won‚Äôt participate (eg, $SRPT) and those that do are driven by the ability to recoup cost (which could be very expensive). These issues and more were raised prior to RTT becoming law",en,[],[],[],0,5,11,['righttotry'],['srpt'],https://twitter.com/Becker_MichaelD/status/1009537023542210560,False,,0,,,,,,,,"[{'screen_name': 'JohnCendpts', 'name': 'John Carroll', 'id': '102754598'}]",,,,
1009397885698564098,1009397885698564098,2018-06-20 16:59:44 IST,2018-06-20,16:59:44,+0530,102754598,johncendpts,John Carroll,,"Have to wonder if they will turn on the company at some point, demanding access to that gene therapy under Right to Try -- $SRPT CEO says they aren't doing it.  https://t.co/Hq4HoYhSC4",en,[],['https://twitter.com/sciencescanner/status/1009397126806335488'],[],0,0,4,[],['srpt'],https://twitter.com/JohnCendpts/status/1009397885698564098,False,https://twitter.com/sciencescanner/status/1009397126806335488,0,,,,,,,,[],,,,
1009175336729415681,1009175336729415681,2018-06-20 02:15:24 IST,2018-06-20,02:15:24,+0530,295746612,faycortez,Michelle Fay Cortez,,Those early $SRPT results look phenomenal. I wonder how long the company held the findings given the significance. Here's the 3 month share price before today vs SPX. Normal or nah?  https://t.co/Ostwoe6S1T,en,[],[],['https://pbs.twimg.com/media/DgFPfLbW4AIxnnV.jpg'],7,1,8,[],['srpt'],https://twitter.com/FayCortez/status/1009175336729415681,False,,1,https://pbs.twimg.com/media/DgFPfLbW4AIxnnV.jpg,,,,,,,[],,,,
1009143599617933312,1009143599617933312,2018-06-20 00:09:17 IST,2018-06-20,00:09:17,+0530,47678782,megtirrell,Meg Tirrell,,"Coming up on @CNBCClosingBell, we're joined by $SRPT CEO Doug @douglas_ingram. What do you want to know?",en,"[{'screen_name': 'cnbcclosingbell', 'name': ""cnbc's closing bell"", 'id': '21778391'}, {'screen_name': 'douglas_ingram', 'name': 'douglas ingram', 'id': '1584787405'}]",[],[],13,11,22,[],['srpt'],https://twitter.com/megtirrell/status/1009143599617933312,False,,0,,,,,,,,[],,,,
1009089208902774784,1009084256818290689,2018-06-19 20:33:10 IST,2018-06-19,20:33:10,+0530,873399943,jacobplieth,Jacob Plieth,,$SRPT in four slides  https://t.co/82nuao0t5J,en,[],[],"['https://pbs.twimg.com/media/DgEBNXUXkAA3N1x.jpg', 'https://pbs.twimg.com/media/DgEBNXTXcAA6W33.jpg', 'https://pbs.twimg.com/media/DgEBQH4WkAMbQ1T.jpg', 'https://pbs.twimg.com/media/DgEBRIHWsAE_7kO.jpg']",1,6,14,[],['srpt'],https://twitter.com/JacobPlieth/status/1009089208902774784,False,,1,https://pbs.twimg.com/media/DgEBNXUXkAA3N1x.jpg,,,,,,,[],,,,
1009084256818290689,1009084256818290689,2018-06-19 20:13:29 IST,2018-06-19,20:13:29,+0530,873399943,jacobplieth,Jacob Plieth,,Nice. $SRPT up $1.3bn per anecdotal case report,en,[],[],[],5,9,22,[],['srpt'],https://twitter.com/JacobPlieth/status/1009084256818290689,False,,0,,,,,,,,[],,,,
1009084060868726784,1009084060868726784,2018-06-19 20:12:42 IST,2018-06-19,20:12:42,+0530,859399368,duchenneuk,Duchenne UK,,"Announcement from @Sarepta: Jerry Mendell, M.D. Presented Positive Preliminary Results from the First Three Children Dosed in the Phase 1/2a #GeneTherapy #Microdystrophin Trial to Treat Patients with DMD:  https://t.co/l01t1rHGYk #sarepta $srpt #Duchenne",en,"[{'screen_name': 'sarepta', 'name': 'sarepta therapeutics', 'id': '2216555822'}]",['http://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-its-first-rd-day-jerry-mendell-md'],[],0,5,12,"['genetherapy', 'microdystrophin', 'sarepta', 'duchenne']",['srpt'],https://twitter.com/DuchenneUK/status/1009084060868726784,False,,0,,,,,,,,[],,,,
1009083643271241729,1009083643271241729,2018-06-19 20:11:03 IST,2018-06-19,20:11:03,+0530,274233761,bradloncar,Brad Loncar,,What a morning. This is stunning.  Let‚Äôs enjoy it for a day. And then best of luck for the randomized trial. $SRPT,en,[],[],[],3,3,50,[],['srpt'],https://twitter.com/bradloncar/status/1009083643271241729,False,,0,,,,,,,,[],,,,
1009083548442288128,1009083548442288128,2018-06-19 20:10:40 IST,2018-06-19,20:10:40,+0530,102754598,johncendpts,John Carroll,,"$SRPT up ......56%  oh, man  https://t.co/TJoYbP3JvL",en,[],['https://endpts.com/sarepta-leads-off-duchenne-md-gene-therapy-study-with-a-home-run-on-efficacy-but-can-they-deliver-in-2-years/'],[],0,6,12,[],['srpt'],https://twitter.com/JohnCendpts/status/1009083548442288128,False,,0,,,,,,,,[],,,,
1009082482149527553,1009081289796923392,2018-06-19 20:06:26 IST,2018-06-19,20:06:26,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT up 47% on data from first 3 patients on experimental gene therapy for Duchenne muscular dystrophy. $SLDB also up, 26%",en,[],[],[],1,7,19,[],"['srpt', 'sldb']",https://twitter.com/megtirrell/status/1009082482149527553,False,,0,,,,,,,,[],,,,
1009081455279050752,1009081455279050752,2018-06-19 20:02:21 IST,2018-06-19,20:02:21,+0530,44438256,matthewherper,Matthew Herper,,"I‚Äôm impressed by these videos, but have qualms about data by anecdote. Much more encouraged by the western blot data than anything else. $srpt",en,[],[],[],4,1,20,[],['srpt'],https://twitter.com/matthewherper/status/1009081455279050752,False,,0,,,,,,,,[],,,,
1009080171234807808,1009080171234807808,2018-06-19 19:57:15 IST,2018-06-19,19:57:15,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT - Great gene therapy data but bringing the three boys into what is really an investor event (not   a medical forum) was too much. Feels exploitive, particularly if something goes wrong later.",en,[],[],[],14,14,84,[],['srpt'],https://twitter.com/adamfeuerstein/status/1009080171234807808,False,,0,,,,,,,,[],,,,
1009079510707392512,1009079510707392512,2018-06-19 19:54:37 IST,2018-06-19,19:54:37,+0530,346605991,sxbegle,sharon begley,,"DNA fixes for genetic disorders: it's not just #CRISPR, people. $SRPT hits it out of the park in early data (3 boys) on gene therapy for #Duchenne, @adamfeuerstein reports:  https://t.co/sCKm82YWEN #dystrophin",en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",['https://www.statnews.com/2018/06/19/sarepta-gene-therapy-duchenne-early-results/'],[],0,6,19,"['crispr', 'duchenne', 'dystrophin']",['srpt'],https://twitter.com/sxbegle/status/1009079510707392512,False,,0,,,,,,,,[],,,,
1009079493435248642,1009079493435248642,2018-06-19 19:54:33 IST,2018-06-19,19:54:33,+0530,576436187,carolineylchen,Caroline Chen,,Good for $SRPT. Hope the trials going forward are robust and well designed.  https://t.co/wZA4a5tT48,en,[],['https://twitter.com/matthewherper/status/1009078221005033472'],[],0,1,13,[],['srpt'],https://twitter.com/CarolineYLChen/status/1009079493435248642,False,https://twitter.com/matthewherper/status/1009078221005033472,0,,,,,,,,[],,,,
1009078756638588928,1009078756638588928,2018-06-19 19:51:38 IST,2018-06-19,19:51:38,+0530,44438256,matthewherper,Matthew Herper,,"In my $SRPT story, there is a link to a Facebook video of a child from the $PFE study climbing stairs.   https://t.co/RaJkZiy2rd",en,[],['https://www.forbes.com/sites/matthewherper/2018/06/19/a-gene-therapy-appears-to-replace-missing-protein-in-muscular-dystrophy-patients/#33694dca5225'],[],1,27,51,[],"['srpt', 'pfe']",https://twitter.com/matthewherper/status/1009078756638588928,False,,0,,,,,,,,[],,,,
1009078368254480385,1009078368254480385,2018-06-19 19:50:05 IST,2018-06-19,19:50:05,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I shared the $SRPT gene therapy data with an independent Duchenne expert for his view, as well as with a patient advocate. Their comments included in my story.  https://t.co/5ay6LhPeeW",en,[],['https://www.statnews.com/2018/06/19/sarepta-gene-therapy-duchenne-early-results/'],[],4,11,24,[],['srpt'],https://twitter.com/adamfeuerstein/status/1009078368254480385,False,,0,,,,,,,,[],,,,
1009078221005033472,1009078221005033472,2018-06-19 19:49:30 IST,2018-06-19,19:49:30,+0530,44438256,matthewherper,Matthew Herper,,$SRPT: I'm impressed. $SLDB $PFE  A Gene Therapy Appears To¬†Replace¬†Missing Protein¬†In Muscular Dystrophy Patients    https://t.co/RaJkZiy2rd,en,[],['https://www.forbes.com/sites/matthewherper/2018/06/19/a-gene-therapy-appears-to-replace-missing-protein-in-muscular-dystrophy-patients/#33694dca5225'],[],2,41,69,[],"['srpt', 'sldb', 'pfe']",https://twitter.com/matthewherper/status/1009078221005033472,False,,0,,,,,,,,[],,,,
1009076817620291584,1009076817620291584,2018-06-19 19:43:55 IST,2018-06-19,19:43:55,+0530,44438256,matthewherper,Matthew Herper,,"In two months that kid is negotiating stairs normally when he wasn't before. You can make up stories about how this could not be just amazing, but it's tough. $SRPT And then, the third kid running. ""Inspiring."" Mendell says.",en,[],[],[],5,15,54,[],['srpt'],https://twitter.com/matthewherper/status/1009076817620291584,False,,0,,,,,,,,[],,,,
1009076499859701760,1009076499859701760,2018-06-19 19:42:39 IST,2018-06-19,19:42:39,+0530,44438256,matthewherper,Matthew Herper,,"Okay everybody, watch this video. $SRPT",en,[],[],[],3,1,11,[],['srpt'],https://twitter.com/matthewherper/status/1009076499859701760,False,,0,,,,,,,,[],,,,
1009076240999952384,1009076240999952384,2018-06-19 19:41:38 IST,2018-06-19,19:41:38,+0530,102754598,johncendpts,John Carroll,,Sarepta leads off Duchenne MD gene therapy study with a ‚Äòhome run‚Äô on efficacy ‚Äî but can they deliver in 2 years? $SRPT  https://t.co/TJoYbP3JvL,en,[],['https://endpts.com/sarepta-leads-off-duchenne-md-gene-therapy-study-with-a-home-run-on-efficacy-but-can-they-deliver-in-2-years/'],[],4,13,23,[],['srpt'],https://twitter.com/JohnCendpts/status/1009076240999952384,False,,0,,,,,,,,[],,,,
1009075998745391104,1009075998745391104,2018-06-19 19:40:40 IST,2018-06-19,19:40:40,+0530,529704495,damiangarde,Damian Garde,,"$srpt's (early, three-patient) gene therapy data comes in waaay better than wall street expected  https://t.co/3c3HBBWAlV",en,[],['https://www.statnews.com/2018/06/19/sarepta-gene-therapy-duchenne-early-results/'],[],1,14,22,[],['srpt'],https://twitter.com/damiangarde/status/1009075998745391104,False,,0,,,,,,,,[],,,,
1009075959214026752,1009075959214026752,2018-06-19 19:40:31 IST,2018-06-19,19:40:31,+0530,44438256,matthewherper,Matthew Herper,,"Now showing western blots. Over 50% by Nationwides methods, Sarepta result 38.2%. Yes, that's quadruple what investors were expecting. $SRPT",en,[],[],[],0,9,18,[],['srpt'],https://twitter.com/matthewherper/status/1009075959214026752,False,,0,,,,,,,,[],,,,
1009075832130809863,1009075832130809863,2018-06-19 19:40:00 IST,2018-06-19,19:40:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"BREAKING: With tantalizing early results, $SRPT gene therapy for Duchenne raises hopes for ‚Äòreal...  https://t.co/5ay6LhPeeW",en,[],['https://www.statnews.com/2018/06/19/sarepta-gene-therapy-duchenne-early-results/'],[],1,36,66,[],['srpt'],https://twitter.com/adamfeuerstein/status/1009075832130809863,False,,0,,,,,,,,[],,,,
1009075719887118336,1009075719887118336,2018-06-19 19:39:33 IST,2018-06-19,19:39:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT  https://t.co/0IzWdlNOEE,und,[],['https://twitter.com/statnews/status/1009075671736504320'],[],0,10,29,[],['srpt'],https://twitter.com/adamfeuerstein/status/1009075719887118336,False,https://twitter.com/statnews/status/1009075671736504320,0,,,,,,,,[],,,,
1009075624978284544,1009075624978284544,2018-06-19 19:39:11 IST,2018-06-19,19:39:11,+0530,44438256,matthewherper,Matthew Herper,,Mean microdystrophin of 74.5%. $SRPT,en,[],[],[],0,4,13,[],['srpt'],https://twitter.com/matthewherper/status/1009075624978284544,False,,0,,,,,,,,[],,,,
1009075471248740352,1009075471248740352,2018-06-19 19:38:34 IST,2018-06-19,19:38:34,+0530,44438256,matthewherper,Matthew Herper,,Mendell: Showing pretty dramatic images of dystrophin production. Says in a natural history study with PPMD that patients over 50% expression have relatively normal skeletal muscle. They're above that. $SRPT,en,[],[],[],0,3,18,[],['srpt'],https://twitter.com/matthewherper/status/1009075471248740352,False,,0,,,,,,,,[],,,,
1009074909757272064,1009074909757272064,2018-06-19 19:36:20 IST,2018-06-19,19:36:20,+0530,44438256,matthewherper,Matthew Herper,,"$SRPT showing an 87% decrease in creatinine kinase in 3 patients treated so far; fourth patient now, too. May mean muscle is not getting destroyed. Positive sign.",en,[],[],[],3,7,28,[],['srpt'],https://twitter.com/matthewherper/status/1009074909757272064,False,,0,,,,,,,,[],,,,
1009072989332299777,1009072989332299777,2018-06-19 19:28:42 IST,2018-06-19,19:28:42,+0530,44438256,matthewherper,Matthew Herper,,Note that $SRPT is selecting out patients who have antibodies for the viral vector they are using. Standard issue for a lot of these new gene therapies.,en,[],[],[],2,3,7,[],['srpt'],https://twitter.com/matthewherper/status/1009072989332299777,False,,0,,,,,,,,[],,,,
1009070866511155200,1009070866511155200,2018-06-19 19:20:16 IST,2018-06-19,19:20:16,+0530,44438256,matthewherper,Matthew Herper,,"Jerry Mendel is starting to talk. $SRPT. ""The opportunities go back to my relationship with Pat Furlong which is at least 30 years old."" Walking down memory lane, mentions Avexis, too. ""All these opportunities have merged to fulfill a lifetime of expectation.""",en,[],[],[],0,1,8,[],['srpt'],https://twitter.com/matthewherper/status/1009070866511155200,False,,0,,,,,,,,[],,,,
1009063505767616512,1009063505767616512,2018-06-19 18:51:01 IST,2018-06-19,18:51:01,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Yes, the $SRPT Duchenne microdystrophin data are coming soon. Stay tuned‚Ä¶.  https://t.co/QcL7LivxWc",en,[],['https://twitter.com/zbiotech/status/1009063294861234180'],[],2,4,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/1009063505767616512,False,https://twitter.com/zbiotech/status/1009063294861234180,0,,,,,,,,[],,,,
1009061974590808066,1009061974590808066,2018-06-19 18:44:56 IST,2018-06-19,18:44:56,+0530,529704495,damiangarde,Damian Garde,,"$srpt hold music went from ""Changes"" by Bowie to ""Brand New Day"" by Sting. presumably Diana Ross's ""I'm Coming Out"" is next",en,[],[],[],1,0,11,[],['srpt'],https://twitter.com/damiangarde/status/1009061974590808066,False,,0,,,,,,,,[],,,,
1006523105186144256,1006523105186144256,2018-06-12 18:36:23 IST,2018-06-12,18:36:23,+0530,15971805,investorslive,Nathan Michaud,,Last time I saw $GLMD style action was $SRPT ...,en,[],[],[],3,0,9,[],"['glmd', 'srpt']",https://twitter.com/InvestorsLive/status/1006523105186144256,False,,0,,,,,,,,[],,,,
1006229350977556480,1006229350977556480,2018-06-11 23:09:06 IST,2018-06-11,23:09:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Prepping for tomorrow's STAT Plus biotech conference call. We‚Äôll preview some big clinical trial events in 2H. What‚Äôs expected? We‚Äôll discuss. $SRPT, $GBT $CELG $XLRN $SGMO Sign up:  https://t.co/7uLblzzClS",en,[],['https://www.statnews.com/subscribe/plan_D088WleEWGBvsj/?utm_content=bufferba6fd&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic'],[],3,8,16,[],"['srpt', 'gbt', 'celg', 'xlrn', 'sgmo']",https://twitter.com/adamfeuerstein/status/1006229350977556480,False,,0,,,,,,,,[],,,,
1004715323507998720,1004715323507998720,2018-06-07 18:52:54 IST,2018-06-07,18:52:54,+0530,47348249,michael_gilman,Michael Gilman,,"Big win for $SRPT, big loss for $BIIB.  https://t.co/AenRigoHON",tl,[],['https://twitter.com/BrittanyMeiling/status/1004714575281864704'],[],0,7,26,[],"['srpt', 'biib']",https://twitter.com/michael_gilman/status/1004715323507998720,False,https://twitter.com/BrittanyMeiling/status/1004714575281864704,0,,,,,,,,[],,,,
992383386005196800,992383386005196800,2018-05-04 18:10:11 IST,2018-05-04,18:10:11,+0530,102754598,johncendpts,John Carroll,,Sarepta CEO Doug Ingram scored a chart-topping $57M compensation deal in 2017. Earning it won‚Äôt be easy $SRPT  https://t.co/7Jei3o9XcJ,en,[],['https://endpts.com/sarepta-ceo-doug-ingram-scored-a-chart-topping-57m-compensation-deal-in-2017-earning-it-wont-be-easy/'],[],2,2,7,[],['srpt'],https://twitter.com/JohnCendpts/status/992383386005196800,False,,0,,,,,,,,[],,,,
992132366247358464,992132366247358464,2018-05-04 01:32:43 IST,2018-05-04,01:32:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Pretty much expected. $SRPT had been talking this down.  https://t.co/gyXSDcnza3,en,[],['https://twitter.com/AndyBiotech/status/992132241433284608'],[],2,2,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/992132366247358464,False,https://twitter.com/AndyBiotech/status/992132241433284608,0,,,,,,,,[],,,,
992116523484446721,992116523484446721,2018-05-04 00:29:46 IST,2018-05-04,00:29:46,+0530,14886375,stocktwits,Stocktwits,,Here are the 10 stocks everyone's watching right now. They all report earnings after the closing bell:  ‚Ä¢ $ATVI ‚Ä¢ $P ‚Ä¢ $SRPT ‚Ä¢ $GPRO ‚Ä¢ $SWKS ‚Ä¢ $WTW ‚Ä¢ $SHAK ‚Ä¢ $EDIT ‚Ä¢ $ACIA ‚Ä¢ $HLF   https://t.co/BrJnctSA18,en,[],['https://stocktwits.com/discover/earnings-calendar'],[],0,10,18,[],"['atvi', 'p', 'srpt', 'gpro', 'swks', 'wtw', 'shak', 'edit', 'acia', 'hlf']",https://twitter.com/Stocktwits/status/992116523484446721,False,,0,,,,,,,,[],,,,
990713367433240576,990713367433240576,2018-04-30 03:34:08 IST,2018-04-30,03:34:08,+0530,14886375,stocktwits,Stocktwits,,Here‚Äôs who reports earnings this week:  Mon - $MCD $AKS $RIG $AGN $AKAM $FDC Tue - $AAPL $SNAP $GILD $SHOP $PFE $BP $MRK $UA Wed - $TSLA $FEYE $SQ $DDD $FIT $CHK $CVS $MRO $SSYS Thu - $GPRO $ATVI $CARA $TEVA $P $AA $SRPT $OSTK Fri - $AMD $BABA $CELG   https://t.co/uSdZZVvSRQ,en,[],['https://stocktwits.com/discover/earnings-calendar/2018-04-30'],[],8,51,121,[],"['mcd', 'aks', 'rig', 'agn', 'akam', 'fdc', 'aapl', 'snap', 'gild', 'shop', 'pfe', 'bp', 'mrk', 'ua', 'tsla', 'feye', 'sq', 'ddd', 'fit', 'chk', 'cvs', 'mro', 'ssys', 'gpro', 'atvi', 'cara', 'teva', 'p', 'aa', 'srpt', 'ostk', 'amd', 'baba', 'celg']",https://twitter.com/Stocktwits/status/990713367433240576,False,,0,,,,,,,,[],,,,
990655202318577664,990655202318577664,2018-04-29 23:43:00 IST,2018-04-29,23:43:00,+0530,274233761,bradloncar,Brad Loncar,,Huge week of earnings coming up.  M: $AGN $NBIX T: $GILD $INCY $IRWD $MRK W: $EXEL $NVO $UTHR T: $ALNY $REGN $SAGE $SRPT F: $AGIO $CELG $IONS  The full list:  https://t.co/iMjW2l3E9A  https://t.co/fa6YYIzhOy,en,[],['http://www.loncarblog.com/april-30-earnings'],['https://pbs.twimg.com/media/Db6nPQMVQAAstIF.jpg'],1,20,42,[],"['agn', 'nbix', 'gild', 'incy', 'irwd', 'mrk', 'exel', 'nvo', 'uthr', 'alny', 'regn', 'sage', 'srpt', 'agio', 'celg', 'ions']",https://twitter.com/bradloncar/status/990655202318577664,False,,1,https://pbs.twimg.com/media/Db6nPQMVQAAstIF.jpg,,,,,,,[],,,,
981903282825293824,981903282825293824,2018-04-05 20:06:00 IST,2018-04-05,20:06:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Trump administration is urged to override patents on pricey $SRPT muscular dystrophy drug  https://t.co/O3wdXeA2Ue via @statnews Good luck with that, people. You'll need it.",en,"[{'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}]",['https://www.statnews.com/pharmalot/2018/04/05/trump-patents-muscular-dystrophy-drug/'],[],2,10,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/981903282825293824,False,,0,,,,,,,,[],,,,
974136095683223552,974121880977211392,2018-03-15 09:41:58 IST,2018-03-15,09:41:58,+0530,14031032,adamsinger,Adam Singer,,"@bradfordnewport @Pharmdca @Lblegend33 @RGstocktrader @skaushi @GantosJ Gantos is the man. I initially found $SRPT from @xpander4 who is aces at markets he is very versatile has gotten me wins in China, Tech, Biotech and even Airlines.",en,"[{'screen_name': 'xpander4', 'name': 'intelligent investor', 'id': '584398003'}]",[],[],1,0,7,[],['srpt'],https://twitter.com/AdamSinger/status/974136095683223552,False,,0,,,,,,,,"[{'screen_name': 'bradfordnewport', 'name': 'Brad', 'id': '880485826831843328'}, {'screen_name': 'Pharmdca', 'name': 'Pharm. D', 'id': '1884013189'}, {'screen_name': 'lblegend33', 'name': 'BIO NEWMAN', 'id': '752268049'}, {'screen_name': 'skaushi', 'name': 'Kaushik', 'id': '28489821'}, {'screen_name': 'GantosJ', 'name': 'Joe', 'id': '223589965'}]",,,,
974121880977211392,974121880977211392,2018-03-15 08:45:29 IST,2018-03-15,08:45:29,+0530,14031032,adamsinger,Adam Singer,,@Lblegend33 @RGstocktrader @Pharmdca @skaushi lol I don't listen to myself on things and should  https://t.co/hT6iL3FoOF $SRPT  https://t.co/om3TmyUifE,en,"[{'screen_name': 'pharmdca', 'name': 'pharm. d', 'id': '1884013189'}, {'screen_name': 'skaushi', 'name': 'kaushik', 'id': '28489821'}]",['https://stocktwits.com/AdamSinger/message/36918316'],['https://pbs.twimg.com/media/DYTGoQUV4AAHcue.jpg'],2,1,14,[],['srpt'],https://twitter.com/AdamSinger/status/974121880977211392,False,,1,https://pbs.twimg.com/media/DYTGoQUV4AAHcue.jpg,,,,,,,[],,,,
973900695073148928,961931991947104256,2018-03-14 18:06:34 IST,2018-03-14,18:06:34,+0530,873399943,jacobplieth,Jacob Plieth,,$SRPT just confirmed to me that it was notified last week that the UK golodirsen study halt has been lifted,en,[],[],[],2,12,14,[],['srpt'],https://twitter.com/JacobPlieth/status/973900695073148928,False,,0,,,,,,,,[],,,,
973868103665889281,973868103665889281,2018-03-14 15:57:04 IST,2018-03-14,15:57:04,+0530,873399943,jacobplieth,Jacob Plieth,,"Another day, another rational twitter exchange with a sareptard $SRPT  https://t.co/YXv3e6YDCj",en,[],[],['https://pbs.twimg.com/media/DYPfucNWkAE-T2T.jpg'],3,0,13,[],['srpt'],https://twitter.com/JacobPlieth/status/973868103665889281,False,,1,https://pbs.twimg.com/media/DYPfucNWkAE-T2T.jpg,,,,,,,[],,,,
973160517043937280,973160517043937280,2018-03-12 17:05:22 IST,2018-03-12,17:05:22,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT to seek FDA approval for its second Duchenne‚Äôs drug by year‚Äôs end  https://t.co/6hVKsFbhkd I talked with CEO Doug Ingram last night. He met with FDA's Ellis Unger. Read what he said.,en,[],['https://www.statnews.com/2018/03/12/sarepta-second-duchenne-drug/'],[],1,14,34,[],['srpt'],https://twitter.com/adamfeuerstein/status/973160517043937280,False,,0,,,,,,,,[],,,,
973159558871994368,973159558871994368,2018-03-12 17:01:33 IST,2018-03-12,17:01:33,+0530,44438256,matthewherper,Matthew Herper,,$SRPT Says FDA Welcomes Review Of New Muscular Dystrophy Drug via @forbes  https://t.co/c5rcwsHRe6,en,"[{'screen_name': 'forbes', 'name': 'forbes', 'id': '91478624'}]",['https://www.forbes.com/sites/matthewherper/2018/03/12/sarepta-says-fda-welcomes-review-of-new-muscular-dystrophy-drug/#5fea986c6bd8'],[],2,10,15,[],['srpt'],https://twitter.com/matthewherper/status/973159558871994368,False,,0,,,,,,,,[],,,,
969319256029581313,969319256029581313,2018-03-02 02:41:34 IST,2018-03-02,02:41:34,+0530,274233761,bradloncar,Brad Loncar,,$SRPT ramp. This was pre-announced at #JPM18 so not new info.  https://t.co/H4nny8Opl3,en,[],[],['https://pbs.twimg.com/media/DXO2r70VwAECRez.jpg'],1,5,14,['jpm18'],['srpt'],https://twitter.com/bradloncar/status/969319256029581313,False,,1,https://pbs.twimg.com/media/DXO2r70VwAECRez.jpg,,,,,,,[],,,,
968100978888183808,968100978888183808,2018-02-26 18:00:34 IST,2018-02-26,18:00:34,+0530,14886375,stocktwits,Stocktwits,,Here's who reports earnings this week. Get ready  Mon - $FIT $EXEL $PANW $CLVS Tue - $SQ $PCLN $M $WTW $FTR $LL $HTZ $ALB $WDAY Wed - $VRX $DDD $CRM $VALE $BOX $LOW $MYL $LB $SSYS Thu - $F $AMBA $SRPT $BBY $SPLK $GPS Fri - $GOGO $FL $EFX $WUBA    https://t.co/BrJnctSA18,en,[],['https://stocktwits.com/discover/earnings-calendar'],[],2,21,38,[],"['fit', 'exel', 'panw', 'clvs', 'sq', 'pcln', 'm', 'wtw', 'ftr', 'll', 'htz', 'alb', 'wday', 'vrx', 'ddd', 'crm', 'vale', 'box', 'low', 'myl', 'lb', 'ssys', 'f', 'amba', 'srpt', 'bby', 'splk', 'gps', 'gogo', 'fl', 'efx', 'wuba']",https://twitter.com/Stocktwits/status/968100978888183808,False,,0,,,,,,,,[],,,,
967839866317713408,967839866317713408,2018-02-26 00:43:00 IST,2018-02-26,00:43:00,+0530,274233761,bradloncar,Brad Loncar,,This week's earnings calendar:  M: $CLVS $EXEL T: $ACAD $FGEN $TSRO W: $HZNP $MYL $VRX T: $NKTR $PBYI $SRPT  Full schedule:  https://t.co/Ecf1Po8wvT  https://t.co/O2qRMw1TI8,en,[],['http://www.loncarblog.com/february-26-earnings'],['https://pbs.twimg.com/media/DW1LOyZUMAASYcl.jpg'],3,14,43,[],"['clvs', 'exel', 'acad', 'fgen', 'tsro', 'hznp', 'myl', 'vrx', 'nktr', 'pbyi', 'srpt']",https://twitter.com/bradloncar/status/967839866317713408,False,,1,https://pbs.twimg.com/media/DW1LOyZUMAASYcl.jpg,,,,,,,[],,,,
965141867003232256,965141867003232256,2018-02-18 14:02:07 IST,2018-02-18,14:02:07,+0530,14031032,adamsinger,Adam Singer,,"This. $RLYP $AKAO $SRPT $JUNO twtr feeds all amazing ex of this in context of info overload where became more noise &gt; signal. Real secret here is not to rely on social for main DD. For Relypsa I spend more time talking to their IR team, nephrologists/CMOs, listening to calls etc  https://t.co/mwftY2F9QL",en,[],['https://twitter.com/iancassel/status/964861495463968768'],[],5,1,31,[],"['rlyp', 'akao', 'srpt', 'juno']",https://twitter.com/AdamSinger/status/965141867003232256,False,https://twitter.com/iancassel/status/964861495463968768,0,,,,,,,,[],,,,
961960125421547520,961960125421547520,2018-02-09 19:19:00 IST,2018-02-09,19:19:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Folks calling out $SRPT CEO Doug Ingram for lack of transparency after he ripped $SLDB for same. Valid criticism.,en,[],[],[],6,5,30,[],"['srpt', 'sldb']",https://twitter.com/adamfeuerstein/status/961960125421547520,False,,0,,,,,,,,[],,,,
961951565107093504,961951565107093504,2018-02-09 18:44:59 IST,2018-02-09,18:44:59,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Good reporting by @JacobPlieth on $SRPT UK  golodirsen temporary study halt. Only thing I‚Äôd add, based on my calls, is that the patient re-started golodirsen in the study w/ no further problems.",en,"[{'screen_name': 'jacobplieth', 'name': 'jacob plieth', 'id': '873399943'}]",[],[],7,22,55,[],['srpt'],https://twitter.com/adamfeuerstein/status/961951565107093504,False,,0,,,,,,,,[],,,,
961931991947104256,961931991947104256,2018-02-09 17:27:13 IST,2018-02-09,17:27:13,+0530,873399943,jacobplieth,Jacob Plieth,,$SRPT confirms UK golodirsen study halt. Scoop via @EPVantage  https://t.co/i6wb2zW9df,en,"[{'screen_name': 'epvantage', 'name': 'vantage', 'id': '841963175729856512'}]",['http://www.epvantage.com/Universal/View.aspx?type=Story&id=764496&isEPVantage=yes'],[],6,34,25,[],['srpt'],https://twitter.com/JacobPlieth/status/961931991947104256,False,,0,,,,,,,,[],,,,
958900791967809538,958829428385071104,2018-02-01 08:42:18 IST,2018-02-01,08:42:18,+0530,14031032,adamsinger,Adam Singer,,"@pawcio2009 @skaushi Rome not built in a day I was stuck in $PRTA for a long time before the market caught on. $KITE too. $BLUE. $SRPT. etc etc etc. You know what I learned? Find good company, do your homework and not read any social media or even look at the chart if you want real gains.",en,[],[],[],2,0,17,[],"['prta', 'kite', 'blue', 'srpt']",https://twitter.com/AdamSinger/status/958900791967809538,False,,0,,,,,,,,"[{'screen_name': 'pawcio2009', 'name': 'WallStreetBioturds', 'id': '24408359'}, {'screen_name': 'skaushi', 'name': 'Kaushik', 'id': '28489821'}]",,,,
958391176436084737,958391176436084737,2018-01-30 22:57:17 IST,2018-01-30,22:57:17,+0530,23085502,antonioregalado,Antonio Regalado,,"Solid Biosciences one of 3 US ""microdystrophin"" trials open. Pfizer's went live 2 days ago. In order of launch:  Nationwide ( $SRPT ) :  https://t.co/cqG0z3HdY8 $SLDB :  https://t.co/crD5hWQhP3 Pfizer : https://t.co/davjxS4haX  What is microdystropin? Read:  https://t.co/l8uUSr3FTo",en,[],"['https://clinicaltrials.gov/ct2/show/NCT0337516', 'https://clinicaltrials.gov/ct2/show/NCT03368742', 'https://clinicaltrials.gov/ct2/show/NCT03362502', 'https://www.technologyreview.com/s/608575/doctors-plan-bold-test-of-gene-therapy-on-boys-with-muscular-dystrophy/']",[],1,3,7,[],"['srpt', 'sldb']",https://twitter.com/antonioregalado/status/958391176436084737,False,,0,,,,,,,,[],,,,
958367011968573446,958367011968573446,2018-01-30 21:21:15 IST,2018-01-30,21:21:15,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"New paper raises safety concerns about neuro gene therapy, stocks slide  https://t.co/Heev0AOq8I $SLDB $AVXS $SRPT",en,[],['https://www.statnews.com/2018/01/30/gene-therapy-safety-concerns/'],[],2,12,12,[],"['sldb', 'avxs', 'srpt']",https://twitter.com/adamfeuerstein/status/958367011968573446,False,,0,,,,,,,,[],,,,
956711601415041025,956711601415041025,2018-01-26 07:43:15 IST,2018-01-26,07:43:15,+0530,529704495,damiangarde,Damian Garde,,$srpt ceo told @BentheFidler this about $sldb  https://t.co/YCoIGvC1Xk  https://t.co/tyo4ex5p9P,en,"[{'screen_name': 'benthefidler', 'name': 'ben fidler', 'id': '1330055544'}]",['https://www.xconomy.com/boston/2018/01/25/solid-delays-ipo-discloses-duchenne-problems-raises-rivals-hackles/?single_page=true'],['https://pbs.twimg.com/media/DUbsHooW0AAMG94.jpg'],1,2,8,[],"['srpt', 'sldb']",https://twitter.com/damiangarde/status/956711601415041025,False,,1,https://pbs.twimg.com/media/DUbsHooW0AAMG94.jpg,,,,,,,[],,,,
956611531269132291,956611531269132291,2018-01-26 01:05:36 IST,2018-01-26,01:05:36,+0530,102094857,adamfeuerstein,Adam Feuerstein,,In which $SRPT CEO Doug Ingram shits all over $SLDB. The rivalry heats up!  https://t.co/dCdjsXlJL3,en,[],['https://twitter.com/BentheFidler/status/956610942531461120'],[],3,1,27,[],"['srpt', 'sldb']",https://twitter.com/adamfeuerstein/status/956611531269132291,False,https://twitter.com/BentheFidler/status/956610942531461120,0,,,,,,,,[],,,,
956535921729392642,956535921729392642,2018-01-25 20:05:09 IST,2018-01-25,20:05:09,+0530,14031032,adamsinger,Adam Singer,,Not just retail/mfg short sellers also toasted in $srpt $kite and other biotechs. They have a death wish in this tape. What you really want to short are those shitty overnight blockchain companies.  https://t.co/7LGwP8kqPF,en,[],['https://twitter.com/lhamtil/status/956535407147126785'],[],1,0,8,[],"['srpt', 'kite']",https://twitter.com/AdamSinger/status/956535921729392642,False,https://twitter.com/lhamtil/status/956535407147126785,0,,,,,,,,[],,,,
953226013965803520,953226013965803520,2018-01-16 16:52:46 IST,2018-01-16,16:52:46,+0530,701464597,cowenresearch,cowenresearch,,"Our #biotech team reviews key themes for 2018 and previews 4Q earnings, including $AGIO $ARRY $BIVV $ESPR $FOLD $HRTX $GWPH $IMMU $IRWD $NBIX $NKTR $ONCE $RARE $SRPT $ALXN $VRTX",en,[],[],[],0,1,8,['biotech'],"['agio', 'arry', 'bivv', 'espr', 'fold', 'hrtx', 'gwph', 'immu', 'irwd', 'nbix', 'nktr', 'once', 'rare', 'srpt', 'alxn', 'vrtx']",https://twitter.com/CowenResearch/status/953226013965803520,False,,0,,,,,,,,[],,,,
950445179734867968,950445179734867968,2018-01-09 00:42:43 IST,2018-01-09,00:42:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"During breakout, $SRPT said preliminary gene therapy data ~ 3 children in middle 2018. #JPM18",en,[],[],[],0,4,20,['jpm18'],['srpt'],https://twitter.com/adamfeuerstein/status/950445179734867968,False,,0,,,,,,,,[],,,,
950441603881041921,950441603881041921,2018-01-09 00:28:31 IST,2018-01-09,00:28:31,+0530,274233761,bradloncar,Brad Loncar,,$SRPT Exondys 51 ramp given today's pre-announce. #JPM18  https://t.co/2nDHbI19ED  https://t.co/Q5tZCpWCaL,en,[],['http://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-pre-announces-fourth-quarter-2017-revenue'],['https://pbs.twimg.com/media/DTClb7gU0AA2YJe.jpg'],2,7,23,['jpm18'],['srpt'],https://twitter.com/bradloncar/status/950441603881041921,False,,1,https://pbs.twimg.com/media/DTClb7gU0AA2YJe.jpg,,,,,,,[],,,,
950439819334709248,950439819334709248,2018-01-09 00:21:25 IST,2018-01-09,00:21:25,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT CEO Doug Ingram is on üî•at his #JPM18 presentation. Super impressed. May give @popsalks run for title of presentation king. Impressive.,en,"[{'screen_name': 'popsalks', 'name': 'richard pops', 'id': '104893583'}]",[],[],2,17,53,['jpm18'],['srpt'],https://twitter.com/adamfeuerstein/status/950439819334709248,False,,0,,,,,,,,[],,,,
950438785698770944,950438785698770944,2018-01-09 00:17:19 IST,2018-01-09,00:17:19,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT will have data from 2 DMD gene therapy programs this year. Big. #JPM18,en,[],[],[],0,5,22,['jpm18'],['srpt'],https://twitter.com/adamfeuerstein/status/950438785698770944,False,,0,,,,,,,,[],,,,
950437571607150592,950437571607150592,2018-01-09 00:12:30 IST,2018-01-09,00:12:30,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT CEO Doug Ingram pauses briefly to drink from bottle of water during #JPM18 presentation. Flawless, one-handed execution, didn't skip a beat. Unlike...",en,[],[],[],5,7,66,['jpm18'],['srpt'],https://twitter.com/adamfeuerstein/status/950437571607150592,False,,0,,,,,,,,[],,,,
935870541889769472,935870046320103425,2017-11-29 19:28:19 IST,2017-11-29,19:28:19,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@PredatorDiaries @Edison_Inv_Res Charles Seife rehashes the same dumb $SRPT story over and over and over‚Ä¶.,en,[],[],[],3,6,35,[],['srpt'],https://twitter.com/adamfeuerstein/status/935870541889769472,False,,0,,,,,,,,"[{'screen_name': 'PredatorDiaries', 'name': 'Andy Smith', 'id': '225911893'}, {'screen_name': 'Edison_Inv_Res', 'name': 'Edison', 'id': '116431218'}]",,,,
928626042511732737,928626042511732737,2017-11-09 19:41:16 IST,2017-11-09,19:41:16,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Important, positive shift in Exondys 51 reimbursement. $SRPT  https://t.co/fBIhmrj7xE",ro,[],['https://twitter.com/fundDuchenne/status/928621681769373697'],[],1,10,45,[],['srpt'],https://twitter.com/adamfeuerstein/status/928626042511732737,False,https://twitter.com/fundDuchenne/status/928621681769373697,0,,,,,,,,[],,,,
925339899657703425,925339899657703425,2017-10-31 18:03:18 IST,2017-10-31,18:03:18,+0530,274233761,bradloncar,Brad Loncar,,$SRPT signs collaboration with Duke for gene editing CRISPR/Cas9 technology to develop new treatments for DMD.  https://t.co/xDPiZAIC4d,en,[],['https://globenewswire.com/news-release/2017/10/31/1169596/0/en/Sarepta-Therapeutics-Signs-Exclusive-Global-Collaboration-with-Duke-University-for-Gene-Editing-CRISPR-Cas9-Technology-to-Develop-New-Treatments-for-Duchenne-Muscular-Dystrophy-DMD.html#.WfhtXZn-4xA.twitter'],[],5,8,30,[],['srpt'],https://twitter.com/bradloncar/status/925339899657703425,False,,0,,,,,,,,[],,,,
923293303285542913,923293303285542913,2017-10-26 02:30:52 IST,2017-10-26,02:30:52,+0530,274233761,bradloncar,Brad Loncar,,$SRPT - the amount of trials they have going and starting up w/ partners is terrific. Wouldn't be possible if they hadn't received approval.,en,[],[],[],4,9,64,[],['srpt'],https://twitter.com/bradloncar/status/923293303285542913,False,,0,,,,,,,,[],,,,
923279511382319104,923279511382319104,2017-10-26 01:36:03 IST,2017-10-26,01:36:03,+0530,274233761,bradloncar,Brad Loncar,,$SRPT $103M in the first four quarters of launch. Well executed.  https://t.co/vfgHOm38sR,en,[],[],['https://pbs.twimg.com/media/DNAlzN_VwAAyAyk.jpg'],8,22,49,[],['srpt'],https://twitter.com/bradloncar/status/923279511382319104,False,,1,https://pbs.twimg.com/media/DNAlzN_VwAAyAyk.jpg,,,,,,,[],,,,
917177965565407232,917177965565407232,2017-10-09 05:30:41 IST,2017-10-09,05:30:41,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT golodirsen (exon53 skipper) poster that was presented this weekend at World Muscle Society ‚Äî&gt;  https://t.co/9HIapjwLXB,en,[],['http://investorrelations.sarepta.com/static-files/64d8d897-2e4a-4119-80b4-115cbae17993'],[],3,15,30,[],['srpt'],https://twitter.com/adamfeuerstein/status/917177965565407232,False,,0,,,,,,,,[],,,,
913873694165958658,913822125865291776,2017-09-30 02:40:42 IST,2017-09-30,02:40:42,+0530,44438256,matthewherper,Matthew Herper,,@bradroeder1 .There is nothing negative about $SRPT you can say based on the FAERS data. MD patients die.,en,[],[],[],0,1,14,[],['srpt'],https://twitter.com/matthewherper/status/913873694165958658,False,,0,,,,,,,,"[{'screen_name': 'bradroeder1', 'name': 'Brad Roeder', 'id': '2453175261'}]",,,,
913822125865291776,913822125865291776,2017-09-29 23:15:47 IST,2017-09-29,23:15:47,+0530,44438256,matthewherper,Matthew Herper,,You really can't use adverse events this way. You really cannot. $SRPT.  https://t.co/pqTK6ywDP8,en,[],['https://twitter.com/adamfeuerstein/status/913819665704669186'],[],7,4,15,[],['srpt'],https://twitter.com/matthewherper/status/913822125865291776,False,https://twitter.com/adamfeuerstein/status/913819665704669186,0,,,,,,,,[],,,,
913819665704669186,913819665704669186,2017-09-29 23:06:00 IST,2017-09-29,23:06:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT - This has been reported already by various analysts, but here‚Äôs co. statement directly on today‚Äôs FAERS kerfuffle.  https://t.co/HUd6COUsBb",en,[],[],['https://pbs.twimg.com/media/DK6KFphVAAAyBEc.jpg'],6,15,34,[],['srpt'],https://twitter.com/adamfeuerstein/status/913819665704669186,False,,1,https://pbs.twimg.com/media/DK6KFphVAAAyBEc.jpg,,,,,,,[],,,,
913816630752415744,913816630752415744,2017-09-29 22:53:57 IST,2017-09-29,22:53:57,+0530,44438256,matthewherper,Matthew Herper,,"If you're looking at FAERS data, read this piece I wrote in 2012. Goes for investors, journos.  $SRPT  https://t.co/Tgj7dGJrSY",en,[],['https://www.forbes.com/sites/matthewherper/2012/05/03/here-is-how-we-know-gardasil-has-not-killed-100-people/#186987333590'],[],3,15,22,[],['srpt'],https://twitter.com/matthewherper/status/913816630752415744,False,,0,,,,,,,,[],,,,
913766650209558528,913766650209558528,2017-09-29 19:35:21 IST,2017-09-29,19:35:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Today‚Äôs pastime seems to be searching FDA‚Äôs FAERS database and tweeting side effects/deaths out of context. $IONS $SRPT,en,[],[],[],7,16,35,[],"['ions', 'srpt']",https://twitter.com/adamfeuerstein/status/913766650209558528,False,,0,,,,,,,,[],,,,
913416641152679936,913416641152679936,2017-09-28 20:24:32 IST,2017-09-28,20:24:32,+0530,873399943,jacobplieth,Jacob Plieth,,"After the inevitable adcom ""no"" vote (&amp; Translarna rejection) I want to see $PTCT sue the FDA $SRPT  https://t.co/MnDC82nMOZ",en,[],[],['https://pbs.twimg.com/tweet_video_thumb/DK0bNKgXkAArOiC.jpg'],4,6,14,[],"['ptct', 'srpt']",https://twitter.com/JacobPlieth/status/913416641152679936,False,,1,https://pbs.twimg.com/tweet_video_thumb/DK0bNKgXkAArOiC.jpg,,,,,,,[],,,,
913391503451574272,913391503451574272,2017-09-28 18:44:39 IST,2017-09-28,18:44:39,+0530,873399943,jacobplieth,Jacob Plieth,,Translation: we hate each other's guts $PTCT $SRPT  https://t.co/mH0tuwv7QQ,en,[],['https://twitter.com/FDAadcomm/status/913391060499537921'],[],0,0,8,[],"['ptct', 'srpt']",https://twitter.com/JacobPlieth/status/913391503451574272,False,https://twitter.com/FDAadcomm/status/913391060499537921,0,,,,,,,,[],,,,
913125470987792386,913125470987792386,2017-09-28 01:07:31 IST,2017-09-28,01:07:31,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Per Leerink from its conference, $SRPT targeting golordirsen NDA filing in Q1 ‚Äô18.  https://t.co/lXuyoq12UH",en,[],['https://twitter.com/QTRResearch/status/913124484378488833'],[],3,8,25,[],['srpt'],https://twitter.com/adamfeuerstein/status/913125470987792386,False,https://twitter.com/QTRResearch/status/913124484378488833,0,,,,,,,,[],,,,
912703326340419584,912703326340419584,2017-09-26 21:10:04 IST,2017-09-26,21:10:04,+0530,44438256,matthewherper,Matthew Herper,,"With $PTCT, FDA needs to make certain that $SRPT doesn't become a precedent.",en,[],[],[],3,0,5,[],"['ptct', 'srpt']",https://twitter.com/matthewherper/status/912703326340419584,False,,0,,,,,,,,[],,,,
905563867887144960,905563867887144960,2017-09-07 04:20:25 IST,2017-09-07,04:20:25,+0530,14115408,jonnajarian,Jon Najarian,,Met Michael Donabedian of $SRPT at @Nasdaq tonight. That team is solid from CEO Doug Ingram on down. Exciting stuff! @petenajarian  https://t.co/lWhQEssvWo,en,"[{'screen_name': 'nasdaq', 'name': 'nasdaq', 'id': '18639734'}, {'screen_name': 'petenajarian', 'name': 'pete najarian', 'id': '14292717'}]",['https://twitter.com/petenajarian/status/905554636366647296'],[],4,4,17,[],['srpt'],https://twitter.com/jonnajarian/status/905563867887144960,False,https://twitter.com/petenajarian/status/905554636366647296,0,,,,,,,,[],,,,
905519971370979331,905519971370979331,2017-09-07 01:25:59 IST,2017-09-07,01:25:59,+0530,18639734,nasdaq,Nasdaq,,.@Sarepta rings the @Nasdaq Closing Bell in recognition of World Duchenne Awareness Day!üõéüéä $SRPT #Duchenne #DMD  https://t.co/VDM69zdZyI,en,"[{'screen_name': 'sarepta', 'name': 'sarepta therapeutics', 'id': '2216555822'}, {'screen_name': 'nasdaq', 'name': 'nasdaq', 'id': '18639734'}]",[],"['https://pbs.twimg.com/media/DJENnDwXcAEcepI.jpg', 'https://pbs.twimg.com/media/DJENnDSXcAAFFv-.jpg', 'https://pbs.twimg.com/media/DJENnDlW4AE04vP.jpg', 'https://pbs.twimg.com/media/DJENnDRWAAAhzBv.jpg']",0,21,25,"['duchenne', 'dmd']",['srpt'],https://twitter.com/Nasdaq/status/905519971370979331,False,,1,https://pbs.twimg.com/media/DJENnDwXcAEcepI.jpg,,,,,,,[],,,,
905421362235400192,905421362235400192,2017-09-06 18:54:09 IST,2017-09-06,18:54:09,+0530,102754598,johncendpts,John Carroll,,I've taken to simply muting the $SRPT trolls at this point. They can thrash and gnash in silence.,en,[],[],[],1,0,6,[],['srpt'],https://twitter.com/JohnCendpts/status/905421362235400192,False,,0,,,,,,,,[],,,,
905419524157136896,905419524157136896,2017-09-06 18:46:51 IST,2017-09-06,18:46:51,+0530,102754598,johncendpts,John Carroll,,Sarepta readies FDA pitch after a small study spotlights 1% dystrophin add for golodirsen in Duchenne MD $SRPT +14%  https://t.co/JqvCD4XKaT,en,[],['https://endpts.com/sarepta-readies-fda-pitch-after-a-small-study-spotlights-1-dystrophin-add-for-golodirsen-in-duchenne-md/'],[],3,8,8,[],['srpt'],https://twitter.com/JohnCendpts/status/905419524157136896,False,,0,,,,,,,,[],,,,
905397075621412869,905397075621412869,2017-09-06 17:17:38 IST,2017-09-06,17:17:38,+0530,20106796,amberkanwar,Amber Kanwar,,#5things that got cut off at the end but you get the gist #CAD $HBC.to $IMG.to $IAG $SRPT  https://t.co/IHA6I42T5X,en,[],[],[],1,5,14,"['5things', 'cad']","['hbc.to', 'img.to', 'iag', 'srpt']",https://twitter.com/amberkanwar/status/905397075621412869,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/905396810633682944/pu/img/_5KOv2uEp8-VF87i.jpg,,,,,,,[],,,,
905387761775017985,905387761775017985,2017-09-06 16:40:38 IST,2017-09-06,16:40:38,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT +7%. New CEO Doug Ingram joins us on @SquawkCNBC 8:10ET. What do you want to know?  https://t.co/9sTEU0Q7xz,en,"[{'screen_name': 'squawkcnbc', 'name': 'squawk box', 'id': '404422077'}]",['https://twitter.com/statnews/status/905385096483672069'],[],5,15,28,[],['srpt'],https://twitter.com/megtirrell/status/905387761775017985,False,https://twitter.com/statnews/status/905385096483672069,0,,,,,,,,[],,,,
905386785877970944,905386785877970944,2017-09-06 16:36:45 IST,2017-09-06,16:36:45,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I‚Äôd love to be in room when $SRPT meets w/ FDA about golodirsen data. ‚ÄúSo, about that accelerated approval pathway‚Ä¶‚Äù  https://t.co/hDXsjOq1mj",en,[],['https://www.statnews.com/2017/09/06/sarepta-dmd-new-drug/'],[],1,8,45,[],['srpt'],https://twitter.com/adamfeuerstein/status/905386785877970944,False,,0,,,,,,,,[],,,,
905385311819231232,905385311819231232,2017-09-06 16:30:54 IST,2017-09-06,16:30:54,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT news!  https://t.co/cR3iBaNqqR,in,[],['https://twitter.com/statnews/status/905385096483672069'],[],3,13,29,[],['srpt'],https://twitter.com/adamfeuerstein/status/905385311819231232,False,https://twitter.com/statnews/status/905385096483672069,0,,,,,,,,[],,,,
905385096483672069,905385096483672069,2017-09-06 16:30:02 IST,2017-09-06,16:30:02,+0530,3290364847,statnews,STAT,,Breaking: Data from Sarepta show new DMD drug boosts production of crucial protein. Will it quiet critics? $SRPT  https://t.co/9ZWqTZ21cS,en,[],['https://www.statnews.com/2017/09/06/sarepta-dmd-new-drug/'],[],0,19,22,[],['srpt'],https://twitter.com/statnews/status/905385096483672069,False,,0,,,,,,,,[],,,,
899734933240807424,899734933240807424,2017-08-22 02:18:19 IST,2017-08-22,02:18:19,+0530,44438256,matthewherper,Matthew Herper,,On $SRPT and retractions.  https://t.co/AxCnRvA3kR,en,[],['https://twitter.com/emilylmullin/status/899733671183364098'],[],1,2,5,[],['srpt'],https://twitter.com/matthewherper/status/899734933240807424,False,https://twitter.com/emilylmullin/status/899733671183364098,0,,,,,,,,[],,,,
893069902826885121,893069902826885121,2017-08-03 16:53:51 IST,2017-08-03,16:53:51,+0530,44438256,matthewherper,Matthew Herper,,Must read on $srpt and FDA. Jenkins' concerns in his own words.  https://t.co/463TUlrtna,en,[],['https://twitter.com/cgseife/status/892890535874224128'],[],3,8,20,[],['srpt'],https://twitter.com/matthewherper/status/893069902826885121,False,https://twitter.com/cgseife/status/892890535874224128,0,,,,,,,,[],,,,
890922182834106368,890922182834106368,2017-07-28 18:39:35 IST,2017-07-28,18:39:35,+0530,274233761,bradloncar,Brad Loncar,,The $SRPT CEO stock purchase is nice news (kudos to him) but FYI it was also pre-announced before they raised the money.,en,[],[],[],2,0,9,[],['srpt'],https://twitter.com/bradloncar/status/890922182834106368,False,,0,,,,,,,,[],,,,
889797318370889728,889797318370889728,2017-07-25 16:09:46 IST,2017-07-25,16:09:46,+0530,274233761,bradloncar,Brad Loncar,,"If there was any doubt about rare disease launches, $BIIB and $SRPT have put them to rest over the last week.",en,[],[],[],2,10,27,[],"['biib', 'srpt']",https://twitter.com/bradloncar/status/889797318370889728,False,,0,,,,,,,,[],,,,
889637501631123460,889637501631123460,2017-07-25 05:34:43 IST,2017-07-25,05:34:43,+0530,274233761,bradloncar,Brad Loncar,,$SRPT priced $325M at $42.50.,en,[],[],[],4,14,27,[],['srpt'],https://twitter.com/bradloncar/status/889637501631123460,False,,0,,,,,,,,[],,,,
889601559201492995,889601559201492995,2017-07-25 03:11:54 IST,2017-07-25,03:11:54,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Let‚Äôs all bookmark tonight‚Äôs bio-Twitter $MRK apologia for Keytruda failure when the confirmatory study of $SRPT eteplirsen is announced.,en,[],[],[],8,5,37,[],"['mrk', 'srpt']",https://twitter.com/adamfeuerstein/status/889601559201492995,False,,0,,,,,,,,[],,,,
889441062988779520,889441062988779520,2017-07-24 16:34:09 IST,2017-07-24,16:34:09,+0530,274233761,bradloncar,Brad Loncar,,$SRPT's new CEO indicates that he wants to buy $2M worth of shares in the $250M proposed follow-on offering. Like that.,en,[],[],[],6,21,47,[],['srpt'],https://twitter.com/bradloncar/status/889441062988779520,False,,0,,,,,,,,[],,,,
888024822286036992,888024822286036992,2017-07-20 18:46:30 IST,2017-07-20,18:46:30,+0530,16827489,cboe,Cboe,,"UPSIDE pre-mkt: $HPJ, $AVA, $SRPT, $AMBC, $SHLD, $CAMT, $HK, $HBHC, $CZZ, $PII, $KEP, $KMI, $TMUS, $URI powered by  https://t.co/scoWUQlK5H  https://t.co/w9dpBuJFyF",en,[],['http://www.livevol.com'],['https://pbs.twimg.com/media/DFLl3m8VwAIAvKi.jpg'],0,2,4,[],"['hpj', 'ava', 'srpt', 'ambc', 'shld', 'camt', 'hk', 'hbhc', 'czz', 'pii', 'kep', 'kmi', 'tmus', 'uri']",https://twitter.com/CBOE/status/888024822286036992,False,,1,https://pbs.twimg.com/media/DFLl3m8VwAIAvKi.jpg,,,,,,,[],,,,
887792415167442944,887792415167442944,2017-07-20 03:23:00 IST,2017-07-20,03:23:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT +15% after hours.,en,[],[],[],3,8,41,[],['srpt'],https://twitter.com/adamfeuerstein/status/887792415167442944,False,,0,,,,,,,,[],,,,
887787782059544578,887787782059544578,2017-07-20 03:04:36 IST,2017-07-20,03:04:36,+0530,102754598,johncendpts,John Carroll,,"Your situational morality doesn't fly too well @statnews. $SRPT charges $750K for a drug with no efficacy data, you shout, mo' money!  https://t.co/Z7TQ1Wui0i",en,"[{'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}]",['https://twitter.com/adamfeuerstein/status/887785070634913793'],[],0,3,13,[],['srpt'],https://twitter.com/JohnCendpts/status/887787782059544578,False,https://twitter.com/adamfeuerstein/status/887785070634913793,0,,,,,,,,[],,,,
887766360998260737,887766360998260737,2017-07-20 01:39:29 IST,2017-07-20,01:39:29,+0530,274233761,bradloncar,Brad Loncar,,$SRPT substantial beat and raise. Busy week of news for them.  https://t.co/uSIcE7EOnU,en,[],[],['https://pbs.twimg.com/media/DFH6sFTUAAAw_my.jpg'],2,17,43,[],['srpt'],https://twitter.com/bradloncar/status/887766360998260737,False,,1,https://pbs.twimg.com/media/DFH6sFTUAAAw_my.jpg,,,,,,,[],,,,
887765150232702982,887765150232702982,2017-07-20 01:34:40 IST,2017-07-20,01:34:40,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT current ‚Äô17 sell side consensus is $105M (buy side probably higher); new guidance $125-130M still nice bump.,en,[],[],[],1,4,18,[],['srpt'],https://twitter.com/adamfeuerstein/status/887765150232702982,False,,0,,,,,,,,[],,,,
887764788033581062,887764788033581062,2017-07-20 01:33:13 IST,2017-07-20,01:33:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Man, those insurance cos. must hate Exondys 51! $SRPT‚Ä¶",en,[],[],[],2,4,52,[],[],https://twitter.com/adamfeuerstein/status/887764788033581062,False,,0,,,,,,,,[],,,,
887290991207751680,887290991207751680,2017-07-18 18:10:32 IST,2017-07-18,18:10:32,+0530,274233761,bradloncar,Brad Loncar,,This $SRPT news is probably what CRSPR settlements will look like one day.   Saved you 10 years of obsessing about it.,en,[],[],[],3,10,46,[],['srpt'],https://twitter.com/bradloncar/status/887290991207751680,False,,0,,,,,,,,[],,,,
887290644963753984,887290644963753984,2017-07-18 18:09:09 IST,2017-07-18,18:09:09,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT to pay $BMRN $35m in settlement around exon-skipping IP, + royalties &amp; potential milestones  https://t.co/qNrWDTPY8P",en,[],['http://investorrelations.sarepta.com/mobile.view?c=64231&v=200&d=1&id=2287040'],[],0,4,8,[],"['srpt', 'bmrn']",https://twitter.com/megtirrell/status/887290644963753984,False,,0,,,,,,,,[],,,,
887289956774948864,887289956774948864,2017-07-18 18:06:25 IST,2017-07-18,18:06:25,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT and $BMRN...  https://t.co/UgT0K0wSlL,en,[],[],['https://pbs.twimg.com/tweet_video_thumb/DFBJghjUIAA8Kcn.jpg'],1,12,43,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/887289956774948864,False,,1,https://pbs.twimg.com/tweet_video_thumb/DFBJghjUIAA8Kcn.jpg,,,,,,,[],,,,
886994459795312641,886994459795312641,2017-07-17 22:32:13 IST,2017-07-17,22:32:13,+0530,16827489,cboe,Cboe,,"#earnings this week: $NFLX, $BAC, $GS, $HOG, $JNJ, $UNH, $CSX, $IBM, $UAL, $AXP, $QCOM, $SRPT, $TMUS powered by  https://t.co/scoWUQlK5H  https://t.co/idbOkHyig8",en,[],['http://www.livevol.com'],['https://pbs.twimg.com/media/DE88wlRVoAIXnrB.jpg'],0,13,9,['earnings'],"['nflx', 'bac', 'gs', 'hog', 'jnj', 'unh', 'csx', 'ibm', 'ual', 'axp', 'qcom', 'srpt', 'tmus']",https://twitter.com/CBOE/status/886994459795312641,False,,1,https://pbs.twimg.com/media/DE88wlRVoAIXnrB.jpg,,,,,,,[],,,,
886676814776590336,886676814776590336,2017-07-17 01:30:00 IST,2017-07-17,01:30:00,+0530,274233761,bradloncar,Brad Loncar,,Healthcare earnings are back.  M: None scheduled T: $JNJ $NVS $UNH W: $SRPT T: $ABT $DHR $ISRG F: $ATHN  Full list:  https://t.co/2Wrl0zMJ44  https://t.co/bjjW0VqRkW,en,[],['http://www.loncarblog.com/july-17-healthcare-earnings'],['https://pbs.twimg.com/media/DEvZjPvVoAAlFYY.jpg'],1,16,22,[],"['jnj', 'nvs', 'unh', 'srpt', 'abt', 'dhr', 'isrg', 'athn']",https://twitter.com/bradloncar/status/886676814776590336,False,,1,https://pbs.twimg.com/media/DEvZjPvVoAAlFYY.jpg,,,,,,,[],,,,
885870985689403392,885870985689403392,2017-07-14 20:07:56 IST,2017-07-14,20:07:56,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT kicks off earnings season Tues. + other bio look-ahead events in Readout Markets ‚Äî&gt;  https://t.co/pMZ4ATa4cd $INSM $SAGE $CYTR $GILD,en,[],['https://www.statnews.com/2017/07/14/gilead-sarepta-sage/'],[],3,5,9,[],"['srpt', 'insm', 'sage', 'cytr', 'gild']",https://twitter.com/adamfeuerstein/status/885870985689403392,False,,0,,,,,,,,[],,,,
884802170658402306,884802170658402306,2017-07-11 21:20:50 IST,2017-07-11,21:20:50,+0530,44438256,matthewherper,Matthew Herper,,Whole sector will be watching those $srpt numbers.  https://t.co/Ui6TxgZ4ZI,en,[],['https://twitter.com/alpbugrabasat/status/884796383563317248'],[],1,1,9,[],['srpt'],https://twitter.com/matthewherper/status/884802170658402306,False,https://twitter.com/alpbugrabasat/status/884796383563317248,0,,,,,,,,[],,,,
880398444782694400,880398444782694400,2017-06-29 17:42:00 IST,2017-06-29,17:42:00,+0530,558997164,stephaniesimon_,Stephanie Simon,,New Sarepta CEO gets strong reviews from @Allergan chief @brentlsaunders: $SRPT. Readout Markets breaks it down.   https://t.co/QdA3F91qfb  https://t.co/W4zEAnqi05,en,"[{'screen_name': 'brentlsaunders', 'name': 'brent saunders', 'id': '3014302521'}]",['https://www.statnews.com/2017/06/29/sarepta-new-ceo/'],['https://pbs.twimg.com/media/DDfJT4CUMAAXCUq.jpg'],0,6,6,[],['srpt'],https://twitter.com/StephanieSimon_/status/880398444782694400,False,,1,https://pbs.twimg.com/media/DDfJT4CUMAAXCUq.jpg,,,,,,,[],,,,
880395502210220035,880395502210220035,2017-06-29 17:30:19 IST,2017-06-29,17:30:19,+0530,44438256,matthewherper,Matthew Herper,,"Doug Ingram a great choice at $SRPT. Honestly, a bigger name than I would have expected.",en,[],[],[],2,1,12,[],['srpt'],https://twitter.com/matthewherper/status/880395502210220035,False,,0,,,,,,,,[],,,,
880384432380817408,880384432380817408,2017-06-29 16:46:20 IST,2017-06-29,16:46:20,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Today‚Äôs Readout Markets: New $SRPT CEO is top talent; Sell-side ‚Äòconfidence‚Äô cliche ‚Äî&gt;  https://t.co/Quol4rncQf,en,[],['https://www.statnews.com/2017/06/29/new-sarepta-ceo-top-drug-talent-coveted-commercial-expertise-sell-side-confidence-cliche/'],[],1,9,17,[],['srpt'],https://twitter.com/adamfeuerstein/status/880384432380817408,False,,0,,,,,,,,[],,,,
878049483019493376,878049483019493376,2017-06-23 06:08:04 IST,2017-06-23,06:08:04,+0530,44438256,matthewherper,Matthew Herper,,"This @katie_thomas $srpt story is so, so good.  https://t.co/IJLGp9QONp",en,"[{'screen_name': 'katie_thomas', 'name': 'katie thomas', 'id': '18318642'}]",['https://nyti.ms/2tU3lnF'],[],0,7,14,[],['srpt'],https://twitter.com/matthewherper/status/878049483019493376,False,,0,,,,,,,,[],,,,
877906746517241856,877906746517241856,2017-06-22 20:40:53 IST,2017-06-22,20:40:53,+0530,44438256,matthewherper,Matthew Herper,,Great job @megtirrell  modearting the $SRPT panel at @NYASciences ! I wanted to note and respond to what @calif001 said from the audience.  https://t.co/H9kq27GqYj,en,"[{'screen_name': 'megtirrell', 'name': 'meg tirrell', 'id': '47678782'}, {'screen_name': 'nyasciences', 'name': 'nyas', 'id': '1620885366'}, {'screen_name': 'calif001', 'name': 'r. califf', 'id': '896975796040085504'}]",[],['https://pbs.twimg.com/media/DC7zhnZWsAM8-Z_.jpg'],3,11,19,[],['srpt'],https://twitter.com/matthewherper/status/877906746517241856,False,,1,https://pbs.twimg.com/media/DC7zhnZWsAM8-Z_.jpg,,,,,,,[],,,,
877883324861218817,877883324861218817,2017-06-22 19:07:49 IST,2017-06-22,19:07:49,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT Eteplirsen panel at #RCT2017 starting in minutes!  https://t.co/VVHsELPdn6,en,[],['https://twitter.com/megtirrell/status/877595591051583488'],[],1,6,12,['rct2017'],['srpt'],https://twitter.com/megtirrell/status/877883324861218817,False,https://twitter.com/megtirrell/status/877595591051583488,0,,,,,,,,[],,,,
877595366580920320,877595366580920320,2017-06-22 00:03:34 IST,2017-06-22,00:03:34,+0530,47678782,megtirrell,Meg Tirrell,,"Looking fwd to panel tmrw on ""Lessons from Eteplirsen"" w $SRPT's Ed Kaye, FDA's Ellis Unger, @ParentProjectMD's Pat Furlong &amp; David Scheer",en,"[{'screen_name': 'parentprojectmd', 'name': 'parent project muscular dystrophy (ppmd)', 'id': '50887683'}]",[],[],7,5,33,[],['srpt'],https://twitter.com/megtirrell/status/877595366580920320,False,,0,,,,,,,,[],,,,
877482600792809472,877482600792809472,2017-06-21 16:35:29 IST,2017-06-21,16:35:29,+0530,274233761,bradloncar,Brad Loncar,,$SRPT and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of Duchenne Muscular Dystrophy  https://t.co/juWOFcasOg  https://t.co/tRBapgbtoo,en,[],['http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&p=irol-newsArticle&ID=2282180'],['https://pbs.twimg.com/media/DC1xuaAVwAEiVMZ.jpg'],1,9,13,[],['srpt'],https://twitter.com/bradloncar/status/877482600792809472,False,,1,https://pbs.twimg.com/media/DC1xuaAVwAEiVMZ.jpg,,,,,,,[],,,,
867825240927350785,867825240927350785,2017-05-26 01:00:35 IST,2017-05-26,01:00:35,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Are ‚Äúwe‚Äù really selling $SRPT because Charley Seife didn‚Äôt get what he wanted from his FDA FOIA request? People, please‚Ä¶.",en,[],[],[],9,7,42,[],['srpt'],https://twitter.com/adamfeuerstein/status/867825240927350785,False,,0,,,,,,,,[],,,,
865551166540730368,865391927817945088,2017-05-19 18:24:13 IST,2017-05-19,18:24:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@CapitolistPig There is no guarantee eteplirsen or $SRPT platform works. But for you to accuse co. of playing w/ patient lives for profit is outrageous,en,[],[],[],3,1,27,[],['srpt'],https://twitter.com/adamfeuerstein/status/865551166540730368,False,,0,,,,,,,,"[{'screen_name': 'CapitolistPig', 'name': 'The Capitolist', 'id': '737423321403248641'}]",,,,
865550526523375617,865391927817945088,2017-05-19 18:21:41 IST,2017-05-19,18:21:41,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@CapitolistPig No. You‚Äôre 100% wrong. I‚Äôve covered $SRPT for years. I know the company and the patients. You have no idea what you‚Äôre talking about.,en,[],[],[],3,6,21,[],['srpt'],https://twitter.com/adamfeuerstein/status/865550526523375617,False,,0,,,,,,,,"[{'screen_name': 'CapitolistPig', 'name': 'The Capitolist', 'id': '737423321403248641'}]",,,,
865549854562435076,865391927817945088,2017-05-19 18:19:01 IST,2017-05-19,18:19:01,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@CapitolistPig I‚Äôm sorry, but you‚Äôre making zero sense. Frankly. your comments re: $SRPT are driven by same profit motive as people you‚Äôre accusing.",en,[],[],[],1,4,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/865549854562435076,False,,0,,,,,,,,"[{'screen_name': 'CapitolistPig', 'name': 'The Capitolist', 'id': '737423321403248641'}]",,,,
865391927817945088,865391927817945088,2017-05-19 07:51:28 IST,2017-05-19,07:51:28,+0530,102094857,adamfeuerstein,Adam Feuerstein,,WSJ should stop writing about $SRPT. Today's sensationalized account of &lt;gasp&gt; a co. talking to its patients was as bad as past editorials.,en,[],[],[],7,15,95,[],['srpt'],https://twitter.com/adamfeuerstein/status/865391927817945088,False,,0,,,,,,,,[],,,,
865241369769541632,865241369769541632,2017-05-18 21:53:12 IST,2017-05-18,21:53:12,+0530,42703163,sarahkarlin,Sarah Karlin-Smith,,The thing abt this WSJ $SRPT story is - I have a hard time believing Woidcock/Califf were not aware of the dynamics here. they oked anyway.,en,[],[],[],1,1,6,[],['srpt'],https://twitter.com/SarahKarlin/status/865241369769541632,False,,0,,,,,,,,[],,,,
865234297309061121,865234297309061121,2017-05-18 21:25:06 IST,2017-05-18,21:25:06,+0530,42703163,sarahkarlin,Sarah Karlin-Smith,,is any1 shocked $SRPT helped pts testify on behalf of their drug? not just this co. industry regularly pays 4 patients 2 attend #FDA mtgs,en,[],[],[],5,8,8,['fda'],['srpt'],https://twitter.com/SarahKarlin/status/865234297309061121,False,,0,,,,,,,,[],,,,
865233530418327552,865233530418327552,2017-05-18 21:22:03 IST,2017-05-18,21:22:03,+0530,44438256,matthewherper,Matthew Herper,,The news here: $srpt helped parents prepare their presentations.  https://t.co/VgYH6ZxmlH,en,[],['https://twitter.com/wsj/status/865211793207173120'],[],16,16,24,[],['srpt'],https://twitter.com/matthewherper/status/865233530418327552,False,https://twitter.com/wsj/status/865211793207173120,0,,,,,,,,[],,,,
859544734276169728,859544734276169728,2017-05-03 04:36:48 IST,2017-05-03,04:36:48,+0530,47678782,megtirrell,Meg Tirrell,,"Former FDA commissioner weighs in on patient advocacy, $SRPT, politics &amp; advice for @ScottGottliebMD @ #WMIF17  https://t.co/eURSZFn6aL",en,"[{'screen_name': 'scottgottliebmd', 'name': 'scott gottlieb, md', 'id': '40156330'}]",['http://www.cnbc.com/2017/05/02/heres-the-advice-the-last-fda-commissioner-has-for-his-successor.html'],[],0,13,12,['wmif17'],['srpt'],https://twitter.com/megtirrell/status/859544734276169728,False,,0,,,,,,,,[],,,,
857944857033060352,857944857033060352,2017-04-28 18:39:28 IST,2017-04-28,18:39:28,+0530,44438256,matthewherper,Matthew Herper,,"I don't want to put a damper on everybody's party, but I don't see why Ed Kaye's exit should change odds of a $SRPT buyout.",en,[],[],[],4,3,12,[],['srpt'],https://twitter.com/matthewherper/status/857944857033060352,False,,0,,,,,,,,[],,,,
857936261021134848,857936261021134848,2017-04-28 18:05:18 IST,2017-04-28,18:05:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT CEO Exits Along With a $SNY Director, So Let's Speculate About a Possible Deal ‚Äî&gt;  https://t.co/VIOkxw2MWE",en,[],['https://www.thestreet.com/story/14109187/1/sarepta-ceo-exits-along-with-a-sanofi-director-so-let-s-speculate-about-a-possible-deal.html'],[],6,31,47,[],"['srpt', 'sny']",https://twitter.com/adamfeuerstein/status/857936261021134848,False,,0,,,,,,,,[],,,,
857703171082342400,857703171082342400,2017-04-28 02:39:05 IST,2017-04-28,02:39:05,+0530,102754598,johncendpts,John Carroll,,"What I would like to see is for $PTCT to buy $SRPT. Then they would have 1 drug competing w prednisone, 1 mystery drug and 1 bad drug at FDA",en,[],[],[],1,0,7,[],"['ptct', 'srpt']",https://twitter.com/JohnCendpts/status/857703171082342400,False,,0,,,,,,,,[],,,,
857702482734174208,857702482734174208,2017-04-28 02:36:21 IST,2017-04-28,02:36:21,+0530,102754598,johncendpts,John Carroll,,You have to give Sarepta credit. They always keep the drama level high.  $SRPT CEO Ed Kaye edging to the exit,en,[],[],[],0,1,10,[],['srpt'],https://twitter.com/JohnCendpts/status/857702482734174208,False,,0,,,,,,,,[],,,,
857702088176005120,857702088176005120,2017-04-28 02:34:47 IST,2017-04-28,02:34:47,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT CEO Ed Kaye üëèüëèüëèüëèüëè Class act. Took over job he didn't really want and executed extremely well.,en,[],[],[],4,14,106,[],['srpt'],https://twitter.com/adamfeuerstein/status/857702088176005120,False,,0,,,,,,,,[],,,,
857700923262595075,857700923262595075,2017-04-28 02:30:10 IST,2017-04-28,02:30:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT - Start the takeout speculation based on whether a new CEO is appointed or not.,en,[],[],[],6,8,34,[],['srpt'],https://twitter.com/adamfeuerstein/status/857700923262595075,False,,0,,,,,,,,[],,,,
857700463805960192,857700463805960192,2017-04-28 02:28:20 IST,2017-04-28,02:28:20,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT CEO Ed Kaye is resigning as CEO but staying with the company as board member and special regulatory and research advisor.,en,[],[],[],3,15,20,[],['srpt'],https://twitter.com/adamfeuerstein/status/857700463805960192,False,,0,,,,,,,,[],,,,
857691228816756739,857691228816756739,2017-04-28 01:51:38 IST,2017-04-28,01:51:38,+0530,274233761,bradloncar,Brad Loncar,,Four charts from tonight's Earnings Palooza. $VRTX $SGEN $SRPT  https://t.co/hAhUkiHSOX,en,[],[],"['https://pbs.twimg.com/media/C-chexwVYAAgvMd.jpg', 'https://pbs.twimg.com/media/C-chfyTU0AAoKwv.jpg', 'https://pbs.twimg.com/media/C-chgx2UQAAKotk.jpg', 'https://pbs.twimg.com/media/C-chht0UMAApC34.jpg']",0,13,18,[],"['vrtx', 'sgen', 'srpt']",https://twitter.com/bradloncar/status/857691228816756739,False,,1,https://pbs.twimg.com/media/C-chexwVYAAgvMd.jpg,,,,,,,[],,,,
857688582433251332,857686272147693568,2017-04-28 01:41:07 IST,2017-04-28,01:41:07,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@space_menagerie $SRPT Sell on the news? Not sure. The higher guidance was expected, 2017 consensus is $96M.",en,[],[],[],3,3,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/857688582433251332,False,,0,,,,,,,,"[{'screen_name': 'space_menagerie', 'name': 'Moondog', 'id': '17736920'}]",,,,
857686272147693568,857686272147693568,2017-04-28 01:31:56 IST,2017-04-28,01:31:56,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT Exondys 51 Q1 sales $16.3M  New 2017 sales guidance ‚Äúexceed $95M""",en,[],[],[],1,12,24,[],['srpt'],https://twitter.com/adamfeuerstein/status/857686272147693568,False,,0,,,,,,,,[],,,,
857678096270594053,857678096270594053,2017-04-28 00:59:27 IST,2017-04-28,00:59:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT Exondys 51 sales consensus, per FactSet.   Q1: $13.8M ‚Äô17: $96M",es,[],[],[],2,5,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/857678096270594053,False,,0,,,,,,,,[],,,,
857618262187704320,857618262187704320,2017-04-27 21:01:42 IST,2017-04-27,21:01:42,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"This morning‚Äôs biotech/pharma earnings calls wind down, but rest up for this afternoon ‚Äî $SRPT $VRTX $SGEN on deck for after close.",en,[],[],[],1,7,14,[],"['srpt', 'vrtx', 'sgen']",https://twitter.com/adamfeuerstein/status/857618262187704320,False,,0,,,,,,,,[],,,,
857298751345610766,857298751345610766,2017-04-26 23:52:04 IST,2017-04-26,23:52:04,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Crazy. Add $ACOR $ALKS $EXAS $SRPT $SGEN  https://t.co/IgxYU7pViu,en,[],['https://twitter.com/megtirrell/status/857298298163646469'],[],0,7,18,[],"['acor', 'alks', 'exas', 'srpt', 'sgen']",https://twitter.com/adamfeuerstein/status/857298751345610766,False,https://twitter.com/megtirrell/status/857298298163646469,0,,,,,,,,[],,,,
856499128452489216,856499128452489216,2017-04-24 18:54:39 IST,2017-04-24,18:54:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT says pediatrics ethics adcomm ‚Äî&gt;  https://t.co/5cnJKKqL3f scheduled to discuss use of drug ports in ESSENCE study. (exon 45/53 skips),en,[],['https://s3.amazonaws.com/public-inspection.federalregister.gov/2017-08299.pdf'],[],3,8,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/856499128452489216,False,,0,,,,,,,,[],,,,
855703552563568640,855703552563568640,2017-04-22 14:13:19 IST,2017-04-22,14:13:19,+0530,274233761,bradloncar,Brad Loncar,,$SRPT feature in today's Barron's.  https://t.co/QLaWrN04Tj,en,[],['http://www.barrons.com/articles/drugmaker-sareptas-stock-could-double-or-more-1492836646'],[],8,24,63,[],['srpt'],https://twitter.com/bradloncar/status/855703552563568640,False,,0,,,,,,,,[],,,,
852477566241951745,852477566241951745,2017-04-13 16:34:24 IST,2017-04-13,16:34:24,+0530,274233761,bradloncar,Brad Loncar,,It's cool to see the increased investment that has been happening in DMD post the $SRPT approval. From Roche no less today.,en,[],[],[],3,5,17,[],['srpt'],https://twitter.com/bradloncar/status/852477566241951745,False,,0,,,,,,,,[],,,,
842415917736824833,842415917736824833,2017-03-16 22:13:00 IST,2017-03-16,22:13:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"If your reaction to my $PTCT Emflaza story is, ‚ÄúHe‚Äôs a jerk for not mentioning the awesomeness of $SRPT,‚Äù you‚Äôre a schmuck.",en,[],[],[],2,1,19,[],"['ptct', 'srpt']",https://twitter.com/adamfeuerstein/status/842415917736824833,False,,0,,,,,,,,[],,,,
837116109451104256,837116109451104256,2017-03-02 07:13:28 IST,2017-03-02,07:13:28,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Disrespectful? Schwartz is brilliant! His $SRPT bear-turned-bull game is ninja-level sell-side. Gotta tip your hat to him.  https://t.co/QWddBeEldq,en,[],['https://twitter.com/genomc50/status/837113249422155776'],[],3,1,26,[],['srpt'],https://twitter.com/adamfeuerstein/status/837116109451104256,False,https://twitter.com/genomc50/status/837113249422155776,0,,,,,,,,[],,,,
837111384366329858,837111384366329858,2017-03-02 06:54:41 IST,2017-03-02,06:54:41,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Leerink's Joe Schwartz upgrades to outperform. PT to $47 from $27.  https://t.co/OynCstg8PG,en,[],[],['https://pbs.twimg.com/tweet_video_thumb/C54EXNyUwAAR_xE.jpg'],6,14,59,[],['srpt'],https://twitter.com/adamfeuerstein/status/837111384366329858,False,,1,https://pbs.twimg.com/tweet_video_thumb/C54EXNyUwAAR_xE.jpg,,,,,,,[],,,,
836697014805069825,836697014805069825,2017-03-01 03:28:08 IST,2017-03-01,03:28:08,+0530,14031032,adamsinger,Adam Singer,,@Pharmdca genetic testing gets a call out on $SRPT call. It's why I like $NVTA a lot they are key for all the rare disease companies.,en,[],[],[],0,1,8,[],"['srpt', 'nvta']",https://twitter.com/AdamSinger/status/836697014805069825,False,,0,,,,,,,,[],,,,
836696322598187008,836696322598187008,2017-03-01 03:25:23 IST,2017-03-01,03:25:23,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT if you weed out the outlier (ridiculous) sell-side forecasts, ‚Äúconsensus‚Äù 2017 sales estimate is $100-110 million. Still higher.",en,[],[],[],6,11,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/836696322598187008,False,,0,,,,,,,,[],,,,
836695591040258048,836695591040258048,2017-03-01 03:22:28 IST,2017-03-01,03:22:28,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT ‚Äî 2017 Exondys sales guidance of $80M is below consensus, which varies widely.",en,[],[],[],3,4,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/836695591040258048,False,,0,,,,,,,,[],,,,
836694889702305796,836694889702305796,2017-03-01 03:19:41 IST,2017-03-01,03:19:41,+0530,274233761,bradloncar,Brad Loncar,,$SRPT $13M-$15M net revenue guidance for Q1. For the year: to exceed $80M.,en,[],[],[],2,4,5,[],['srpt'],https://twitter.com/bradloncar/status/836694889702305796,False,,0,,,,,,,,[],,,,
836691768112447488,836691768112447488,2017-03-01 03:07:17 IST,2017-03-01,03:07:17,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Wow, $SRPT is providing revenue guidance on this call.",en,[],[],[],3,7,21,[],['srpt'],https://twitter.com/adamfeuerstein/status/836691768112447488,False,,0,,,,,,,,[],,,,
836691417623900162,836691417623900162,2017-03-01 03:05:53 IST,2017-03-01,03:05:53,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Please, someone get Ian Estepan a glass of water after reading the longest risk statement ever‚Ä¶. $SRPT",en,[],[],[],5,1,46,[],['srpt'],https://twitter.com/adamfeuerstein/status/836691417623900162,False,,0,,,,,,,,[],,,,
835957618833174529,835957618833174529,2017-02-27 02:30:02 IST,2017-02-27,02:30:02,+0530,274233761,bradloncar,Brad Loncar,,Healthcare calls üìÜ  M: $HZNP $PRGO T: $ACAD $HALO $SRPT $VRX W: $FGEN $JUNO $XON T: $ACRX F: $CTSO  Full calendar:  https://t.co/LRTxfjmU6P,en,[],['http://www.loncarblog.com/february-27-healthcare-earnings'],[],2,14,27,[],"['hznp', 'prgo', 'acad', 'halo', 'srpt', 'vrx', 'fgen', 'juno', 'xon', 'acrx', 'ctso']",https://twitter.com/bradloncar/status/835957618833174529,False,,0,,,,,,,,[],,,,
834048886285148160,834048886285148160,2017-02-21 20:05:25 IST,2017-02-21,20:05:25,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Leerink on $SRPT PRV sale: $125M in free, non-dilutive funds sucks and clearly shows Exondys 51 is a failure. Company should shut down.",en,[],[],[],8,15,43,[],['srpt'],https://twitter.com/adamfeuerstein/status/834048886285148160,False,,0,,,,,,,,[],,,,
834018685027287041,834018685027287041,2017-02-21 18:05:24 IST,2017-02-21,18:05:24,+0530,274233761,bradloncar,Brad Loncar,,$SRPT 8K says $GILD was the buyer of the priority review voucher.  https://t.co/Po4tIBQXBe,en,[],['https://www.sec.gov/Archives/edgar/data/873303/000119312517049361/d354714d8k.htm'],[],0,10,14,[],"['srpt', 'gild']",https://twitter.com/bradloncar/status/834018685027287041,False,,0,,,,,,,,[],,,,
834018541514944512,834018541514944512,2017-02-21 18:04:50 IST,2017-02-21,18:04:50,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT sells priority review voucher for $125m; buyer not disclosed  https://t.co/3tMP4bmxaN,en,[],['http://www.businesswire.com/news/home/20170221005678/en/'],[],3,6,8,[],['srpt'],https://twitter.com/megtirrell/status/834018541514944512,False,,0,,,,,,,,[],,,,
834012962352459777,786911762155081728,2017-02-21 17:42:40 IST,2017-02-21,17:42:40,+0530,873399943,jacobplieth,Jacob Plieth,,"I did keep on saying that #PRV scarcity &amp; value was falling, so it's your own fault if you're disappointed by $SRPT today  https://t.co/KDbJHTzKu7",en,[],[],['https://pbs.twimg.com/media/C5MCQ7JWEAASK3a.jpg'],5,2,12,['prv'],['srpt'],https://twitter.com/JacobPlieth/status/834012962352459777,False,,1,https://pbs.twimg.com/media/C5MCQ7JWEAASK3a.jpg,,,,,,,[],,,,
834010027040047104,834010027040047104,2017-02-21 17:31:00 IST,2017-02-21,17:31:00,+0530,274233761,bradloncar,Brad Loncar,,$SRPT sold its priority review voucher for $125M.,en,[],[],[],1,7,13,[],['srpt'],https://twitter.com/bradloncar/status/834010027040047104,False,,0,,,,,,,,[],,,,
832573123543310339,832573123543310339,2017-02-17 18:21:15 IST,2017-02-17,18:21:15,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Biotech Stock Mailbag: Bulls love a distracted Trump, $PLX $ACAD $SRPT  https://t.co/CZIqZ9bDnE",en,[],['https://www.thestreet.com/story/14006436/1/biotech-stock-mailbag-bulls-love-a-distracted-trump-protalix-acadia-sarepta.html'],[],4,12,19,[],"['plx', 'acad', 'srpt']",https://twitter.com/adamfeuerstein/status/832573123543310339,False,,0,,,,,,,,[],,,,
831519279719862272,831519279719862272,2017-02-14 20:33:39 IST,2017-02-14,20:33:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Defending $SRPT Against Blowback from the Marathon Pharma Steroid Price Gouging Scandal ‚Äî&gt;  https://t.co/TXrHs2pcE7,en,[],['https://www.thestreet.com/story/14001431/1/defending-sarepta-against-blowback-from-the-marathon-pharma-steroid-price-gouging-scandal.html'],[],5,22,47,[],['srpt'],https://twitter.com/adamfeuerstein/status/831519279719862272,False,,0,,,,,,,,[],,,,
831267998652649472,831267154888708098,2017-02-14 03:55:09 IST,2017-02-14,03:55:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@zbiotech What pisses me off most about Marathon‚Äôs letter ‚Äî and past statements ‚Äî is how they try to rope in $SRPT &amp; Exondys.,en,[],[],[],4,5,27,[],['srpt'],https://twitter.com/adamfeuerstein/status/831267998652649472,False,,0,,,,,,,,"[{'screen_name': 'zbiotech', 'name': 'zach', 'id': '19717430'}]",,,,
831190589714620416,831190589714620416,2017-02-13 22:47:34 IST,2017-02-13,22:47:34,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"People, please. Whatever you might think of Marathon and Emflaza, IT IS NOT COMPETITION FOR $SRPT EXONDYS! Seriously, stop that.",en,[],[],[],7,16,70,[],['srpt'],https://twitter.com/adamfeuerstein/status/831190589714620416,False,,0,,,,,,,,[],,,,
828998618606628870,828998618606628870,2017-02-07 21:37:27 IST,2017-02-07,21:37:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT spox:  ‚ÄúNo, we did not cancel out of a conference.‚Äù  So, shut the fuck up, idiots.",en,[],[],[],4,9,28,[],['srpt'],https://twitter.com/adamfeuerstein/status/828998618606628870,False,,0,,,,,,,,[],,,,
827956644478853121,827953657438023680,2017-02-05 00:37:01 IST,2017-02-05,00:37:01,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@DrSManian Joe's report is not bogus. It's only meaningful if you're trading $SRPT short term. Doesn't alter fundamental thesis.,en,[],[],[],2,2,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/827956644478853121,False,,0,,,,,,,,[],,,,
827178132306272256,827178132306272256,2017-02-02 21:03:29 IST,2017-02-02,21:03:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"The new normal, even for drugs to treat kids dying from rare diseases. Why I‚Äôm not sweating $SRPT.  https://t.co/CZ3wofGyRO",en,[],['https://twitter.com/BentheFidler/status/827177531673423872'],[],4,5,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/827178132306272256,False,https://twitter.com/BentheFidler/status/827177531673423872,0,,,,,,,,[],,,,
826452207864258562,826452207864258562,2017-01-31 20:58:55 IST,2017-01-31,20:58:55,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT up 6%, presumably after Trump comments on lowering regulations for smaller cos getting to market -- but it's already on market..?",en,[],[],[],4,0,9,[],['srpt'],https://twitter.com/megtirrell/status/826452207864258562,False,,0,,,,,,,,[],,,,
823565919318405120,823565919318405120,2017-01-23 21:49:50 IST,2017-01-23,21:49:50,+0530,44438256,matthewherper,Matthew Herper,,Here was Califf's bottom line on $SRPT.  https://t.co/cOdDcTQR5O  https://t.co/qPWm3CEW4U,en,[],['http://www.forbes.com/sites/matthewherper/2017/01/23/keep-politics-out-of-science-says-departing-fda-chief/#6a5cf6035f90'],['https://pbs.twimg.com/media/C23k0y1WEAM52q5.jpg'],3,5,10,[],['srpt'],https://twitter.com/matthewherper/status/823565919318405120,False,,1,https://pbs.twimg.com/media/C23k0y1WEAM52q5.jpg,,,,,,,[],,,,
823565317322502146,823565317322502146,2017-01-23 21:47:27 IST,2017-01-23,21:47:27,+0530,44438256,matthewherper,Matthew Herper,,"A few things in my exit interview with Robert Califf, including how he thinks FDA should change, thoughts on $SRPT.  https://t.co/cOdDcTQR5O",en,[],['http://www.forbes.com/sites/matthewherper/2017/01/23/keep-politics-out-of-science-says-departing-fda-chief/#6a5cf6035f90'],[],1,15,23,[],['srpt'],https://twitter.com/matthewherper/status/823565317322502146,False,,0,,,,,,,,[],,,,
818852160465240066,818852160465240066,2017-01-10 21:39:03 IST,2017-01-10,21:39:03,+0530,15281391,thestreet,TheStreet,,"As 250 Duchenne patients receive treatment, Sarepta reports sales of its Exondys 51 drug at $5.4 million:  https://t.co/WW5pPijjzj $SRPT  https://t.co/oVl5lXnSL5",en,[],['http://trib.al/yssPmZQ'],['https://pbs.twimg.com/media/C10lssXWgAA7i7Y.jpg'],0,3,4,[],['srpt'],https://twitter.com/TheStreet/status/818852160465240066,False,,1,https://pbs.twimg.com/media/C10lssXWgAA7i7Y.jpg,,,,,,,[],,,,
818851842872328192,818844808894480384,2017-01-10 21:37:47 IST,2017-01-10,21:37:47,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@JacobPlieth ‚ÄúConsensus"" q1 and all of 2017 was pretty much meaningless bc no visibility into launch until today. 250 is good #. $SRPT",en,[],[],[],1,4,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/818851842872328192,False,,0,,,,,,,,"[{'screen_name': 'JacobPlieth', 'name': 'Jacob Plieth', 'id': '873399943'}]",,,,
818844808894480384,818844808894480384,2017-01-10 21:09:50 IST,2017-01-10,21:09:50,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I spoke with $SRPT CEO Ed Kaye last night about Exondys 51 launch. His comments in my story ‚Äî&gt;  https://t.co/s0QgkigW8O #JPM17,en,[],['https://www.thestreet.com/story/13948568/1/sarepta-opens-up-about-duchenne-drug-launch-allays-investors-worst-fears.html'],[],7,22,36,['jpm17'],['srpt'],https://twitter.com/adamfeuerstein/status/818844808894480384,False,,0,,,,,,,,[],,,,
818843648603262976,818843648603262976,2017-01-10 21:05:13 IST,2017-01-10,21:05:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT 250 DMD patients in the Exondys start queue. $5.4M in sales in Q4.   My story ‚Äî&gt;  https://t.co/s0QgkigW8O,en,[],['https://www.thestreet.com/story/13948568/1/sarepta-opens-up-about-duchenne-drug-launch-allays-investors-worst-fears.html'],[],2,24,21,[],['srpt'],https://twitter.com/adamfeuerstein/status/818843648603262976,False,,0,,,,,,,,[],,,,
818843257362731009,818843257362731009,2017-01-10 21:03:40 IST,2017-01-10,21:03:40,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Sarepta Opens Up About Duchenne Drug Launch, Allays Investors' Worst Fears $SRPT ‚Äî&gt;  https://t.co/s0QgkigW8O #JPM17",en,[],['https://www.thestreet.com/story/13948568/1/sarepta-opens-up-about-duchenne-drug-launch-allays-investors-worst-fears.html'],[],3,11,19,['jpm17'],['srpt'],https://twitter.com/adamfeuerstein/status/818843257362731009,False,,0,,,,,,,,[],,,,
818843098616713217,818843098616713217,2017-01-10 21:03:02 IST,2017-01-10,21:03:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT news coming‚Ä¶,en,[],[],[],3,3,12,[],['srpt'],https://twitter.com/adamfeuerstein/status/818843098616713217,False,,0,,,,,,,,[],,,,
818813602639425537,818813602639425537,2017-01-10 19:05:50 IST,2017-01-10,19:05:50,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT presents at #JPM17 at 10:30 am ET.,tl,[],[],[],1,6,16,['jpm17'],['srpt'],https://twitter.com/adamfeuerstein/status/818813602639425537,False,,0,,,,,,,,[],,,,
816351715951775745,816351715951775745,2017-01-04 00:03:10 IST,2017-01-04,00:03:10,+0530,44438256,matthewherper,Matthew Herper,,"John Jenkins on $SRPT, from interview with @steveusdin1 at @BioCentury.  https://t.co/JSW8uTPUXH",en,"[{'screen_name': 'steveusdin1', 'name': 'steve usdin', 'id': '371790609'}, {'screen_name': 'biocentury', 'name': 'biocentury', 'id': '227778014'}]",[],['https://pbs.twimg.com/media/C1RDi2fVQAAJOI0.jpg'],0,11,11,[],['srpt'],https://twitter.com/matthewherper/status/816351715951775745,False,,1,https://pbs.twimg.com/media/C1RDi2fVQAAJOI0.jpg,,,,,,,[],,,,
812294093757972482,812294093757972482,2016-12-23 19:19:38 IST,2016-12-23,19:19:38,+0530,102754598,johncendpts,John Carroll,,"WSJ‚Äôs editorial page puts the blame over Exondys 51 controversy on insurers, regulators and reporters $SRPT  https://t.co/KF8OI2ECN3",en,[],['https://endpts.com/wsjs-editorial-page-puts-the-blame-over-exondys-51-controversy-on-insurers-regulators-and-reporters/'],[],1,4,6,[],['srpt'],https://twitter.com/JohnCendpts/status/812294093757972482,False,,0,,,,,,,,[],,,,
811322753370456064,811322538269822979,2016-12-21 02:59:52 IST,2016-12-21,02:59:52,+0530,274233761,bradloncar,Brad Loncar,,"For example, $SRPT (22521) will present on January 10 at 7:30 AM. #JPM17",en,[],[],[],0,4,13,['jpm17'],['srpt'],https://twitter.com/bradloncar/status/811322753370456064,False,,0,,,,,,,,[],,,,
810850457925062656,810850457925062656,2016-12-19 19:43:08 IST,2016-12-19,19:43:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,The Best Biopharma CEOs of 2016 are‚Ä¶ ‚Äî&gt;  https://t.co/rmvHsHI6UP  $MRK Frazier $MDVN Hung $CPXX Jackson $SRPT Kaye $EXEL Morrissey,en,[],['https://www.thestreet.com/story/13930531/1/the-best-biopharma-ceos-of-2016-are.html'],[],8,31,57,[],"['mrk', 'mdvn', 'cpxx', 'srpt', 'exel']",https://twitter.com/adamfeuerstein/status/810850457925062656,False,,0,,,,,,,,[],,,,
810474576450818049,810474576450818049,2016-12-18 18:49:31 IST,2016-12-18,18:49:31,+0530,102754598,johncendpts,John Carroll,,And there's so much more to come on $SRPT.  https://t.co/VqCbFif79q,en,[],['https://twitter.com/DavidJuurlink/status/810469012916277248'],[],1,0,6,[],['srpt'],https://twitter.com/JohnCendpts/status/810474576450818049,False,https://twitter.com/DavidJuurlink/status/810469012916277248,0,,,,,,,,[],,,,
809748784339152896,809748784339152896,2016-12-16 18:45:29 IST,2016-12-16,18:45:29,+0530,47678782,megtirrell,Meg Tirrell,,"The title of RBC's Simos Simeonidis note on $SRPT this AM is designed to be sung to the tune of Taylor Swift's ""Shake It Off,"" right?  https://t.co/BGXdIEpwxw",en,[],[],['https://pbs.twimg.com/media/CzzON64UAAAte0e.jpg'],6,11,38,[],['srpt'],https://twitter.com/megtirrell/status/809748784339152896,False,,1,https://pbs.twimg.com/media/CzzON64UAAAte0e.jpg,,,,,,,[],,,,
809121948231958528,809121948231958528,2016-12-15 01:14:39 IST,2016-12-15,01:14:39,+0530,47678782,megtirrell,Meg Tirrell,,"Our interview w FDA's Janet Woodcock, talking $SRPT, 21st Century Cures, &amp; the influence of the president  https://t.co/kXBZAe5Jre",en,[],['http://www.cnbc.com/2016/12/14/fdas-woodcock-speaks-about-one-of-the-agencys-most-controversial-decisions.html'],[],0,47,61,[],['srpt'],https://twitter.com/megtirrell/status/809121948231958528,False,,0,,,,,,,,[],,,,
809042616935415809,809042616935415809,2016-12-14 19:59:25 IST,2016-12-14,19:59:25,+0530,47678782,megtirrell,Meg Tirrell,,We asked FDA's Woodcock whether $SRPT opened floodgates to subpar applications as many warned. Her answer soon on  https://t.co/zafIV8hEOW,en,[],['http://CNBC.com'],[],1,6,13,[],['srpt'],https://twitter.com/megtirrell/status/809042616935415809,False,,0,,,,,,,,[],,,,
809033616600735744,809033616600735744,2016-12-14 19:23:39 IST,2016-12-14,19:23:39,+0530,47678782,megtirrell,Meg Tirrell,,"We'll hear from one mom, @JettFoundation's Christine McSherry, on $SRPT case study panel at FDA-CMS Summit today!  https://t.co/0GXYw2zcGS",en,"[{'screen_name': 'jettfoundation', 'name': 'jett foundation', 'id': '1707456762'}]",['https://twitter.com/adamfeuerstein/status/808666744965464064'],[],2,3,11,[],['srpt'],https://twitter.com/megtirrell/status/809033616600735744,False,https://twitter.com/adamfeuerstein/status/808666744965464064,0,,,,,,,,[],,,,
806812420429807616,786911762155081728,2016-12-08 16:17:25 IST,2016-12-08,16:17:25,+0530,873399943,jacobplieth,Jacob Plieth,,Attn fans of $SRPT $ALXN &amp; priority review vouchers #PRV  https://t.co/KyUCLUaaqZ,en,[],[],['https://pbs.twimg.com/media/CzJfmQiXUAAUvSH.jpg'],2,2,10,['prv'],"['srpt', 'alxn']",https://twitter.com/JacobPlieth/status/806812420429807616,False,,1,https://pbs.twimg.com/media/CzJfmQiXUAAUvSH.jpg,,,,,,,[],,,,
806302994132246528,805804745562750976,2016-12-07 06:33:08 IST,2016-12-07,06:33:08,+0530,44438256,matthewherper,Matthew Herper,,@AndyBiotech @PharmaPinkSheet @adamfeuerstein The big Q isn't whether he left b/c of $SRPT. It's how agency changes with him gone.,en,[],[],[],1,0,6,[],['srpt'],https://twitter.com/matthewherper/status/806302994132246528,False,,0,,,,,,,,"[{'screen_name': 'AndyBiotech', 'name': 'Andy Biotech', 'id': '632341632'}, {'screen_name': 'PharmaPinkSheet', 'name': 'Pink Sheet', 'id': '1020244080'}, {'screen_name': 'adamfeuerstein', 'name': 'Adam Feuerstein', 'id': '102094857'}]",,,,
805895144163708928,805895144163708928,2016-12-06 03:32:29 IST,2016-12-06,03:32:29,+0530,102754598,johncendpts,John Carroll,,"$SRPT critic Jenkins is exiting the FDA, and Woodcock takes direct charge of the OND after a painful rupture  https://t.co/xtmVHNAzW0",en,[],['https://endpts.com/sarepta-critic-jenkins-is-exiting-the-fda-and-woodcock-takes-direct-charge-of-the-ond-after-a-deep-split/'],[],3,12,11,[],['srpt'],https://twitter.com/JohnCendpts/status/805895144163708928,False,,0,,,,,,,,[],,,,
800720254452244480,800720254452244480,2016-11-21 20:49:19 IST,2016-11-21,20:49:19,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT - Aetna ( $AET ) providing reimbursement for Exondys.  Links:  https://t.co/GkzcyaI2v7   https://t.co/Iq0tyzr1Wk,ro,[],"['https://pbs.twimg.com/media/CxvlA3LUcAAElQl.jpg:large', 'http://www.aetna.com/pharmacy-insurance/healthcare-professional/documents/exondys51-precert-request.pdf']",[],3,12,15,[],"['srpt', 'aet']",https://twitter.com/adamfeuerstein/status/800720254452244480,False,,0,,,,,,,,[],,,,
797053505890648064,797053505890648064,2016-11-11 17:58:58 IST,2016-11-11,17:58:58,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"EMA's flexibility w/ $PTCT Ataluren has to be positive for $SRPT Exondys, right? Logically consistent?",en,[],[],[],4,9,18,[],"['ptct', 'srpt']",https://twitter.com/adamfeuerstein/status/797053505890648064,False,,0,,,,,,,,[],,,,
794660002787160065,794660002787160065,2016-11-05 03:28:03 IST,2016-11-05,03:28:03,+0530,102754598,johncendpts,John Carroll,,Top story: FDA officials: There was ‚Äúno scientific basis‚Äù for Duchenne drug OK as $SRPT complained of dire condition  https://t.co/WFh0XsJZz3,en,[],['https://endpts.com/fda-officials-there-was-no-scientific-basis-for-duchenne-drug-ok-as-sarepta-complained-of-dire-financial-condition/'],[],3,12,9,[],['srpt'],https://twitter.com/JohnCendpts/status/794660002787160065,False,,0,,,,,,,,[],,,,
794354859529093123,794354859529093123,2016-11-04 07:15:31 IST,2016-11-04,07:15:31,+0530,44438256,matthewherper,Matthew Herper,,This seems pretty clear. $srpt  https://t.co/6w6gSSoA09  https://t.co/ggx2wuMozu,en,[],[],"['https://pbs.twimg.com/media/CwYdh77UsAAmHVd.jpg', 'https://pbs.twimg.com/media/CwYYBvHWQAApQQ2.jpg']",2,2,8,[],['srpt'],https://twitter.com/matthewherper/status/794354859529093123,False,,1,https://pbs.twimg.com/media/CwYdh77UsAAmHVd.jpg,,,,,,,[],,,,
791400264171487233,791400264171487233,2016-10-27 03:35:01 IST,2016-10-27,03:35:01,+0530,102754598,johncendpts,John Carroll,,Humana spells out its conditional Exondys 51 coverage policy ‚Äî strings attached $SRPT  https://t.co/WirYYHwkA8,en,[],['http://endpts.com/humana-spells-out-its-conditional-exondys-51-coverage-policy-strings-attached/'],[],2,5,6,[],['srpt'],https://twitter.com/JohnCendpts/status/791400264171487233,False,,0,,,,,,,,[],,,,
791368560362659840,791368560362659840,2016-10-27 01:29:02 IST,2016-10-27,01:29:02,+0530,16827489,cboe,Cboe,,"#earnings tomorrow bmo: $BMY, $CELG, $CLF, $DOW, $F, $NOK, $SRPT, $TWTR, $UPS, $VALE powered by  https://t.co/scoWUQ48H7  https://t.co/5SPcPoORgu",en,[],['http://www.livevol.com'],['https://pbs.twimg.com/media/CvuBgpPUIAAzsNg.jpg'],0,9,10,['earnings'],"['bmy', 'celg', 'clf', 'dow', 'f', 'nok', 'srpt', 'twtr', 'ups', 'vale']",https://twitter.com/CBOE/status/791368560362659840,False,,1,https://pbs.twimg.com/media/CvuBgpPUIAAzsNg.jpg,,,,,,,[],,,,
791304717448146946,791304717448146946,2016-10-26 21:15:21 IST,2016-10-26,21:15:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Pardon me, but I have a few things to say... $VRTX $BIIB $ARIA $SRPT  https://t.co/vDPdSoQNvP via @TheStreet",en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['https://www.thestreet.com/story/13868013/1/pardon-me-but-i-have-a-few-things-to-say-vertex-biogen-ariad-sarepta.html'],[],2,11,22,[],"['vrtx', 'biib', 'aria', 'srpt']",https://twitter.com/adamfeuerstein/status/791304717448146946,False,,0,,,,,,,,[],,,,
791256032878202880,791256032878202880,2016-10-26 18:01:53 IST,2016-10-26,18:01:53,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Shhh‚Ä¶. Don‚Äôt tell the $SRPT ankle biters.  https://t.co/vF7PlDF0Kz,en,[],['https://twitter.com/zbiotech/status/791255857631723521'],[],0,5,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/791256032878202880,False,https://twitter.com/zbiotech/status/791255857631723521,0,,,,,,,,[],,,,
790600217460703238,790600217460703238,2016-10-24 22:35:55 IST,2016-10-24,22:35:55,+0530,102754598,johncendpts,John Carroll,,Backlash:Harvard experts fret over the fallout from FDA‚Äôs OK for  $SRPT's controversial Duchenne drug #justbeginning  https://t.co/XXkmkqhSGm,en,[],['http://endpts.com/backlash-harvard-experts-fret-over-the-fallout-from-fdas-ok-for-sareptas-controversial-duchenne-drug/'],[],7,13,18,['justbeginning'],['srpt'],https://twitter.com/JohnCendpts/status/790600217460703238,False,,0,,,,,,,,[],,,,
790590784483516416,790590784483516416,2016-10-24 21:58:26 IST,2016-10-24,21:58:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Serious question: Who‚Äôs more deceptive and misleading: $SRPT or the company‚Äôs critics? With every editorial, it seems like the latter.",en,[],[],[],6,12,48,[],['srpt'],https://twitter.com/adamfeuerstein/status/790590784483516416,False,,0,,,,,,,,[],,,,
789222648488325120,789222648488325120,2016-10-21 03:21:57 IST,2016-10-21,03:21:57,+0530,44438256,matthewherper,Matthew Herper,,"A Biotech's Depression Drug Returns From Dead, Setting Up Test For FDA via @forbes  https://t.co/TJ93qzCtBP $ALKS $SRPT $ACAD $ITCI",en,"[{'screen_name': 'forbes', 'name': 'forbes', 'id': '91478624'}]",['http://www.forbes.com/sites/matthewherper/2016/10/20/biotechs-depression-drug-returns-from-dead-setting-up-test-for-fda/'],[],5,18,12,[],"['alks', 'srpt', 'acad', 'itci']",https://twitter.com/matthewherper/status/789222648488325120,False,,0,,,,,,,,[],,,,
788869187271876608,788869187271876608,2016-10-20 03:57:25 IST,2016-10-20,03:57:25,+0530,102754598,johncendpts,John Carroll,,"Now that Sarepta has bolted out of the barn, the #FDA wants to shut the door $SRPT  https://t.co/xUSzeRvIWz",en,[],['http://endpts.com/now-that-sarepta-has-bolted-out-the-barn-door-fdas-john-jenkins-wants-to-shut-it/'],[],1,5,8,['fda'],['srpt'],https://twitter.com/JohnCendpts/status/788869187271876608,False,,0,,,,,,,,[],,,,
788783374324334592,788783374324334592,2016-10-19 22:16:25 IST,2016-10-19,22:16:25,+0530,576436187,carolineylchen,Caroline Chen,,FDA slide deck on $SRPT shows rare drugs get expedited a lot (h/t @DoniBloomfield)   https://t.co/lKFPoHYdUT  https://t.co/yyUYF8mLCD,en,"[{'screen_name': 'donibloomfield', 'name': 'doni bloomfield', 'id': '132613598'}]",['http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/UCM525805.pdf'],['https://pbs.twimg.com/media/CvJSH7aXEAAsUke.jpg'],2,5,7,[],['srpt'],https://twitter.com/CarolineYLChen/status/788783374324334592,False,,1,https://pbs.twimg.com/media/CvJSH7aXEAAsUke.jpg,,,,,,,[],,,,
786946425779347456,786946425779347456,2016-10-14 20:37:03 IST,2016-10-14,20:37:03,+0530,47348249,michael_gilman,Michael Gilman,,Buy-siders unsettled by $SRPT approval - unpredictable/inconsistent FDA is a problem for investors and industry. #AVR16,en,[],[],[],3,10,7,['avr16'],['srpt'],https://twitter.com/michael_gilman/status/786946425779347456,False,,0,,,,,,,,[],,,,
786593308730531840,786593308730531840,2016-10-13 21:13:53 IST,2016-10-13,21:13:53,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Pardon me, but I have a few things to say... $SGEN $BMRN $SRPT $TGTX $GILD  https://t.co/SJW8tIg5xo via @TheStreet",en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['https://www.thestreet.com/story/13852472/1/pardon-me-but-i-have-a-few-things-to-say-seattle-genetics-biomarin-sarepta-tg-therapeutics.html'],[],6,12,37,[],"['sgen', 'bmrn', 'srpt', 'tgtx', 'gild']",https://twitter.com/adamfeuerstein/status/786593308730531840,False,,0,,,,,,,,[],,,,
786541650923454464,786541650923454464,2016-10-13 17:48:37 IST,2016-10-13,17:48:37,+0530,873399943,jacobplieth,Jacob Plieth,,Bottom like: $BMRN (Prosensa's) biggest mistake was to design a robust trial capable of proving drisa didn't work and/or was toxic $SRPT  https://t.co/E0iEcpCEfT,en,[],['https://twitter.com/AndyBiotech/status/786540921395425284'],[],7,8,18,[],"['bmrn', 'srpt']",https://twitter.com/JacobPlieth/status/786541650923454464,False,https://twitter.com/AndyBiotech/status/786540921395425284,0,,,,,,,,[],,,,
786526846565441536,786526846565441536,2016-10-13 16:49:47 IST,2016-10-13,16:49:47,+0530,102754598,johncendpts,John Carroll,,"Sounds like $BMRN is pissed. If $SRPT gets a free ride on eteplirsen failure, why shouldn't they approve drisa as well?",en,[],[],[],18,5,11,[],"['bmrn', 'srpt']",https://twitter.com/JohnCendpts/status/786526846565441536,False,,0,,,,,,,,[],,,,
786521794551373824,786521794551373824,2016-10-13 16:29:43 IST,2016-10-13,16:29:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Some advice for $SRPT CEO Ed Kaye: When $BMRN CEO JJ Bienaime comes to you w/ a takeout offer, make him beg.",en,[],[],[],3,17,55,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/786521794551373824,False,,0,,,,,,,,[],,,,
785476102764498944,785476102764498944,2016-10-10 19:14:30 IST,2016-10-10,19:14:30,+0530,102754598,johncendpts,John Carroll,,The interview: The Sarepta dilemma: Arthur Caplan says it‚Äôs time to rethink how to regulate compassion $SRPT  https://t.co/WfVvteZXPl,en,[],['http://endpts.com/the-sarepta-dilemma-arthur-caplan-says-its-time-to-rethink-how-to-regulate-compassion/'],[],8,7,8,[],['srpt'],https://twitter.com/JohnCendpts/status/785476102764498944,False,,0,,,,,,,,[],,,,
784491080934952960,784491080934952960,2016-10-08 02:00:23 IST,2016-10-08,02:00:23,+0530,47678782,megtirrell,Meg Tirrell,,Insurers tell me today on $SRPT Exondys 51: $UNH: covered w prior authorization $HUM: evaluating $CI: covered $ANTM: not covered,en,[],[],[],1,22,29,[],"['srpt', 'unh', 'hum', 'ci', 'antm']",https://twitter.com/megtirrell/status/784491080934952960,False,,0,,,,,,,,[],,,,
784423283760439296,784423283760439296,2016-10-07 21:30:59 IST,2016-10-07,21:30:59,+0530,44438256,matthewherper,Matthew Herper,,"Wow. Well, if someone wanted to take on ultra-orphan pricing, this was the obvious place. $SRPT.  https://t.co/mRDttiyZk9",en,[],['https://twitter.com/JohnCendpts/status/784414781755170817'],[],0,6,7,[],['srpt'],https://twitter.com/matthewherper/status/784423283760439296,False,https://twitter.com/JohnCendpts/status/784414781755170817,0,,,,,,,,[],,,,
784420323986923524,784420323986923524,2016-10-07 21:19:13 IST,2016-10-07,21:19:13,+0530,102754598,johncendpts,John Carroll,,The idea of families being left to pay for a drug that may have absolutely no effect on DMD literally sickens me. $SRPT  https://t.co/IBP5RHSvVl,en,[],['https://twitter.com/ethanjweiss/status/784419753725046785'],[],4,4,13,[],['srpt'],https://twitter.com/JohnCendpts/status/784420323986923524,False,https://twitter.com/ethanjweiss/status/784419753725046785,0,,,,,,,,[],,,,
784403579180376064,784403579180376064,2016-10-07 20:12:41 IST,2016-10-07,20:12:41,+0530,47678782,megtirrell,Meg Tirrell,,"Whoa. Anthem declares $SRPT's Exondys51 ""investigational and not medically necessary"" (h/t StreetAccount):  https://t.co/gOFoUkpCbv",en,[],['https://www.anthem.com/medicalpolicies/policies/mp_pw_c192386.htm'],[],13,39,25,[],['srpt'],https://twitter.com/megtirrell/status/784403579180376064,False,,0,,,,,,,,[],,,,
783278610652262401,783278610652262401,2016-10-04 17:42:28 IST,2016-10-04,17:42:28,+0530,102754598,johncendpts,John Carroll,,Summit shares up 70% on the LSE -- $SRPT deal  https://t.co/1fxIudlkmi,en,[],['http://endpts.com/sarepta-eyes-a-new-dmd-combo-approach-with-874m-summit-collaboration/'],[],1,9,5,[],['srpt'],https://twitter.com/JohnCendpts/status/783278610652262401,False,,0,,,,,,,,[],,,,
781928887668334592,781928887668334592,2016-10-01 00:19:09 IST,2016-10-01,00:19:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Heading into close, here‚Äôs your biotech top performers for Q3  (&gt;$300M mkt cap)  1. $CLCD 2. $SRPT 3. $TBRA 4. $CLVS 5. $PBYI",en,[],[],[],3,7,15,[],"['clcd', 'srpt', 'tbra', 'clvs', 'pbyi']",https://twitter.com/adamfeuerstein/status/781928887668334592,False,,0,,,,,,,,[],,,,
781220407340834816,781220407340834816,2016-09-29 01:23:54 IST,2016-09-29,01:23:54,+0530,44438256,matthewherper,Matthew Herper,,Re post-marketing studies and $SRPT: delays are routine. cc: @adamfeuerstein @FayCortez @SarahKarlin  https://t.co/0FONsxGxnr,en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}, {'screen_name': 'faycortez', 'name': 'michelle fay cortez', 'id': '295746612'}, {'screen_name': 'sarahkarlin', 'name': 'sarah karlin-smith', 'id': '42703163'}]",['http://jama.jamanetwork.com/article.aspx?articleid=1710442'],[],3,5,7,[],['srpt'],https://twitter.com/matthewherper/status/781220407340834816,False,,0,,,,,,,,[],,,,
781126855256571904,781126855256571904,2016-09-28 19:12:09 IST,2016-09-28,19:12:09,+0530,295746612,faycortez,Michelle Fay Cortez,,"So it begins: $SRPT's Exondys gets broad coverage from $CI. 1st major insurer backs drug w/o risk-sharing, age limits, pay for performance.",en,[],[],[],2,4,8,[],"['srpt', 'ci']",https://twitter.com/FayCortez/status/781126855256571904,False,,0,,,,,,,,[],,,,
780847642347761664,780847642347761664,2016-09-28 00:42:40 IST,2016-09-28,00:42:40,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Richard Mosicki, FDA‚Äôa Deputy Center Director for Science Ops, says eteplirsen approval was ""science-based decision.‚Äù $SRPT #STATHUBweek",en,[],[],[],4,25,42,['stathubweek'],['srpt'],https://twitter.com/adamfeuerstein/status/780847642347761664,False,,0,,,,,,,,[],,,,
780845271861297152,780845271861297152,2016-09-28 00:33:14 IST,2016-09-28,00:33:14,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$FOLD Crowley: Last thing I‚Äôd do is go to my board, use $SRPT as ex. of how to get drug approved. It was 1-off FDA exception. #STATHUBweek",en,[],[],[],4,8,15,['stathubweek'],"['fold', 'srpt']",https://twitter.com/adamfeuerstein/status/780845271861297152,False,,0,,,,,,,,[],,,,
780844134970056704,780844134970056704,2016-09-28 00:28:43 IST,2016-09-28,00:28:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"This #STATHUBweek FDA panel moderated by @pharmalot is trying to be a $SRPT bash party, but failing badly.",en,"[{'screen_name': 'pharmalot', 'name': 'pharmalot', 'id': '13171622'}]",[],[],0,5,12,['stathubweek'],['srpt'],https://twitter.com/adamfeuerstein/status/780844134970056704,False,,0,,,,,,,,[],,,,
780746644794908672,780746644794908672,2016-09-27 18:01:20 IST,2016-09-27,18:01:20,+0530,44438256,matthewherper,Matthew Herper,,Important piece in $srpt  https://t.co/ElzKzp7JvM,en,[],['https://twitter.com/resachs/status/780742202813054976'],[],3,6,6,[],['srpt'],https://twitter.com/matthewherper/status/780746644794908672,False,https://twitter.com/resachs/status/780742202813054976,0,,,,,,,,[],,,,
780510297056575488,780508644270039040,2016-09-27 02:22:10 IST,2016-09-27,02:22:10,+0530,17393219,dereklowe,Derek Lowe,,"@sciencescanner @JohnCendpts @JacobPlieth Who could deny darn near anyone an accelerated approval after $SRPT, is the problem. . .",en,"[{'screen_name': 'jacobplieth', 'name': 'jacob plieth', 'id': '873399943'}]",[],[],1,3,5,[],['srpt'],https://twitter.com/Dereklowe/status/780510297056575488,False,,0,,,,,,,,"[{'screen_name': 'sciencescanner', 'name': 'David Grainger', 'id': '71372467'}]",,,,
780487743164088320,780487743164088320,2016-09-27 00:52:33 IST,2016-09-27,00:52:33,+0530,102754598,johncendpts,John Carroll,,"$SRPT and Trump, two subjects always guaranteed to bring out the best in people on Twitter. Heartwarming.",en,[],[],[],1,0,11,[],['srpt'],https://twitter.com/JohnCendpts/status/780487743164088320,False,,0,,,,,,,,[],,,,
779333750970839040,779333750970839040,2016-09-23 20:27:00 IST,2016-09-23,20:27:00,+0530,102754598,johncendpts,John Carroll,,Thumbs Up/Thumbs Down: The FDA damaged itself badly with the Sarepta OK $SRPT  https://t.co/Uiyhsu3cLR,en,[],['http://endpts.com/thumbs-upthumbs-down-the-fda-damages-itself-badly-with-the-sarepta-ok/'],[],12,5,9,[],['srpt'],https://twitter.com/JohnCendpts/status/779333750970839040,False,,0,,,,,,,,[],,,,
779307492455186432,779307492455186432,2016-09-23 18:42:39 IST,2016-09-23,18:42:39,+0530,19988458,dougkass,Dougie Kass,,51 million short on $TWTR‚Ä¶‚Ä¶..17 million short on $SRPT‚Ä¶‚Ä¶bad week for the shorts.,en,[],[],[],7,15,42,[],[],https://twitter.com/DougKass/status/779307492455186432,False,,0,,,,,,,,[],,,,
779248890906288128,779205793421950976,2016-09-23 14:49:47 IST,2016-09-23,14:49:47,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@ByJonGardner You have been a longtime $SRPT bear. You were wrong about Exondys approval. I see no admission of your error here. Man up.,en,[],[],[],2,1,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/779248890906288128,False,,0,,,,,,,,"[{'screen_name': 'ByJonGardner', 'name': 'Jon Gardner', 'id': '960747870'}]",,,,
779134376390995969,779133161657610240,2016-09-23 07:14:45 IST,2016-09-23,07:14:45,+0530,274233761,bradloncar,Brad Loncar,,"@damiangarde There's an old Seinfeld episode about ""having hand"" (meaning the upper hand). $SRPT has got that right now.",en,[],[],[],1,0,13,[],['srpt'],https://twitter.com/bradloncar/status/779134376390995969,False,,0,,,,,,,,"[{'screen_name': 'damiangarde', 'name': 'Damian Garde', 'id': '529704495'}]",,,,
779133161657610240,779133161657610240,2016-09-23 07:09:55 IST,2016-09-23,07:09:55,+0530,274233761,bradloncar,Brad Loncar,,"Getting caught up and I see the $SRPT follow-on pricing. Wow, strong.",en,[],[],[],1,0,10,[],['srpt'],https://twitter.com/bradloncar/status/779133161657610240,False,,0,,,,,,,,[],,,,
779072137529143296,779072137529143296,2016-09-23 03:07:26 IST,2016-09-23,03:07:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT 4-5x oversubscribed, offering increased to $300M @ $59.75, per source.",en,[],[],[],7,40,55,[],['srpt'],https://twitter.com/adamfeuerstein/status/779072137529143296,False,,0,,,,,,,,[],,,,
779042151279710208,779042151279710208,2016-09-23 01:08:17 IST,2016-09-23,01:08:17,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT latest chatter on offering: well oversubscribed, upsizing, will price at modest discount to close.",en,[],[],[],4,6,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/779042151279710208,False,,0,,,,,,,,[],,,,
779000583931826177,779000583931826177,2016-09-22 22:23:06 IST,2016-09-22,22:23:06,+0530,14886375,stocktwits,Stocktwits,,Here are 12 of the most shorted stocks in the market right now. All shown on one chart:  https://t.co/LnEMWrxVM1  $GPRO $SRPT $CLVS,en,[],['http://stocktwits.com/ivanhoff/message/63197832?utm_medium=community-twitter&utm_source=t.co&utm_campaign=outboundteam'],[],1,16,23,[],"['gpro', 'srpt', 'clvs']",https://twitter.com/Stocktwits/status/779000583931826177,False,,0,,,,,,,,[],,,,
778746081890840576,778746081890840576,2016-09-22 05:31:48 IST,2016-09-22,05:31:48,+0530,44438256,matthewherper,Matthew Herper,,"FDA commish Robert Califf's call for retraction of $SRPT's pivotal study may be unprecedented, @ivanoransky writes.   https://t.co/tJt2tTO5wF",en,"[{'screen_name': 'ivanoransky', 'name': 'ivan oransky', 'id': '15859033'}]",['http://retractionwatch.com/2016/09/21/amid-controversial-sarepta-approval-decision-fda-head-calls-for-key-study-retraction/'],[],7,22,34,[],['srpt'],https://twitter.com/matthewherper/status/778746081890840576,False,,0,,,,,,,,[],,,,
778687841228378112,778687841228378112,2016-09-22 01:40:23 IST,2016-09-22,01:40:23,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT $225 million stock offering. With the expected sales of the voucher, the company should add around $500 million to its coffers.",en,[],[],[],5,7,18,[],['srpt'],https://twitter.com/adamfeuerstein/status/778687841228378112,False,,0,,,,,,,,[],,,,
778687642313498624,778687642313498624,2016-09-22 01:39:35 IST,2016-09-22,01:39:35,+0530,15971805,investorslive,Nathan Michaud,,$SRPT should be FULLY expected and over subscribed wouldn't be surprised to see it keep ripping.. but I'm not playing after hours,en,[],[],[],1,1,8,[],['srpt'],https://twitter.com/InvestorsLive/status/778687642313498624,False,,0,,,,,,,,[],,,,
778582750181797889,778582750181797889,2016-09-21 18:42:47 IST,2016-09-21,18:42:47,+0530,274233761,bradloncar,Brad Loncar,,"Biotech bad news speak. You haven't lost a patent ruling....you've decided to ""review its status."" $BMRN $SRPT",en,[],[],[],0,1,12,[],"['bmrn', 'srpt']",https://twitter.com/bradloncar/status/778582750181797889,False,,0,,,,,,,,[],,,,
778575069735899136,778575069735899136,2016-09-21 18:12:16 IST,2016-09-21,18:12:16,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT officially appoints Ed Kaye CEO (had been interim since last year)  https://t.co/ViHIsnTHMn,en,[],['https://www.sec.gov/Archives/edgar/data/873303/000119312516715424/d437079d8k.htm'],[],1,4,9,[],['srpt'],https://twitter.com/megtirrell/status/778575069735899136,False,,0,,,,,,,,[],,,,
778378394400620544,778378394400620544,2016-09-21 05:10:45 IST,2016-09-21,05:10:45,+0530,102754598,johncendpts,John Carroll,,"You're doing great. According to $SRPT fans, I'm 90% Neanderthal and 10% rat.  https://t.co/2bg6CanWqC",en,[],['https://twitter.com/Dereklowe/status/778377972935974912'],[],1,1,5,[],['srpt'],https://twitter.com/JohnCendpts/status/778378394400620544,False,https://twitter.com/Dereklowe/status/778377972935974912,0,,,,,,,,[],,,,
778302332178227200,778302332178227200,2016-09-21 00:08:30 IST,2016-09-21,00:08:30,+0530,102754598,johncendpts,John Carroll,,"If $SRPT can win an OK after the FDA clearly accused it of running a con, what's to stop any approval with the right lobbying campaign?",en,[],[],[],14,8,28,[],['srpt'],https://twitter.com/JohnCendpts/status/778302332178227200,False,,0,,,,,,,,[],,,,
778276205866942464,778276205866942464,2016-09-20 22:24:41 IST,2016-09-20,22:24:41,+0530,44438256,matthewherper,Matthew Herper,,Important point on $SRPT: Many are worried about lowering FDA standards. The few with rare diseases don't seem to be among the worriers.,en,[],[],[],11,8,20,[],['srpt'],https://twitter.com/matthewherper/status/778276205866942464,False,,0,,,,,,,,[],,,,
778252068721201152,778252068721201152,2016-09-20 20:48:47 IST,2016-09-20,20:48:47,+0530,873399943,jacobplieth,Jacob Plieth,,"After all the $SRPT and $TBRA excitement, I try to unravel the most important upcoming CAR-T event to date $KITE  https://t.co/gb9sFVeFN0",en,[],['http://ow.ly/SdgT304o9Vk'],[],5,21,34,[],"['srpt', 'tbra', 'kite']",https://twitter.com/JacobPlieth/status/778252068721201152,False,,0,,,,,,,,[],,,,
778235544698515462,778235544698515462,2016-09-20 19:43:07 IST,2016-09-20,19:43:07,+0530,47678782,megtirrell,Meg Tirrell,,I was so jazzed up yday at finally getting $SRPT FDA decision I think I was literally bouncing in my chair on air:  https://t.co/awQ5SaLi17,en,[],['http://video.cnbc.com/gallery/?video=3000552180&play=1'],[],7,7,51,[],['srpt'],https://twitter.com/megtirrell/status/778235544698515462,False,,0,,,,,,,,[],,,,
778227398726782976,778225278745280513,2016-09-20 19:10:45 IST,2016-09-20,19:10:45,+0530,102094857,adamfeuerstein,Adam Feuerstein,,". @ethanjweiss Please re-read the section of my $SRPT Mailbag explaining why Woodcock did what she did. She‚Äôs very smart, made right call.",en,"[{'screen_name': 'ethanjweiss', 'name': 'ethan weiss', 'id': '95292805'}]",[],[],6,3,19,[],['srpt'],https://twitter.com/adamfeuerstein/status/778227398726782976,False,,0,,,,,,,,[],,,,
778225642030661632,778225278745280513,2016-09-20 19:03:46 IST,2016-09-20,19:03:46,+0530,44438256,matthewherper,Matthew Herper,,".@adamfeuerstein If I'm wrong, it's on ""ignites"" not on ""civil war."" I hear disagreements go beyond $SRPT here.",en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",[],[],1,2,4,[],['srpt'],https://twitter.com/matthewherper/status/778225642030661632,False,,0,,,,,,,,[],,,,
778224885445304322,778224885445304322,2016-09-20 19:00:46 IST,2016-09-20,19:00:46,+0530,44438256,matthewherper,Matthew Herper,,"I wound up writing 2,000 words on $SRPT. Here they are.  https://t.co/ddy4zdvROT",en,[],['http://www.forbes.com/sites/matthewherper/2016/09/20/approving-a-muscular-dystrophy-drug-ignites-civil-war-at-the-fda/#488e8390353d'],[],3,14,18,[],['srpt'],https://twitter.com/matthewherper/status/778224885445304322,False,,0,,,,,,,,[],,,,
778213589291143168,778213589291143168,2016-09-20 18:15:52 IST,2016-09-20,18:15:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,As promised --&gt; Biotech Stock Mailbag: $SRPT Approval Edition  https://t.co/5bmCrXpHTB via Thanks for your questions.,en,[],['https://www.thestreet.com/story/13745109/1/biotech-stock-mailbag-sarepta-therapeutics-approval-edition.html'],[],7,7,34,[],['srpt'],https://twitter.com/adamfeuerstein/status/778213589291143168,False,,0,,,,,,,,[],,,,
778065356627775488,778065356627775488,2016-09-20 08:26:51 IST,2016-09-20,08:26:51,+0530,15971805,investorslive,Nathan Michaud,,Gift of the day  $SRPT amazing ripper on news today hopefully brings us another few trades this‚Ä¶  https://t.co/J6F1NzKj2L,en,[],['https://www.instagram.com/p/BKj9BgIgrul/'],[],0,0,10,[],['srpt'],https://twitter.com/InvestorsLive/status/778065356627775488,False,,0,,,,,,,,[],,,,
778039353436143616,778039353436143616,2016-09-20 06:43:31 IST,2016-09-20,06:43:31,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT CEO Ed Kaye told me he was pulled out of board mtg this morning to take FDA phone call about Exondys' approval. No advance warning.,en,[],[],[],5,11,65,[],['srpt'],https://twitter.com/adamfeuerstein/status/778039353436143616,False,,0,,,,,,,,[],,,,
777988966079270912,777988966079270912,2016-09-20 03:23:18 IST,2016-09-20,03:23:18,+0530,274233761,bradloncar,Brad Loncar,,$SRPT's last five years. What it looked like vs what it felt like.  https://t.co/i1aaTqi0IN,en,[],[],"['https://pbs.twimg.com/media/Csv4uw-UMAAajmS.jpg', 'https://pbs.twimg.com/media/Csv4wKiVYAApKcW.jpg']",5,3,26,[],['srpt'],https://twitter.com/bradloncar/status/777988966079270912,False,,1,https://pbs.twimg.com/media/Csv4uw-UMAAajmS.jpg,,,,,,,[],,,,
777980646119604224,777980646119604224,2016-09-20 02:50:14 IST,2016-09-20,02:50:14,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT CEO Dr Edward Kaye joins us tonight on @CNBCFastMoney. What do you want to know?,en,"[{'screen_name': 'cnbcfastmoney', 'name': ""cnbc's fast money"", 'id': '16732770'}]",[],[],18,10,27,[],['srpt'],https://twitter.com/megtirrell/status/777980646119604224,False,,0,,,,,,,,[],,,,
777974046713446400,777974046713446400,2016-09-20 02:24:01 IST,2016-09-20,02:24:01,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Many of you have emailed me or tweeted questions re: $SRPT. I will try to answer as many a possible in a mailbag column for tomorrow.,en,[],[],[],5,2,22,[],['srpt'],https://twitter.com/adamfeuerstein/status/777974046713446400,False,,0,,,,,,,,[],,,,
777972483131531264,777972483131531264,2016-09-20 02:17:48 IST,2016-09-20,02:17:48,+0530,274233761,bradloncar,Brad Loncar,,$SRPT has already reached out to buyers about the priority review voucher. Actively pursuing it.,en,[],[],[],2,11,20,[],['srpt'],https://twitter.com/bradloncar/status/777972483131531264,False,,0,,,,,,,,[],,,,
777964794351529984,777964794351529984,2016-09-20 01:47:15 IST,2016-09-20,01:47:15,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT taking page from Genzyme playbook w/ weight-based pricing. Exondys price goes up as kids grow.,en,[],[],[],1,11,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/777964794351529984,False,,0,,,,,,,,[],,,,
777963192815382528,777963192815382528,2016-09-20 01:40:53 IST,2016-09-20,01:40:53,+0530,44438256,matthewherper,Matthew Herper,,"$SRPT average cost per patient: $300,000. 10ml vial  $8,000",en,[],[],[],1,10,7,[],['srpt'],https://twitter.com/matthewherper/status/777963192815382528,False,,0,,,,,,,,[],,,,
777963113308049409,777963113308049409,2016-09-20 01:40:34 IST,2016-09-20,01:40:34,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT Exondys priced at approx $300K per yr, based on avg weight of patients starting therapy.",en,[],[],[],2,1,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/777963113308049409,False,,0,,,,,,,,[],,,,
777959965734633472,777959965734633472,2016-09-20 01:28:04 IST,2016-09-20,01:28:04,+0530,44438256,matthewherper,Matthew Herper,,What one of the best former pharma reporters thinks about the $SRPT decision.  https://t.co/wq1arSQdB2,en,[],['https://twitter.com/AlexBerenson/status/777959060163457025'],[],3,0,7,[],['srpt'],https://twitter.com/matthewherper/status/777959965734633472,False,0,0,,,,,,,,[],,,,
777955435802394624,777955435802394624,2016-09-20 01:10:04 IST,2016-09-20,01:10:04,+0530,15971805,investorslive,Nathan Michaud,,"$SRPT @CNBC interview 2:48PM guest vocabulary: ""buyout"" ""holding long term"" ""no selling""  thus $6 fade LOL couldn't have been more bullish",en,"[{'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}]",[],[],3,0,5,[],['srpt'],https://twitter.com/InvestorsLive/status/777955435802394624,False,,0,,,,,,,,[],,,,
777951631799361536,777951631799361536,2016-09-20 00:54:57 IST,2016-09-20,00:54:57,+0530,15971805,investorslive,Nathan Michaud,,$SRPT what a monster of a trader today,en,[],[],[],0,0,10,[],['srpt'],https://twitter.com/InvestorsLive/status/777951631799361536,False,,0,,,,,,,,[],,,,
777945882373328896,777945882373328896,2016-09-20 00:32:06 IST,2016-09-20,00:32:06,+0530,15971805,investorslive,Nathan Michaud,,That patience paid off today on his reaction to $SRPT pre halt - biggest career trade ever. Major props + reminder patience/passion !! (3/3),en,[],[],[],2,0,30,[],['srpt'],https://twitter.com/InvestorsLive/status/777945882373328896,False,,0,,,,,,,,[],,,,
777944727064678400,777944727064678400,2016-09-20 00:27:31 IST,2016-09-20,00:27:31,+0530,274233761,bradloncar,Brad Loncar,,Ed Kaye is going to be on Fast Money tonight. $SRPT,en,[],[],[],3,1,9,[],['srpt'],https://twitter.com/bradloncar/status/777944727064678400,False,,0,,,,,,,,[],,,,
777942889745776640,777942889745776640,2016-09-20 00:20:13 IST,2016-09-20,00:20:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Hat tip to Baird analyst Brian Skorney for getting the $SRPT call right. He was one of few sell siders to be believe Exondys approval.,en,[],[],[],1,4,22,[],['srpt'],https://twitter.com/adamfeuerstein/status/777942889745776640,False,,0,,,,,,,,[],,,,
777932407425081344,777932407425081344,2016-09-19 23:38:33 IST,2016-09-19,23:38:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"For nostalgia, first 2 substantive stories I wrote on $SRPT, then $AVII ‚Äî&gt;  https://t.co/BVATPMWnKO  &amp;   https://t.co/Sh8TZECnvr   April 2012",en,[],"['https://www.thestreet.com/story/11479635/1/genetic-fix-from-avi-biopharma-builds-key-muscle-function-protein.html', 'https://www.thestreet.com/story/11510797/1/biotech-stock-mailbag-avi-aveo-spectrum.html']",[],1,4,9,[],"['srpt', 'avii']",https://twitter.com/adamfeuerstein/status/777932407425081344,False,,0,,,,,,,,[],,,,
777931774743703552,777931774743703552,2016-09-19 23:36:03 IST,2016-09-19,23:36:03,+0530,44438256,matthewherper,Matthew Herper,,One precedent on $SRPT: This means dystrophin by Western blot is a valid endpoint for accelerated approval.,en,[],[],[],4,0,4,[],['srpt'],https://twitter.com/matthewherper/status/777931774743703552,False,,0,,,,,,,,[],,,,
777927557639499776,777927557639499776,2016-09-19 23:19:17 IST,2016-09-19,23:19:17,+0530,274233761,bradloncar,Brad Loncar,,I remember when @ianestepan quit his job to go work at $SRPT because he believed in it so much. Bold move no matter what the outcome.,en,"[{'screen_name': 'ianestepan', 'name': 'ian estepan', 'id': '166711687'}]",[],[],0,2,17,[],['srpt'],https://twitter.com/bradloncar/status/777927557639499776,False,,0,,,,,,,,[],,,,
777923663077277696,777923663077277696,2016-09-19 23:03:49 IST,2016-09-19,23:03:49,+0530,16827489,cboe,Cboe,,"Bulls in $AAPL, $FIT &amp; $ADBE calls, $LEN, $SRPT #FDA approval, $SWHC synthetic long call  https://t.co/c4sQAwKs8W  https://t.co/Vq0YHa7hda",en,[],['http://bit.ly/2cTKgNo'],[],0,7,9,['fda'],"['aapl', 'fit', 'adbe', 'len', 'srpt', 'swhc']",https://twitter.com/CBOE/status/777923663077277696,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/777922163227713537/pu/img/v2BpDJvQrQahUzgD.jpg,,,,,,,[],,,,
777918017191763968,777918017191763968,2016-09-19 22:41:22 IST,2016-09-19,22:41:22,+0530,42703163,sarahkarlin,Sarah Karlin-Smith,,re $SRPT - #FDA tells me all patients will get drug for confirmatory trial. different doses. NO PLACEBO. #pharma,en,[],[],[],1,7,9,"['fda', 'pharma']",['srpt'],https://twitter.com/SarahKarlin/status/777918017191763968,False,,0,,,,,,,,[],,,,
777915274381127681,777915274381127681,2016-09-19 22:30:29 IST,2016-09-19,22:30:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Perceptive's Joe Edelman on $SRPT: I always believed Exondys would be approved  https://t.co/5MpIAIgKAV Wall St's biggest $SRPT bull speaks,en,[],['https://www.thestreet.com/story/13744432/1/perceptive-s-joe-edelman-on-sarepta-i-always-believed-exondys-would-be-approved.html'],[],0,2,12,[],"['srpt', 'srpt']",https://twitter.com/adamfeuerstein/status/777915274381127681,False,,0,,,,,,,,[],,,,
777914380604338178,777914380604338178,2016-09-19 22:26:55 IST,2016-09-19,22:26:55,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I spoke w/ Perceptive Advisors‚Äô Joe Edelman about $SRPT and the future now that Exondys is approved. Q&amp;A here ‚Äî&gt;   https://t.co/5MpIAIgKAV,en,[],['https://www.thestreet.com/story/13744432/1/perceptive-s-joe-edelman-on-sarepta-i-always-believed-exondys-would-be-approved.html'],[],0,12,20,[],['srpt'],https://twitter.com/adamfeuerstein/status/777914380604338178,False,,0,,,,,,,,[],,,,
777900614483382272,777900614483382272,2016-09-19 21:32:13 IST,2016-09-19,21:32:13,+0530,3290364847,statnews,STAT,,A deep dive into $SRPT and Duchenne from @megtirrell &amp; @ldtimmerman  https://t.co/p28ddVf0IC  https://t.co/C7LXEwRJuN,en,"[{'screen_name': 'megtirrell', 'name': 'meg tirrell', 'id': '47678782'}, {'screen_name': 'ldtimmerman', 'name': 'luke timmerman', 'id': '50753411'}]",['http://bit.ly/2ddFY3Y'],['https://pbs.twimg.com/media/CsuofEdXEAALkHU.jpg'],1,8,5,[],['srpt'],https://twitter.com/statnews/status/777900614483382272,False,,1,https://pbs.twimg.com/media/CsuofEdXEAALkHU.jpg,,,,,,,[],,,,
777895051808477188,777895051808477188,2016-09-19 21:10:07 IST,2016-09-19,21:10:07,+0530,14886375,stocktwits,Stocktwits,,And here's what short interest for Sarepta Therapeutics looks like üò≥:  https://t.co/Z6eqvkqJlz  $SRPT,en,[],['http://stocktwits.com/jackdamn/message/62891915?utm_medium=community-twitter&utm_source=t.co&utm_campaign=outboundteam'],[],1,6,11,[],['srpt'],https://twitter.com/Stocktwits/status/777895051808477188,False,,0,,,,,,,,[],,,,
777887267713146880,777887267713146880,2016-09-19 20:39:11 IST,2016-09-19,20:39:11,+0530,102094857,adamfeuerstein,Adam Feuerstein,,You‚Äôre welcome. $SRPT easily most fascinating biotech story I‚Äôve ever covered. And I fully expect more twists/turns.  https://t.co/kG3ANlnXI7,en,[],['https://twitter.com/Bikepedler/status/777887015077412868'],[],8,10,59,[],['srpt'],https://twitter.com/adamfeuerstein/status/777887267713146880,False,https://twitter.com/Bikepedler/status/777887015077412868,0,,,,,,,,[],,,,
777880426283139072,777880426283139072,2016-09-19 20:12:00 IST,2016-09-19,20:12:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I have a rough picture of Exondys sales potential in my story ‚Äî&gt;  https://t.co/pVh8UEPgg3 $SRPT,en,[],['https://www.thestreet.com/story/13673965/1/sarepta-secures-fda-approval-for-duchenne-drug-after-long-fight.html'],[],3,9,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/777880426283139072,False,,0,,,,,,,,[],,,,
777880418607570944,777880418607570944,2016-09-19 20:11:58 IST,2016-09-19,20:11:58,+0530,44438256,matthewherper,Matthew Herper,,"One big result for all FDA reviews: Woodcock, who is industry friendly, just got a lot more power. $SRPT. Also, more reviewers may quit.",en,[],[],[],0,5,6,[],['srpt'],https://twitter.com/matthewherper/status/777880418607570944,False,,0,,,,,,,,[],,,,
777878659033993217,777878659033993217,2016-09-19 20:04:59 IST,2016-09-19,20:04:59,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"From April adcomm, this was the tell Woodcock was going to get Exondys approved --&gt;   https://t.co/JssMCr9PVU via @TheStreet $SRPT",en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['https://www.thestreet.com/story/13548113/1/how-sarepta-can-secure-speedy-fda-drug-approval-despite-a-negative-panel-vote.html'],[],5,7,17,[],['srpt'],https://twitter.com/adamfeuerstein/status/777878659033993217,False,,0,,,,,,,,[],,,,
777878412140707840,777878412140707840,2016-09-19 20:04:00 IST,2016-09-19,20:04:00,+0530,529704495,damiangarde,Damian Garde,,from FDA scientist's letter protesting $SRPT approval  https://t.co/Dwc7UeB60u,en,[],[],['https://pbs.twimg.com/media/CsuUIz2XEAAp334.jpg'],2,33,33,[],['srpt'],https://twitter.com/damiangarde/status/777878412140707840,False,,1,https://pbs.twimg.com/media/CsuUIz2XEAAp334.jpg,,,,,,,[],,,,
777877400877236224,777877400877236224,2016-09-19 19:59:59 IST,2016-09-19,19:59:59,+0530,873399943,jacobplieth,Jacob Plieth,,A sad day for scientific rigor $SRPT  https://t.co/acP6386wVe,en,[],['https://twitter.com/adamfeuerstein/status/777876175108595712'],[],2,3,11,[],['srpt'],https://twitter.com/JacobPlieth/status/777877400877236224,False,https://twitter.com/adamfeuerstein/status/777876175108595712,0,,,,,,,,[],,,,
777877189194878976,777877189194878976,2016-09-19 19:59:08 IST,2016-09-19,19:59:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT - Per FDA documents, Woodcock wanted to approve Exondys as early as May 4.",en,[],[],[],3,10,20,[],['srpt'],https://twitter.com/adamfeuerstein/status/777877189194878976,False,,0,,,,,,,,[],,,,
777876562066694164,777876562066694164,2016-09-19 19:56:39 IST,2016-09-19,19:56:39,+0530,15971805,investorslive,Nathan Michaud,,$SRPT and now we are going to have 6 months err I mean years of slow bleed back down and perma bulls defending lol,en,[],[],[],3,1,7,[],['srpt'],https://twitter.com/InvestorsLive/status/777876562066694164,False,,0,,,,,,,,[],,,,
777876480680267777,777876480680267777,2016-09-19 19:56:19 IST,2016-09-19,19:56:19,+0530,274233761,bradloncar,Brad Loncar,,It is absolutely amazing and fitting that the $SRPT decision came down to this.  https://t.co/r6wsQCrKoS,en,[],[],['https://pbs.twimg.com/media/CsuSebRUMAEXBj-.jpg'],1,4,28,[],['srpt'],https://twitter.com/bradloncar/status/777876480680267777,False,,1,https://pbs.twimg.com/media/CsuSebRUMAEXBj-.jpg,,,,,,,[],,,,
777876376594415616,777876376594415616,2016-09-19 19:55:55 IST,2016-09-19,19:55:55,+0530,243215442,mmarchioneap,Marilynn Marchione,,"A win for rare disease advocates: #FDA approves1st Duchenne #musculardystrophy drug, $SRPT Sarepta's eteplirsen  https://t.co/B49u38Rl82",en,[],['http://tinyurl.com/zboal5z'],[],1,6,6,"['fda', 'musculardystrophy']",['srpt'],https://twitter.com/MMarchioneAP/status/777876376594415616,False,,0,,,,,,,,[],,,,
777876175108595712,777876175108595712,2016-09-19 19:55:07 IST,2016-09-19,19:55:07,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT ‚Äî As theorized for months, Janet Woodcock pushed thru Exondys approval, over-ruling medical reviewers.  https://t.co/hteKlDvj63",en,[],['http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/206488_summary%20review_Redacted.pdf'],[],6,15,26,[],['srpt'],https://twitter.com/adamfeuerstein/status/777876175108595712,False,,0,,,,,,,,[],,,,
777875550719344640,777875550719344640,2016-09-19 19:52:38 IST,2016-09-19,19:52:38,+0530,102754598,johncendpts,John Carroll,,Congrats to $SRPT and its legion of supporters. I sincerely hope this drug does everything advocates say it does.,en,[],[],[],3,8,34,[],['srpt'],https://twitter.com/JohnCendpts/status/777875550719344640,False,,0,,,,,,,,[],,,,
777875262503387137,777875262503387137,2016-09-19 19:51:29 IST,2016-09-19,19:51:29,+0530,102754598,johncendpts,John Carroll,,Sarepta rockets up after FDA approves its controversial Duchenne drug $SRPT  https://t.co/RaJvtewfoN,en,[],['http://endpts.com/sarepta-rockets-up-after-fda-approves-its-controversial-duchenne-drug/'],[],0,16,10,[],['srpt'],https://twitter.com/JohnCendpts/status/777875262503387137,False,,0,,,,,,,,[],,,,
777873723487621120,777873723487621120,2016-09-19 19:45:22 IST,2016-09-19,19:45:22,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚Äî Let‚Äôs all quibble about western blots as every parent of an eligible DMD patient sprints to get their kid on APPROVED Exondys.,en,[],[],[],6,9,24,[],['srpt'],https://twitter.com/adamfeuerstein/status/777873723487621120,False,,0,,,,,,,,[],,,,
777871752298893312,777871752298893312,2016-09-19 19:37:32 IST,2016-09-19,19:37:32,+0530,44438256,matthewherper,Matthew Herper,,$SRPT approval looks close to the compromise I would have wanted: Company must do an RCT. Big question: What happens if it drags its feet?,en,[],[],[],1,8,8,[],['srpt'],https://twitter.com/matthewherper/status/777871752298893312,False,,0,,,,,,,,[],,,,
777871109140119552,777871109140119552,2016-09-19 19:34:59 IST,2016-09-19,19:34:59,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT up 75%  https://t.co/ElbA845Oxw,en,[],['https://twitter.com/adamfeuerstein/status/777868146841649154'],[],0,6,21,[],['srpt'],https://twitter.com/megtirrell/status/777871109140119552,False,https://twitter.com/adamfeuerstein/status/777868146841649154,0,,,,,,,,[],,,,
777870781586010113,777870781586010113,2016-09-19 19:33:41 IST,2016-09-19,19:33:41,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT secures FDA approval for duchenne drug after long fight  https://t.co/pVh8UEPgg3 My quick story, will update. Wowza!!!",en,[],['https://www.thestreet.com/story/13673965/1/sarepta-secures-fda-approval-for-duchenne-drug-after-long-fight.html'],[],3,25,44,[],['srpt'],https://twitter.com/adamfeuerstein/status/777870781586010113,False,,0,,,,,,,,[],,,,
777869797279223808,777869797279223808,2016-09-19 19:29:46 IST,2016-09-19,19:29:46,+0530,14031032,adamsinger,Adam Singer,,Congrats @given2tweet who called $SRPT like 4+ years ago before everyone. What a long journey it's been.,en,"[{'screen_name': 'given2tweet', 'name': 'matt rosen', 'id': '293294726'}]",[],[],1,0,13,[],['srpt'],https://twitter.com/AdamSinger/status/777869797279223808,False,,0,,,,,,,,[],,,,
777869536850800640,777869536850800640,2016-09-19 19:28:44 IST,2016-09-19,19:28:44,+0530,44438256,matthewherper,Matthew Herper,,$SRPT approved.   https://t.co/9YSYoIXKSd,en,[],['http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/UCM521263'],[],2,4,7,[],['srpt'],https://twitter.com/matthewherper/status/777869536850800640,False,,0,,,,,,,,[],,,,
777868931763580928,777868931763580928,2016-09-19 19:26:20 IST,2016-09-19,19:26:20,+0530,14031032,adamsinger,Adam Singer,,$SRPT approval:  https://t.co/8yseYVzrJQ  https://t.co/GST27qncUq,en,[],"['http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/206488Orig1s000ltr.pdf', 'https://twitter.com/AdamSinger/status/723133313938911232']",[],0,0,5,[],['srpt'],https://twitter.com/AdamSinger/status/777868931763580928,False,https://twitter.com/AdamSinger/status/723133313938911232,0,,,,,,,,[],,,,
777868146841649154,777868146841649154,2016-09-19 19:23:12 IST,2016-09-19,19:23:12,+0530,102094857,adamfeuerstein,Adam Feuerstein,,And there it is‚Ä¶. $SRPT eteplirsen approved.  FDA letter ‚Äî&gt;  https://t.co/KoxupYjLIb,en,[],['http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/206488Orig1s000ltr.pdf'],[],4,52,64,[],['srpt'],https://twitter.com/adamfeuerstein/status/777868146841649154,False,,0,,,,,,,,[],,,,
776097440579645441,776097440579645441,2016-09-14 22:07:03 IST,2016-09-14,22:07:03,+0530,130289750,maxnisen,Max Nisen,,"$SRPT up on Farkas out already feels straw-graspy to me, departure just as likely to be unrelated, and poss. rejection not down to just him.",en,[],[],[],4,3,10,[],['srpt'],https://twitter.com/MaxNisen/status/776097440579645441,False,,0,,,,,,,,[],,,,
776076047074922496,776076047074922496,2016-09-14 20:42:03 IST,2016-09-14,20:42:03,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT - You no doubt saw by now FDA confirm Farkas departure. Apologies, I was driving.",en,[],[],[],3,5,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/776076047074922496,False,,0,,,,,,,,[],,,,
776075140278857728,776075140278857728,2016-09-14 20:38:26 IST,2016-09-14,20:38:26,+0530,102754598,johncendpts,John Carroll,,"BTW, hats off to Benzinga for getting this into the arena. $SRPT",en,[],[],[],0,3,6,[],['srpt'],https://twitter.com/JohnCendpts/status/776075140278857728,False,,0,,,,,,,,[],,,,
776072478565212161,776072478565212161,2016-09-14 20:27:52 IST,2016-09-14,20:27:52,+0530,44438256,matthewherper,Matthew Herper,,Confirmed: FDA says Ronald Farkas is no longer at the agency. $SRPT,en,[],[],[],2,5,11,[],['srpt'],https://twitter.com/matthewherper/status/776072478565212161,False,,0,,,,,,,,[],,,,
776063471804907520,776063471804907520,2016-09-14 19:52:04 IST,2016-09-14,19:52:04,+0530,576436187,carolineylchen,Caroline Chen,,FDA confirms Ron Farkas is gone. -- via Bloomberg @business  $SRPT,en,"[{'screen_name': 'business', 'name': 'bloomberg', 'id': '34713362'}]",[],[],1,5,7,[],['srpt'],https://twitter.com/CarolineYLChen/status/776063471804907520,False,,0,,,,,,,,[],,,,
776062535279714305,776062535279714305,2016-09-14 19:48:21 IST,2016-09-14,19:48:21,+0530,13471032,jasonraznick,JasonRaznick,,Congrats to the @Benzinga @BenzingaPro team on breaking the $SRPT news yesterday!,en,"[{'screen_name': 'benzinga', 'name': 'benzinga', 'id': '44060322'}, {'screen_name': 'benzingapro', 'name': 'benzingapro', 'id': '248836670'}]",[],[],2,2,7,[],['srpt'],https://twitter.com/JasonRaznick/status/776062535279714305,False,,0,,,,,,,,[],,,,
776056595717492736,776056595717492736,2016-09-14 19:24:45 IST,2016-09-14,19:24:45,+0530,102094857,adamfeuerstein,Adam Feuerstein,,FDA not responding to my email queries re: Farkas. That‚Äôs unusual. $SRPT,en,[],[],[],7,7,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/776056595717492736,False,,0,,,,,,,,[],,,,
776026993716502528,776026993716502528,2016-09-14 17:27:07 IST,2016-09-14,17:27:07,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT up 14% pre mkt on this speculation  https://t.co/5lO5uym7Iz,en,[],['https://twitter.com/artkrieg/status/775815974272458754'],[],1,2,13,[],['srpt'],https://twitter.com/megtirrell/status/776026993716502528,False,https://twitter.com/artkrieg/status/775815974272458754,0,,,,,,,,[],,,,
776026731841028096,776026731841028096,2016-09-14 17:26:05 IST,2016-09-14,17:26:05,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"A weird twist to the $SRPT FDA Farkas story ‚Äî Since last night, you can‚Äôt call into Parexel‚Äôs main phone line.",en,[],[],[],2,3,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/776026731841028096,False,,0,,,,,,,,[],,,,
776017142550585344,776009655663427585,2016-09-14 16:47:59 IST,2016-09-14,16:47:59,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@John_Hempton Eteplirsen isn‚Äôt Addyi. We‚Äôre taking about kids with rare, fatal disease, not women who want more sex. Read my $SRPT stories.",en,[],[],[],6,1,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/776017142550585344,False,,0,,,,,,,,"[{'screen_name': 'John_Hempton', 'name': 'John_Hempton', 'id': '15003446'}]",,,,
776009655663427585,776009655663427585,2016-09-14 16:18:14 IST,2016-09-14,16:18:14,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT Drug Critic Departs FDA, Raising Hope for Approval  https://t.co/gsjs6C70oq The latest plot twist in the never-ending eteplirsen story.",en,[],['https://www.thestreet.com/story/13728022/1/sarepta-drug-critic-departs-fda-raising-hope-for-approval.html'],[],1,28,29,[],['srpt'],https://twitter.com/adamfeuerstein/status/776009655663427585,False,,0,,,,,,,,[],,,,
775872830131044352,775872830131044352,2016-09-14 07:14:32 IST,2016-09-14,07:14:32,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Tweeting at me with death wishes for Ron Farkas will get you blocked. Grow up. $SRPT.,en,[],[],[],4,2,38,[],['srpt'],https://twitter.com/adamfeuerstein/status/775872830131044352,False,,0,,,,,,,,[],,,,
775864134361554944,775864134361554944,2016-09-14 06:39:59 IST,2016-09-14,06:39:59,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT -- still no iron-clad confirmation of Ron Farkas' FDA exit but @BenzingaPro reporting he did leave and I believe it to be true.,en,"[{'screen_name': 'benzingapro', 'name': 'benzingapro', 'id': '248836670'}]",[],[],5,18,35,[],['srpt'],https://twitter.com/adamfeuerstein/status/775864134361554944,False,,0,,,,,,,,[],,,,
775858600451465217,775858600451465217,2016-09-14 06:17:59 IST,2016-09-14,06:17:59,+0530,44060322,benzinga,Benzinga,,"Dr. Ron Farkas, Eteplirsen's Harshest Critic, Has Left The FDA  https://t.co/kFnczcZYDF $SRPT",en,[],['http://benzinga.com/z/8455408'],[],2,7,19,[],['srpt'],https://twitter.com/Benzinga/status/775858600451465217,False,,0,,,,,,,,[],,,,
775816683675979777,775815974272458754,2016-09-14 03:31:26 IST,2016-09-14,03:31:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,". @ArtKrieg it would suggest approval, agreed, but i want confirmation of Farkas' exit. Still waiting. Never short of drama in $SRPT",en,"[{'screen_name': 'artkrieg', 'name': 'art krieg', 'id': '2966010609'}]",[],[],4,2,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/775816683675979777,False,,0,,,,,,,,[],,,,
775810733267230724,775810733267230724,2016-09-14 03:07:47 IST,2016-09-14,03:07:47,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT -- other side of Ron Farkas rumor is that he joined Paraxel. I have asked co. for comment, still waiting for response.",en,[],[],[],5,10,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/775810733267230724,False,,0,,,,,,,,[],,,,
775809580035026948,775809580035026948,2016-09-14 03:03:12 IST,2016-09-14,03:03:12,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT -- Be careful bc there is a false Ron Farkas LinkedIn profile floating around.,en,[],[],[],1,6,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/775809580035026948,False,,0,,,,,,,,[],,,,
775809353085440001,775809353085440001,2016-09-14 03:02:18 IST,2016-09-14,03:02:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT -- I have asked but FDA has not yet confirmed if eteplirsen reviewer Ron Farkas left agency.,en,[],[],[],6,9,19,[],['srpt'],https://twitter.com/adamfeuerstein/status/775809353085440001,False,,0,,,,,,,,[],,,,
775315016576864258,775315016576864258,2016-09-12 18:17:59 IST,2016-09-12,18:17:59,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Voting results from my biotech sentiment polls Friday --&gt;   https://t.co/h7fhur5TOM $LLY $IBB $SRPT $GILD $KITE,en,[],['https://www.thestreet.com/story/13702897/1/five-questions-and-answers-take-a-measure-of-biotech-investor-sentiment.html'],[],0,12,11,[],"['lly', 'ibb', 'srpt', 'gild', 'kite']",https://twitter.com/adamfeuerstein/status/775315016576864258,False,,0,,,,,,,,[],,,,
774239959691780096,774239959691780096,2016-09-09 19:06:05 IST,2016-09-09,19:06:05,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I made this list for you --&gt; 10 must-know biotech stock events to close out 2016  https://t.co/YBM7BZNhNE $LLY $BLUE $SRPT $CELG  $KITE,en,[],['https://www.thestreet.com/story/13699729/1/10-must-know-biotech-stock-events-to-close-out-2016.html'],[],5,39,87,[],"['lly', 'blue', 'srpt', 'celg', 'kite']",https://twitter.com/adamfeuerstein/status/774239959691780096,False,,0,,,,,,,,[],,,,
773252266765717504,773252266765717504,2016-09-07 01:41:21 IST,2016-09-07,01:41:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT on agenda of Morgan Stanley h/c conference Sept. 14 but co. spox tells me quiet period still intact, no presentation w/o FDA news.",en,[],[],[],4,11,27,[],['srpt'],https://twitter.com/adamfeuerstein/status/773252266765717504,False,,0,,,,,,,,[],,,,
773101807602196484,773101807602196484,2016-09-06 15:43:29 IST,2016-09-06,15:43:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SANN intends to ""re-engage"" with FDA re: accelerated approval filing of Raxone in DMD. Speaking of... $SRPT? FDA, did you forget?",en,[],[],[],2,8,24,[],"['sann', 'srpt']",https://twitter.com/adamfeuerstein/status/773101807602196484,False,,0,,,,,,,,[],,,,
771146660428722177,771107801166782465,2016-09-01 06:14:25 IST,2016-09-01,06:14:25,+0530,14031032,adamsinger,Adam Singer,,"@Pharmdca @GSD_MDPhD @sfef84 @HedgeMind @RedDogT3 Twitter was right on $rlyp, $mkto, $srpt, $petx and others while ws dead wrong. Love it.",en,[],[],[],2,0,7,[],"['rlyp', 'mkto', 'srpt', 'petx']",https://twitter.com/AdamSinger/status/771146660428722177,False,,0,,,,,,,,"[{'screen_name': 'Pharmdca', 'name': 'Pharm. D', 'id': '1884013189'}, {'screen_name': 'GSD_MDPhD', 'name': 'Darshan_Singh', 'id': '564953773'}, {'screen_name': 'sfef84', 'name': 'Steven Feffer', 'id': '23249152'}, {'screen_name': 'HedgeMind', 'name': 'HedgeMind', 'id': '2272207286'}, {'screen_name': 'RedDogT3', 'name': 'Scott Redler', 'id': '455824771'}]",,,,
769589989864673280,769546752248524800,2016-08-27 23:08:46 IST,2016-08-27,23:08:46,+0530,14031032,adamsinger,Adam Singer,,Made it to the tie store. Oh my god ties are expensive - I could buy a few shares of $srpt or have this.  https://t.co/CiBfBw3nWQ,en,[],[],['https://pbs.twimg.com/media/Cq4iATVUMAAmPFW.jpg'],12,1,15,[],['srpt'],https://twitter.com/AdamSinger/status/769589989864673280,False,,1,https://pbs.twimg.com/media/Cq4iATVUMAAmPFW.jpg,,,,,,,[],,,,
768481319676510208,768481319676510208,2016-08-24 21:43:18 IST,2016-08-24,21:43:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT ‚Äî Today‚Äôs stock move higher triggered by someone selling puts to get longer, I‚Äôm told.",en,[],[],[],2,6,21,[],['srpt'],https://twitter.com/adamfeuerstein/status/768481319676510208,False,,0,,,,,,,,[],,,,
766791899294208000,766791899294208000,2016-08-20 05:50:09 IST,2016-08-20,05:50:09,+0530,274233761,bradloncar,Brad Loncar,,Think this idea of monthly updates for which a PDUFA date has already passed is probably a good idea. $SRPT  https://t.co/0xq96O2vxr,en,[],['http://www.biocentury.com/dailynews/politics/2016-08-19/ppmd-asks-fda-to-clarify-dmd-decisions'],[],6,7,20,[],['srpt'],https://twitter.com/bradloncar/status/766791899294208000,False,,0,,,,,,,,[],,,,
763769689348706304,763769689348706304,2016-08-11 21:40:58 IST,2016-08-11,21:40:58,+0530,44438256,matthewherper,Matthew Herper,,".@adamfeuerstein and I are both away next week. That guarantees $SRPT news, right?",en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",[],[],5,6,26,[],['srpt'],https://twitter.com/matthewherper/status/763769689348706304,False,,0,,,,,,,,[],,,,
763714858818891776,763311592708661248,2016-08-11 18:03:06 IST,2016-08-11,18:03:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@bio_clouseau The Cowen note on $SRPT is absurd.,en,[],[],[],1,7,19,[],['srpt'],https://twitter.com/adamfeuerstein/status/763714858818891776,False,,0,,,,,,,,"[{'screen_name': 'bio_clouseau', 'name': 'M', 'id': '43475268'}]",,,,
763372996887281664,763372996887281664,2016-08-10 19:24:39 IST,2016-08-10,19:24:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT -- this DPO mishegas is POSITIVE for eteplirsen. FDA staff would only file internal protest if decision makers were leaning approval.,en,[],[],[],9,20,55,[],['srpt'],https://twitter.com/adamfeuerstein/status/763372996887281664,False,,0,,,,,,,,[],,,,
763017290472357888,763017290472357888,2016-08-09 19:51:12 IST,2016-08-09,19:51:12,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Mid-August. Pondering these three graphs depicting eteplirsen scenarios.  https://t.co/vy4tGN7M76,en,[],[],"['https://pbs.twimg.com/media/CpbILI_WgAAZzZK.jpg', 'https://pbs.twimg.com/media/CpbILJKWAAAQfp6.jpg', 'https://pbs.twimg.com/media/CpbILQ1XgAEx8PK.jpg']",11,7,26,[],['srpt'],https://twitter.com/adamfeuerstein/status/763017290472357888,False,,1,https://pbs.twimg.com/media/CpbILI_WgAAZzZK.jpg,,,,,,,[],,,,
760852054239748096,760852054239748096,2016-08-03 20:27:20 IST,2016-08-03,20:27:20,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Today‚Äôs $SRPT chatter focuses on start of enrollment in ESSENCE study of exons 45 &amp; 53. Trial design favorable -&gt;  https://t.co/TK1UC6Ra70,en,[],['https://clinicaltrials.gov/ct2/show/NCT02500381?term=sarepta&rank=1'],[],5,14,18,[],['srpt'],https://twitter.com/adamfeuerstein/status/760852054239748096,False,,0,,,,,,,,[],,,,
758652599784660992,758652599784660992,2016-07-28 18:47:29 IST,2016-07-28,18:47:29,+0530,44438256,matthewherper,Matthew Herper,,"$BMRN CEO JJB on Kyndrisa: ""‚ÄúCall it a mistake‚Äìfine.‚Äù  https://t.co/O5P3PWnPIO $SRPT",en,[],['http://www.forbes.com/sites/matthewherper/2016/07/28/from-rare-to-great/#784611aa256a'],[],7,11,10,[],"['bmrn', 'srpt']",https://twitter.com/matthewherper/status/758652599784660992,False,,0,,,,,,,,[],,,,
753632986881548288,753631972820418560,2016-07-14 22:21:20 IST,2016-07-14,22:21:20,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"B/c @matthewherper is too polite to say it, I will. To $SRPT fans who can‚Äôt deal w/ anyone who disagrees w/ them...  https://t.co/he9dC6w2MJ",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",[],['https://pbs.twimg.com/tweet_video_thumb/CnVwsTVWIAAfett.jpg'],5,2,12,[],['srpt'],https://twitter.com/adamfeuerstein/status/753632986881548288,False,,1,https://pbs.twimg.com/tweet_video_thumb/CnVwsTVWIAAfett.jpg,,,,,,,[],,,,
753631972820418560,753631972820418560,2016-07-14 22:17:18 IST,2016-07-14,22:17:18,+0530,44438256,matthewherper,Matthew Herper,,FYI for $SRPT people: I don't think there is any read-through from Santhera to Sarepta.,en,[],[],[],3,2,16,[],['srpt'],https://twitter.com/matthewherper/status/753631972820418560,False,,0,,,,,,,,[],,,,
753620733083934720,753620733083934720,2016-07-14 21:32:39 IST,2016-07-14,21:32:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Baird‚Äôs Skorney defends $SRPT, says $SANN.SW delay no impact on FDA eteplirsen review.   And w/ that, $SRPT Twitter trolls can kiss my ass.",en,[],[],[],2,7,23,[],"['srpt', 'sann.sw', 'srpt']",https://twitter.com/adamfeuerstein/status/753620733083934720,False,,0,,,,,,,,[],,,,
753618336487997441,753589182879109120,2016-07-14 21:23:07 IST,2016-07-14,21:23:07,+0530,44438256,matthewherper,Matthew Herper,,"More from Simos: Approving $SRPT invites other companies to delay, ignore FDA, + rally patient support. @adamfeuerstein",en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",[],[],5,1,6,[],['srpt'],https://twitter.com/matthewherper/status/753618336487997441,False,,0,,,,,,,,[],,,,
753589182879109120,753589182879109120,2016-07-14 19:27:16 IST,2016-07-14,19:27:16,+0530,102094857,adamfeuerstein,Adam Feuerstein,,RBC‚Äôs Simos: $SANN.SW delay shows FDA is NOT acting differently or more lenient w/ DMD drugs. $SRPT rejection next.  https://t.co/TiyNeuEywS,en,[],[],['https://pbs.twimg.com/media/CnVJFxGXgAAD3WR.jpg'],10,7,12,[],"['sann.sw', 'srpt']",https://twitter.com/adamfeuerstein/status/753589182879109120,False,,1,https://pbs.twimg.com/media/CnVJFxGXgAAD3WR.jpg,,,,,,,[],,,,
752950124184297472,752950124184297472,2016-07-13 01:07:53 IST,2016-07-13,01:07:53,+0530,44418062,naturebiotech,Nature Biotechnology,,"#Duchenne drugs at the crossroads, as newer agents advance - @Cormac_Sheridan  https://t.co/DeINSX2DGn $SRPT $BMRN  https://t.co/vTUQc25fW2",en,"[{'screen_name': 'cormac_sheridan', 'name': 'cormac sheridan', 'id': '308526080'}]",['http://rdcu.be/jgwd'],['https://pbs.twimg.com/media/CnMCjhTWgAAk1KT.jpg'],0,13,16,['duchenne'],"['srpt', 'bmrn']",https://twitter.com/NatureBiotech/status/752950124184297472,False,,1,https://pbs.twimg.com/media/CnMCjhTWgAAk1KT.jpg,,,,,,,[],,,,
752521241190367232,752521241190367232,2016-07-11 20:43:39 IST,2016-07-11,20:43:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT opposite of $CYTR in that passage of time is a positive. Odds of ‚Äúdystrophin total zero‚Äù lower with each passing no news day.,en,[],[],[],9,9,32,[],"['srpt', 'cytr']",https://twitter.com/adamfeuerstein/status/752521241190367232,False,,0,,,,,,,,[],,,,
750835995931766784,750835668406956032,2016-07-07 05:07:05 IST,2016-07-07,05:07:05,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@SarahKarlin I hope you apologized for almost running him over, then asked him about $SRPT.",en,[],[],[],2,1,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/750835995931766784,False,,0,,,,,,,,"[{'screen_name': 'SarahKarlin', 'name': 'Sarah Karlin-Smith', 'id': '42703163'}]",,,,
750358353197600768,750358353197600768,2016-07-05 21:29:07 IST,2016-07-05,21:29:07,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚Äî Some of you asked me about the recent uptick in the stock price. Here is an explanation ‚Äî&gt;  https://t.co/uFFYmzvyQi,en,[],['https://www.thestreet.com/story/13629174/1/sarepta-stock-price-lifted-by-the-no-bad-news-is-good-news-argument.html'],[],4,13,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/750358353197600768,False,,0,,,,,,,,[],,,,
749311714336739328,749311714336739328,2016-07-03 00:10:08 IST,2016-07-03,00:10:08,+0530,274233761,bradloncar,Brad Loncar,,"Guessing this already made the rounds yesterday, but WSJ has another editorial on $SRPT. Fair points on pbo ethics.  https://t.co/cUKp1B4Tok",en,[],['http://www.wsj.com/articles/wheres-the-drug-fda-1467413266'],[],5,8,18,[],['srpt'],https://twitter.com/bradloncar/status/749311714336739328,False,,0,,,,,,,,[],,,,
747397087348817920,747397087348817920,2016-06-27 17:22:06 IST,2016-06-27,17:22:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Biotech short interest Top 5 (% of float) as of June 15:  $SRPT 48.3% $ZIOP 31.8% $INVA 30.3% $IMMU 29% $AXON 27%  h/t Jefferies,en,[],[],[],5,12,16,[],"['srpt', 'ziop', 'inva', 'immu', 'axon']",https://twitter.com/adamfeuerstein/status/747397087348817920,False,,0,,,,,,,,[],,,,
746424664537210880,746424664537210880,2016-06-25 00:58:02 IST,2016-06-25,00:58:02,+0530,274233761,bradloncar,Brad Loncar,,"Out of 189 stocks in the $IBB, 5 are currently green. $SRPT $XBIT $TLGT $TRVN and $CHMA. And not by much.  https://t.co/M9VKwHOthd",en,[],['https://docs.google.com/spreadsheets/d/1Lxm6Oufzu_XWsHN0_9R3uh3kFJYB4TsNcFkzktkPf-0/edit?usp=sharing'],[],5,5,17,[],"['ibb', 'srpt', 'xbit', 'tlgt', 'trvn', 'chma']",https://twitter.com/bradloncar/status/746424664537210880,False,,0,,,,,,,,[],,,,
746383633259368448,746383633259368448,2016-06-24 22:14:59 IST,2016-06-24,22:14:59,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT -- Baird's Skorney says FDA approval decision on eteplirsen is ""imminent."" Defined thusly...  https://t.co/ZK9f7SNM6c",en,[],[],['https://pbs.twimg.com/media/Cluv9OGWMAAS2E2.jpg'],5,19,41,[],['srpt'],https://twitter.com/adamfeuerstein/status/746383633259368448,False,,1,https://pbs.twimg.com/media/Cluv9OGWMAAS2E2.jpg,,,,,,,[],,,,
746381113459871745,746381113459871745,2016-06-24 22:04:59 IST,2016-06-24,22:04:59,+0530,102754598,johncendpts,John Carroll,,"Skorney says $SRPT FDA decision is ""imminent""",en,[],[],[],3,15,14,[],['srpt'],https://twitter.com/JohnCendpts/status/746381113459871745,False,,0,,,,,,,,[],,,,
746057858551320576,746057858551320576,2016-06-24 00:40:29 IST,2016-06-24,00:40:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Push for Duchenne Drug Approval Helped by Clinical Trial Changes  https://t.co/dJ9x8PGiJ1,en,[],['https://www.thestreet.com/story/13618395/1/sarepta-push-for-duchenne-drug-approval-helped-by-clinical-trial-changes.html'],[],5,23,25,[],['srpt'],https://twitter.com/adamfeuerstein/status/746057858551320576,False,,0,,,,,,,,[],,,,
745943745087029248,745943745087029248,2016-06-23 17:07:02 IST,2016-06-23,17:07:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,That Jefferies note on $SRPT ‚Äî Totally wrong.,en,[],[],[],7,7,18,[],['srpt'],https://twitter.com/adamfeuerstein/status/745943745087029248,False,,0,,,,,,,,[],,,,
741231544883351553,741231544883351553,2016-06-10 17:02:26 IST,2016-06-10,17:02:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"This week's Biotech Stock Mailbag: SRPT! Can't Get Enough of $SRPT. More $SRPT. And Gilead, too  https://t.co/IOOB3iUBTS via @TheStreet",en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['https://www.thestreet.com/story/13602879/1/biotech-stock-mailbag-sarepta-always-more-sarepta-and-gilead-too.html'],[],1,12,19,[],"['srpt', 'srpt']",https://twitter.com/adamfeuerstein/status/741231544883351553,False,,0,,,,,,,,[],,,,
740640064020074496,740640064020074496,2016-06-09 01:52:06 IST,2016-06-09,01:52:06,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT looking to raise money after stock bump on FDA data request: plans $37.5m offering through Credit Suisse, Baird",en,[],[],[],2,11,12,[],['srpt'],https://twitter.com/megtirrell/status/740640064020074496,False,,0,,,,,,,,[],,,,
740252696444346369,740239459854258177,2016-06-08 00:12:50 IST,2016-06-08,00:12:50,+0530,102094857,adamfeuerstein,Adam Feuerstein,,. @BiotechBbqBeats @matthewherper Bulls &amp; bears should be happy w/ FDA $SRPT compromise. Eteplirsen dystrophin data will decide approval.,en,"[{'screen_name': 'biotechbbqbeats', 'name': 'insain hot sauce', 'id': '831314602637955073'}, {'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",[],[],2,2,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/740252696444346369,False,,0,,,,,,,,[],,,,
740231163344760833,740231163344760833,2016-06-07 22:47:16 IST,2016-06-07,22:47:16,+0530,44438256,matthewherper,Matthew Herper,,Nobody Should Have Any Certainty About Sarepta $SRPT  https://t.co/5ys4aRTVPK,en,[],['http://www.forbes.com/sites/matthewherper/2016/06/07/nobody-should-have-any-certainty-about-sarepta/#5f7e0ee856a8'],[],6,12,23,[],['srpt'],https://twitter.com/matthewherper/status/740231163344760833,False,,0,,,,,,,,[],,,,
740153317809131520,740153317809131520,2016-06-07 17:37:57 IST,2016-06-07,17:37:57,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT , FDA Compromise on Plan to Secure Duchenne Drug Approval  https://t.co/56QrvBvFuG via @TheStreet",en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['https://www.thestreet.com/story/13598536/1/sarepta-fda-compromise-on-plan-to-secure-duchenne-drug-approval.html'],[],6,33,39,[],['srpt'],https://twitter.com/adamfeuerstein/status/740153317809131520,False,,0,,,,,,,,[],,,,
740152421490524161,740152421490524161,2016-06-07 17:34:23 IST,2016-06-07,17:34:23,+0530,102094857,adamfeuerstein,Adam Feuerstein,,My $SRPT story coming in a sec..,en,[],[],[],1,2,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/740152421490524161,False,,0,,,,,,,,[],,,,
740018180215574528,740018180215574528,2016-06-07 08:40:57 IST,2016-06-07,08:40:57,+0530,102754598,johncendpts,John Carroll,,"For the record, I've said for some time now that $SRPT's only chance at an OK now was due to lobbying campaign. Today's action proved that",en,[],[],[],4,0,9,[],['srpt'],https://twitter.com/JohnCendpts/status/740018180215574528,False,,0,,,,,,,,[],,,,
740008985500254209,740008985500254209,2016-06-07 08:04:25 IST,2016-06-07,08:04:25,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT new dystrophin production threshold will be confirmation of ph2 data, NOT Becker's like dystrophin levels. Reasonable hurdle to meet.",en,[],[],[],3,13,36,[],['srpt'],https://twitter.com/adamfeuerstein/status/740008985500254209,False,,0,,,,,,,,[],,,,
740008520238702592,740008520238702592,2016-06-07 08:02:34 IST,2016-06-07,08:02:34,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT -- today's development is good news, step towards eteplirsen approval. Confirms FDA &amp; SRPT are compromising, working together.",en,[],[],[],4,37,69,[],['srpt'],https://twitter.com/adamfeuerstein/status/740008520238702592,False,,0,,,,,,,,[],,,,
739938547373867008,739938547373867008,2016-06-07 03:24:31 IST,2016-06-07,03:24:31,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Daughter's HS graduation &gt; $SRPT. Back tomorrow. Proud dad.,en,[],[],[],5,2,67,[],['srpt'],https://twitter.com/adamfeuerstein/status/739938547373867008,False,,0,,,,,,,,[],,,,
739937434000101376,739937434000101376,2016-06-07 03:20:06 IST,2016-06-07,03:20:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT -- I called it.  https://t.co/STjOJkDodJ,en,[],['https://www.thestreet.com/story/13584754/1/a-what-s-next-scenario-for-the-delayed-sarepta-duchenne-drug-review.html'],[],19,10,51,[],['srpt'],https://twitter.com/adamfeuerstein/status/739937434000101376,False,,0,,,,,,,,[],,,,
739936562566172672,739936562566172672,2016-06-07 03:16:38 IST,2016-06-07,03:16:38,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT up 28% after hrs on announcing FDA asked for dystrophin data from ongoing confirmatory study  https://t.co/HvchZBL98z,en,[],['http://investorrelations.sarepta.com/mobile.view?c=64231&v=203&d=1&id=2175522'],[],6,20,24,[],['srpt'],https://twitter.com/megtirrell/status/739936562566172672,False,,0,,,,,,,,[],,,,
738464524303486976,738464524303486976,2016-06-03 01:47:17 IST,2016-06-03,01:47:17,+0530,102754598,johncendpts,John Carroll,,"So $SRPT shares tanked, dropping 26% on the compassionate use update from the FDA. Twig snaps, everybody stampedes.",en,[],[],[],5,3,7,[],['srpt'],https://twitter.com/JohnCendpts/status/738464524303486976,False,,0,,,,,,,,[],,,,
738436859798294528,738436859798294528,2016-06-02 23:57:21 IST,2016-06-02,23:57:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT ‚Äî A savvy, knowledgable reader adds to today‚Äôs cost-recovery debate. (I hope you can read this.)  https://t.co/uE2qCPTSJm",en,[],[],['https://pbs.twimg.com/media/Cj90UbYWgAAP5xP.jpg'],6,19,65,[],['srpt'],https://twitter.com/adamfeuerstein/status/738436859798294528,False,,1,https://pbs.twimg.com/media/Cj90UbYWgAAP5xP.jpg,,,,,,,[],,,,
738422737782312960,738422737782312960,2016-06-02 23:01:14 IST,2016-06-02,23:01:14,+0530,42703163,sarahkarlin,Sarah Karlin-Smith,,this has always been the case. FDA made no policy changes in docs released today. ppl way overthinking ties to $SRPt  https://t.co/hZO1yBsxM6,en,[],['https://twitter.com/CMichaelGibson/status/738422334567092225'],[],2,4,13,[],['srpt'],https://twitter.com/SarahKarlin/status/738422737782312960,False,https://twitter.com/CMichaelGibson/status/738422334567092225,0,,,,,,,,[],,,,
738408594991906817,738408594991906817,2016-06-02 22:05:02 IST,2016-06-02,22:05:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Baird‚Äôs B Skorney defends $SRPT, says expanded access w/ cost recovery would be + for company. Neg. market reaction ‚Äúfundamentally wrong.""",en,[],[],[],3,6,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/738408594991906817,False,,0,,,,,,,,[],,,,
738378169993048065,738378169993048065,2016-06-02 20:04:08 IST,2016-06-02,20:04:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Sinks on Speculation Over 'Compassionate Use' of Duchenne Drug  https://t.co/rJwMXJLccb via @TheStreet,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['https://www.thestreet.com/story/13594214/1/sarepta-sinks-on-speculation-over-compassionate-use-of-duchenne-drug.html'],[],4,6,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/738378169993048065,False,,0,,,,,,,,[],,,,
738372405714911232,738372405714911232,2016-06-02 19:41:14 IST,2016-06-02,19:41:14,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT down 19% on concerns FDA's finalized compassionate use procedures bode poorly for eteplirsen accelerated approval,en,[],[],[],4,11,12,[],['srpt'],https://twitter.com/megtirrell/status/738372405714911232,False,,0,,,,,,,,[],,,,
738366810484035584,738366810484035584,2016-06-02 19:19:00 IST,2016-06-02,19:19:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"It would be a shame if I had to start blocking $SRPT fans from my Twitter feed. Tread carefully, people. You know I‚Äôll do it.",en,[],[],[],2,2,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/738366810484035584,False,,0,,,,,,,,[],,,,
738364897151602688,738364897151602688,2016-06-02 19:11:24 IST,2016-06-02,19:11:24,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT FDA spox says new expanded access rules ‚Äúnot at all related to any specific drug or any other actions.‚Äù 2 of 2.,en,[],[],[],9,20,17,[],['srpt'],https://twitter.com/adamfeuerstein/status/738364897151602688,False,,0,,,,,,,,[],,,,
738364658818617344,738364658818617344,2016-06-02 19:10:27 IST,2016-06-02,19:10:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT ‚Äî Stand down, people. FDA spox tells me new rules on expanded access to experimental drug has been in works for long time‚Ä¶ 1 of 2",en,[],[],[],3,14,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/738364658818617344,False,,0,,,,,,,,[],,,,
738358684871471104,738358261733265408,2016-06-02 18:46:43 IST,2016-06-02,18:46:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,". @sharkbiotech Possibly, but this compromise won‚Äôt be financially friendly to $SRPT (or its stock price.)",en,"[{'screen_name': 'sharkbiotech', 'name': 'dan rosenblum', 'id': '255996385'}]",[],[],6,2,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/738358684871471104,False,,0,,,,,,,,[],,,,
738358261733265408,738358261733265408,2016-06-02 18:45:02 IST,2016-06-02,18:45:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,FDA statement on expanded use of  experimental drugs ‚Äî&gt;  https://t.co/umOGMwdrLB  $SRPT?,en,[],['http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm504579.htm'],[],3,7,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/738358261733265408,False,,0,,,,,,,,[],,,,
737758538618052608,737758538618052608,2016-06-01 03:01:57 IST,2016-06-01,03:01:57,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BMRN spox tells me company intends to protect and extract value from drisapersen exon51 patents. $SRPT,en,[],[],[],10,6,11,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/737758538618052608,False,,0,,,,,,,,[],,,,
736195975644123136,736195975644123136,2016-05-27 19:32:53 IST,2016-05-27,19:32:53,+0530,14115408,jonnajarian,Jon Najarian,,Been a great week! $SRPT $ABBV $RLYP @bocafreshrinse  @HalftimeReport rockstar! :)      https://t.co/8Xxsm4DDEY  https://t.co/O8lvSZs0j4,en,"[{'screen_name': 'halftimereport', 'name': 'cnbc halftime report', 'id': '234905402'}]",['https://twitter.com/bocafreshrinse/status/736173558330707968'],['https://pbs.twimg.com/tweet_video_thumb/Cjd97_oWkAEJuM-.jpg'],0,1,14,[],"['srpt', 'abbv', 'rlyp']",https://twitter.com/jonnajarian/status/736195975644123136,False,0,1,https://pbs.twimg.com/tweet_video_thumb/Cjd97_oWkAEJuM-.jpg,,,,,,,[],,,,
735797917894774788,735797917894774788,2016-05-26 17:11:08 IST,2016-05-26,17:11:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Good $SRPT read by @matthewherper. Option 4 is very interesting. Option 3 is not feasible, more I talk to folks.  https://t.co/7kdq79WuPF",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['http://www.forbes.com/sites/matthewherper/2016/05/26/approving-sareptas-muscular-dystrophy-drug-could-force-fda-to-get-creative/3/#2c9870236ab1'],[],5,8,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/735797917894774788,False,,0,,,,,,,,[],,,,
735795966838767617,735795966838767617,2016-05-26 17:03:23 IST,2016-05-26,17:03:23,+0530,44438256,matthewherper,Matthew Herper,,Approving Sarepta's Muscular Dystrophy Drug Could Force FDA To Get Creative $SRPT  https://t.co/Si4RzyUgg9,en,[],['http://www.forbes.com/sites/matthewherper/2016/05/26/approving-sareptas-muscular-dystrophy-drug-could-force-fda-to-get-creative/#19c6dea165f8'],[],11,15,20,[],['srpt'],https://twitter.com/matthewherper/status/735795966838767617,False,,0,,,,,,,,[],,,,
735605043240554497,735605043240554497,2016-05-26 04:24:43 IST,2016-05-26,04:24:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Maybe you don't spend all day glued to Twitter. If not, I wrote a short something about $SRPT today.   https://t.co/STjOJkDodJ",en,[],['https://www.thestreet.com/story/13584754/1/a-what-s-next-scenario-for-the-delayed-sarepta-duchenne-drug-review.html'],[],3,6,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/735605043240554497,False,,0,,,,,,,,[],,,,
735603128947597312,735603128947597312,2016-05-26 04:17:07 IST,2016-05-26,04:17:07,+0530,102754598,johncendpts,John Carroll,,Trending - behind $SRPT- today: Biotech entrepreneurs grab $49M to bankroll a neuroscience startup (Arrivo)  https://t.co/oXBGwfDN3P,en,[],['http://www.fiercebiotech.com/biotech-entrepreneurs-raise-49m-to-bankroll-a-neuroscience-startup'],[],1,3,4,[],['srpt'],https://twitter.com/JohnCendpts/status/735603128947597312,False,,0,,,,,,,,[],,,,
735577042419392512,735577042419392512,2016-05-26 02:33:27 IST,2016-05-26,02:33:27,+0530,15971805,investorslive,Nathan Michaud,,Lesson for today was buy $SRPT and head to beach.. don't sell when I did lol #alwaysbelearning,en,[],[],[],1,0,12,['alwaysbelearning'],['srpt'],https://twitter.com/InvestorsLive/status/735577042419392512,False,,0,,,,,,,,[],,,,
735533142644293633,735533142644293633,2016-05-25 23:39:01 IST,2016-05-25,23:39:01,+0530,15971805,investorslive,Nathan Michaud,,Life's a beach ... sometimes gotta get away from the screens after a nice morning !! $CLRB $CBYL $SRPT   https://t.co/IvrljEuslk @etrade,en,"[{'screen_name': 'etrade', 'name': 'e*trade', 'id': '32570672'}]",['https://www.instagram.com/p/BF1vcNOG4J2/'],[],2,0,15,[],"['clrb', 'cbyl', 'srpt']",https://twitter.com/InvestorsLive/status/735533142644293633,False,,0,,,,,,,,[],,,,
735465554794971136,735465554794971136,2016-05-25 19:10:27 IST,2016-05-25,19:10:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"A 'What's Next?' Scenario for the Delayed $SRPT Duchenne Drug Review  https://t.co/STjOJkDodJ My ""hot take."" Compromise in the works?",en,[],['https://www.thestreet.com/story/13584754/1/a-what-s-next-scenario-for-the-delayed-sarepta-duchenne-drug-review.html'],[],6,23,15,[],['srpt'],https://twitter.com/adamfeuerstein/status/735465554794971136,False,,0,,,,,,,,[],,,,
735441315882766336,735441315882766336,2016-05-25 17:34:08 IST,2016-05-25,17:34:08,+0530,47678782,megtirrell,Meg Tirrell,,SunTrust's Edward Nash says he expects same 2-wk delay for $SRPT as for $BMRN and continues to expect rejection based on FDA briefing docs,en,[],[],[],2,12,39,[],"['srpt', 'bmrn']",https://twitter.com/megtirrell/status/735441315882766336,False,,0,,,,,,,,[],,,,
735440135605628928,735440135605628928,2016-05-25 17:29:26 IST,2016-05-25,17:29:26,+0530,873399943,jacobplieth,Jacob Plieth,,"FDA needs more time to figure out how to say ""no"" to $SRPT",en,[],[],[],5,0,13,[],['srpt'],https://twitter.com/JacobPlieth/status/735440135605628928,False,,0,,,,,,,,[],,,,
735439260887699456,735439260887699456,2016-05-25 17:25:58 IST,2016-05-25,17:25:58,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"FDA did not give $SRPT new timeline for competing eteplirsen review.   That‚Äôs different from $BMRN, which was told ‚Äúearly January.‚Äù",en,[],[],[],6,6,13,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/735439260887699456,False,,0,,,,,,,,[],,,,
735433535050416132,735433535050416132,2016-05-25 17:03:13 IST,2016-05-25,17:03:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,FDA spokesperson statement on $SRPT eteplirsen review delay.  https://t.co/YOWxVJ1eFU,en,[],[],['https://pbs.twimg.com/media/CjTIysMXAAA8msL.jpg'],8,9,17,[],['srpt'],https://twitter.com/adamfeuerstein/status/735433535050416132,False,,1,https://pbs.twimg.com/media/CjTIysMXAAA8msL.jpg,,,,,,,[],,,,
735429453539647488,735429453539647488,2016-05-25 16:46:59 IST,2016-05-25,16:46:59,+0530,14115408,jonnajarian,Jon Najarian,,$SRPT Disclosed FDA Will Not Complete Review of Eteplirsen NDA by PDUFA Date of May 26th  Shares +21% in pre!  https://t.co/CPor4SfxTn,en,[],[],['https://pbs.twimg.com/media/CjTFHjGWkAA4VZ2.jpg'],4,3,10,[],['srpt'],https://twitter.com/jonnajarian/status/735429453539647488,False,,1,https://pbs.twimg.com/media/CjTFHjGWkAA4VZ2.jpg,,,,,,,[],,,,
735426099002376192,735426099002376192,2016-05-25 16:33:40 IST,2016-05-25,16:33:40,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT - FDA delays eteplirsen approval decision. No timetable for completion of review.,en,[],[],[],4,10,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/735426099002376192,False,,0,,,,,,,,[],,,,
735226260633358336,735226260633358336,2016-05-25 03:19:35 IST,2016-05-25,03:19:35,+0530,14216123,jimcramer,Jim Cramer,,I think $SRPT's drug should be approved..   https://t.co/zifcFw4qid,en,[],['https://twitter.com/BiotechPays/status/735219609905860608'],[],15,28,79,[],['srpt'],https://twitter.com/jimcramer/status/735226260633358336,False,https://twitter.com/BiotechPays/status/735219609905860608,0,,,,,,,,[],,,,
735065356381736960,735065356381736960,2016-05-24 16:40:12 IST,2016-05-24,16:40:12,+0530,274233761,bradloncar,Brad Loncar,,"In a note this morning, Janney‚Äôs odds for $SRPT:  AA: 15% PDUFA delay: 35% CRL: 50%",en,[],[],[],3,6,10,[],['srpt'],https://twitter.com/bradloncar/status/735065356381736960,False,,0,,,,,,,,[],,,,
734852802179141637,734833201693089792,2016-05-24 02:35:35 IST,2016-05-24,02:35:35,+0530,47678782,megtirrell,Meg Tirrell,,@adamfeuerstein @matthewherper @jargall27 @FT $SRPT CEO told us day of adcom they're committed to keep working on it  https://t.co/XXNT1L8T8s,en,[],['http://video.cnbc.com/gallery/?video=3000512578'],[],3,0,7,[],['srpt'],https://twitter.com/megtirrell/status/734852802179141637,False,,0,,,,,,,,"[{'screen_name': 'adamfeuerstein', 'name': 'Adam Feuerstein', 'id': '102094857'}, {'screen_name': 'matthewherper', 'name': 'Matthew Herper', 'id': '44438256'}, {'screen_name': 'FT', 'name': 'Financial Times', 'id': '18949452'}]",,,,
734818979504652288,734818979504652288,2016-05-24 00:21:11 IST,2016-05-24,00:21:11,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Seriously, there's nothing new to be said about $SRPT until FDA speaks. Traders gonna trade. Everyone else waits.",en,[],[],[],3,4,31,[],['srpt'],https://twitter.com/adamfeuerstein/status/734818979504652288,False,,0,,,,,,,,[],,,,
734710222497980418,734710222497980418,2016-05-23 17:09:01 IST,2016-05-23,17:09:01,+0530,102754598,johncendpts,John Carroll,,"""the skimpiest, most pathetic data I‚Äôve ever seen""  ‚Äî $SRPT continues to be a lightning rod --  https://t.co/IBXuLouq13",en,[],['http://www.ft.com/intl/cms/s/0/59587d78-1dbc-11e6-a7bc-ee846770ec15.html?siteedition=intl#axzz49TgTzuMp'],[],3,10,8,[],['srpt'],https://twitter.com/JohnCendpts/status/734710222497980418,False,,0,,,,,,,,[],,,,
734699503232618496,734699503232618496,2016-05-23 16:26:26 IST,2016-05-23,16:26:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I'm going to write two $SRPT stories today. I'll publish one. Which one?,en,[],[],[],20,3,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/734699503232618496,False,,0,,,,,,,,[],,,,
733706474443157504,733706474443157504,2016-05-20 22:40:29 IST,2016-05-20,22:40:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"w/ 373 votes so far, my $SRPT poll as close (uninformative?) as you‚Äôd expect.   37% approval 36% rejection 27% delay",en,[],[],[],5,6,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/733706474443157504,False,,0,,,,,,,,[],,,,
731288256529174528,731288256529174528,2016-05-14 06:31:21 IST,2016-05-14,06:31:21,+0530,44438256,matthewherper,Matthew Herper,,Art Caplan on $SRPT  https://t.co/kVUAQhxBsS,en,[],['https://twitter.com/arthurcaplan/status/731235224416342016'],[],8,4,10,[],['srpt'],https://twitter.com/matthewherper/status/731288256529174528,False,https://twitter.com/arthurcaplan/status/731235224416342016,0,,,,,,,,[],,,,
731084038862163969,731084038862163969,2016-05-13 16:59:52 IST,2016-05-13,16:59:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Biotech Stock Mailbag: Why $XON CEO R.J. Kirk should not be trusted $XON  https://t.co/tHHHFZ7UWJ + $SRPT $NWBO $CYTR,en,[],['http://www.thestreet.com/story/13569790/1/biotech-stock-mailbag-why-intrexon-ceo-r-j-kirk-should-not-be-trusted.html'],[],4,13,32,[],"['xon', 'xon', 'srpt', 'nwbo', 'cytr']",https://twitter.com/adamfeuerstein/status/731084038862163969,False,,0,,,,,,,,[],,,,
730839939152269312,730839939152269312,2016-05-13 00:49:54 IST,2016-05-13,00:49:54,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I just realized $ZSPH and $SRPT share the same May 26 PDUFA date.   Not sure Twitter is capable of handling this.,en,[],[],[],4,17,80,[],"['zsph', 'srpt']",https://twitter.com/adamfeuerstein/status/730839939152269312,False,,0,,,,,,,,[],,,,
730100391245926400,729842522873286657,2016-05-10 23:51:12 IST,2016-05-10,23:51:12,+0530,44438256,matthewherper,Matthew Herper,,@RxRegA @steveusdin1 @dgingery @ChazMac09 Anyone who has real certainty about $SRPT is wrong. The middle muddle is where it's at.,en,"[{'screen_name': 'steveusdin1', 'name': 'steve usdin', 'id': '371790609'}, {'screen_name': 'dgingery', 'name': 'derrick', 'id': '16697257'}]",[],[],5,1,10,[],['srpt'],https://twitter.com/matthewherper/status/730100391245926400,False,,0,,,,,,,,[],,,,
730044875119448064,730044875119448064,2016-05-10 20:10:36 IST,2016-05-10,20:10:36,+0530,44438256,matthewherper,Matthew Herper,,Question on $SRPT: Will insurance companies pay for compassionate use?,en,[],[],[],15,6,9,[],['srpt'],https://twitter.com/matthewherper/status/730044875119448064,False,,0,,,,,,,,[],,,,
729851644226080768,729851644226080768,2016-05-10 07:22:46 IST,2016-05-10,07:22:46,+0530,274233761,bradloncar,Brad Loncar,,Another WSJ editorial on $SRPT.  https://t.co/XrGN17UFaR,en,[],['http://www.wsj.com/articles/a-legal-test-for-the-fda-1462836044?ru=yahoo?mod=yahoo_itp'],[],4,4,16,[],['srpt'],https://twitter.com/bradloncar/status/729851644226080768,False,,0,,,,,,,,[],,,,
729749070856769537,729749070856769537,2016-05-10 00:35:11 IST,2016-05-10,00:35:11,+0530,47678782,megtirrell,Meg Tirrell,,Marco Rubio writes oped in @statnews in support of eteplirsen approval:  https://t.co/tHe4470Dwb $SRPT,en,"[{'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}]",['https://www.statnews.com/2016/05/09/rare-disease-duchenne-muscular-dystrophy-marco-rubio-fda/'],[],6,35,39,[],['srpt'],https://twitter.com/megtirrell/status/729749070856769537,False,,0,,,,,,,,[],,,,
729468947804901377,729468947804901377,2016-05-09 06:02:04 IST,2016-05-09,06:02:04,+0530,15130891,kunal00,Kunal Desai,,Trading Watch List 05.09.2016 |  https://t.co/7sD5lAHwXv $spy $ibb $labu $acad $srpt $clf $fcx $x $tsla $nflx $amzn  https://t.co/nSVVniIIJF,en,[],['http://bit.ly/1UL3hRk'],['https://pbs.twimg.com/media/Ch-YJIUWkAI0IPc.jpg'],0,6,11,[],"['spy', 'ibb', 'labu', 'acad', 'srpt', 'clf', 'fcx', 'x', 'tsla', 'nflx', 'amzn']",https://twitter.com/kunal00/status/729468947804901377,False,,1,https://pbs.twimg.com/media/Ch-YJIUWkAI0IPc.jpg,,,,,,,[],,,,
728259932995366912,728259932995366912,2016-05-05 21:57:53 IST,2016-05-05,21:57:53,+0530,47678782,megtirrell,Meg Tirrell,,"Perceptive's Joe Edelman coming up on @HalftimeReport -- find out how he sees $SRPT post adcom, next!",en,"[{'screen_name': 'halftimereport', 'name': 'cnbc halftime report', 'id': '234905402'}]",[],[],1,2,8,[],['srpt'],https://twitter.com/megtirrell/status/728259932995366912,False,,0,,,,,,,,[],,,,
728237168540450816,728237168540450816,2016-05-05 20:27:25 IST,2016-05-05,20:27:25,+0530,47678782,megtirrell,Meg Tirrell,,"Perceptive's Joe Edelman joins us today on @HalftimeReport to discuss $SRPT, biotech investing -- what do you want to know?",en,"[{'screen_name': 'halftimereport', 'name': 'cnbc halftime report', 'id': '234905402'}]",[],[],20,8,14,[],['srpt'],https://twitter.com/megtirrell/status/728237168540450816,False,,0,,,,,,,,[],,,,
727451877516951552,727451877516951552,2016-05-03 16:26:57 IST,2016-05-03,16:26:57,+0530,44438256,matthewherper,Matthew Herper,,This is an important read on $SRPT.  https://t.co/9UKVmKgxIO,en,[],['https://twitter.com/steveusdin1/status/727322486677729281'],[],2,5,9,[],['srpt'],https://twitter.com/matthewherper/status/727451877516951552,False,https://twitter.com/steveusdin1/status/727322486677729281,0,,,,,,,,[],,,,
727356277236465664,727356277236465664,2016-05-03 10:07:04 IST,2016-05-03,10:07:04,+0530,274233761,bradloncar,Brad Loncar,,This $SRPT opinion by @BiotechSusan and @steveusdin1 is a must read if you haven‚Äôt already seen it.  https://t.co/3VAdJIFDAU,en,"[{'screen_name': 'biotechsusan', 'name': 'susan schaeffer', 'id': '3566649624'}, {'screen_name': 'steveusdin1', 'name': 'steve usdin', 'id': '371790609'}]",['http://www.biocentury.com/biotech-pharma-news/coverstory/2016-05-02/why-fda-should-grant-accelerated-approval-to-eteplirsen-for-dmd-a02'],[],5,13,34,[],['srpt'],https://twitter.com/bradloncar/status/727356277236465664,False,,0,,,,,,,,[],,,,
727242740493352960,727242740493352960,2016-05-03 02:35:55 IST,2016-05-03,02:35:55,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT - Leerink downgrades tonight. Fine. But also lowers probability of eteplirsen FDA approval to 15% from 40%. Today? Really?,en,[],[],[],17,7,26,[],['srpt'],https://twitter.com/adamfeuerstein/status/727242740493352960,False,,0,,,,,,,,[],,,,
727212261786406912,727212261786406912,2016-05-03 00:34:48 IST,2016-05-03,00:34:48,+0530,20106796,amberkanwar,Amber Kanwar,,Most shorted stocks reporting this week $SRPT $HCG.TO $TSLA  https://t.co/hW3g9eV5gi  https://t.co/kzxihdftiO,en,[],['http://www.bnn.ca/Video/player.aspx?vid=860960'],['https://pbs.twimg.com/media/CheTssvWkAAWkQm.jpg'],2,10,9,[],"['srpt', 'hcg.to', 'tsla']",https://twitter.com/amberkanwar/status/727212261786406912,False,,1,https://pbs.twimg.com/media/CheTssvWkAAWkQm.jpg,,,,,,,[],,,,
727130724671746049,727130724671746049,2016-05-02 19:10:48 IST,2016-05-02,19:10:48,+0530,14216123,jimcramer,Jim Cramer,,$SRPT not quitting-- @adamfeuerstein  -his piece still resonating--must read on  https://t.co/BMLa0qx0Qo..,en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",['http://thestreet.com'],[],3,2,11,[],['srpt'],https://twitter.com/jimcramer/status/727130724671746049,False,,0,,,,,,,,[],,,,
726063243916132353,726063243916132353,2016-04-29 20:29:01 IST,2016-04-29,20:29:01,+0530,873399943,jacobplieth,Jacob Plieth,,Unbelievable garbage from the WSJ. Now I'm starting to believe the conspiracy theories $SRPT  https://t.co/IfSOhXbwjR,en,[],['https://twitter.com/RNAiAnalyst/status/726023248622837763'],[],5,8,17,[],['srpt'],https://twitter.com/JacobPlieth/status/726063243916132353,False,https://twitter.com/RNAiAnalyst/status/726023248622837763,0,,,,,,,,[],,,,
725897027846983680,725897027846983680,2016-04-29 09:28:32 IST,2016-04-29,09:28:32,+0530,274233761,bradloncar,Brad Loncar,,WSJ says the $SRPT panel is an example of why people have become disillusioned with government.  https://t.co/eqFQvIOUIR,en,[],['http://www.wsj.com/articles/mental-dystrophy-at-the-fda-1461885588'],[],3,12,27,[],['srpt'],https://twitter.com/bradloncar/status/725897027846983680,False,,0,,,,,,,,[],,,,
725878299063402496,725878299063402496,2016-04-29 08:14:07 IST,2016-04-29,08:14:07,+0530,15281391,thestreet,TheStreet,,How Sarepta can secure speedy FDA drug approval despite a negative panel vote $SRPT  https://t.co/fBL0tAZkIR,en,[],['http://bit.ly/1pJyZl3'],[],0,9,11,[],['srpt'],https://twitter.com/TheStreet/status/725878299063402496,False,,0,,,,,,,,[],,,,
725736910338052097,725736910338052097,2016-04-28 22:52:17 IST,2016-04-28,22:52:17,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I love the Jefferies trading desk. Except for the Blackberry comment. I‚Äôm not that much of a dork. $SRPT  https://t.co/WlR861STGD,en,[],[],['https://pbs.twimg.com/media/ChJVfJZXEAEcMZu.jpg'],6,5,38,[],['srpt'],https://twitter.com/adamfeuerstein/status/725736910338052097,False,,1,https://pbs.twimg.com/media/ChJVfJZXEAEcMZu.jpg,,,,,,,[],,,,
725701605602037760,725701605602037760,2016-04-28 20:32:00 IST,2016-04-28,20:32:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I appreciate all the feedback on my $SRPT story. That includes criticism. Fascinating story, will play out over next month.",en,[],[],[],12,4,32,[],['srpt'],https://twitter.com/adamfeuerstein/status/725701605602037760,False,,0,,,,,,,,[],,,,
725693239148294144,725690511172980736,2016-04-28 19:58:45 IST,2016-04-28,19:58:45,+0530,102094857,adamfeuerstein,Adam Feuerstein,,. @sciencescanner I understand the $SRPT bear thesis. But you need to explain behavior/statements made by Woodcock et al on Monday.,en,"[{'screen_name': 'sciencescanner', 'name': 'david grainger', 'id': '71372467'}]",[],[],2,3,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/725693239148294144,False,,0,,,,,,,,[],,,,
725666479023202304,725666479023202304,2016-04-28 18:12:25 IST,2016-04-28,18:12:25,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT up 18%  https://t.co/bedtI4fghh,en,[],['https://twitter.com/adamfeuerstein/status/725653467872763904'],[],0,6,8,[],['srpt'],https://twitter.com/megtirrell/status/725666479023202304,False,https://twitter.com/adamfeuerstein/status/725653467872763904,0,,,,,,,,[],,,,
725658467780841472,725658467780841472,2016-04-28 17:40:35 IST,2016-04-28,17:40:35,+0530,15281391,thestreet,TheStreet,,How Sarepta can secure speedy FDA drug approval despite a negative panel vote $SRPT  https://t.co/0zrW0oJUs9  https://t.co/MfeaWtKedN,en,[],['http://dlvr.it/L9hrBZ'],['https://pbs.twimg.com/media/ChIOiBPU8AECybf.jpg'],1,9,11,[],['srpt'],https://twitter.com/TheStreet/status/725658467780841472,False,,1,https://pbs.twimg.com/media/ChIOiBPU8AECybf.jpg,,,,,,,[],,,,
725653467872763904,725653467872763904,2016-04-28 17:20:43 IST,2016-04-28,17:20:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"If Janet Woodcock intends to reject $SRPT eteplirsen, why did she meet with DMD boys, families after Monday‚Äôs panel?  https://t.co/4m4kJUjxQh",en,[],['http://www.thestreet.com/story/13548113/1/how-sarepta-can-secure-speedy-fda-drug-approval-despite-a-negative-panel-vote.html'],[],15,23,28,[],['srpt'],https://twitter.com/adamfeuerstein/status/725653467872763904,False,,0,,,,,,,,[],,,,
725653294895517696,725653294895517696,2016-04-28 17:20:02 IST,2016-04-28,17:20:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Top FDA officials, including Janet Woodcock, said some remarkably positive things about $SRPT at Monday‚Äôs panel ‚Äî&gt;  https://t.co/4m4kJUjxQh",en,[],['http://www.thestreet.com/story/13548113/1/how-sarepta-can-secure-speedy-fda-drug-approval-despite-a-negative-panel-vote.html'],[],5,15,25,[],['srpt'],https://twitter.com/adamfeuerstein/status/725653294895517696,False,,0,,,,,,,,[],,,,
725652626998714368,725652626998714368,2016-04-28 17:17:22 IST,2016-04-28,17:17:22,+0530,102094857,adamfeuerstein,Adam Feuerstein,,How $SRPT can secure speedy FDA drug approval despite a negative panel vote $SRPT  https://t.co/4m4kJUjxQh Watch/Listen to Janet Woodcock!,en,[],['http://www.thestreet.com/story/13548113/1/how-sarepta-can-secure-speedy-fda-drug-approval-despite-a-negative-panel-vote.html'],[],6,18,21,[],"['srpt', 'srpt']",https://twitter.com/adamfeuerstein/status/725652626998714368,False,,0,,,,,,,,[],,,,
725644371459198977,725644371459198977,2016-04-28 16:44:34 IST,2016-04-28,16:44:34,+0530,102094857,adamfeuerstein,Adam Feuerstein,,And I have a $SRPT story coming‚Ä¶ Stay tuned. I think it‚Äôs interesting.   https://t.co/2z7yf3izMn,en,[],['https://twitter.com/CGrantWSJ/status/725644122757959681'],[],5,6,17,[],['srpt'],https://twitter.com/adamfeuerstein/status/725644371459198977,False,https://twitter.com/CGrantWSJ/status/725644122757959681,0,,,,,,,,[],,,,
725373909021892608,725373909021892608,2016-04-27 22:49:51 IST,2016-04-27,22:49:51,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,"$SRPT Still believers out there, I see  https://t.co/i4dCRwpcRn",en,[],[],['https://pbs.twimg.com/media/ChELueUU0AAjwuK.jpg'],1,1,7,[],['srpt'],https://twitter.com/OphirGottlieb/status/725373909021892608,False,,1,https://pbs.twimg.com/media/ChELueUU0AAjwuK.jpg,,,,,,,[],,,,
725053913498529792,725053913498529792,2016-04-27 01:38:18 IST,2016-04-27,01:38:18,+0530,19546277,yahoofinance,Yahoo Finance,,"Today‚Äôs #Stocks Losers: $WHR, $NBR, $SRPT  https://t.co/egVG7Du9xI  https://t.co/4LSIdh77lT",en,[],['http://yhoo.it/1VAvMCk'],['https://pbs.twimg.com/media/Cg_oryDWkAAao5r.jpg'],1,5,4,['stocks'],"['whr', 'nbr', 'srpt']",https://twitter.com/YahooFinance/status/725053913498529792,False,,1,https://pbs.twimg.com/media/Cg_oryDWkAAao5r.jpg,,,,,,,[],,,,
725031264168906753,725031264168906753,2016-04-27 00:08:18 IST,2016-04-27,00:08:18,+0530,14216123,jimcramer,Jim Cramer,,"you heard what I said this morning about this terrible disease. $SRPT didn't do a good job. Study, focus. Enough  https://t.co/1PESUTwvSg",en,[],['https://twitter.com/19fluid75/status/725025238501756929'],[],3,1,7,[],['srpt'],https://twitter.com/jimcramer/status/725031264168906753,False,https://twitter.com/19fluid75/status/725025238501756929,0,,,,,,,,[],,,,
725010639786246144,725010639786246144,2016-04-26 22:46:21 IST,2016-04-26,22:46:21,+0530,14216123,jimcramer,Jim Cramer,,Look I don't really care what people say about $SRPT. I have not liked it as a stock even as I had hope for the drug,en,[],[],[],10,4,17,[],['srpt'],https://twitter.com/jimcramer/status/725010639786246144,False,,0,,,,,,,,[],,,,
725001696494125056,725001696494125056,2016-04-26 22:10:48 IST,2016-04-26,22:10:48,+0530,263197731,scottwapnercnbc,Scott Wapner,,Tough talking about stock $$$ when so many good folks were in that hearing room hoping for $SRPT drug approval.,en,[],[],[],2,4,14,[],['srpt'],https://twitter.com/ScottWapnerCNBC/status/725001696494125056,False,,0,,,,,,,,[],,,,
724985540202754049,724985540202754049,2016-04-26 21:06:37 IST,2016-04-26,21:06:37,+0530,130289750,maxnisen,Max Nisen,,"The FDA panel made a hard, correct decision on $SRPT. Approval on poorly managed 12 person trial is bad precedent.  https://t.co/nY4TfSbF6N",en,[],['http://www.bloomberg.com/gadfly/articles/2016-04-26/sarepta-s-dmd-drug-fda-rejection-would-be-the-right-call'],[],2,8,11,[],['srpt'],https://twitter.com/MaxNisen/status/724985540202754049,False,,0,,,,,,,,[],,,,
724984655980691460,724984655980691460,2016-04-26 21:03:06 IST,2016-04-26,21:03:06,+0530,15971805,investorslive,Nathan Michaud,,$SRPT took the rest ~ +$2 ish give or take a dime done w/ trade .. that was the best patience I've had in a while  https://t.co/Aw8z4GL5Cc,en,[],[],['https://pbs.twimg.com/media/Cg-pnfNW0AAt4wr.jpg'],5,1,31,[],['srpt'],https://twitter.com/InvestorsLive/status/724984655980691460,False,,1,https://pbs.twimg.com/media/Cg-pnfNW0AAt4wr.jpg,,,,,,,[],,,,
724976241846145024,724976241846145024,2016-04-26 20:29:40 IST,2016-04-26,20:29:40,+0530,15971805,investorslive,Nathan Michaud,,I got a LOT of feedback on this post- it was a big hurdle for me as well   https://t.co/n9PyhOELWe  $SRPT $PRGO $XON  https://t.co/Y4E5ABVzWQ,en,[],['http://www.investorsunderground.com/avoid-fomo-trades'],['https://pbs.twimg.com/media/Cg-h-pgU8AA7K_s.jpg'],1,5,17,[],"['srpt', 'prgo', 'xon']",https://twitter.com/InvestorsLive/status/724976241846145024,False,,1,https://pbs.twimg.com/media/Cg-h-pgU8AA7K_s.jpg,,,,,,,[],,,,
724966703315177472,724966703315177472,2016-04-26 19:51:45 IST,2016-04-26,19:51:45,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"My $SRPT live blog set a viewership record at TheStreet, topping even Apple/Tesla live blogs, so thx all for helping make that happen.",en,[],[],[],11,2,78,[],['srpt'],https://twitter.com/adamfeuerstein/status/724966703315177472,False,,0,,,,,,,,[],,,,
724963717260148737,724963717260148737,2016-04-26 19:39:54 IST,2016-04-26,19:39:54,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Getting $SRPT ?s following y‚Äôday‚Äôs FDA panel. I have thoughts on what‚Äôs next (AA odds) but I need a day or two separation. In SRPT overload.,en,[],[],[],9,1,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/724963717260148737,False,,0,,,,,,,,[],,,,
724961754451705856,724961754451705856,2016-04-26 19:32:06 IST,2016-04-26,19:32:06,+0530,44438256,matthewherper,Matthew Herper,,Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients $SRPT  https://t.co/d6yjuV6QVd,en,[],['http://www.forbes.com/sites/matthewherper/2016/04/26/here-are-three-ways-to-prevent-tragic-battles-between-the-fda-and-patients/#48705484634d'],[],11,36,39,[],['srpt'],https://twitter.com/matthewherper/status/724961754451705856,False,,0,,,,,,,,[],,,,
724946263444209665,724946263444209665,2016-04-26 18:30:32 IST,2016-04-26,18:30:32,+0530,14216123,jimcramer,Jim Cramer,,"$SRPT==nothing else to say, change symbol to RIP",en,[],[],[],27,17,36,[],['srpt'],https://twitter.com/jimcramer/status/724946263444209665,False,,0,,,,,,,,[],,,,
724922075408904193,724922075408904193,2016-04-26 16:54:25 IST,2016-04-26,16:54:25,+0530,47678782,megtirrell,Meg Tirrell,,See our full interview with $SRPT interim CEO Dr Edward Kaye directly after panel vote here:  https://t.co/XXNT1L8T8s  https://t.co/XXNT1L8T8s,en,[],"['http://video.cnbc.com/gallery/?video=3000512578', 'http://video.cnbc.com/gallery/?video=3000512578']",[],2,21,26,[],['srpt'],https://twitter.com/megtirrell/status/724922075408904193,False,,0,,,,,,,,[],,,,
724802192054603776,724802192054603776,2016-04-26 08:58:03 IST,2016-04-26,08:58:03,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT: ""Today more than ever, we remain committed to our mission of bringing a treatment to the Duchenne community.""  https://t.co/cKBsEsJHRJ",en,[],['http://investorrelations.sarepta.com/mobile.view?c=64231&v=203&d=1&id=2161215'],[],6,8,15,[],['srpt'],https://twitter.com/megtirrell/status/724802192054603776,False,,0,,,,,,,,[],,,,
724758664662364160,724758664662364160,2016-04-26 06:05:05 IST,2016-04-26,06:05:05,+0530,3290364847,statnews,STAT,,"Despite strong patient advocacy, an FDA panel voted against Sarepta's drug for Duchenne muscular dystrophy:  https://t.co/LcaAcSOVrG $SRPT",en,[],['https://www.statnews.com/pharmalot/2016/04/25/fda-panel-sarepta-muscular-dystrophy/'],[],2,30,11,[],['srpt'],https://twitter.com/statnews/status/724758664662364160,False,,0,,,,,,,,[],,,,
724745059720110081,724745059720110081,2016-04-26 05:11:02 IST,2016-04-26,05:11:02,+0530,295746612,faycortez,Michelle Fay Cortez,,"So third strike for boys with #DMD and their families. My heart goes out to them all. Hope companies see their passion, stick with it. $SRPT",en,[],[],[],2,15,28,['dmd'],['srpt'],https://twitter.com/FayCortez/status/724745059720110081,False,,0,,,,,,,,[],,,,
724743834538790916,724743834538790916,2016-04-26 05:06:09 IST,2016-04-26,05:06:09,+0530,47678782,megtirrell,Meg Tirrell,,FDA's Billy Dunn: emotion &amp; passion in room is clear. We listen carefully. Realize there's great concern about results. $SRPT,en,[],[],[],2,4,11,[],['srpt'],https://twitter.com/megtirrell/status/724743834538790916,False,,0,,,,,,,,[],,,,
724743692318322690,724743692318322690,2016-04-26 05:05:35 IST,2016-04-26,05:05:35,+0530,102094857,adamfeuerstein,Adam Feuerstein,,There are kids with DMD and their families feeling a lot of disappointment and pain right now. $SRPT.,en,[],[],[],13,30,87,[],['srpt'],https://twitter.com/adamfeuerstein/status/724743692318322690,False,,0,,,,,,,,[],,,,
724743556670349312,724743556670349312,2016-04-26 05:05:03 IST,2016-04-26,05:05:03,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚Äî I know we focus mostly on stocks here but there should be no joy or gloating over the negative panel vote. This was really tough.,en,[],[],[],19,36,168,[],['srpt'],https://twitter.com/adamfeuerstein/status/724743556670349312,False,,0,,,,,,,,[],,,,
724742699362975744,724742699362975744,2016-04-26 05:01:39 IST,2016-04-26,05:01:39,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT FDA adcom audience yelling at panelists - after suggestion of another biopsy,en,[],[],[],7,10,11,[],['srpt'],https://twitter.com/megtirrell/status/724742699362975744,False,,0,,,,,,,,[],,,,
724740893123698688,724740893123698688,2016-04-26 04:54:28 IST,2016-04-26,04:54:28,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT panel voting on Q7: ""full approval Q""  https://t.co/Sxbzm26Not",en,[],[],['https://pbs.twimg.com/media/Cg7MAH8WMAUP1bh.jpg'],1,8,5,[],['srpt'],https://twitter.com/megtirrell/status/724740893123698688,False,,1,https://pbs.twimg.com/media/Cg7MAH8WMAUP1bh.jpg,,,,,,,[],,,,
724740747451314176,724740747451314176,2016-04-26 04:53:53 IST,2016-04-26,04:53:53,+0530,295746612,faycortez,Michelle Fay Cortez,,"Oooh, Temple on historical controls could work for $SRPT drug. Hope everyone read @matthewherper on trial design:  https://t.co/m7Y0edO6Nu",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['http://www.forbes.com/sites/matthewherper/2016/04/21/a-muscular-dystrophy-debacle-shows-trying-to-speed-drugs-approvals-up-can-slow-them-down/#700b6c5c7587'],[],0,6,6,[],['srpt'],https://twitter.com/FayCortez/status/724740747451314176,False,,0,,,,,,,,[],,,,
724740686365511680,724740686365511680,2016-04-26 04:53:39 IST,2016-04-26,04:53:39,+0530,47678782,megtirrell,Meg Tirrell,,Q7 $SRPT adcom vote (do clinical results provide substantial evidence etep is effective)? Yes: 3 No: 7 Abstain: 3,en,[],[],[],2,23,8,[],['srpt'],https://twitter.com/megtirrell/status/724740686365511680,False,,0,,,,,,,,[],,,,
724740567687548928,724740567687548928,2016-04-26 04:53:11 IST,2016-04-26,04:53:11,+0530,274233761,bradloncar,Brad Loncar,,"It‚Äôs nuts that panel doesn‚Äôt just vote on a straightforward, unambiguous question like: should the drug be given accelerated approval. $SRPT",en,[],[],[],5,2,28,[],['srpt'],https://twitter.com/bradloncar/status/724740567687548928,False,,0,,,,,,,,[],,,,
724733262766170112,724733262766170112,2016-04-26 04:24:09 IST,2016-04-26,04:24:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"If you hadn‚Äôt heard yet, this FDA panel is not going well for $SRPT.",en,[],[],[],7,6,12,[],['srpt'],https://twitter.com/adamfeuerstein/status/724733262766170112,False,,0,,,,,,,,[],,,,
724726647149203456,724726647149203456,2016-04-26 03:57:52 IST,2016-04-26,03:57:52,+0530,102754598,johncendpts,John Carroll,,"In setback, a majority of FDA experts reject Sarepta‚Äôs emotional campaign to gain Duchenne drug OK $SRPT   https://t.co/UDMsL51FrE",en,[],['http://bit.ly/1UdgaDu'],[],1,14,9,[],['srpt'],https://twitter.com/JohnCendpts/status/724726647149203456,False,,0,,,,,,,,[],,,,
724723306138476544,724723306138476544,2016-04-26 03:44:35 IST,2016-04-26,03:44:35,+0530,274233761,bradloncar,Brad Loncar,,"One panelist: We have Tylenol and Heparin‚Ä¶.we don‚Äôt know how they work, but it doesn‚Äôt mean we should throw them out. $SRPT",en,[],[],[],3,5,15,[],['srpt'],https://twitter.com/bradloncar/status/724723306138476544,False,,0,,,,,,,,[],,,,
724721863167897600,724721863167897600,2016-04-26 03:38:51 IST,2016-04-26,03:38:51,+0530,274233761,bradloncar,Brad Loncar,,One voter (Romitti) says he it the wrong button. Turns a no to a yes. $SRPT,en,[],[],[],5,0,10,[],['srpt'],https://twitter.com/bradloncar/status/724721863167897600,False,,0,,,,,,,,[],,,,
724710735859736578,724710735859736578,2016-04-26 02:54:38 IST,2016-04-26,02:54:38,+0530,274233761,bradloncar,Brad Loncar,,Andy Pollack/NY Times already has a $SRPT story up.  https://t.co/DOP8oMHTgY,en,[],['http://www.nytimes.com/2016/04/26/business/muscular-dystrophy-drug-fda-sarepta-eteplirsen.html?ref=health'],[],1,6,9,[],['srpt'],https://twitter.com/bradloncar/status/724710735859736578,False,,0,,,,,,,,[],,,,
724705938641444864,724705938641444864,2016-04-26 02:35:34 IST,2016-04-26,02:35:34,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I can‚Äôt believe it‚Äôs 5 pm and I‚Äôm still hours away from finishing this $SRPT live blog. Pray for me. #sendbourbonnow,en,[],[],[],13,4,45,['sendbourbonnow'],['srpt'],https://twitter.com/adamfeuerstein/status/724705938641444864,False,,0,,,,,,,,[],,,,
724702550667075584,724702550667075584,2016-04-26 02:22:07 IST,2016-04-26,02:22:07,+0530,47678782,megtirrell,Meg Tirrell,,Eteplirsen has given us a future. We no longer plan his funeral -- Duchenne dad says at $SRPT FDA adcom,en,[],[],[],2,10,23,[],['srpt'],https://twitter.com/megtirrell/status/724702550667075584,False,,0,,,,,,,,[],,,,
724701196078948352,724701196078948352,2016-04-26 02:16:44 IST,2016-04-26,02:16:44,+0530,102754598,johncendpts,John Carroll,,Duchenne parent says our kids are not your (FDA's) science experiment. But they are. That's what a clinical trial is. Emotion vs data. $SRPT,en,[],[],[],7,12,41,[],['srpt'],https://twitter.com/JohnCendpts/status/724701196078948352,False,,0,,,,,,,,[],,,,
724696513121783810,724696513121783810,2016-04-26 01:58:07 IST,2016-04-26,01:58:07,+0530,47678782,megtirrell,Meg Tirrell,,Had to step out a moment - but have any of the 35 speakers so far been against approval? $SRPT,en,[],[],[],10,1,7,[],['srpt'],https://twitter.com/megtirrell/status/724696513121783810,False,,0,,,,,,,,[],,,,
724694909291245569,724694909291245569,2016-04-26 01:51:45 IST,2016-04-26,01:51:45,+0530,47678782,megtirrell,Meg Tirrell,,"""If eteplirsen gets approved, we would move our family here for 0.9% of dystrophin,"" mother from UK tells FDA $SRPT",en,[],[],[],3,7,15,[],['srpt'],https://twitter.com/megtirrell/status/724694909291245569,False,,0,,,,,,,,[],,,,
724694197836615680,724694197836615680,2016-04-26 01:48:55 IST,2016-04-26,01:48:55,+0530,44438256,matthewherper,Matthew Herper,,This kid sure doesn't look like a 13yo with Duchenne. $SRPT.  https://t.co/sYqL5ultNA,en,[],['https://twitter.com/megtirrell/status/724693628178862080'],[],6,4,17,[],['srpt'],https://twitter.com/matthewherper/status/724694197836615680,False,https://twitter.com/megtirrell/status/724693628178862080,0,,,,,,,,[],,,,
724693628178862080,724693628178862080,2016-04-26 01:46:39 IST,2016-04-26,01:46:39,+0530,47678782,megtirrell,Meg Tirrell,,"Ryan, 13yo on etep, to FDA: If you are 100% sure this drug doesn't work, don't approve it. If you are not 100% sure, approve $SRPT",en,[],[],[],7,16,34,[],['srpt'],https://twitter.com/megtirrell/status/724693628178862080,False,,0,,,,,,,,[],,,,
724693407713599490,724693407713599490,2016-04-26 01:45:47 IST,2016-04-26,01:45:47,+0530,42703163,sarahkarlin,Sarah Karlin-Smith,,seems pretty clear to me - what lawmakers think accelerated approval means and what #FDA scientists think its means is not the same. $SRPT,en,[],[],[],2,6,9,['fda'],['srpt'],https://twitter.com/SarahKarlin/status/724693407713599490,False,,0,,,,,,,,[],,,,
724687861275082754,724687861275082754,2016-04-26 01:23:44 IST,2016-04-26,01:23:44,+0530,15971805,investorslive,Nathan Michaud,,Please be sure to grab a cold craft beer and popcorn for the $SRPT show later tonight @adamfeuerstein,en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",[],[],1,0,8,[],['srpt'],https://twitter.com/InvestorsLive/status/724687861275082754,False,,0,,,,,,,,[],,,,
724687603543379969,724687603543379969,2016-04-26 01:22:43 IST,2016-04-26,01:22:43,+0530,47678782,megtirrell,Meg Tirrell,,Everyone in this room wants a drug that works for DMD. Two sides just very far apart on whether etep is proven to be that drug. $SRPT,en,[],[],[],8,18,30,[],['srpt'],https://twitter.com/megtirrell/status/724687603543379969,False,,0,,,,,,,,[],,,,
724682241700450304,724682241700450304,2016-04-26 01:01:25 IST,2016-04-26,01:01:25,+0530,44438256,matthewherper,Matthew Herper,,"""Making .9% is amazing. It let's me feed myself."" --Austin, about $SRPT; he and broth Max got the drug. Heartrending.",en,[],[],[],0,4,20,[],['srpt'],https://twitter.com/matthewherper/status/724682241700450304,False,,0,,,,,,,,[],,,,
724682000817336321,724682000817336321,2016-04-26 01:00:27 IST,2016-04-26,01:00:27,+0530,44438256,matthewherper,Matthew Herper,,Seeing these kids really is heartbreaking. $SRPT,en,[],[],[],1,0,14,[],['srpt'],https://twitter.com/matthewherper/status/724682000817336321,False,,0,,,,,,,,[],,,,
724681484657922048,724681484657922048,2016-04-26 00:58:24 IST,2016-04-26,00:58:24,+0530,44438256,matthewherper,Matthew Herper,,"While I am a strong advocate of corticosteroids, corticosteroids to do not explain [the benefits for these patients]. $SRPT",en,[],[],[],0,1,7,[],['srpt'],https://twitter.com/matthewherper/status/724681484657922048,False,,0,,,,,,,,[],,,,
724674809184002050,724674809184002050,2016-04-26 00:31:52 IST,2016-04-26,00:31:52,+0530,44438256,matthewherper,Matthew Herper,,"Ryan's dad speaking. No side effects. ""Eteplirsen has given us a reason to hope."" Teachers, friends, notice he is doing better. $SRPT",en,[],[],[],0,8,13,[],['srpt'],https://twitter.com/matthewherper/status/724674809184002050,False,,0,,,,,,,,[],,,,
724671334219796482,724671334219796482,2016-04-26 00:18:04 IST,2016-04-26,00:18:04,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Bo not impressed by $SRPT panel.  https://t.co/BR87ZHb73r,en,[],[],['https://pbs.twimg.com/media/Cg6MufEU8AAy8n_.jpg'],5,2,21,[],['srpt'],https://twitter.com/adamfeuerstein/status/724671334219796482,False,,1,https://pbs.twimg.com/media/Cg6MufEU8AAy8n_.jpg,,,,,,,[],,,,
724671281967312897,724671281967312897,2016-04-26 00:17:52 IST,2016-04-26,00:17:52,+0530,47678782,megtirrell,Meg Tirrell,,"Speaker 3: ""I find it insulting that anyone would tell me they understand. Unless you have a child w MD you don't understand."" $SRPT",en,[],[],[],1,10,10,[],['srpt'],https://twitter.com/megtirrell/status/724671281967312897,False,,0,,,,,,,,[],,,,
724670864411791361,724670864411791361,2016-04-26 00:16:12 IST,2016-04-26,00:16:12,+0530,102094857,adamfeuerstein,Adam Feuerstein,,When was last time heard top FDA official accuse drug sponsor of presenting misleading data at adcomm? It just happened! Incredible. $SRPT,en,[],[],[],8,36,36,[],['srpt'],https://twitter.com/adamfeuerstein/status/724670864411791361,False,,0,,,,,,,,[],,,,
724665064310116354,724665064310116354,2016-04-25 23:53:09 IST,2016-04-25,23:53:09,+0530,47678782,megtirrell,Meg Tirrell,,"FDA: If eteplirsen gets approved on accelerated basis, may be difficult to get pts to enroll in placebo-controlled confirmatory study $SRPT",en,[],[],[],6,9,5,[],['srpt'],https://twitter.com/megtirrell/status/724665064310116354,False,,0,,,,,,,,[],,,,
724664544811950080,724664544811950080,2016-04-25 23:51:05 IST,2016-04-25,23:51:05,+0530,47678782,megtirrell,Meg Tirrell,,Audience openly heckling FDA's Farkas at $SRPT adcom,en,[],[],[],3,7,16,[],['srpt'],https://twitter.com/megtirrell/status/724664544811950080,False,,0,,,,,,,,[],,,,
724663112037703680,724663112037703680,2016-04-25 23:45:24 IST,2016-04-25,23:45:24,+0530,47678782,megtirrell,Meg Tirrell,,Tensions high between DMD community &amp; FDA at $SRPT adcom. Clear grumble from community during Bastings concluding remarks,en,[],[],[],0,10,13,[],['srpt'],https://twitter.com/megtirrell/status/724663112037703680,False,,0,,,,,,,,[],,,,
724656579316998144,724656579316998144,2016-04-25 23:19:26 IST,2016-04-25,23:19:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT FDA panel afternoon session starting up. This is when all the real action happens. My live blog here -&gt;  https://t.co/3HR4AWzm0R,en,[],['http://www.thestreet.com/story/13541457/1/sarepta-therapeutics-fda-panel-live-blog.html'],[],1,4,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/724656579316998144,False,,0,,,,,,,,[],,,,
724643021715836929,724643021715836929,2016-04-25 22:25:34 IST,2016-04-25,22:25:34,+0530,47678782,megtirrell,Meg Tirrell,,"FDA's Farkas: I think for many years you haven't heard the whole story. But I remain open to community, haven't made final decision $SRPT",en,[],[],[],2,3,7,[],['srpt'],https://twitter.com/megtirrell/status/724643021715836929,False,,0,,,,,,,,[],,,,
724628720120664065,724628720120664065,2016-04-25 21:28:44 IST,2016-04-25,21:28:44,+0530,47678782,megtirrell,Meg Tirrell,,FDA's Farkas calls this one of the most important slides we'll see today $SRPT  https://t.co/BUSulZ8B7F,en,[],[],['https://pbs.twimg.com/media/Cg5l-yRXEAAgVAN.jpg'],5,14,15,[],['srpt'],https://twitter.com/megtirrell/status/724628720120664065,False,,1,https://pbs.twimg.com/media/Cg5l-yRXEAAgVAN.jpg,,,,,,,[],,,,
724627945596149760,724627945596149760,2016-04-25 21:25:39 IST,2016-04-25,21:25:39,+0530,274233761,bradloncar,Brad Loncar,,Farkas has the most difficult job of any presenter today because all the clinicians think this should be approved. $SRPT,en,[],[],[],1,1,11,[],['srpt'],https://twitter.com/bradloncar/status/724627945596149760,False,,0,,,,,,,,[],,,,
724616037782683649,724616037782683649,2016-04-25 20:38:20 IST,2016-04-25,20:38:20,+0530,47678782,megtirrell,Meg Tirrell,,Woodcock: Sometimes we will get it wrong -- otherwise accel apprvl would have no diff standards than regular $SRPT,en,[],[],[],2,2,12,[],['srpt'],https://twitter.com/megtirrell/status/724616037782683649,False,,0,,,,,,,,[],,,,
724615805380530176,724615805380530176,2016-04-25 20:37:25 IST,2016-04-25,20:37:25,+0530,47678782,megtirrell,Meg Tirrell,,"Woodcock: failing to approve a drug that actually works -- in devastating diseases, these consequences are extreme $SRPT",en,[],[],[],0,15,22,[],['srpt'],https://twitter.com/megtirrell/status/724615805380530176,False,,0,,,,,,,,[],,,,
724610341552959488,724610341552959488,2016-04-25 20:15:42 IST,2016-04-25,20:15:42,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT presentation was very well done. On break, FDA up next. The tone will be much different.",en,[],[],[],2,6,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/724610341552959488,False,,0,,,,,,,,[],,,,
724601015350251521,724601015350251521,2016-04-25 19:38:39 IST,2016-04-25,19:38:39,+0530,102754598,johncendpts,John Carroll,,"forget the data, let's get the moms up front. $SRPT",en,[],[],[],9,3,13,[],['srpt'],https://twitter.com/JohnCendpts/status/724601015350251521,False,,0,,,,,,,,[],,,,
724600041139220487,724600041139220487,2016-04-25 19:34:46 IST,2016-04-25,19:34:46,+0530,102754598,johncendpts,John Carroll,,"Jerry Mendell whips up some cheers. $SRPT ""I can't see any grounds for denying this drug for DMD boys.""",en,[],[],[],0,2,13,[],['srpt'],https://twitter.com/JohnCendpts/status/724600041139220487,False,,0,,,,,,,,[],,,,
724599778181402627,724599778181402627,2016-04-25 19:33:44 IST,2016-04-25,19:33:44,+0530,47678782,megtirrell,Meg Tirrell,,Applause to Mendell remarks at $SRPT adcom. Ed Kaye giving concluding remarks now. Energy in room just picked up quite a bit,en,[],[],[],0,0,8,[],['srpt'],https://twitter.com/megtirrell/status/724599778181402627,False,,0,,,,,,,,[],,,,
724599705041145856,724599705041145856,2016-04-25 19:33:26 IST,2016-04-25,19:33:26,+0530,274233761,bradloncar,Brad Loncar,,Dr. Mendell: I can‚Äôt see any grounds for withholding this treatment from DMD boys. $SRPT,en,[],[],[],0,7,11,[],['srpt'],https://twitter.com/bradloncar/status/724599705041145856,False,,0,,,,,,,,[],,,,
724598931573727233,724598931573727233,2016-04-25 19:30:22 IST,2016-04-25,19:30:22,+0530,47678782,megtirrell,Meg Tirrell,,"Mendell: eteplirsen slows progression, which results in maintained ambulation. No claims of cure for DMD $SRPT",en,[],[],[],1,5,9,[],['srpt'],https://twitter.com/megtirrell/status/724598931573727233,False,,0,,,,,,,,[],,,,
724598431000326146,724598431000326146,2016-04-25 19:28:22 IST,2016-04-25,19:28:22,+0530,47678782,megtirrell,Meg Tirrell,,Mendell: I've done clinical trials over the last 40 yrs and I've never seen tolerability like I've seen in this trial $SRPT,en,[],[],[],1,4,9,[],['srpt'],https://twitter.com/megtirrell/status/724598431000326146,False,,0,,,,,,,,[],,,,
724598178985570308,724598178985570308,2016-04-25 19:27:22 IST,2016-04-25,19:27:22,+0530,47678782,megtirrell,Meg Tirrell,,"Mendell's ""treatment triad:""  1) prolonged ambulation - refutes FDA claim DMD pts walk to age 16 2) safety 3) consistency $SRPT",en,[],[],[],0,6,7,[],['srpt'],https://twitter.com/megtirrell/status/724598178985570308,False,,0,,,,,,,,[],,,,
724598142390276096,724598142390276096,2016-04-25 19:27:14 IST,2016-04-25,19:27:14,+0530,274233761,bradloncar,Brad Loncar,,Dr. Mendell has been treating this disease since 1969. $SRPT,en,[],[],[],0,3,8,[],['srpt'],https://twitter.com/bradloncar/status/724598142390276096,False,,0,,,,,,,,[],,,,
724595488943648768,724595488943648768,2016-04-25 19:16:41 IST,2016-04-25,19:16:41,+0530,44438256,matthewherper,Matthew Herper,,"If we're going to make approvals dependent on after-the-fact arguments about FDA meetings, we need concurrent minutes. $SRPT",en,[],[],[],4,2,14,[],['srpt'],https://twitter.com/matthewherper/status/724595488943648768,False,,0,,,,,,,,[],,,,
724594918900043778,724594918900043778,2016-04-25 19:14:25 IST,2016-04-25,19:14:25,+0530,47678782,megtirrell,Meg Tirrell,,"Can we get count on # of times $SRPT uses ""unequivocal"" to reference production of dystrophin?",en,[],[],[],1,1,11,[],['srpt'],https://twitter.com/megtirrell/status/724594918900043778,False,,0,,,,,,,,[],,,,
724592670694342656,724592670694342656,2016-04-25 19:05:29 IST,2016-04-25,19:05:29,+0530,44438256,matthewherper,Matthew Herper,,$SRPT is doing a GREAT job presenting its data.,en,[],[],[],4,12,23,[],['srpt'],https://twitter.com/matthewherper/status/724592670694342656,False,,0,,,,,,,,[],,,,
724589636274802688,724589636274802688,2016-04-25 18:53:26 IST,2016-04-25,18:53:26,+0530,102754598,johncendpts,John Carroll,,Expect complete disconnect between $SRPT and FDA today. Like they're looking at 2 different sets of data. --#dmd,en,[],[],[],2,2,9,['dmd'],['srpt'],https://twitter.com/JohnCendpts/status/724589636274802688,False,,0,,,,,,,,[],,,,
724585264237129728,724585264237129728,2016-04-25 18:36:03 IST,2016-04-25,18:36:03,+0530,47348249,michael_gilman,Michael Gilman,,"If you are a biotech other than $SRPT, this is probably a pretty good day to release bad news.",en,[],[],[],0,8,26,[],['srpt'],https://twitter.com/michael_gilman/status/724585264237129728,False,,0,,,,,,,,[],,,,
724580128890732545,724580128890732545,2016-04-25 18:15:39 IST,2016-04-25,18:15:39,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT points out accelerated approval allows for ""acceptable degree of uncertainty regarding anticipated benefit""",en,[],[],[],0,9,9,[],['srpt'],https://twitter.com/megtirrell/status/724580128890732545,False,,0,,,,,,,,[],,,,
724580074238939136,724580074238939136,2016-04-25 18:15:26 IST,2016-04-25,18:15:26,+0530,44438256,matthewherper,Matthew Herper,,$SRPT laying the idea that they couldn't do this study on the DMD community. My memory is $SRPT helped create this situation.,en,[],[],[],4,2,9,[],"['srpt', 'srpt']",https://twitter.com/matthewherper/status/724580074238939136,False,,0,,,,,,,,[],,,,
724571025682378753,724571025682378753,2016-04-25 17:39:29 IST,2016-04-25,17:39:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,You can watch my $SRPT FDA panel  live blog here ‚Äî&gt;  https://t.co/3HR4AWzm0R,en,[],['http://www.thestreet.com/story/13541457/1/sarepta-therapeutics-fda-panel-live-blog.html'],[],5,11,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/724571025682378753,False,,0,,,,,,,,[],,,,
724570711432564736,724570711432564736,2016-04-25 17:38:14 IST,2016-04-25,17:38:14,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Whew. Tech issue fixed.   $SRPT LIVE BLOG LINK ‚Äî&gt;  https://t.co/3HR4AWzm0R,en,[],['http://www.thestreet.com/story/13541457/1/sarepta-therapeutics-fda-panel-live-blog.html'],[],0,5,5,[],['srpt'],https://twitter.com/adamfeuerstein/status/724570711432564736,False,,0,,,,,,,,[],,,,
724567248850030592,724567248850030592,2016-04-25 17:24:28 IST,2016-04-25,17:24:28,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT FDA adcom room, now minutes from start of event  https://t.co/ZfSMfDXzXk",en,[],[],['https://pbs.twimg.com/media/Cg4uEt3W0AA4vSq.jpg'],1,1,4,[],['srpt'],https://twitter.com/megtirrell/status/724567248850030592,False,,1,https://pbs.twimg.com/media/Cg4uEt3W0AA4vSq.jpg,,,,,,,[],,,,
724561644089708544,724561644089708544,2016-04-25 17:02:12 IST,2016-04-25,17:02:12,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT FDA live blog command center. The coffee is most important tool.  https://t.co/8zV0EDZbVO,en,[],[],['https://pbs.twimg.com/media/Cg4o8UfWIAAtJ4M.jpg'],9,3,35,[],['srpt'],https://twitter.com/adamfeuerstein/status/724561644089708544,False,,1,https://pbs.twimg.com/media/Cg4o8UfWIAAtJ4M.jpg,,,,,,,[],,,,
724561512677953538,724561512677953538,2016-04-25 17:01:40 IST,2016-04-25,17:01:40,+0530,47678782,megtirrell,Meg Tirrell,,Our live coverage of $SRPT FDA advisory committee meeting starts in minutes on @SquawkCNBC. Tune in!,en,"[{'screen_name': 'squawkcnbc', 'name': 'squawk box', 'id': '404422077'}]",[],[],0,5,5,[],['srpt'],https://twitter.com/megtirrell/status/724561512677953538,False,,0,,,,,,,,[],,,,
724558479818551297,724558479818551297,2016-04-25 16:49:37 IST,2016-04-25,16:49:37,+0530,15281391,thestreet,TheStreet,,"Here's how to trade 7 of the market's most active stocks, including $FB and $SRPT  https://t.co/pJAYbsIw3g  https://t.co/Lt6PVpQcaN",en,[],['http://dlvr.it/L8D5pp'],['https://pbs.twimg.com/media/Cg4mGRcU0AAue2S.jpg'],0,3,15,[],"['fb', 'srpt']",https://twitter.com/TheStreet/status/724558479818551297,False,,1,https://pbs.twimg.com/media/Cg4mGRcU0AAue2S.jpg,,,,,,,[],,,,
724557102287560705,724557102287560705,2016-04-25 16:44:09 IST,2016-04-25,16:44:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"For those not working on Sunday, I wrote an investors‚Äô guide to today‚Äôs $SRPT FDA advisory panel ‚Äî&gt;  https://t.co/foWHGcMT9a",en,[],['http://www.thestreet.com/story/13542139/1/an-investors-guide-to-sarepta-s-eteplirsen-fda-advisory-panel-meeting.html'],[],1,4,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/724557102287560705,False,,0,,,,,,,,[],,,,
724554472647757824,724554472647757824,2016-04-25 16:33:42 IST,2016-04-25,16:33:42,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT halted. Guess there's something happening today,en,[],[],[],2,2,13,[],['srpt'],https://twitter.com/megtirrell/status/724554472647757824,False,,0,,,,,,,,[],,,,
724552179982458882,724552179982458882,2016-04-25 16:24:35 IST,2016-04-25,16:24:35,+0530,47678782,megtirrell,Meg Tirrell,,View from inside $SRPT adcom ballroom... more than an hour before it begins  https://t.co/1TGZY3SkJx,en,[],[],['https://pbs.twimg.com/media/Cg4gWTmUcAAu3HF.jpg'],2,19,18,[],['srpt'],https://twitter.com/megtirrell/status/724552179982458882,False,,1,https://pbs.twimg.com/media/Cg4gWTmUcAAu3HF.jpg,,,,,,,[],,,,
724548896161144832,724548896161144832,2016-04-25 16:11:32 IST,2016-04-25,16:11:32,+0530,47678782,megtirrell,Meg Tirrell,,Line already wrapped through hotel lobby waiting for $SRPT adcom to start at 8amET,en,[],[],[],1,7,10,[],['srpt'],https://twitter.com/megtirrell/status/724548896161144832,False,,0,,,,,,,,[],,,,
724543407100682240,724543407100682240,2016-04-25 15:49:44 IST,2016-04-25,15:49:44,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I have pre-game nerves! Weird. $SRPT FDA panel live blog coming up around 7:30 am EDT.,en,[],[],[],7,5,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/724543407100682240,False,,0,,,,,,,,[],,,,
724538783664730112,724538783664730112,2016-04-25 15:31:21 IST,2016-04-25,15:31:21,+0530,274233761,bradloncar,Brad Loncar,,The BIG DAY is here. Good luck to all of the kids and families impacted by this. #History #DMD $SRPT,en,[],[],[],3,4,26,"['history', 'dmd']",['srpt'],https://twitter.com/bradloncar/status/724538783664730112,False,,0,,,,,,,,[],,,,
724527615298678784,724527615298678784,2016-04-25 14:46:59 IST,2016-04-25,14:46:59,+0530,14216123,jimcramer,Jim Cramer,,I have been bullish on $BMRN not $SRPT  https://t.co/tyBVeHcor2,en,[],['https://twitter.com/kaukin9969/status/724423928412790785'],[],5,2,7,[],"['bmrn', 'srpt']",https://twitter.com/jimcramer/status/724527615298678784,False,0,0,,,,,,,,[],,,,
724516456508055552,724516456508055552,2016-04-25 14:02:38 IST,2016-04-25,14:02:38,+0530,102754598,johncendpts,John Carroll,,Today we'll find out if lobbying pressure alone can sway an FDA expert panel. I'd say there's a pretty decent chance of that. $SRPT,en,[],[],[],4,4,9,[],['srpt'],https://twitter.com/JohnCendpts/status/724516456508055552,False,,0,,,,,,,,[],,,,
724370780923039744,724370780923039744,2016-04-25 04:23:46 IST,2016-04-25,04:23:46,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I'm blocking the next person who asks me if $SRPT is going to trade tomorrow.,en,[],[],[],5,3,42,[],['srpt'],https://twitter.com/adamfeuerstein/status/724370780923039744,False,,0,,,,,,,,[],,,,
724366209068584960,724363659145699328,2016-04-25 04:05:36 IST,2016-04-25,04:05:36,+0530,14031032,adamsinger,Adam Singer,,@nixon786 yeah somehow $SRPT makes $RLYP look like a mutual fund lol.,en,[],[],[],0,0,8,[],"['srpt', 'rlyp']",https://twitter.com/AdamSinger/status/724366209068584960,False,,0,,,,,,,,[],,,,
724363659145699328,724363659145699328,2016-04-25 03:55:29 IST,2016-04-25,03:55:29,+0530,14031032,adamsinger,Adam Singer,,"Culmination of 1 of most emotional stories for patients, advocacy groups, team members/investors. Rooting for $SRPT.  https://t.co/xcAOis2Bel",en,[],['https://twitter.com/adamfeuerstein/status/724279295758221312'],[],1,0,5,[],['srpt'],https://twitter.com/AdamSinger/status/724363659145699328,False,https://twitter.com/adamfeuerstein/status/724279295758221312,0,,,,,,,,[],,,,
724356134723792897,724356134723792897,2016-04-25 03:25:35 IST,2016-04-25,03:25:35,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Before GoT tonight, read my investors‚Äô guide to tomorrow‚Äôs $SRPT FDA advisory panel ‚Äî&gt;  https://t.co/foWHGcMT9a #eteplirsen #DMD",en,[],['http://www.thestreet.com/story/13542139/1/an-investors-guide-to-sarepta-s-eteplirsen-fda-advisory-panel-meeting.html'],[],5,10,17,"['eteplirsen', 'dmd']",['srpt'],https://twitter.com/adamfeuerstein/status/724356134723792897,False,,0,,,,,,,,[],,,,
724279295758221312,724279295758221312,2016-04-24 22:20:15 IST,2016-04-24,22:20:15,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Special Sunday story!   An Investors‚Äô Guide to $SRPT Eteplirsen FDA Advisory Panel Meeting ‚Äî&gt;  https://t.co/foWHGcMT9a,en,[],['http://www.thestreet.com/story/13542139/1/an-investors-guide-to-sarepta-s-eteplirsen-fda-advisory-panel-meeting.html'],[],14,25,39,[],['srpt'],https://twitter.com/adamfeuerstein/status/724279295758221312,False,,0,,,,,,,,[],,,,
723931162880688128,723931162880688128,2016-04-23 23:16:53 IST,2016-04-23,23:16:53,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Of course! I'll get the live blog fired up around 7:30 am Monday. All day, until the final vote. $SRPT  https://t.co/DEIS3GGzFF",en,[],['https://twitter.com/tekka_maki/status/723930750966362112'],[],3,5,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/723931162880688128,False,https://twitter.com/tekka_maki/status/723930750966362112,0,,,,,,,,[],,,,
723880060395098112,723833693975003137,2016-04-23 19:53:50 IST,2016-04-23,19:53:50,+0530,102094857,adamfeuerstein,Adam Feuerstein,,. @RickSantorum Hey Rick -- Do you or any members of your family own Sarepta $SRPT stock?,en,"[{'screen_name': 'ricksantorum', 'name': 'rick santorum', 'id': '58379000'}]",[],[],14,6,30,[],['srpt'],https://twitter.com/adamfeuerstein/status/723880060395098112,False,,0,,,,,,,,[],,,,
723836149886791680,723836149886791680,2016-04-23 16:59:21 IST,2016-04-23,16:59:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT - Read what I wrote about eteplirsen April 27, 2012.    https://t.co/hrL2Qivrzb  4 yrs later, same patients, same questions.   Monday!",en,[],['http://www.thestreet.com/story/11510797/1/biotech-stock-mailbag-avi-aveo-spectrum.html'],[],6,8,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/723836149886791680,False,,0,,,,,,,,[],,,,
723833693975003137,723833693975003137,2016-04-23 16:49:35 IST,2016-04-23,16:49:35,+0530,58379000,ricksantorum,Rick Santorum,,Will be attending #fda Advisory Comm Monday on 1st ever treatment for Duchenne Muscular Dystrophy. Pray to #MakeDuchenneHistory $SRPT #DMD,en,[],[],[],16,60,110,"['fda', 'makeduchennehistory', 'dmd']",['srpt'],https://twitter.com/RickSantorum/status/723833693975003137,False,,0,,,,,,,,[],,,,
723560726619508736,723560726619508736,2016-04-22 22:44:54 IST,2016-04-22,22:44:54,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,"$SRPT Just made a horrible trade; got out of it for a small loss, deserved to be a bigger loss. Day trading options -- bad.",en,[],[],[],3,2,4,[],['srpt'],https://twitter.com/OphirGottlieb/status/723560726619508736,False,,0,,,,,,,,[],,,,
723558868865957889,723558868865957889,2016-04-22 22:37:32 IST,2016-04-22,22:37:32,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT bulls also emboldened by presence of clear-cut voting questions. These were absent from $BMRN panel. On to Monday!!,en,[],[],[],2,2,11,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/723558868865957889,False,,0,,,,,,,,[],,,,
723557749880180736,723557749880180736,2016-04-22 22:33:05 IST,2016-04-22,22:33:05,+0530,102754598,johncendpts,John Carroll,,It's more clear than ever that lobbying is the only hope that $SRPT has left.,en,[],[],[],3,4,8,[],['srpt'],https://twitter.com/JohnCendpts/status/723557749880180736,False,,0,,,,,,,,[],,,,
723554867063709696,723554867063709696,2016-04-22 22:21:37 IST,2016-04-22,22:21:37,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT bulls very focused on Question 2 re: dystrophin. They see this as most likely positive vote, helpful for accelerated approval.",en,[],[],[],6,12,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/723554867063709696,False,,0,,,,,,,,[],,,,
723547796247330816,723547796247330816,2016-04-22 21:53:32 IST,2016-04-22,21:53:32,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Two words that will be discussed and debated A LOT on Monday:  Substantial evidence  $SRPT,en,[],[],[],7,6,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/723547796247330816,False,,0,,,,,,,,[],,,,
723547053356400640,723547053356400640,2016-04-22 21:50:35 IST,2016-04-22,21:50:35,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚Äî FDA added a voting question to Monday‚Äôs eteplirsen advisory panel. ‚Äî&gt;  https://t.co/DIQG4av2Rn,en,[],['http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM497241.pdf'],[],6,15,12,[],['srpt'],https://twitter.com/adamfeuerstein/status/723547053356400640,False,,0,,,,,,,,[],,,,
723545574352543745,723545574352543745,2016-04-22 21:44:42 IST,2016-04-22,21:44:42,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"As if you needed reminding, I will be live-blogging $SRPT FDA panel on Monday. ALL DAY AND INTO THE EARLY EVENING. Pls make plans to join me",en,[],[],[],3,2,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/723545574352543745,False,,0,,,,,,,,[],,,,
723491768210100224,723491768210100224,2016-04-22 18:10:54 IST,2016-04-22,18:10:54,+0530,15281391,thestreet,TheStreet,,Biotech stock mailbag: Is there a future for Sarepta Therapeutics? $SRPT  https://t.co/GTG77zMRFB  https://t.co/DCYkGzV7Od,en,[],['http://dlvr.it/L6zLqt'],['https://pbs.twimg.com/media/Cgpb7gdU0AALU9m.jpg'],2,12,14,[],['srpt'],https://twitter.com/TheStreet/status/723491768210100224,False,,1,https://pbs.twimg.com/media/Cgpb7gdU0AALU9m.jpg,,,,,,,[],,,,
723340288580702208,723340288580702208,2016-04-22 08:08:58 IST,2016-04-22,08:08:58,+0530,274233761,bradloncar,Brad Loncar,,The WSJ $SRPT editorial:  https://t.co/lFo0zZJGsf,en,[],['http://www.wsj.com/articles/the-fda-vs-austin-leclaire-1461281386'],[],2,6,17,[],['srpt'],https://twitter.com/bradloncar/status/723340288580702208,False,,0,,,,,,,,[],,,,
723179623664611328,723179623664611328,2016-04-21 21:30:32 IST,2016-04-21,21:30:32,+0530,44438256,matthewherper,Matthew Herper,,"Also, more patients are harmed by regulatory mirages than regulatory walls. $SRPT  https://t.co/TfrxbBytyK",en,[],['http://www.forbes.com/sites/matthewherper/2016/04/21/a-muscular-dystrophy-debacle-shows-trying-to-speed-drugs-approvals-up-can-slow-them-down/#7a9be9a97587'],[],7,10,6,[],['srpt'],https://twitter.com/matthewherper/status/723179623664611328,False,,0,,,,,,,,[],,,,
723179548888600576,723179548888600576,2016-04-21 21:30:15 IST,2016-04-21,21:30:15,+0530,44438256,matthewherper,Matthew Herper,,It's an absolute travesty that FDA's view on meetings with companies is not made public. $SRPT  https://t.co/TfrxbBytyK,en,[],['http://www.forbes.com/sites/matthewherper/2016/04/21/a-muscular-dystrophy-debacle-shows-trying-to-speed-drugs-approvals-up-can-slow-them-down/#7a9be9a97587'],[],7,11,19,[],['srpt'],https://twitter.com/matthewherper/status/723179548888600576,False,,0,,,,,,,,[],,,,
723179439287226368,723179439287226368,2016-04-21 21:29:49 IST,2016-04-21,21:29:49,+0530,44438256,matthewherper,Matthew Herper,,Here are my thoughts on $SRPT. This was hard to write. I think things could have been different.  https://t.co/TfrxbBytyK,en,[],['http://www.forbes.com/sites/matthewherper/2016/04/21/a-muscular-dystrophy-debacle-shows-trying-to-speed-drugs-approvals-up-can-slow-them-down/#7a9be9a97587'],[],14,25,33,[],['srpt'],https://twitter.com/matthewherper/status/723179439287226368,False,,0,,,,,,,,[],,,,
723150664419807232,723136052836356096,2016-04-21 19:35:28 IST,2016-04-21,19:35:28,+0530,44438256,matthewherper,Matthew Herper,,"""FDA consistently and strongly encouraged $SRPT to conduct adequately powered randomized placebo-controlled trials."" p. 26 @adamfeuerstein",en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",[],[],3,2,10,[],['srpt'],https://twitter.com/matthewherper/status/723150664419807232,False,,0,,,,,,,,[],,,,
723136052836356096,723136052836356096,2016-04-21 18:37:24 IST,2016-04-21,18:37:24,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT ‚Äî The full, updated FDA review is more negative on eteplirsen than in January. FDA really takes apart historical control study.",en,[],[],[],9,20,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/723136052836356096,False,,0,,,,,,,,[],,,,
723131056589664256,723131056589664256,2016-04-21 18:17:33 IST,2016-04-21,18:17:33,+0530,274233761,bradloncar,Brad Loncar,,Quick $SRPT take from Janney (I hope it‚Äôs wrong).  https://t.co/FFsLRHOa90,en,[],[],['https://pbs.twimg.com/media/CgkT3TbVEAAtDTu.jpg'],4,2,5,[],['srpt'],https://twitter.com/bradloncar/status/723131056589664256,False,,1,https://pbs.twimg.com/media/CgkT3TbVEAAtDTu.jpg,,,,,,,[],,,,
723130769552470017,723130769552470017,2016-04-21 18:16:25 IST,2016-04-21,18:16:25,+0530,14031032,adamsinger,Adam Singer,,Every time I look @ this (via $SRPT or FDA) get closer to really interesting pt. At yr 5 no one can deny drug works.  https://t.co/gWnDHAUXXB,en,[],[],['https://pbs.twimg.com/media/CgkTmm8UYAExUSM.jpg'],8,7,9,[],['srpt'],https://twitter.com/AdamSinger/status/723130769552470017,False,,1,https://pbs.twimg.com/media/CgkTmm8UYAExUSM.jpg,,,,,,,[],,,,
723127671207632896,723127671207632896,2016-04-21 18:04:06 IST,2016-04-21,18:04:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Now that the rush of adrenalin has subsided, a reminder that I will be live blogging $SRPT FDA panel on Monday. It will be action packed!",en,[],[],[],2,2,5,[],['srpt'],https://twitter.com/adamfeuerstein/status/723127671207632896,False,,0,,,,,,,,[],,,,
723125800191574016,723125800191574016,2016-04-21 17:56:40 IST,2016-04-21,17:56:40,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT ‚Äî FDA‚Äôs Janet Woodcock and Bob Temple are on the speaking agenda at Monday‚Äôs panel. You do not see this very often, if ever.",en,[],[],[],4,18,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/723125800191574016,False,,0,,,,,,,,[],,,,
723097093620043776,723097093620043776,2016-04-21 16:02:36 IST,2016-04-21,16:02:36,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚Äî Is it too early to start hitting refresh on the FDA adcomm page?,en,[],[],[],6,5,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/723097093620043776,False,,0,,,,,,,,[],,,,
722791987158597632,722791987158597632,2016-04-20 19:50:13 IST,2016-04-20,19:50:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Monday‚Äôs $SRPT FDA panel scheduled for 8 am to 6:30 pm EDT. 10.5 hours!   And I will live blog the entire panel. &lt;gulp&gt; Please join me.,en,[],[],[],8,7,36,[],['srpt'],https://twitter.com/adamfeuerstein/status/722791987158597632,False,,0,,,,,,,,[],,,,
722566877185183744,722566877185183744,2016-04-20 04:55:42 IST,2016-04-20,04:55:42,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I might have to try Intravenous coffee delivery for this live blog. And bourbon. $SRPT  https://t.co/jCZrWfKQpk,en,[],['https://twitter.com/biorunup/status/722558523289112576'],[],2,4,17,[],['srpt'],https://twitter.com/adamfeuerstein/status/722566877185183744,False,https://twitter.com/biorunup/status/722558523289112576,0,,,,,,,,[],,,,
722421232499625984,722421232499625984,2016-04-19 19:16:58 IST,2016-04-19,19:16:58,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT.  If only‚Ä¶.   https://t.co/bbBJeOfKYS,en,[],['https://twitter.com/RPMReportMike/status/722420953326751744'],[],1,8,5,[],['srpt'],https://twitter.com/adamfeuerstein/status/722421232499625984,False,https://twitter.com/RPMReportMike/status/722420953326751744,0,,,,,,,,[],,,,
722377761692721152,722377573645295616,2016-04-19 16:24:14 IST,2016-04-19,16:24:14,+0530,102094857,adamfeuerstein,Adam Feuerstein,,. @Sport234a The first document I‚Äôm opening on Thursday will be the questions to the panel. $SRPT.,en,[],[],[],2,1,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/722377761692721152,False,,0,,,,,,,,[],,,,
722029681759748096,722029681759748096,2016-04-18 17:21:05 IST,2016-04-18,17:21:05,+0530,274233761,bradloncar,Brad Loncar,,$SRPT has to keep up its streak of having news on Boston Marathon day today somehow.,en,[],[],[],2,0,6,[],['srpt'],https://twitter.com/bradloncar/status/722029681759748096,False,,0,,,,,,,,[],,,,
722019297581789184,722019297581789184,2016-04-18 16:39:49 IST,2016-04-18,16:39:49,+0530,102094857,adamfeuerstein,Adam Feuerstein,,This week:   $BMRN R&amp;D Day Wednesday $BIIB Q1 EPS Thursday $SRPT FDA adcomm briefing docs Thursday (?),en,[],[],[],1,7,8,[],"['bmrn', 'biib', 'srpt']",https://twitter.com/adamfeuerstein/status/722019297581789184,False,,0,,,,,,,,[],,,,
720996125885472769,720996125885472769,2016-04-15 20:54:06 IST,2016-04-15,20:54:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$PTCT sets a very low bar for NICE reimbursement, helpful to $SRPT $BMRN if they can get their DMD drugs approved.   https://t.co/EWT5CVDqYf",en,[],['https://twitter.com/bradloncar/status/720995348731142144'],[],3,6,11,[],"['ptct', 'srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/720996125885472769,False,https://twitter.com/bradloncar/status/720995348731142144,0,,,,,,,,[],,,,
720935971169169408,720935971169169408,2016-04-15 16:55:04 IST,2016-04-15,16:55:04,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I wrote abt $SRPT in this wk‚Äôs Mailbag but fear there‚Äôs really nothing new to say until the adcomm. But, here ya go  https://t.co/1i1jFONy0r",en,[],['http://www.thestreet.com/story/13531459/1/biotech-stock-mailbag-sarepta-therapeutics-big-event-is-coming.html'],[],4,7,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/720935971169169408,False,,0,,,,,,,,[],,,,
718867811662045185,718867811662045185,2016-04-09 23:56:56 IST,2016-04-09,23:56:56,+0530,14031032,adamsinger,Adam Singer,,$SRPT has to be one of the wildest charts in the market past few years. Just the untamable serpent.  https://t.co/U6gUJLPTfj,en,[],[],['https://pbs.twimg.com/media/CfnudznUIAAIIW8.jpg'],1,0,9,[],['srpt'],https://twitter.com/AdamSinger/status/718867811662045185,False,,1,https://pbs.twimg.com/media/CfnudznUIAAIIW8.jpg,,,,,,,[],,,,
718191293189505026,718170625190338560,2016-04-08 03:08:42 IST,2016-04-08,03:08:42,+0530,102094857,adamfeuerstein,Adam Feuerstein,,". @alwol311 @JJvert I sympathize w/ DMD parents but you have to think about the next drug and the next one after that, not just etep. $SRPT",en,"[{'screen_name': 'alwol311', 'name': 'shadow', 'id': '272386122'}]",[],[],6,2,4,[],['srpt'],https://twitter.com/adamfeuerstein/status/718191293189505026,False,,0,,,,,,,,[],,,,
718172659394207744,718172659394207744,2016-04-08 01:54:39 IST,2016-04-08,01:54:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,The next call from Sen. Asswipe to FDA will be to pressure approval of a bad drug which doesn't work or harms pats. $SRPT,en,[],[],[],4,4,21,[],['srpt'],https://twitter.com/adamfeuerstein/status/718172659394207744,False,,0,,,,,,,,[],,,,
718165695985541121,718165695985541121,2016-04-08 01:26:59 IST,2016-04-08,01:26:59,+0530,102094857,adamfeuerstein,Adam Feuerstein,,This is a really bad precedent. Terrible. $SRPT  https://t.co/wybGuwY7X4,en,[],['https://twitter.com/biorunup/status/718164785808826368'],[],8,9,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/718165695985541121,False,https://twitter.com/biorunup/status/718164785808826368,0,,,,,,,,[],,,,
717679288577888256,717679288577888256,2016-04-06 17:14:10 IST,2016-04-06,17:14:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Oppy raised $SRPT PT to $60 from $45, expects positive vote on eteplirsen at FDA panel.   https://t.co/CIf6nMfqLu",en,[],['https://twitter.com/Mahmissa/status/717678944527507458'],[],3,13,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/717679288577888256,False,https://twitter.com/Mahmissa/status/717678944527507458,0,,,,,,,,[],,,,
715194343083143168,715194343083143168,2016-03-30 20:39:53 IST,2016-03-30,20:39:53,+0530,47678782,megtirrell,Meg Tirrell,,Want to hear more from Perceptive's Joe Edelman on why he's so sure $SRPT gets approved? Stay tuned for CNBCPro interview!,en,[],[],[],0,3,15,[],['srpt'],https://twitter.com/megtirrell/status/715194343083143168,False,,0,,,,,,,,[],,,,
715189520292061184,715189520292061184,2016-03-30 20:20:43 IST,2016-03-30,20:20:43,+0530,47678782,megtirrell,Meg Tirrell,,"$BMRN's drisapersen ""was a bad drug,"" Edelman tells @SquawkStreet. Still betting $SRPT gets approved",en,"[{'screen_name': 'squawkstreet', 'name': 'squawk on the street', 'id': '106498703'}]",[],[],2,6,6,[],"['bmrn', 'srpt']",https://twitter.com/megtirrell/status/715189520292061184,False,,0,,,,,,,,[],,,,
715189330482962432,715189330482962432,2016-03-30 20:19:58 IST,2016-03-30,20:19:58,+0530,47678782,megtirrell,Meg Tirrell,,""" $SRPT we're very bullish on,"" Joe Edelman tells @SquawkStreet. ""Find it hard to believe the FDA turns it down.""",en,"[{'screen_name': 'squawkstreet', 'name': 'squawk on the street', 'id': '106498703'}]",[],[],1,19,34,[],['srpt'],https://twitter.com/megtirrell/status/715189330482962432,False,,0,,,,,,,,[],,,,
715188612346855424,715188612346855424,2016-03-30 20:17:07 IST,2016-03-30,20:17:07,+0530,47678782,megtirrell,Meg Tirrell,,Perceptive's big winners of 2015: $SRPT $NBIX $RTRX Acerta (2nd largest holder) -- Joe Edelman on @SquawkStreet now,en,"[{'screen_name': 'squawkstreet', 'name': 'squawk on the street', 'id': '106498703'}]",[],[],1,2,5,[],"['srpt', 'nbix', 'rtrx']",https://twitter.com/megtirrell/status/715188612346855424,False,,0,,,,,,,,[],,,,
713004121436110848,713004121436110848,2016-03-24 19:36:44 IST,2016-03-24,19:36:44,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Good tips here! --&gt; Biotech Stock Mailbag: How to Spot Red Flags in Clinical Trial Data  https://t.co/NlBrs86lN1 Also briefly on $SRPT $ACAD,en,[],['http://www.thestreet.com/story/13506801/1/biotech-stock-mailbag-how-to-spot-red-flags-in-clinical-trial-data.html'],[],4,11,42,[],"['srpt', 'acad']",https://twitter.com/adamfeuerstein/status/713004121436110848,False,,0,,,,,,,,[],,,,
712010672889008128,712010672889008128,2016-03-22 01:49:07 IST,2016-03-22,01:49:07,+0530,102754598,johncendpts,John Carroll,,I don't buy or sell any stocks. $SRPT  https://t.co/Zi3xkDO5X5,en,[],['https://twitter.com/jeffreymaxin/status/712010513442480129'],[],1,0,5,[],['srpt'],https://twitter.com/JohnCendpts/status/712010672889008128,False,https://twitter.com/jeffreymaxin/status/712010513442480129,0,,,,,,,,[],,,,
712007563374624768,712007563374624768,2016-03-22 01:36:46 IST,2016-03-22,01:36:46,+0530,102754598,johncendpts,John Carroll,,Those letter writers for $SRPT would have done well to spell out conflicts.,en,[],[],[],4,0,4,[],['srpt'],https://twitter.com/JohnCendpts/status/712007563374624768,False,,0,,,,,,,,[],,,,
712006858744197122,712006858744197122,2016-03-22 01:33:58 IST,2016-03-22,01:33:58,+0530,102754598,johncendpts,John Carroll,,Duchenne docs ‚Äì and Sarepta trial investigators ‚Äì back biotech's controversial case for eteplirsen $SRPT   https://t.co/gR4MnLUkYe,en,[],['http://www.fiercebiotech.com/story/duchenne-docs-and-trial-sarepta-investigators-back-biotechs-controversial-c/2016-03-21'],[],2,9,12,[],['srpt'],https://twitter.com/JohnCendpts/status/712006858744197122,False,,0,,,,,,,,[],,,,
711983485792198656,711983485792198656,2016-03-22 00:01:05 IST,2016-03-22,00:01:05,+0530,47678782,megtirrell,Meg Tirrell,,Wow. Poking head up from $VRX story to find $SRPT up 21% on this:  https://t.co/HhEG2dgzWZ,en,[],['https://twitter.com/adamfeuerstein/status/711963417339416576'],[],0,3,9,[],"['vrx', 'srpt']",https://twitter.com/megtirrell/status/711983485792198656,False,https://twitter.com/adamfeuerstein/status/711963417339416576,0,,,,,,,,[],,,,
711983209458884608,711983209458884608,2016-03-21 23:59:59 IST,2016-03-21,23:59:59,+0530,15971805,investorslive,Nathan Michaud,,$SRPT please take this piggy as HIGH as POSSIBLE for tomorrow - thanks in advance !!,en,[],[],[],2,0,9,[],['srpt'],https://twitter.com/InvestorsLive/status/711983209458884608,False,,0,,,,,,,,[],,,,
711963417339416576,711963417339416576,2016-03-21 22:41:20 IST,2016-03-21,22:41:20,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Bolstered by Doctor Letter Urging FDA Approval of DMD Drug  https://t.co/Ae1z1C52OB via @TheStreet,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/13502082/1/sarepta-bolstered-by-doctor-letter-urging-fda-approval-of-dmd-drug.html'],[],2,17,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/711963417339416576,False,,0,,,,,,,,[],,,,
711942431894343681,711942431894343681,2016-03-21 21:17:57 IST,2016-03-21,21:17:57,+0530,102094857,adamfeuerstein,Adam Feuerstein,,That‚Äôs a good letter. Much better and more helpful than the politicians lobbying for eteplirsen. $SRPT  https://t.co/ENstT8H8Yt,en,[],['https://twitter.com/fundDuchenne/status/711938183370555393'],[],5,23,44,[],['srpt'],https://twitter.com/adamfeuerstein/status/711942431894343681,False,https://twitter.com/fundDuchenne/status/711938183370555393,0,,,,,,,,[],,,,
709356203705442304,709356203705442304,2016-03-14 18:01:12 IST,2016-03-14,18:01:12,+0530,274233761,bradloncar,Brad Loncar,,$SRPT finally PR‚Äôd the April 25 advisory committee meeting.,en,[],[],[],1,1,5,[],['srpt'],https://twitter.com/bradloncar/status/709356203705442304,False,,0,,,,,,,,[],,,,
708076266742792192,708076266742792192,2016-03-11 05:15:12 IST,2016-03-11,05:15:12,+0530,102754598,johncendpts,John Carroll,,"$SRPT up 15% on an adcom date? Puh-leeze, people. What are you drinking?",en,[],[],[],14,6,15,[],['srpt'],https://twitter.com/JohnCendpts/status/708076266742792192,False,,0,,,,,,,,[],,,,
708040171778736128,708039808258482176,2016-03-11 02:51:46 IST,2016-03-11,02:51:46,+0530,14031032,adamsinger,Adam Singer,,To anyone in Sarepta (prob lots of new folk today) consider donating to a DMD nonprofit like Jett Foundation:  https://t.co/agHErooV0l $SRPT,en,[],['http://jettfoundation.org/'],[],1,4,9,[],['srpt'],https://twitter.com/AdamSinger/status/708040171778736128,False,,0,,,,,,,,[],,,,
708039808258482176,708039808258482176,2016-03-11 02:50:19 IST,2016-03-11,02:50:19,+0530,14031032,adamsinger,Adam Singer,,What a crazy few days for one of my fav mass biotechs - $SRPT has unfortunate round of layoffs but FDA solidifies adcom. Hope it works out.,en,[],[],[],2,1,7,[],['srpt'],https://twitter.com/AdamSinger/status/708039808258482176,False,,0,,,,,,,,[],,,,
707945053088514048,707945053088514048,2016-03-10 20:33:48 IST,2016-03-10,20:33:48,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT -- FDA spox tells me webcast plans being made for eteplirsen Adcomm.,en,[],[],[],1,10,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/707945053088514048,False,,0,,,,,,,,[],,,,
707944234444267520,707944234444267520,2016-03-10 20:30:33 IST,2016-03-10,20:30:33,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT up 9.5% as FDA reschedules adcom for April 25:  https://t.co/bwYCrrV4zD,en,[],['http://www.bizjournals.com/boston/blog/bioflash/2016/03/fda-sets-new-date-for-hearing-on-sarepta-s.html'],[],2,5,5,[],['srpt'],https://twitter.com/megtirrell/status/707944234444267520,False,,0,,,,,,,,[],,,,
707930047672360960,707930047672360960,2016-03-10 19:34:10 IST,2016-03-10,19:34:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT ‚Äî Impt note: FDA is holding eteplirsen adcomm at an offsite hotel, not on agency‚Äôs campus, which usually means no free webcast.",en,[],[],[],4,3,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/707930047672360960,False,,0,,,,,,,,[],,,,
707928659286425600,707928659286425600,2016-03-10 19:28:39 IST,2016-03-10,19:28:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT FDA adcomm on April 25 comes 3 years after company annc‚Äôd accelerated approval filing plan. Remember that?  https://t.co/H7huUGzWHM,en,[],['http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&p=irol-newsArticle&ID=1806913'],[],2,10,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/707928659286425600,False,,0,,,,,,,,[],,,,
707543690001182722,707543690001182722,2016-03-09 17:58:55 IST,2016-03-09,17:58:55,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"As we wait, FDA spox affirms to me that $SRPT adcomm was ‚Äúpostponed‚Äù not cancelled. Won‚Äôt say more about efforts to reschedule.",en,[],[],[],1,9,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/707543690001182722,False,,0,,,,,,,,[],,,,
702203863374372864,702203863374372864,2016-02-24 00:20:22 IST,2016-02-24,00:20:22,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Hope for $SRPT Drug Approval Found in Obscure FDA Document ‚Äî&gt;  https://t.co/cinh37HXGL This is kinda interesting, I think. Maybe.",en,[],['http://www.thestreet.com/story/13468745/1/hope-for-sarepta-drug-approval-found-in-obscure-fda-document.html'],[],10,23,27,[],['srpt'],https://twitter.com/adamfeuerstein/status/702203863374372864,False,,0,,,,,,,,[],,,,
700447544170696704,700447544170696704,2016-02-19 04:01:22 IST,2016-02-19,04:01:22,+0530,26141091,sashadamouni,Sasha Damouni Ellis,,"109 congress member signatures for Duchenne, that's impressive $SRPT, $PTCT, $BMRN   https://t.co/eXQhCZJNGp   https://t.co/YPgpS6Kqk2",en,[],"['http://jettfoundation.org/jett/wp-content/uploads/2016/02/FINAL-Group-Letter-to-FDA-re-Duchenne-2.17.16.pdf', 'https://twitter.com/GantosJ/status/700387529267269632']",[],1,8,20,[],"['srpt', 'ptct', 'bmrn']",https://twitter.com/SashaDamouni/status/700447544170696704,False,https://twitter.com/GantosJ/status/700387529267269632,0,,,,,,,,[],,,,
699955197418688513,699955197418688513,2016-02-17 19:24:58 IST,2016-02-17,19:24:58,+0530,274233761,bradloncar,Brad Loncar,,Credit Suisse investor survey on DMD. Which will be approved in 2016:  $SRPT - 6.5% $PTCT - 18.7% Both - 9.3% Neither - 65.4%,en,[],[],[],3,10,5,[],"['srpt', 'ptct']",https://twitter.com/bradloncar/status/699955197418688513,False,,0,,,,,,,,[],,,,
698142231488811009,698142231488811009,2016-02-12 19:20:53 IST,2016-02-12,19:20:53,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Lots of new adcomms scheduled, except for $SRPT. Is it possible FDA won‚Äôt reschedule the eteplirsen panel?",en,[],[],[],8,7,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/698142231488811009,False,,0,,,,,,,,[],,,,
694917646119256064,694917646119256064,2016-02-03 21:47:32 IST,2016-02-03,21:47:32,+0530,873399943,jacobplieth,Jacob Plieth,,By my calculation biopharma valuations fell $644bn in January. Via @EPVantage  https://t.co/b6RUtalK3E $SRPT $OMED $GILD $PBYI $BLCM,en,"[{'screen_name': 'epvantage', 'name': 'vantage', 'id': '841963175729856512'}]",['http://ow.ly/XTR6a'],[],1,13,10,[],"['srpt', 'omed', 'gild', 'pbyi', 'blcm']",https://twitter.com/JacobPlieth/status/694917646119256064,False,,0,,,,,,,,[],,,,
694116269038108676,694116269038108676,2016-02-01 16:43:09 IST,2016-02-01,16:43:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Biotech String: Assessing Jan. damage, rumored $SRPT panel date, $GILD bottoming P/E ‚Äî&gt;   https://t.co/dlFznbC9T2 Get your week started‚Ä¶",en,[],['http://www.thestreet.com/story/13441387/1/biotech-string-assessing-the-january-damage-gilead-s-bottoming-p-e-sarepta-panel-date.html'],[],2,10,13,[],"['srpt', 'gild']",https://twitter.com/adamfeuerstein/status/694116269038108676,False,,0,,,,,,,,[],,,,
692280378690813952,692280378690813952,2016-01-27 15:07:58 IST,2016-01-27,15:07:58,+0530,873399943,jacobplieth,Jacob Plieth,,"Catching up with this unusually sane take on $SRPT. Good job, @Pharmalot  https://t.co/W24OKTNq4K via @statnews $BMRN",en,"[{'screen_name': 'pharmalot', 'name': 'pharmalot', 'id': '13171622'}, {'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}]",['http://www.statnews.com/pharmalot/2016/01/26/duchenne-fda/'],[],5,11,11,[],"['srpt', 'bmrn']",https://twitter.com/JacobPlieth/status/692280378690813952,False,,0,,,,,,,,[],,,,
692101285915574273,692101285915574273,2016-01-27 03:16:19 IST,2016-01-27,03:16:19,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT update: .@JettFoundation says convos w FDA suggest new adcom date within a month  https://t.co/b4buq7HqP1,en,"[{'screen_name': 'jettfoundation', 'name': 'jett foundation', 'id': '1707456762'}]",['http://jettfoundation.org/blog/we-must-get-up-again/'],[],1,14,16,[],['srpt'],https://twitter.com/megtirrell/status/692101285915574273,False,,0,,,,,,,,[],,,,
692077424834646017,692077424834646017,2016-01-27 01:41:30 IST,2016-01-27,01:41:30,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Dear $SRPT fans ‚Äî Attacking FDA medical reviewer Farkas is a stupid tactic.   https://t.co/EfJgGBQNKX,en,[],['https://twitter.com/likeafox7210/status/692061597309612032'],[],11,7,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/692077424834646017,False,https://twitter.com/likeafox7210/status/692061597309612032,0,,,,,,,,[],,,,
690625710944305152,690625710944305152,2016-01-23 01:32:55 IST,2016-01-23,01:32:55,+0530,576436187,carolineylchen,Caroline Chen,,Snowstorm dashes hopes for $SRPT DMD patients and families  https://t.co/rjWFWuwSoE my story with @FayCortez #blizzard2016,en,"[{'screen_name': 'faycortez', 'name': 'michelle fay cortez', 'id': '295746612'}]",['http://bloom.bg/1Pbaasd'],[],1,1,5,['blizzard2016'],['srpt'],https://twitter.com/CarolineYLChen/status/690625710944305152,False,,0,,,,,,,,[],,,,
690615971485204480,690615971485204480,2016-01-23 00:54:13 IST,2016-01-23,00:54:13,+0530,44438256,matthewherper,Matthew Herper,,"Some thoughts on $SRPT: I'm not optimistic, but maybe I'm more optimistic than @adamfeuerstein and @JohnCFierce.  https://t.co/xkLQuhBn4h",en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}, {'screen_name': 'johncfierce', 'name': 'phyllis m. yang', 'id': '739133634532106240'}]",['http://onforb.es/1OCFT3T'],[],6,13,17,[],['srpt'],https://twitter.com/matthewherper/status/690615971485204480,False,,0,,,,,,,,[],,,,
690523144969256960,690523144969256960,2016-01-22 18:45:21 IST,2016-01-22,18:45:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Biotech Stock Mailbag: Snow Stops $SRPT FDA Show, so What's Next? -&gt;  https://t.co/U7zGG0otkZ The ‚ÄúNo Adcomm‚Äù consolation prize. :-(",en,[],['http://www.thestreet.com/story/13432008/1/biotech-stock-mailbag-snow-stops-sarepta-s-fda-show-so-what-s-next.html'],[],5,11,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/690523144969256960,False,,0,,,,,,,,[],,,,
690283628744568832,690283628744568832,2016-01-22 02:53:36 IST,2016-01-22,02:53:36,+0530,529704495,damiangarde,Damian Garde,,the $SRPT cancellation robbed us of a situation in which Ed Kaye and Janet Woodcock are trapped in White Oak and have to unite to survive.,en,[],[],[],0,0,9,[],['srpt'],https://twitter.com/damiangarde/status/690283628744568832,False,,0,,,,,,,,[],,,,
690260148581974017,690260148581974017,2016-01-22 01:20:18 IST,2016-01-22,01:20:18,+0530,23094787,arleneweintraub,Arlene Weintraub,,"400 patients, parents will lobby FDA to approve $SRPT's embattled #DMD drug @forbeshealth  https://t.co/NTCW9UFHCv  https://t.co/sU5uhMYZZW",en,"[{'screen_name': 'forbeshealth', 'name': 'forbes health', 'id': '47443693'}]","['http://ow.ly/XmZeJ', 'http://ow.ly/i/g5mH8']",[],0,5,6,['dmd'],['srpt'],https://twitter.com/arleneweintraub/status/690260148581974017,False,,0,,,,,,,,[],,,,
690154957350277121,690154957350277121,2016-01-21 18:22:18 IST,2016-01-21,18:22:18,+0530,274233761,bradloncar,Brad Loncar,,"Amen to this ‚Äî&gt; ‚ÄúIt doesn‚Äôt appear to benefit everyone, but if it benefits one kid I want it. I want the ability to prescribe it.‚Äù $SRPT",en,[],[],[],4,8,31,[],['srpt'],https://twitter.com/bradloncar/status/690154957350277121,False,,0,,,,,,,,[],,,,
689948032356487169,689948032356487169,2016-01-21 04:40:04 IST,2016-01-21,04:40:04,+0530,873399943,jacobplieth,Jacob Plieth,,Biotwitter really imagines that the $SRPT adcom is so so much more important to the FDA than any other adcom?,en,[],[],[],6,2,7,[],['srpt'],https://twitter.com/JacobPlieth/status/689948032356487169,False,,0,,,,,,,,[],,,,
689944869633155072,689944869633155072,2016-01-21 04:27:30 IST,2016-01-21,04:27:30,+0530,44438256,matthewherper,Matthew Herper,,$srpt well that is anticlimactic.,en,[],[],[],1,1,5,[],['srpt'],https://twitter.com/matthewherper/status/689944869633155072,False,,0,,,,,,,,[],,,,
689940179310768129,689940179310768129,2016-01-21 04:08:51 IST,2016-01-21,04:08:51,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Hey FDA ‚Äî You should still release the rest of the $SRPT briefing documents. Transparency? Accountability? Those mean anything to you?,en,[],[],[],7,18,52,[],['srpt'],https://twitter.com/adamfeuerstein/status/689940179310768129,False,,0,,,,,,,,[],,,,
689938797803343872,689938797803343872,2016-01-21 04:03:22 IST,2016-01-21,04:03:22,+0530,14031032,adamsinger,Adam Singer,,"@Gdubya1 am starting to think $SRPT was built on some sort of haunted burial ground. Literally nothing can go right for them, ever.",en,[],[],[],1,2,17,[],['srpt'],https://twitter.com/AdamSinger/status/689938797803343872,False,,0,,,,,,,,[],,,,
689938314225434624,689938314225434624,2016-01-21 04:01:27 IST,2016-01-21,04:01:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚Äî Lots of people in DC already or w/ booked (non-refundable?) plane tix to attend FDA adcomm. Postponing for a little snow is BS.,en,[],[],[],10,8,30,[],['srpt'],https://twitter.com/adamfeuerstein/status/689938314225434624,False,,0,,,,,,,,[],,,,
689937101362728960,689937101362728960,2016-01-21 03:56:38 IST,2016-01-21,03:56:38,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT FDA adcomm postponed.,en,[],[],[],2,13,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/689937101362728960,False,,0,,,,,,,,[],,,,
689926482773282817,689926482773282817,2016-01-21 03:14:26 IST,2016-01-21,03:14:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Still nothing from FDA on remainder of $SRPT adcomm briefing documents. Unbelievable.,en,[],[],[],10,7,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/689926482773282817,False,,0,,,,,,,,[],,,,
689836072956760064,689836072956760064,2016-01-20 21:15:10 IST,2016-01-20,21:15:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT Remember last Friday when FDA was in a rush to post its eteplirsen review b/c, you know, there was SO MUCH INTEREST! Today? &lt;crickets&gt;",en,[],[],[],7,2,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/689836072956760064,False,,0,,,,,,,,[],,,,
689776085966426113,689776085966426113,2016-01-20 17:16:48 IST,2016-01-20,17:16:48,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"This morning, we should get the panel roster and questions for the $SRPT FDA adcomm.",en,[],[],[],1,6,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/689776085966426113,False,,0,,,,,,,,[],,,,
689506162924847104,689506162924847104,2016-01-19 23:24:14 IST,2016-01-19,23:24:14,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT -- I was referring to this in my last tweet.   https://t.co/9h5ZKmy30v,en,[],['https://twitter.com/terriellsworth/status/689497750375960576'],[],1,3,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/689506162924847104,False,https://twitter.com/terriellsworth/status/689497750375960576,0,,,,,,,,[],,,,
689497088049086464,689497088049086464,2016-01-19 22:48:10 IST,2016-01-19,22:48:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Parents of boys in eteplirsen study 201/202 pressuring FDA to approve. This is lobbying campaign $BMRN lacked. Difference maker?,en,[],[],[],15,6,19,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/689497088049086464,False,,0,,,,,,,,[],,,,
688710665645744128,688710665645744128,2016-01-17 18:43:12 IST,2016-01-17,18:43:12,+0530,102754598,johncendpts,John Carroll,,$SRPT's posturing offers one of the worst disconnects with #FDA reality I've seen. It's only realistic hope lies with patient advocates.,en,[],[],[],7,5,13,['fda'],['srpt'],https://twitter.com/JohnCendpts/status/688710665645744128,False,,0,,,,,,,,[],,,,
688707132129173504,688707132129173504,2016-01-17 18:29:10 IST,2016-01-17,18:29:10,+0530,102754598,johncendpts,John Carroll,,"Class action suit against $SRPT, first of many. Sarepta and the FDA clearly weren't speaking the same language.  https://t.co/OPbUgwdTp8",en,[],['http://finance.yahoo.com/news/important-shareholder-notice-khang-khang-020100002.html'],[],3,4,9,[],['srpt'],https://twitter.com/JohnCendpts/status/688707132129173504,False,,0,,,,,,,,[],,,,
688098636111085568,688098636111085568,2016-01-16 02:11:13 IST,2016-01-16,02:11:13,+0530,274233761,bradloncar,Brad Loncar,,A law office already put out a note on $SRPT. What jerks.  https://t.co/3o5g4XSiKL,en,[],['http://finance.yahoo.com/news/shareholder-alert-law-offices-vincent-185700638.html'],[],3,0,9,[],['srpt'],https://twitter.com/bradloncar/status/688098636111085568,False,,0,,,,,,,,[],,,,
688076173390286848,688076173390286848,2016-01-16 00:41:58 IST,2016-01-16,00:41:58,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT Janet Woodcock is attending Jan. 22 eteplirsen advisory panel, agency spox tells me. She was absent from $BMRN panel. Speculate away!",en,[],[],[],9,15,18,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/688076173390286848,False,,0,,,,,,,,[],,,,
688073783769346048,688073783769346048,2016-01-16 00:32:28 IST,2016-01-16,00:32:28,+0530,274233761,bradloncar,Brad Loncar,,Sounds like it is going to be a packed house. $SRPT,en,[],[],[],3,0,6,[],['srpt'],https://twitter.com/bradloncar/status/688073783769346048,False,,0,,,,,,,,[],,,,
688073675115859968,688073675115859968,2016-01-16 00:32:02 IST,2016-01-16,00:32:02,+0530,274233761,bradloncar,Brad Loncar,,"Thought I‚Äôd attend the $SRPT panel, but after reading @BosBizDon‚Äôs story on it I don‚Äôt want to take the place of someone who really matters.",en,"[{'screen_name': 'bosbizdon', 'name': 'don seiffert', 'id': '15752608'}]",[],[],1,1,12,[],['srpt'],https://twitter.com/bradloncar/status/688073675115859968,False,,0,,,,,,,,[],,,,
688051127745691648,688051127745691648,2016-01-15 23:02:26 IST,2016-01-15,23:02:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT - I updated my story w/ more thoughts on today‚Äôs FDA review of eteplirsen and what it means for Jan. 22 ‚Äî&gt;   https://t.co/O88le1Vyhl,en,[],['http://www.thestreet.com/story/13425559/1/sarepta-plunges-on-harsh-fda-eteplirsen-review-ahead-of-next-week-s-advisory-panel-meeting.html'],[],16,16,20,[],['srpt'],https://twitter.com/adamfeuerstein/status/688051127745691648,False,,0,,,,,,,,[],,,,
688048412256825344,688048412256825344,2016-01-15 22:51:39 IST,2016-01-15,22:51:39,+0530,44438256,matthewherper,Matthew Herper,,"$SRPT documents are not what I hoped, but what I expected. Still an appreciable chance of approval, but tough. Dystrophin is key.",en,[],[],[],8,5,11,[],['srpt'],https://twitter.com/matthewherper/status/688048412256825344,False,,0,,,,,,,,[],,,,
688022362697121792,688022362697121792,2016-01-15 21:08:08 IST,2016-01-15,21:08:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"No final verdict yet, but I should‚Äôve been more critical of $SRPT. Like I was w/ $BMRN. Clearly, big mistake on my part. I had blinders on.",en,[],[],[],12,4,37,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/688022362697121792,False,,0,,,,,,,,[],,,,
688019721036402692,688019721036402692,2016-01-15 20:57:38 IST,2016-01-15,20:57:38,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT won‚Äôt comment on today‚Äôs FDA review of eteplirsen but did point to this data addendum ‚Äî&gt;  https://t.co/zvTPk2lFqt,en,[],['http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM481913.pdf'],[],1,7,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/688019721036402692,False,,0,,,,,,,,[],,,,
688006217940221952,688006217940221952,2016-01-15 20:03:59 IST,2016-01-15,20:03:59,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT Plunges on Harsh FDA Eteplirsen Review Ahead of Next Week‚Äôs Advisory Panel Meeting ‚Äî&gt;  https://t.co/O88le1Vyhl Quick hit, will update.",en,[],['http://www.thestreet.com/story/13425559/1/sarepta-plunges-on-harsh-fda-eteplirsen-review-ahead-of-next-week-s-advisory-panel-meeting.html'],[],3,11,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/688006217940221952,False,,0,,,,,,,,[],,,,
687997792535621633,687997792535621633,2016-01-15 19:30:30 IST,2016-01-15,19:30:30,+0530,102094857,adamfeuerstein,Adam Feuerstein,,A LOT of healthcare investors take off Friday after JP Morgan conference to extend MLK weekend. $SRPT is bad surprise.,en,[],[],[],3,4,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/687997792535621633,False,,0,,,,,,,,[],,,,
687997484241563652,687997484241563652,2016-01-15 19:29:17 IST,2016-01-15,19:29:17,+0530,14031032,adamsinger,Adam Singer,,So FDA called $SRPT back to the table for what exactly. Why even get people's hopes up? Fail.,en,[],[],[],2,4,11,[],['srpt'],https://twitter.com/AdamSinger/status/687997484241563652,False,,0,,,,,,,,[],,,,
687996760443236354,687996760443236354,2016-01-15 19:26:24 IST,2016-01-15,19:26:24,+0530,102094857,adamfeuerstein,Adam Feuerstein,,FDA engineered $BMRN drisa review to steer that panel to neg vote it wanted. Looks like agency is doing same for $SRPT eteplirsen.,en,[],[],[],1,6,8,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/687996760443236354,False,,0,,,,,,,,[],,,,
687994684107546624,687994684107546624,2016-01-15 19:18:09 IST,2016-01-15,19:18:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚Äî FDA spox tells me FDA review of eteplirsen released early bc of high public interest and MLK holiday on Monday.,en,[],[],[],6,15,12,[],['srpt'],https://twitter.com/adamfeuerstein/status/687994684107546624,False,,0,,,,,,,,[],,,,
687994248461991941,687994248461991941,2016-01-15 19:16:25 IST,2016-01-15,19:16:25,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚Äî eteplirsen dystrophin production better than drisapersen but not saying much. 0.9% of normal. Yikes.,en,[],[],[],1,5,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/687994248461991941,False,,0,,,,,,,,[],,,,
687992343379574784,687992343379574784,2016-01-15 19:08:51 IST,2016-01-15,19:08:51,+0530,14031032,adamsinger,Adam Singer,,"Seems like the AdCom w/ $SRPT will go similarly to $BMRN, except difference is Sarepta's drug is safe. I still say they approve. #unmetneed",en,[],[],[],2,1,15,['unmetneed'],"['srpt', 'bmrn']",https://twitter.com/AdamSinger/status/687992343379574784,False,,0,,,,,,,,[],,,,
687674140468228096,687674140468228096,2016-01-14 22:04:26 IST,2016-01-14,22:04:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Elliot Favus short report on $SRPT. ‚ÄúSeven Reasons to Sell‚Ä¶‚Äù,en,[],[],[],8,7,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/687674140468228096,False,,0,,,,,,,,[],,,,
687635507103174656,687635507103174656,2016-01-14 19:30:55 IST,2016-01-14,19:30:55,+0530,14031032,adamsinger,Adam Singer,,And then there was one $srpt.   https://t.co/wgcFlYuA8r,en,[],['https://twitter.com/MarketCurrents/status/687632033938411520'],[],0,1,13,[],['srpt'],https://twitter.com/AdamSinger/status/687635507103174656,False,https://twitter.com/MarketCurrents/status/687632033938411520,0,,,,,,,,[],,,,
687632650186559488,687632650186559488,2016-01-14 19:19:34 IST,2016-01-14,19:19:34,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"This is a good time to promote my $SRPT FDA panel live blog on Jan. 22.   It will be epic. Make a note to join me, please.",en,[],[],[],6,9,41,[],['srpt'],https://twitter.com/adamfeuerstein/status/687632650186559488,False,,0,,,,,,,,[],,,,
685891593220403200,685891593220403200,2016-01-10 00:01:13 IST,2016-01-10,00:01:13,+0530,14031032,adamsinger,Adam Singer,,"Despite terrible market was right on my $QURE call ( https://t.co/Yj8PRu9zy5). Next predictions: $SRPT approved, $RLYP bears crushed. GL all.",en,[],['https://twitter.com/AdamSinger/status/684892033924739073'],[],7,4,37,[],"['qure', 'srpt', 'rlyp']",https://twitter.com/AdamSinger/status/685891593220403200,False,https://twitter.com/AdamSinger/status/684892033924739073,0,,,,,,,,[],,,,
685484093262446592,685484093262446592,2016-01-08 21:01:58 IST,2016-01-08,21:01:58,+0530,47678782,megtirrell,Meg Tirrell,,"Best bets out of #JPM16, historically speaking? $GHDX $SRPT $ILMN $CERS $ARIA, per .@Kensho  https://t.co/MeNF2bi7Ww",en,"[{'screen_name': 'kensho', 'name': 'kensho', 'id': '1022869560'}]",[],['https://pbs.twimg.com/media/CYNUJmOUoAUUL8q.png'],2,20,33,['jpm16'],"['ghdx', 'srpt', 'ilmn', 'cers', 'aria']",https://twitter.com/megtirrell/status/685484093262446592,False,,1,https://pbs.twimg.com/media/CYNUJmOUoAUUL8q.png,,,,,,,[],,,,
684436675443965956,684436675443965956,2016-01-05 23:39:54 IST,2016-01-05,23:39:54,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$VRX CEO not speaking at #JPM16 reminds me to note $SRPT is also not making an appearance in SF. Busy prepping for etep adcomm, per spox.",en,[],[],[],0,5,15,['jpm16'],"['vrx', 'srpt']",https://twitter.com/adamfeuerstein/status/684436675443965956,False,,0,,,,,,,,[],,,,
683771203798958082,683771203798958082,2016-01-04 03:35:33 IST,2016-01-04,03:35:33,+0530,14031032,adamsinger,Adam Singer,,Since some of you asked: sold a bunch @ end of Dec but my biotech holdings going into 2016 are: $RLYP $SRPT $QURE $PETX $CDTX. GL to all.,en,[],[],[],1,3,26,[],"['rlyp', 'srpt', 'qure', 'petx', 'cdtx']",https://twitter.com/AdamSinger/status/683771203798958082,False,,0,,,,,,,,[],,,,
677925953897545729,677918966191386624,2015-12-19 00:28:37 IST,2015-12-19,00:28:37,+0530,14031032,adamsinger,Adam Singer,,@GantosJ everything + for $SRPT get BioMarin out of here.,en,[],[],[],0,0,6,[],['srpt'],https://twitter.com/AdamSinger/status/677925953897545729,False,,0,,,,,,,,[],,,,
677859307757559809,677859307757559809,2015-12-18 20:03:47 IST,2015-12-18,20:03:47,+0530,14031032,adamsinger,Adam Singer,,@Pharmdca  new CEO for $qure will be as good for the stock as the $srpt change. Is good news.,en,[],[],[],2,1,6,[],"['qure', 'srpt']",https://twitter.com/AdamSinger/status/677859307757559809,False,,0,,,,,,,,[],,,,
677846116298129408,677846116298129408,2015-12-18 19:11:22 IST,2015-12-18,19:11:22,+0530,274233761,bradloncar,Brad Loncar,,"$BMRN - Since it is now early January, why doesn't FDA just wait a couple more weeks to see what is learned from the $SRPT panel?",en,[],[],[],4,5,7,[],"['bmrn', 'srpt']",https://twitter.com/bradloncar/status/677846116298129408,False,,0,,,,,,,,[],,,,
677594334078758912,677594334078758912,2015-12-18 02:30:52 IST,2015-12-18,02:30:52,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,$SRPT   I did this today:  Bot Dec 31 (W) 40 Calls Sld Dec 24 (W) 40 Calls  Debit: $0.675  Goal: Cheap play on BMRN PDUFA.,en,[],[],[],2,0,4,[],['srpt'],https://twitter.com/OphirGottlieb/status/677594334078758912,False,,0,,,,,,,,[],,,,
672160402730389504,672160402730389504,2015-12-03 02:38:22 IST,2015-12-03,02:38:22,+0530,274233761,bradloncar,Brad Loncar,,Check out this free report on DMD courtesy of @BioCentury. Thanks @StevenEdelson. $SRPT $BMRN $PTCT $SMMT  https://t.co/gLHxb53lDe,en,"[{'screen_name': 'biocentury', 'name': 'biocentury', 'id': '227778014'}, {'screen_name': 'stevenedelson', 'name': 'steven edelson', 'id': '191230737'}]",['https://twitter.com/stevenedelson/status/672159639740395520'],[],3,3,14,[],"['srpt', 'bmrn', 'ptct', 'smmt']",https://twitter.com/bradloncar/status/672160402730389504,False,https://twitter.com/stevenedelson/status/672159639740395520,0,,,,,,,,[],,,,
671113335757103104,671113335757103104,2015-11-30 05:17:42 IST,2015-11-30,05:17:42,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,Tomorrow:  Selling some $SRPT Buying $TSLA small $OLED Possible triple down $RLYP  CML Pro  https://t.co/FAACNdYrLK  CML Pro members know why,en,[],['http://pro.cmlviz.com/cml-pro-promotion/'],[],6,0,16,[],"['srpt', 'tsla', 'oled', 'rlyp']",https://twitter.com/OphirGottlieb/status/671113335757103104,False,,0,,,,,,,,[],,,,
671036647933386753,671036647933386753,2015-11-30 00:12:58 IST,2015-11-30,00:12:58,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,Which biotech has best odds of doubling or more in next 3-months?  $RLYP $SRPT $JUNO $KITE,en,[],[],[],10,15,21,[],"['rlyp', 'srpt', 'juno', 'kite']",https://twitter.com/OphirGottlieb/status/671036647933386753,False,,0,,,,,,,,[],,,,
669653502889717760,669653502889717760,2015-11-26 04:36:51 IST,2015-11-26,04:36:51,+0530,873399943,jacobplieth,Jacob Plieth,,"Hey, my data dredge beats your data dredge! Shameless to the end $SRPT $BMRN  https://t.co/MihizZ4GFd",en,[],['https://twitter.com/bosbizdon/status/669544325764673537'],[],4,2,10,[],"['srpt', 'bmrn']",https://twitter.com/JacobPlieth/status/669653502889717760,False,https://twitter.com/bosbizdon/status/669544325764673537,0,,,,,,,,[],,,,
669596515564933120,669596515564933120,2015-11-26 00:50:24 IST,2015-11-26,00:50:24,+0530,47678782,megtirrell,Meg Tirrell,,Talking #DMD15 next on @PowerLunch $BMRN $SRPT,en,"[{'screen_name': 'powerlunch', 'name': 'power lunch', 'id': '25360971'}]",[],[],1,3,8,['dmd15'],"['bmrn', 'srpt']",https://twitter.com/megtirrell/status/669596515564933120,False,,0,,,,,,,,[],,,,
669483706055327744,669483706055327744,2015-11-25 17:22:08 IST,2015-11-25,17:22:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$BMRN Duchenne Drug is Done, $SRPT Survives But Faces Challenge ‚Äî&gt;  https://t.co/Hk9EHFZXSt",en,[],['http://www.thestreet.com/story/13378278/1/biomarin-s-duchenne-drug-is-done-sarepta-survives-but-faces-challenge.html'],[],12,31,35,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/669483706055327744,False,,0,,,,,,,,[],,,,
669295557874196481,669289911187406848,2015-11-25 04:54:30 IST,2015-11-25,04:54:30,+0530,14031032,adamsinger,Adam Singer,,@ramlan61 @Pharmdca St has been negative on $srpt forever. they've also been wrong forever. Let's trap some more shorts is win long.,en,"[{'screen_name': 'pharmdca', 'name': 'pharm. d', 'id': '1884013189'}]",[],[],1,1,7,[],['srpt'],https://twitter.com/AdamSinger/status/669295557874196481,False,,0,,,,,,,,[],,,,
669225461843664898,669225461843664898,2015-11-25 00:15:58 IST,2015-11-25,00:15:58,+0530,47678782,megtirrell,Meg Tirrell,,"""Thank you for listening, and please don't take this drug away from us,"" 16-yr-old drisa pt says, to applause. #DMD15 $BMRN $SRPT",en,[],[],[],1,9,19,['dmd15'],"['bmrn', 'srpt']",https://twitter.com/megtirrell/status/669225461843664898,False,,0,,,,,,,,[],,,,
669225057605013504,669225057605013504,2015-11-25 00:14:21 IST,2015-11-25,00:14:21,+0530,47678782,megtirrell,Meg Tirrell,,Hearing from kids is a pretty powerful experience at an adcom. #DMD15 $BMRN $SRPT,en,[],[],[],2,4,14,['dmd15'],"['bmrn', 'srpt']",https://twitter.com/megtirrell/status/669225057605013504,False,,0,,,,,,,,[],,,,
669219991430914048,669219991430914048,2015-11-24 23:54:14 IST,2015-11-24,23:54:14,+0530,47678782,megtirrell,Meg Tirrell,,"""There is no way that Jett could manage those risks,"" @fundDuchenne says of drisa. #DMD15 $BMRN $SRPT",en,[],[],[],2,2,7,['dmd15'],"['bmrn', 'srpt']",https://twitter.com/megtirrell/status/669219991430914048,False,,0,,,,,,,,[],,,,
668656435601911808,668564729925754880,2015-11-23 10:34:51 IST,2015-11-23,10:34:51,+0530,274233761,bradloncar,Brad Loncar,,"@bullltalk I basically agree with all of it. $BMRN has no dystrophin, concerning safety, and inconclusive (at best) efficacy. $SRPT",en,[],[],[],1,0,5,[],"['bmrn', 'srpt']",https://twitter.com/bradloncar/status/668656435601911808,False,,0,,,,,,,,[],,,,
668128054942674944,668128054942674944,2015-11-21 23:35:16 IST,2015-11-21,23:35:16,+0530,14886375,stocktwits,Stocktwits,,It just dropped.  HERE are the stocks with extreme social media sentiment:  https://t.co/9JF5TARcDZ $SPY $ANF $SRPT  https://t.co/fXp6WPvqaA,en,[],['http://stks.co/j3Uxa'],['https://pbs.twimg.com/media/CUWq7OMUwAAlDQy.png'],2,7,12,[],"['spy', 'anf', 'srpt']",https://twitter.com/Stocktwits/status/668128054942674944,False,,1,https://pbs.twimg.com/media/CUWq7OMUwAAlDQy.png,,,,,,,[],,,,
668116252464803840,668116252464803840,2015-11-21 22:48:22 IST,2015-11-21,22:48:22,+0530,14031032,adamsinger,Adam Singer,,@Pharmdca new conclusion: both $RLYP and $SRPT were the companies that should have been acquired instead of competitors.,en,[],[],[],3,2,13,[],"['rlyp', 'srpt']",https://twitter.com/AdamSinger/status/668116252464803840,False,,0,,,,,,,,[],,,,
668073948240674816,668073948240674816,2015-11-21 20:00:16 IST,2015-11-21,20:00:16,+0530,20449296,barronsonline,Barron's,,There‚Äôs much at stake in the race between $SRPT and $BMRN to develop a DMD treatment:  https://t.co/VaxUMKnpI5  https://t.co/3qMnhF1CP6,en,[],['http://bit.ly/1XgF3M8'],['https://pbs.twimg.com/media/CUV5U-uUEAAGeSB.jpg'],1,12,9,[],"['srpt', 'bmrn']",https://twitter.com/barronsonline/status/668073948240674816,False,,1,https://pbs.twimg.com/media/CUV5U-uUEAAGeSB.jpg,,,,,,,[],,,,
667740701170470912,667740701170470912,2015-11-20 21:56:03 IST,2015-11-20,21:56:03,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Best argument for $SRPT etep approval might be drisa absolutely CANNOT be only DMD drug on market, not w. those horrible safety risks. $BMRN",en,[],[],[],5,4,19,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/667740701170470912,False,,0,,,,,,,,[],,,,
667723050117271552,667723050117271552,2015-11-20 20:45:55 IST,2015-11-20,20:45:55,+0530,14031032,adamsinger,Adam Singer,,Gotta call out @23aloha @given2tweet @redacre @bradloncar @Gdubya1 &amp; @OphirGottlieb for holding onto the $SRPT thesis this long. Conviction!,en,"[{'screen_name': '23aloha', 'name': 'sarie', 'id': '210862918'}, {'screen_name': 'given2tweet', 'name': 'matt rosen', 'id': '293294726'}, {'screen_name': 'redacre', 'name': 'red acre investments', 'id': '380500399'}, {'screen_name': 'bradloncar', 'name': 'brad loncar', 'id': '274233761'}, {'screen_name': 'gdubya1', 'name': 'greg wierenga', 'id': '887931745'}, {'screen_name': 'ophirgottlieb', 'name': 'ophir gottlieb', 'id': '100024370'}]",[],[],6,0,10,[],['srpt'],https://twitter.com/AdamSinger/status/667723050117271552,False,,0,,,,,,,,[],,,,
667719710239301633,667719710239301633,2015-11-20 20:32:39 IST,2015-11-20,20:32:39,+0530,102754598,johncendpts,John Carroll,,"Of course, if $BMRN is rejected, the advocacy pressure in favor of $SRPT is going to be INTENSE, no matter what the risk/benefit looks like.",en,[],[],[],1,3,6,[],"['bmrn', 'srpt']",https://twitter.com/JohnCendpts/status/667719710239301633,False,,0,,,,,,,,[],,,,
667701644843421696,667701440278896640,2015-11-20 19:20:52 IST,2015-11-20,19:20:52,+0530,44438256,matthewherper,Matthew Herper,,@adamfeuerstein DING DING DING DING DING! There is no drug where I need to see briefing docs more than $SRPT.,en,[],[],[],4,0,4,[],['srpt'],https://twitter.com/matthewherper/status/667701644843421696,False,,0,,,,,,,,[],,,,
667701440278896640,667701440278896640,2015-11-20 19:20:03 IST,2015-11-20,19:20:03,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"But before you wave your $SRPT victory flag, what eteplirsen nasty secrets lie in wait in the FDA briefing documents?",en,[],[],[],4,5,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/667701440278896640,False,,0,,,,,,,,[],,,,
667698285285670912,667698285285670912,2015-11-20 19:07:31 IST,2015-11-20,19:07:31,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BMRN Duchenne Drug Receives Hard Review from FDA ‚Äî&gt;  https://t.co/SuUNrCAlC8 Initial quick take. $SRPT,en,[],['http://www.thestreet.com/story/13373797/1/biomarin-duchenne-drug-receives-harsh-review-from-fda.html'],[],0,14,12,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/667698285285670912,False,,0,,,,,,,,[],,,,
667697870053744640,667697870053744640,2015-11-20 19:05:52 IST,2015-11-20,19:05:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I know we‚Äôre 100% $BMRN $SRPT, but resignation of $MNKD CEO is pretty incredible news this morning. Al Mann stepping in as interim CEO? Eek!",en,[],[],[],3,0,7,[],"['bmrn', 'srpt', 'mnkd']",https://twitter.com/adamfeuerstein/status/667697870053744640,False,,0,,,,,,,,[],,,,
667693825637396480,667691977270558720,2015-11-20 18:49:47 IST,2015-11-20,18:49:47,+0530,44438256,matthewherper,Matthew Herper,,@JacobPlieth @RXRegA You could read these documents as setting up an AA path for $SRPT based on dystrophin. Possibly.,en,"[{'screen_name': 'rxrega', 'name': 'jessica adams', 'id': '2426498719'}]",[],[],5,7,9,[],['srpt'],https://twitter.com/matthewherper/status/667693825637396480,False,,0,,,,,,,,[],,,,
667664580244406272,667664580244406272,2015-11-20 16:53:35 IST,2015-11-20,16:53:35,+0530,274233761,bradloncar,Brad Loncar,,My entire life I'll remember the 48wk data day in Oct 2012. Hard to believe we are only just now having a meeting 3 years later. $SRPT $BMRN,en,[],[],[],2,7,27,[],"['srpt', 'bmrn']",https://twitter.com/bradloncar/status/667664580244406272,False,,0,,,,,,,,[],,,,
667661420025114624,667661420025114624,2015-11-20 16:41:01 IST,2015-11-20,16:41:01,+0530,274233761,bradloncar,Brad Loncar,,Everybody up and ready?? $SRPT$BRMN,en,[],[],[],1,1,18,[],['srpt'],https://twitter.com/bradloncar/status/667661420025114624,False,,0,,,,,,,,[],,,,
667558081744650240,667558081744650240,2015-11-20 09:50:23 IST,2015-11-20,09:50:23,+0530,14031032,adamsinger,Adam Singer,,Will hold my $SRPT to either 0 or 100+. Tempted to not even listen to AdCom next week (will be on much needed vacay)  https://t.co/oiZUUaHRFx,en,[],['https://twitter.com/tgtxdough/status/667510582501842944'],[],2,1,10,[],['srpt'],https://twitter.com/AdamSinger/status/667558081744650240,False,https://twitter.com/tgtxdough/status/667510582501842944,0,,,,,,,,[],,,,
667383437150560257,667383437150560257,2015-11-19 22:16:25 IST,2015-11-19,22:16:25,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Follow up to y‚Äôday‚Äôs $BMRN preview: How might $SRPT $PTCT trade on Tuesday + How drisa panel could go very wrong  https://t.co/QI1KWwPc7o,en,[],['http://www.thestreet.com/story/13372626/1/these-biotech-stocks-could-move-on-biomarin-s-duchenne-drug-fda-panel.html'],[],2,8,6,[],"['bmrn', 'srpt', 'ptct']",https://twitter.com/adamfeuerstein/status/667383437150560257,False,,0,,,,,,,,[],,,,
667318276377079808,667318276377079808,2015-11-19 17:57:29 IST,2015-11-19,17:57:29,+0530,47678782,megtirrell,Meg Tirrell,,2nd ep of #Signal podcast is up! This wk @ldtimmerman &amp; I go into history of drisapersen &amp; eteplirsen.  https://t.co/wG9Ptyvkie $BMRN $SRPT,en,"[{'screen_name': 'ldtimmerman', 'name': 'luke timmerman', 'id': '50753411'}]",['https://soundcloud.com/user-691958643/two-drugs-and-the-boys-lives-they-might-save'],[],3,23,36,['signal'],"['bmrn', 'srpt']",https://twitter.com/megtirrell/status/667318276377079808,False,,0,,,,,,,,[],,,,
666947939080790017,666947939080790017,2015-11-18 17:25:54 IST,2015-11-18,17:25:54,+0530,102094857,adamfeuerstein,Adam Feuerstein,,How to Prepare for $BMRN (and Biotech's) Biggest Event of 2015  https://t.co/4JRlE3KrTa $SRPT,en,[],['http://www.thestreet.com/story/13369737/1/how-to-prepare-for-biomarin-s-and-biotech-s-biggest-event-of-2015.html'],[],5,35,58,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/666947939080790017,False,,0,,,,,,,,[],,,,
666632709725253632,666632709725253632,2015-11-17 20:33:18 IST,2015-11-17,20:33:18,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,$SRPT Announces Positive Long-Term Safety and Efficacy Data for Eteplirsen  https://t.co/ZKMYi7SyAU - $SRPT is my single largest position.,en,[],['http://finance.yahoo.com/news/sarepta-therapeutics-announces-publication-positive-134300290.html'],[],0,1,6,[],"['srpt', 'srpt']",https://twitter.com/OphirGottlieb/status/666632709725253632,False,,0,,,,,,,,[],,,,
665547730954031104,665541108882100224,2015-11-14 20:41:58 IST,2015-11-14,20:41:58,+0530,14031032,adamsinger,Adam Singer,,@WhiteCoatMafia @plungeprotect did $azn buy a clunker? Just like $bmrn. Long $rlyp and $srpt :-),en,[],[],[],0,0,10,[],"['azn', 'bmrn', 'rlyp', 'srpt']",https://twitter.com/AdamSinger/status/665547730954031104,False,,0,,,,,,,,[],,,,
665288594513235968,665241639967944706,2015-11-14 03:32:16 IST,2015-11-14,03:32:16,+0530,47678782,megtirrell,Meg Tirrell,,@AdamSinger @CNBCClosingBell  Here's setup w @jennmcnary:  https://t.co/4WZBIxv4GM   And intvw w Dr Kaye:  https://t.co/SZjiwUpUDA $SRPT $BMRN,en,"[{'screen_name': 'cnbcclosingbell', 'name': ""cnbc's closing bell"", 'id': '21778391'}, {'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}]","['http://video.cnbc.com/gallery/?video=3000453521', 'http://video.cnbc.com/gallery/?video=3000453522']",[],2,6,8,[],"['srpt', 'bmrn']",https://twitter.com/megtirrell/status/665288594513235968,False,,0,,,,,,,,[],,,,
665286716190687233,665286716190687233,2015-11-14 03:24:48 IST,2015-11-14,03:24:48,+0530,274233761,bradloncar,Brad Loncar,,Here's a video clip of the Ed Kaye interview from earlier. $SRPT  https://t.co/dDjTdbnhG9,en,[],['http://video.cnbc.com/gallery/?video=3000453522&play=1'],[],2,4,22,[],['srpt'],https://twitter.com/bradloncar/status/665286716190687233,False,,0,,,,,,,,[],,,,
665267516579688448,665267516579688448,2015-11-14 02:08:30 IST,2015-11-14,02:08:30,+0530,47678782,megtirrell,Meg Tirrell,,Huge thanks to @jennmcnary + sons Austin &amp; Max for welcoming @cnbc yesterday. Tune in to @bizrpt on PBS tonight for their story! $SRPT $BMRN,en,"[{'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}, {'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}, {'screen_name': 'bizrpt', 'name': 'nbr', 'id': '13159032'}]",[],[],3,15,24,[],"['srpt', 'bmrn']",https://twitter.com/megtirrell/status/665267516579688448,False,,0,,,,,,,,[],,,,
665262904757850112,665262904757850112,2015-11-14 01:50:11 IST,2015-11-14,01:50:11,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT CEO coming up next on @CNBCClosingBell. What do you want to know?,en,"[{'screen_name': 'cnbcclosingbell', 'name': ""cnbc's closing bell"", 'id': '21778391'}]",[],[],7,4,6,[],['srpt'],https://twitter.com/megtirrell/status/665262904757850112,False,,0,,,,,,,,[],,,,
665241639967944706,665241639967944706,2015-11-14 00:25:41 IST,2015-11-14,00:25:41,+0530,47678782,megtirrell,Meg Tirrell,,Big couple weeks ahead for Duchenne. Tune in to @CNBCClosingBell today for our interview with $SRPT CEO Ed Kaye,en,"[{'screen_name': 'cnbcclosingbell', 'name': ""cnbc's closing bell"", 'id': '21778391'}]",[],[],4,14,14,[],['srpt'],https://twitter.com/megtirrell/status/665241639967944706,False,,0,,,,,,,,[],,,,
662628640727896065,662628640727896065,2015-11-06 19:22:33 IST,2015-11-06,19:22:33,+0530,47678782,megtirrell,Meg Tirrell,,Another moment in the life of a medical reporter: your colleagues mention Exxon and you think they're talking about $BMRN $SRPT,en,[],[],[],4,2,28,[],"['bmrn', 'srpt']",https://twitter.com/megtirrell/status/662628640727896065,False,,0,,,,,,,,[],,,,
661222243524038656,661222243524038656,2015-11-02 22:14:02 IST,2015-11-02,22:14:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,FDA Letter Raises Questions About $BMRN Handling of Muscular Dystrophy Drug ‚Äî&gt;  https://t.co/Dku7kQubON $SRPT,en,[],['http://www.thestreet.com/story/13347422/1/fda-letter-raises-questions-about-biomarin-handling-of-muscular-dystrophy-drug.html'],[],5,15,15,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/661222243524038656,False,,0,,,,,,,,[],,,,
656130088837083136,656130088837083136,2015-10-19 20:59:38 IST,2015-10-19,20:59:38,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"They want FDA to move $SRPT adcomm to Nov. 23-24, same as $BMRN.   https://t.co/QT5JZVw1na",en,[],['https://twitter.com/jennmcnary/status/656129676386115584'],[],5,9,11,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/656130088837083136,False,https://twitter.com/jennmcnary/status/656129676386115584,0,,,,,,,,[],,,,
654984663946149888,654984663946149888,2015-10-16 17:08:07 IST,2015-10-16,17:08:07,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"For your reading pleasure,  Biotech Stock Mailbag: New $SRPT Risk, $ZFGN Patient Death, $BLUE Gene Therapy Update  http://t.co/kXuhHloMV4",en,[],['http://www.thestreet.com/story/13326145/1/biotech-stock-mailbag-new-sarepta-risk-zafgen-patient-death-bluebird-gene-therapy-update.html'],[],0,13,18,[],"['srpt', 'zfgn', 'blue']",https://twitter.com/adamfeuerstein/status/654984663946149888,False,,0,,,,,,,,[],,,,
654407989273608192,654407276116221953,2015-10-15 02:56:37 IST,2015-10-15,02:56:37,+0530,14031032,adamsinger,Adam Singer,,@bradloncar market overreacting to everything right now in small cap land. $SRPT will be approved. Long term hold easily the sector winner.,en,[],[],[],1,2,6,[],['srpt'],https://twitter.com/AdamSinger/status/654407989273608192,False,,0,,,,,,,,[],,,,
654339506150219776,654339506150219776,2015-10-14 22:24:29 IST,2015-10-14,22:24:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I‚Äôm such a fucking homer for $SRPT so ignore me, but they reacted well to today‚Äôs events. This proactive PR should calm (some) nerves.",en,[],[],[],4,0,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/654339506150219776,False,,0,,,,,,,,[],,,,
651135711656079361,651135711656079361,2015-10-06 02:13:45 IST,2015-10-06,02:13:45,+0530,274233761,bradloncar,Brad Loncar,,"$SRPT offering is in the ""would be crazy not to"" category. Nothing to see there.",en,[],[],[],1,5,15,[],['srpt'],https://twitter.com/bradloncar/status/651135711656079361,False,,0,,,,,,,,[],,,,
649958283076325380,649958283076325380,2015-10-02 20:15:04 IST,2015-10-02,20:15:04,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Amicus, Other Biotech CEOs Should Listen More, Talk Less About FDA Matters  http://t.co/5TtVZRExa4 $FOLD $ESPR $SRPT $ACRX",en,[],['http://www.thestreet.com/story/13310628/1/amicus-other-biotech-ceos-should-listen-more-talk-less-about-fda-matters.html'],[],1,15,25,[],"['fold', 'espr', 'srpt', 'acrx']",https://twitter.com/adamfeuerstein/status/649958283076325380,False,,0,,,,,,,,[],,,,
649611739747610625,649611739747610625,2015-10-01 21:18:02 IST,2015-10-01,21:18:02,+0530,15130891,kunal00,Kunal Desai,,$srpt like this here 39 short.,en,[],[],[],0,1,4,[],['srpt'],https://twitter.com/kunal00/status/649611739747610625,False,,0,,,,,,,,[],,,,
649603149414592512,649603149414592512,2015-10-01 20:43:54 IST,2015-10-01,20:43:54,+0530,14031032,adamsinger,Adam Singer,,Locked in some $SRPT gains. Not bad idea: I do think they can fly now just had far too much and it's taken my $ too many times on catalysts.,en,[],[],[],2,0,5,[],['srpt'],https://twitter.com/AdamSinger/status/649603149414592512,False,,0,,,,,,,,[],,,,
649562905415974912,649562905415974912,2015-10-01 18:03:59 IST,2015-10-01,18:03:59,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT up 16% pre-mkt on announcement of additional ph2b data:  http://t.co/PUSxHT6Hf0,en,[],['http://investorrelations.sarepta.com/mobile.view?c=64231&v=200&d=1&id=2092129'],[],2,1,6,[],['srpt'],https://twitter.com/megtirrell/status/649562905415974912,False,,0,,,,,,,,[],,,,
649554410977296384,649554410977296384,2015-10-01 17:30:14 IST,2015-10-01,17:30:14,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT 1. etep boys still walking 2. matched control supportive 3. exon-skip confirmed 4. dystrophin production confirmed 5. safe  Approvable,en,[],[],[],5,39,80,[],['srpt'],https://twitter.com/adamfeuerstein/status/649554410977296384,False,,0,,,,,,,,[],,,,
649551432656535552,649551432656535552,2015-10-01 17:18:24 IST,2015-10-01,17:18:24,+0530,44438256,matthewherper,Matthew Herper,,"If FDA winds up approving $srpt, I bet the Western blot data is more important than anything else that is new today.",en,[],[],[],7,1,5,[],['srpt'],https://twitter.com/matthewherper/status/649551432656535552,False,,0,,,,,,,,[],,,,
649546444697935872,649542814418759680,2015-10-01 16:58:35 IST,2015-10-01,16:58:35,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@JohnCFierce @JacobPlieth Disagree. $SRPT data aren‚Äôt a mess at all. Remarkably consistent. Is there enough? Is it persuasive? We‚Äôll see.,en,"[{'screen_name': 'jacobplieth', 'name': 'jacob plieth', 'id': '873399943'}]",[],[],3,2,5,[],['srpt'],https://twitter.com/adamfeuerstein/status/649546444697935872,False,,0,,,,,,,,[],,,,
649544612793708544,649544612793708544,2015-10-01 16:51:18 IST,2015-10-01,16:51:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT fourth biopsy summary:  http://t.co/v7drEUQZXK,en,[],[],['https://pbs.twimg.com/media/CQOlYVuW8AE484R.jpg'],0,10,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/649544612793708544,False,,1,https://pbs.twimg.com/media/CQOlYVuW8AE484R.jpg,,,,,,,[],,,,
649544080242962432,649544080242962432,2015-10-01 16:49:11 IST,2015-10-01,16:49:11,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT ‚ÄúMoney slide‚Äù showing eteplrisen 6MWT data vs new historical matched control.  http://t.co/j8zKVNW6KE,en,[],[],['https://pbs.twimg.com/media/CQOk4udWIAATygv.jpg'],4,13,19,[],['srpt'],https://twitter.com/adamfeuerstein/status/649544080242962432,False,,1,https://pbs.twimg.com/media/CQOk4udWIAATygv.jpg,,,,,,,[],,,,
649543724309942272,649543724309942272,2015-10-01 16:47:46 IST,2015-10-01,16:47:46,+0530,274233761,bradloncar,Brad Loncar,,$SRPT dystrophin fibers treated vs untreated from the 4th biopsy.  http://t.co/qz1jUUtbvN,en,[],[],['https://pbs.twimg.com/media/CQOkk1UUwAAVPfc.jpg'],0,8,14,[],['srpt'],https://twitter.com/bradloncar/status/649543724309942272,False,,1,https://pbs.twimg.com/media/CQOkk1UUwAAVPfc.jpg,,,,,,,[],,,,
649542814418759680,649542814418759680,2015-10-01 16:44:09 IST,2015-10-01,16:44:09,+0530,873399943,jacobplieth,Jacob Plieth,,"Do a study, choose some other patients from some other studies, run statistical analysis to compare the two. Hit stat sig. Genius! $SRPT",en,[],[],[],4,4,10,[],['srpt'],https://twitter.com/JacobPlieth/status/649542814418759680,False,,0,,,,,,,,[],,,,
649540730558509056,649540730558509056,2015-10-01 16:35:52 IST,2015-10-01,16:35:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Unveils New Data to Make Stronger Case for Duchenne Drug Approval  http://t.co/iVXACOWQvQ I spoke w/ interim CEO Ed Kaye last night.,en,[],['http://www.thestreet.com/story/13308077/1/sarepta-unveils-new-data-to-make-stronger-case-for-duchenne-drug-approval.html'],[],2,26,30,[],['srpt'],https://twitter.com/adamfeuerstein/status/649540730558509056,False,,0,,,,,,,,[],,,,
648989436538191872,648988707031154688,2015-09-30 04:05:13 IST,2015-09-30,04:05:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@BioRunUp Worse case for $SRPT is royalty to $BMRN. Can you imagine patient uproar if $BMRN tried to block $SRPT from market?,en,[],[],[],1,3,11,[],"['srpt', 'bmrn', 'bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/648989436538191872,False,,0,,,,,,,,[],,,,
648856781523845121,648856781523845121,2015-09-29 19:18:06 IST,2015-09-29,19:18:06,+0530,14031032,adamsinger,Adam Singer,,@srqstockpicker I added to $QURE and $SRPT #loco,en,[],[],[],1,1,8,['loco'],"['qure', 'srpt']",https://twitter.com/AdamSinger/status/648856781523845121,False,,0,,,,,,,,[],,,,
648508052958654464,648508052958654464,2015-09-28 20:12:23 IST,2015-09-28,20:12:23,+0530,14031032,adamsinger,Adam Singer,,Adding more to $SRPT ahead of this critical catalyst. Thanks market for the cheap shares.,en,[],[],[],2,0,5,[],['srpt'],https://twitter.com/AdamSinger/status/648508052958654464,False,,0,,,,,,,,[],,,,
647389036521353216,647389036521353216,2015-09-25 18:05:48 IST,2015-09-25,18:05:48,+0530,47678782,megtirrell,Meg Tirrell,,"$SRPT announces conf call for corp update, report on recent data from phase 2b study, Oct 1 @7am ET:  http://t.co/zs9YVKuK3e",en,"[{'screen_name': '7am', 'name': '7am', 'id': '12712502'}]",['http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&p=irol-newsArticle&ID=2090453'],[],0,8,7,[],['srpt'],https://twitter.com/megtirrell/status/647389036521353216,False,,0,,,,,,,,[],,,,
647388641203871744,647388641203871744,2015-09-25 18:04:14 IST,2015-09-25,18:04:14,+0530,274233761,bradloncar,Brad Loncar,,$SRPT update will be October 1 at 7:00 AM.  http://t.co/7wbKT7SaVG,en,[],['http://finance.yahoo.com/news/sarepta-therapeutics-announces-corporate-report-123000988.html'],[],1,5,9,[],['srpt'],https://twitter.com/bradloncar/status/647388641203871744,False,,0,,,,,,,,[],,,,
647168349215006720,647167969894658048,2015-09-25 03:28:52 IST,2015-09-25,03:28:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"@bradloncar Dream scenario for biotech longs: Big clinical wins from $ONCE $PTCT, + panels for $BMRN $SRPT, great ASH data from $BLUE.",en,[],[],[],2,9,14,[],"['once', 'ptct', 'bmrn', 'srpt', 'blue']",https://twitter.com/adamfeuerstein/status/647168349215006720,False,,0,,,,,,,,[],,,,
643782005616807937,643782005616807937,2015-09-15 19:12:45 IST,2015-09-15,19:12:45,+0530,14031032,adamsinger,Adam Singer,,Roth has been right on $srpt the whole year. Give someone over there a raise please.   https://t.co/BnwXUtozrQ,en,[],['https://twitter.com/GantosJ/status/643773400238956544'],[],0,0,6,[],['srpt'],https://twitter.com/AdamSinger/status/643782005616807937,False,https://twitter.com/GantosJ/status/643773400238956544,0,,,,,,,,[],,,,
643124429581496320,643124429581496320,2015-09-13 23:39:47 IST,2015-09-13,23:39:47,+0530,100024370,ophirgottlieb,Ophir Gottlieb,,$SRPT A Small Cap Biotech Ready to Explode  http://t.co/vSV7gTOINu,en,[],['http://bit.ly/1Qouy7u'],[],1,3,6,[],['srpt'],https://twitter.com/OphirGottlieb/status/643124429581496320,False,,0,,,,,,,,[],,,,
639797235119730688,639772706905452544,2015-09-04 19:18:42 IST,2015-09-04,19:18:42,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@RSIDayTrader @matthewherper I DID NOT CHANGE MY STANCE ON $SRPT!!!! I ONLY EXPLAINED THE BEAR THESIS. STOP BEING A DUMBASS.,en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",[],[],5,4,18,[],['srpt'],https://twitter.com/adamfeuerstein/status/639797235119730688,False,,0,,,,,,,,[],,,,
636959021598121985,636959021598121985,2015-08-27 23:20:39 IST,2015-08-27,23:20:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"The next $BMRN $SRPT bull-bear debate, if FDA approves both‚Ä¶   https://t.co/plku4NZEjm",en,[],['https://twitter.com/jeffreymaxin/status/636958784770801664'],[],2,2,5,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/636959021598121985,False,https://twitter.com/jeffreymaxin/status/636958784770801664,0,,,,,,,,[],,,,
636943869515538433,636943869515538433,2015-08-27 22:20:26 IST,2015-08-27,22:20:26,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Predicting the Outcome of the $BMRN and $SRPT FDA Drug Reviews  http://t.co/7rgR6MyLEE Here's what happens to drisa and etep,en,[],['http://www.thestreet.com/story/13269118/1/predicting-the-outcome-of-the-biomarin-and-sarepta-fda-drug-reviews.html'],[],12,23,21,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/636943869515538433,False,,0,,,,,,,,[],,,,
636544807616278528,636544807616278528,2015-08-26 19:54:43 IST,2015-08-26,19:54:43,+0530,44438256,matthewherper,Matthew Herper,,My biggest fear about $SRPT and $BMRN is that the push toward approval has PREVENTED studies that would clarify both drugs' benefits.,en,[],[],[],9,5,7,[],"['srpt', 'bmrn']",https://twitter.com/matthewherper/status/636544807616278528,False,,0,,,,,,,,[],,,,
636524283167158272,636524283167158272,2015-08-26 18:33:09 IST,2015-08-26,18:33:09,+0530,47678782,megtirrell,Meg Tirrell,,"RBC upgrades $SRPT to outperform, raises price target to $62 from $35, saying ""We just can't see this FDA not approving eteplirsen""",en,[],[],[],4,18,27,[],['srpt'],https://twitter.com/megtirrell/status/636524283167158272,False,,0,,,,,,,,[],,,,
636288388149157888,636288388149157888,2015-08-26 02:55:48 IST,2015-08-26,02:55:48,+0530,47678782,megtirrell,Meg Tirrell,,"FDA accepts $SRPT filing for eteplirsen in DMD; pdufa Feb 26, 2016",da,[],[],[],2,23,17,[],['srpt'],https://twitter.com/megtirrell/status/636288388149157888,False,,0,,,,,,,,[],,,,
636287936841953280,636287936841953280,2015-08-26 02:54:00 IST,2015-08-26,02:54:00,+0530,14031032,adamsinger,Adam Singer,,Sarepta Therapeutics Announces FDA Has Filed Eteplirsen NDA:  http://t.co/3xK1F4o6YA $SRPT #itshappening #racetoyes,en,[],['http://finance.yahoo.com/news/sarepta-therapeutics-announces-fda-filed-211700263.html'],[],0,10,14,"['itshappening', 'racetoyes']",['srpt'],https://twitter.com/AdamSinger/status/636287936841953280,False,,0,,,,,,,,[],,,,
636225540324589569,636225540324589569,2015-08-25 22:46:03 IST,2015-08-25,22:46:03,+0530,44060322,benzinga,Benzinga,,Market Panic Has Created 'Compelling' Opportunities In #Biotech $BLUE $CEMP $MGNX $SRPT $QURE  http://t.co/bqcfXCMzKF,en,[],['http://benzinga.com/z/5789764'],[],1,7,11,['biotech'],"['blue', 'cemp', 'mgnx', 'srpt', 'qure']",https://twitter.com/Benzinga/status/636225540324589569,False,,0,,,,,,,,[],,,,
635767876960415744,635767149999468546,2015-08-24 16:27:28 IST,2015-08-24,16:27:28,+0530,274233761,bradloncar,Brad Loncar,,RT @AnalystWire: Piper Jaffray Upgrades Sarepta Therapeutic $SRPT to Overweight; Expect FDA to Accept Eteplirsen ...  http://t.co/PIyzsEsq7w,en,"[{'screen_name': 'analystwire', 'name': 'sianalystwire', 'id': '818081647'}]",['http://streetinsider.com/r/10837130'],[],0,2,7,[],['srpt'],https://twitter.com/bradloncar/status/635767876960415744,False,,0,,,,,,,,[],,,,
635569278960320512,635568795608707072,2015-08-24 03:18:19 IST,2015-08-24,03:18:19,+0530,274233761,bradloncar,Brad Loncar,,@brettyo12239407 My guess is that $SRPT will be a hot stock through the panel meeting in Nov. That will probably be the height of insanity.,en,[],[],[],0,2,7,[],['srpt'],https://twitter.com/bradloncar/status/635569278960320512,False,,0,,,,,,,,[],,,,
634704281686310912,634704281686310912,2015-08-21 18:01:07 IST,2015-08-21,18:01:07,+0530,274233761,bradloncar,Brad Loncar,,$SRPT Receives Rare Pediatric Disease Designation From FDA for Eteplirsen  http://t.co/k7peasaFqL,en,[],['http://finance.yahoo.com/news/sarepta-therapeutics-receives-rare-pediatric-123000809.html?soc_src=mediacontentstory&soc_trk=t'],[],1,7,15,[],['srpt'],https://twitter.com/bradloncar/status/634704281686310912,False,,0,,,,,,,,[],,,,
634350230511611904,634350230511611904,2015-08-20 18:34:15 IST,2015-08-20,18:34:15,+0530,274233761,bradloncar,Brad Loncar,,"Great @matthewherper story shows why FDA talks with $SRPT about whether to file have been such a long saga. Once filed, very hard to reject.",en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",[],[],3,1,5,[],['srpt'],https://twitter.com/bradloncar/status/634350230511611904,False,,0,,,,,,,,[],,,,
634201804457152512,615475273845248000,2015-08-20 08:44:27 IST,2015-08-20,08:44:27,+0530,274233761,bradloncar,Brad Loncar,,@unifygovernment @fundDuchenne $SRPT all the way. It's no contest.,en,[],[],[],1,4,8,[],['srpt'],https://twitter.com/bradloncar/status/634201804457152512,False,,0,,,,,,,,[],,,,
631921083474669568,631920454710657024,2015-08-14 01:41:41 IST,2015-08-14,01:41:41,+0530,274233761,bradloncar,Brad Loncar,,@AdamSinger Hey and 6 months ago people were saying...everything is great except that loser $SRPT. That's biotech for you.,en,[],[],[],2,0,7,[],['srpt'],https://twitter.com/bradloncar/status/631921083474669568,False,,0,,,,,,,,[],,,,
631127549007958017,631127549007958017,2015-08-11 21:08:28 IST,2015-08-11,21:08:28,+0530,14031032,adamsinger,Adam Singer,,@srqstockpicker $SRPT is the safe haven in this market. We should just be 100% in that. Not joking.,en,[],[],[],0,0,6,[],['srpt'],https://twitter.com/AdamSinger/status/631127549007958017,False,,0,,,,,,,,[],,,,
629675178822242304,629675178822242304,2015-08-07 20:57:16 IST,2015-08-07,20:57:16,+0530,14031032,adamsinger,Adam Singer,,In case you guys care what I'm doing in bioland: holding $SRPT $QURE $KITE v. long positions. Added to $JUNO $ESPR $SGYP. GL friends.,en,[],[],[],2,4,26,[],"['srpt', 'qure', 'kite', 'juno', 'espr', 'sgyp']",https://twitter.com/AdamSinger/status/629675178822242304,False,,0,,,,,,,,[],,,,
629628009851523072,629628009851523072,2015-08-07 17:49:50 IST,2015-08-07,17:49:50,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"If FDA approves $SRPT eteplirsen, the self-congratulatory back-slapping might break Twitter.",en,[],[],[],6,2,18,[],['srpt'],https://twitter.com/adamfeuerstein/status/629628009851523072,False,,0,,,,,,,,[],,,,
629295477117186049,629295477117186049,2015-08-06 19:48:28 IST,2015-08-06,19:48:28,+0530,14031032,adamsinger,Adam Singer,,@srqstockpicker $srpt does not care what the broader market is doing. Still the best stock to own in 2015 you don't even need any others.,en,[],[],[],1,0,7,[],['srpt'],https://twitter.com/AdamSinger/status/629295477117186049,False,,0,,,,,,,,[],,,,
624021412437602304,624021412437602304,2015-07-23 06:31:13 IST,2015-07-23,06:31:13,+0530,14031032,adamsinger,Adam Singer,,Sarepta easily wins my 'most improved player' award of any public biotech co this yr. Unstoppable. Today's PR:  http://t.co/fAzYzky1Ax $SRPT,en,[],['http://finance.yahoo.com/news/sarepta-therapeutics-announces-england-journal-210100167.html'],[],2,1,10,[],['srpt'],https://twitter.com/AdamSinger/status/624021412437602304,False,,0,,,,,,,,[],,,,
623261219433152512,623220151438196736,2015-07-21 04:10:29 IST,2015-07-21,04:10:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,. @BioDueDiligence I envision @JohnCFierce doing $BMRN $SRPT adcomm play-by-play while I do color commentary. Entire thing b'cast live.,en,"[{'screen_name': 'bioduediligence', 'name': 'andrew g.', 'id': '244969675'}, {'screen_name': 'johncfierce', 'name': 'phyllis m. yang', 'id': '739133634532106240'}]",[],[],7,0,6,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/623261219433152512,False,,0,,,,,,,,[],,,,
623224678564405248,623224678564405248,2015-07-21 01:45:16 IST,2015-07-21,01:45:16,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Looks like FDA erased the Nov. 23-24 tentative dates for $BMRN $SRPT adcomm. Means the dates are real. Wait for Federal Register listing.,en,[],[],[],2,3,15,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/623224678564405248,False,,0,,,,,,,,[],,,,
623220151438196736,623220151438196736,2015-07-21 01:27:17 IST,2015-07-21,01:27:17,+0530,102754598,johncendpts,John Carroll,,"Translating for a family audience, @adamfeuerstein says he will most definitely live blog $SRPT $BMRN adcoms.",en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",[],[],4,2,14,[],"['srpt', 'bmrn']",https://twitter.com/JohnCendpts/status/623220151438196736,False,,0,,,,,,,,[],,,,
623193936165797888,623193936165797888,2015-07-20 23:43:07 IST,2015-07-20,23:43:07,+0530,102094857,adamfeuerstein,Adam Feuerstein,,YO! YO! YO! --&gt; FDA Closing In on November Expert Panel Date for $BMRN $SRPT Drugs  http://t.co/3yTc09KSsA via @TheStreet,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/13224276/1/fda-closing-in-on-november-expert-panel-date-for-biomarin-sarepta-drugs.html'],[],5,15,24,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/623193936165797888,False,,0,,,,,,,,[],,,,
620933964140646400,620933964140646400,2015-07-14 18:02:48 IST,2015-07-14,18:02:48,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Hey $SRPT - Focus.,en,[],[],[],4,4,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/620933964140646400,False,,0,,,,,,,,[],,,,
618436094506303490,618436094506303490,2015-07-07 20:37:09 IST,2015-07-07,20:37:09,+0530,47678782,megtirrell,Meg Tirrell,,Things I missed while on vacation: $VRTX Orkambi approval $JUNO / $CELG Ebola returned to Liberia $SRPT named Termeer advisor What else?,en,[],[],[],16,4,10,[],"['vrtx', 'juno', 'celg', 'srpt']",https://twitter.com/megtirrell/status/618436094506303490,False,,0,,,,,,,,[],,,,
616229452951859200,616229452951859200,2015-07-01 18:28:45 IST,2015-07-01,18:28:45,+0530,274233761,bradloncar,Brad Loncar,,Interesting that Henri Termeer was previously advisor to Prosensa. $BMRN $SRPT  http://t.co/C2K2NMMYvV,en,[],['http://ir.prosensa.eu/releasedetail.cfm?ReleaseID=775407'],[],4,8,9,[],"['bmrn', 'srpt']",https://twitter.com/bradloncar/status/616229452951859200,False,,0,,,,,,,,[],,,,
615501952424783872,615501952424783872,2015-06-29 18:17:55 IST,2015-06-29,18:17:55,+0530,873399943,jacobplieth,Jacob Plieth,,$SRPT $40m loan at 7.75%? This is a fantastic deal for Midcap Financial.,en,[],[],[],1,3,7,[],['srpt'],https://twitter.com/JacobPlieth/status/615501952424783872,False,,0,,,,,,,,[],,,,
615498646730219521,615498646730219521,2015-06-29 18:04:47 IST,2015-06-29,18:04:47,+0530,102094857,adamfeuerstein,Adam Feuerstein,,PPMD chief Pat Furlong gives canned congratulatory quote to $BMRN for its PR. Will she do same for $SRPT?,en,[],[],[],4,3,7,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/615498646730219521,False,,0,,,,,,,,[],,,,
615480941599789056,615480941599789056,2015-06-29 16:54:26 IST,2015-06-29,16:54:26,+0530,274233761,bradloncar,Brad Loncar,,Thanks to $SRPT for reminding us already how utterly meaningless this Greek news is to biotech fundamentals.,en,[],[],[],1,10,27,[],['srpt'],https://twitter.com/bradloncar/status/615480941599789056,False,,0,,,,,,,,[],,,,
615476928871596037,615476651598589952,2015-06-29 16:38:29 IST,2015-06-29,16:38:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@bradloncar $SRPT CFO told me the debt was stop-gap $ raising measure. Didn‚Äôt want to raise equity until share price recovers more.,en,[],[],[],2,6,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/615476928871596037,False,,0,,,,,,,,[],,,,
615476651598589952,615476651598589952,2015-06-29 16:37:23 IST,2015-06-29,16:37:23,+0530,274233761,bradloncar,Brad Loncar,,Why would $SRPT not just raise $40M equity here given the current share price/cost of capital? Never a fan of these bios taking on debt.,en,[],[],[],7,3,7,[],['srpt'],https://twitter.com/bradloncar/status/615476651598589952,False,,0,,,,,,,,[],,,,
615476180104384512,615476180104384512,2015-06-29 16:35:30 IST,2015-06-29,16:35:30,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Submits DMD Drug for FDA Approval Review  http://t.co/Q5ZyacI1Pe via @TheStreet,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/13201482/1/sarepta-submits-dmd-drug-for-fda-approval-review.html'],[],1,14,17,[],['srpt'],https://twitter.com/adamfeuerstein/status/615476180104384512,False,,0,,,,,,,,[],,,,
615475273845248000,615475273845248000,2015-06-29 16:31:54 IST,2015-06-29,16:31:54,+0530,274233761,bradloncar,Brad Loncar,,$SRPT Completes NDA Submission to FDA for Eteplirsen  http://t.co/RkhV2TmbzU,en,[],['http://finance.yahoo.com/news/sarepta-therapeutics-completes-nda-submission-110000619.html?soc_src=mediacontentstory&soc_trk=tw'],[],1,16,16,[],['srpt'],https://twitter.com/bradloncar/status/615475273845248000,False,,0,,,,,,,,[],,,,
613816738572951552,613813659488292864,2015-06-25 02:41:29 IST,2015-06-25,02:41:29,+0530,14031032,adamsinger,Adam Singer,,@BosBizDon @SudhanvaRaj this is what I picture every day is like for $SRPT shorts at this point:  http://t.co/n3DGi7eyrS,en,"[{'screen_name': 'sudhanvaraj', 'name': 'sudhanva raj', 'id': '344752927'}]",['http://media.giphy.com/media/dbtDDSvWErdf2/giphy.gif'],[],1,1,6,[],['srpt'],https://twitter.com/AdamSinger/status/613816738572951552,False,,0,,,,,,,,[],,,,
613445128200458240,613445128200458240,2015-06-24 02:04:50 IST,2015-06-24,02:04:50,+0530,14031032,adamsinger,Adam Singer,,"@Kalapoof $BMRN: ""we have more data than $SRPT ""   http://t.co/Uv08ZG8dsc ...congrats they have more data for a drug that's toxic / inferior!",en,[],['http://video.cnbc.com/gallery/?video=3000391016'],[],3,1,8,[],"['bmrn', 'srpt']",https://twitter.com/AdamSinger/status/613445128200458240,False,,0,,,,,,,,[],,,,
613098372501762048,613098372501762048,2015-06-23 03:06:57 IST,2015-06-23,03:06:57,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Barclays summary from today's $BMRN $PTCT failed DMD studies spin-a-thon. Dystrophin biomarker? Of course not. $SRPT  http://t.co/aNxKlx6H8P,en,[],[],['https://pbs.twimg.com/media/CIIpuKYWIAAuduV.png'],5,11,16,[],"['bmrn', 'ptct', 'srpt']",https://twitter.com/adamfeuerstein/status/613098372501762048,False,,1,https://pbs.twimg.com/media/CIIpuKYWIAAuduV.png,,,,,,,[],,,,
612814040075669506,612814040075669506,2015-06-22 08:17:07 IST,2015-06-22,08:17:07,+0530,14031032,adamsinger,Adam Singer,,"Looks like documentary to raise awareness for kids w/muscular dystrophy hit our goal!  https://t.co/WgEBezUS1W (346 backers, $125K!) $SRPT",en,[],['https://www.kickstarter.com/projects/897834209/to-the-edge-of-the-sky-a-new-film-about-family-and'],[],0,2,9,[],['srpt'],https://twitter.com/AdamSinger/status/612814040075669506,False,,0,,,,,,,,[],,,,
611998542853357568,611998542853357568,2015-06-20 02:16:37 IST,2015-06-20,02:16:37,+0530,14031032,adamsinger,Adam Singer,,Nearly a year since my fav biotech that could $SRPT closed &gt;$30/share. Wonderful job CEO Ed Kaye &amp; rest of team &amp; great news for patients!,en,[],[],[],3,3,14,[],['srpt'],https://twitter.com/AdamSinger/status/611998542853357568,False,,0,,,,,,,,[],,,,
611960242562166784,611958325568106496,2015-06-19 23:44:26 IST,2015-06-19,23:44:26,+0530,14031032,adamsinger,Adam Singer,,@Mykalt45 @GantosJ $SRPT doing those biopsies was really smart they have so much good data.,en,"[{'screen_name': 'gantosj', 'name': 'joe', 'id': '223589965'}]",[],[],1,3,7,[],['srpt'],https://twitter.com/AdamSinger/status/611960242562166784,False,,0,,,,,,,,[],,,,
611881190837080064,611880763873755136,2015-06-19 18:30:18 IST,2015-06-19,18:30:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,. @SJGMoney Baird's Brian Skorney is a very good sell-side analyst. It will be fun to watch him cover $BMRN and $SRPT.,en,"[{'screen_name': 'sjgmoney', 'name': 'sjg$', 'id': '50722395'}]",[],[],0,2,7,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/611881190837080064,False,,0,,,,,,,,[],,,,
609485143992958976,609482966423597056,2015-06-13 03:49:16 IST,2015-06-13,03:49:16,+0530,14031032,adamsinger,Adam Singer,,"@pawcio2009 this week I almost just threw everything into $QURE, $PRTA &amp; $SRPT and considered going into hibernation until 2016.",en,[],[],[],4,0,8,[],"['qure', 'prta', 'srpt']",https://twitter.com/AdamSinger/status/609485143992958976,False,,0,,,,,,,,[],,,,
608292228566544384,608292228566544384,2015-06-09 20:49:03 IST,2015-06-09,20:49:03,+0530,102094857,adamfeuerstein,Adam Feuerstein,,FDA DMD guidance is + for $BMRN (if you are a $BMRN supporter)  FDA DMD guidance is + for $SRPT (if you are a $SRPT supporter.),en,[],[],[],6,10,10,[],"['bmrn', 'bmrn', 'srpt', 'srpt']",https://twitter.com/adamfeuerstein/status/608292228566544384,False,,0,,,,,,,,[],,,,
606888968655937536,606790101029548032,2015-06-05 23:53:00 IST,2015-06-05,23:53:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,@AndyBiotech $BMRN could have told $PTCt no. I wish JJ would be honest. He wants to screw w/ $SRPT.,en,[],[],[],0,0,7,[],"['bmrn', 'ptct', 'srpt']",https://twitter.com/adamfeuerstein/status/606888968655937536,False,,0,,,,,,,,[],,,,
606790101029548032,606790101029548032,2015-06-05 17:20:08 IST,2015-06-05,17:20:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Did you know $BMRN &amp; $PTCT are partnering to educate investors about DMD? $SRPT is excluded. ‚Äî&gt;  http://t.co/kVwrBqIJUo,en,[],['http://www.thestreet.com/story/13175996/1/biotech-stock-mailbag-more-duchenne-drama-car-t-trouble-asco-15-rewind.html'],[],9,11,17,[],"['bmrn', 'ptct', 'srpt']",https://twitter.com/adamfeuerstein/status/606790101029548032,False,,0,,,,,,,,[],,,,
606563663994978305,606563663994978305,2015-06-05 02:20:21 IST,2015-06-05,02:20:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"If FDA caves to contrived public pressure &amp; approves flibanserin, the approval of eteplirsen should be a 1000% slam dunk. $SRPT",en,[],[],[],11,9,33,[],['srpt'],https://twitter.com/adamfeuerstein/status/606563663994978305,False,,0,,,,,,,,[],,,,
603283711702999041,603269364696096769,2015-05-27 01:06:59 IST,2015-05-27,01:06:59,+0530,14886375,stocktwits,Stocktwits,,How the StockTwits Heat Map helps: People are finding green stocks on a red day -&gt;  http://t.co/jkivHdcVj5 $SRPT $AMBA  http://t.co/Oyr3EE5Y6l,en,[],['http://stks.co/s28uX'],['https://pbs.twimg.com/media/CF9LVrjVEAEVoFW.png'],1,11,10,[],"['srpt', 'amba']",https://twitter.com/Stocktwits/status/603283711702999041,False,,1,https://pbs.twimg.com/media/CF9LVrjVEAEVoFW.png,,,,,,,[],,,,
601500845432176643,601500845432176643,2015-05-22 03:02:31 IST,2015-05-22,03:02:31,+0530,274233761,bradloncar,Brad Loncar,,They are talking $SRPT as a &gt; $100 or &lt; $10 binary event this year on Fast Money. That's going to add fuel to the already insane fire.,en,[],[],[],5,9,19,[],['srpt'],https://twitter.com/bradloncar/status/601500845432176643,False,,0,,,,,,,,[],,,,
601340175344672768,601340175344672768,2015-05-21 16:24:04 IST,2015-05-21,16:24:04,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I respect @CGrantWSJ but his comparative valuation analysis on $SRPT and $BMRN was whack-a-doodle.,en,"[{'screen_name': 'cgrantwsj', 'name': 'charley grant', 'id': '3043828834'}]",[],[],2,6,13,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/601340175344672768,False,,0,,,,,,,,[],,,,
601146751551082496,601144710514610176,2015-05-21 03:35:28 IST,2015-05-21,03:35:28,+0530,274233761,bradloncar,Brad Loncar,,@biorunup I wish investing in development stage biotechs was as easy as looking at price-to-sales estimates on FactSet. $SRPT,en,[],[],[],2,3,15,[],['srpt'],https://twitter.com/bradloncar/status/601146751551082496,False,,0,,,,,,,,[],,,,
601122180001308672,601121282592223234,2015-05-21 01:57:50 IST,2015-05-21,01:57:50,+0530,14886375,stocktwits,Stocktwits,,"First up, Sarepta Therapeutics. This stock was up 60% today alone. Here's why -&gt;  http://t.co/yDzk7hxPiD $SRPT  http://t.co/pfdd22GomB",en,[],['http://stks.co/t26wH'],['https://pbs.twimg.com/media/CFedb_uW8AEyFAJ.png'],2,6,12,[],['srpt'],https://twitter.com/Stocktwits/status/601122180001308672,False,,1,https://pbs.twimg.com/media/CFedb_uW8AEyFAJ.png,,,,,,,[],,,,
601050443385610240,601050443385610240,2015-05-20 21:12:47 IST,2015-05-20,21:12:47,+0530,576436187,carolineylchen,Caroline Chen,,"$SRPT now up 48%... CEO told me yesterday his focus: ""we made sure we gave [FDA] exactly what they asked for.""  http://t.co/npLIo3yqRE",en,[],['http://www.bloomberg.com/news/articles/2015-05-19/sarepta-soars-after-starting-fda-submission-for-duchenne-drug'],[],3,17,14,[],['srpt'],https://twitter.com/CarolineYLChen/status/601050443385610240,False,,0,,,,,,,,[],,,,
600998451606851585,600998451606851585,2015-05-20 17:46:11 IST,2015-05-20,17:46:11,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT +50% to $24.40 this morning. Remember the good old days when bulls &amp; bears fought over etep data? Welcome back!,en,[],[],[],4,6,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/600998451606851585,False,,0,,,,,,,,[],,,,
600767521604644864,600767521604644864,2015-05-20 02:28:33 IST,2015-05-20,02:28:33,+0530,44438256,matthewherper,Matthew Herper,,"Congrats to $SRPT. Great news! Longs, just remember that acceptance &lt;&gt; approval, and it's not over yet. It's OK to take some profits.",en,[],[],[],3,3,19,[],['srpt'],https://twitter.com/matthewherper/status/600767521604644864,False,,0,,,,,,,,[],,,,
600763867715735552,600763867715735552,2015-05-20 02:14:02 IST,2015-05-20,02:14:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,FDA Tells $SRPT: Come on Down With Your DMD Drug!  http://t.co/YN9Tsgbb0V,en,[],['http://www.thestreet.com/story/13157414/1/fda-tells-sarepta-therapeutics-come-on-down-with-your-dmd-drug.html'],[],0,12,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/600763867715735552,False,,0,,,,,,,,[],,,,
600760023573139456,600760023573139456,2015-05-20 01:58:45 IST,2015-05-20,01:58:45,+0530,286654612,mark_dow,Dow,,Long $SRPT short $YHOO is getting crowded already,en,[],[],[],1,0,5,[],"['srpt', 'yhoo']",https://twitter.com/mark_dow/status/600760023573139456,False,,0,,,,,,,,[],,,,
600754065748799488,600754065748799488,2015-05-20 01:35:05 IST,2015-05-20,01:35:05,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"With $SRPT filing NDA mid-year, the dual adcomm scenario with $BMRN I wrote about here is more likely ‚Äî&gt;  http://t.co/ti1jp0H8X1",en,[],['http://www.thestreet.com/story/13129304/1/heres-whats-next-as-biomarin-moves-closer-to-duchenne-drug-approval.html'],[],1,10,12,[],"['srpt', 'bmrn']",https://twitter.com/adamfeuerstein/status/600754065748799488,False,,0,,,,,,,,[],,,,
600753911415214085,600753911415214085,2015-05-20 01:34:28 IST,2015-05-20,01:34:28,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT up 22% after-mkt on announcing plan to submit rolling NDA for eterplirsen:  http://t.co/3dKtUozATA,en,[],['http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&p=irol-newsArticle&ID=2050184'],[],1,21,14,[],['srpt'],https://twitter.com/megtirrell/status/600753911415214085,False,,0,,,,,,,,[],,,,
600753475513810945,600753475513810945,2015-05-20 01:32:44 IST,2015-05-20,01:32:44,+0530,274233761,bradloncar,Brad Loncar,,FDA really kicked butt today. $SRPT $BLUE,en,[],[],[],3,4,13,[],"['srpt', 'blue']",https://twitter.com/bradloncar/status/600753475513810945,False,,0,,,,,,,,[],,,,
600753209330696194,600753209330696194,2015-05-20 01:31:41 IST,2015-05-20,01:31:41,+0530,14031032,adamsinger,Adam Singer,,$SRPT NDA filing! #itshappening #racetoyes,in,[],[],[],6,2,6,"['itshappening', 'racetoyes']",['srpt'],https://twitter.com/AdamSinger/status/600753209330696194,False,,0,,,,,,,,[],,,,
595892704023867392,595892704023867392,2015-05-06 15:37:46 IST,2015-05-06,15:37:46,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT -- Baird's Skorney upgrades on favorable risk/reward heading into FDA guidance on eteplirsen filing.,en,[],[],[],0,4,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/595892704023867392,False,,0,,,,,,,,[],,,,
594922196721500160,594922196721500160,2015-05-03 23:21:19 IST,2015-05-03,23:21:19,+0530,274233761,bradloncar,Brad Loncar,,The featured story in the Kansas City Star today is about #DMD. $SRPT $BMRN $PTCT mentioned.  http://t.co/khAlcZjCDt  http://t.co/aGzN2r9yvv,en,[],['http://www.kansascity.com/news/local/article20104104.html'],['https://pbs.twimg.com/media/CEGWldbUsAAg-YP.jpg'],2,5,14,['dmd'],"['srpt', 'bmrn', 'ptct']",https://twitter.com/bradloncar/status/594922196721500160,False,,1,https://pbs.twimg.com/media/CEGWldbUsAAg-YP.jpg,,,,,,,[],,,,
593797043073626115,593797043073626115,2015-04-30 20:50:21 IST,2015-04-30,20:50:21,+0530,14031032,adamsinger,Adam Singer,,Purchased more $QURE and starter in $ADRO this morning since the market stopped me out of $SRPT. Will re-buy Sarepta in a bit.,en,[],[],[],1,0,4,[],"['qure', 'adro', 'srpt']",https://twitter.com/AdamSinger/status/593797043073626115,False,,0,,,,,,,,[],,,,
593122881690685440,593122881690685440,2015-04-29 00:11:29 IST,2015-04-29,00:11:29,+0530,14031032,adamsinger,Adam Singer,,Really long insightful interview with ex Sarepta CEO on FDA / Rare Diseases / DMD:  http://t.co/wF6iXI0GDz [via @BosBizDon] $SRPT,en,"[{'screen_name': 'bosbizdon', 'name': 'don seiffert', 'id': '15752608'}]",['http://www.bizjournals.com/boston/blog/bioflash/2015/04/transcript-of-interview-with-former-sarepta-ceo.html?page=all'],[],3,3,8,[],['srpt'],https://twitter.com/AdamSinger/status/593122881690685440,False,,0,,,,,,,,[],,,,
593092588128841729,593092588128841729,2015-04-28 22:11:06 IST,2015-04-28,22:11:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Here's What's Next as $BMRN Moves Closer to Duchenne Drug Approval  http://t.co/ti1jp0py5t via @TheStreet $SRPT,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/13129304/1/heres-whats-next-as-biomarin-moves-closer-to-duchenne-drug-approval.html'],[],1,14,12,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/593092588128841729,False,,0,,,,,,,,[],,,,
592886879080550401,592885823034564608,2015-04-28 08:33:41 IST,2015-04-28,08:33:41,+0530,14031032,adamsinger,Adam Singer,,"As a note, when $SRPT's drug is approved I plan to make a much larger donation to Muscular Dystrophy Association. Is the right thing to do.",en,[],[],[],1,0,6,[],['srpt'],https://twitter.com/AdamSinger/status/592886879080550401,False,,0,,,,,,,,[],,,,
591243275052396544,591243275052396544,2015-04-23 19:42:36 IST,2015-04-23,19:42:36,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Santhera -- A Duchenne Drug With Positive Study Results That Few Know About  http://t.co/hi2wJOYXV7 via @TheStreet $SANN.SW $BMRN $SRPT $PTCT,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/13123457/1/santhera--a-duchenne-drug-with-positive-study-results-that-few-know-about.html'],[],0,7,6,[],"['sann.sw', 'bmrn', 'srpt', 'ptct']",https://twitter.com/adamfeuerstein/status/591243275052396544,False,,0,,,,,,,,[],,,,
590968286269071361,590968286269071361,2015-04-23 01:29:53 IST,2015-04-23,01:29:53,+0530,14031032,adamsinger,Adam Singer,,@given2tweet I bought more $SRPT today. It's an addiction.,en,[],[],[],1,0,9,[],['srpt'],https://twitter.com/AdamSinger/status/590968286269071361,False,,0,,,,,,,,[],,,,
590636864597581824,590629391723536385,2015-04-22 03:32:56 IST,2015-04-22,03:32:56,+0530,102094857,adamfeuerstein,Adam Feuerstein,,. @hydrogenblimp What if $BMRN AND $SRPT on same FDA adcomm in spring? It‚Äôs a possibility.,en,[],[],[],3,2,7,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/590636864597581824,False,,0,,,,,,,,[],,,,
590272834645037057,590272834645037057,2015-04-21 03:26:25 IST,2015-04-21,03:26:25,+0530,274233761,bradloncar,Brad Loncar,,$SRPT - M. Kathleen Behrens is now Chairwoman of the board of directors.  http://t.co/m3oHywwSo1,en,[],['http://www.sec.gov/Archives/edgar/data/873303/000117494715000658/c407751_8-k.htm'],[],0,4,9,[],['srpt'],https://twitter.com/bradloncar/status/590272834645037057,False,,0,,,,,,,,[],,,,
583796245031858176,583796245031858176,2015-04-03 06:30:45 IST,2015-04-03,06:30:45,+0530,360154668,harrisonsfund,Harrison's Fund,,Harrison and William have a message for @US_FDA #GetBackOnTrack $SRPT #Eteplirsen @TheRacetoYes  http://t.co/pLVv0CAETA,en,"[{'screen_name': 'us_fda', 'name': 'u.s. fda', 'id': '208120290'}, {'screen_name': 'theracetoyes', 'name': 'the race to yes', 'id': '2362580712'}]",[],"['https://pbs.twimg.com/media/CBoPi0aUIAAafOO.jpg', 'https://pbs.twimg.com/media/CBoPi0jVEAA0WtS.jpg']",2,13,18,"['getbackontrack', 'eteplirsen']",['srpt'],https://twitter.com/HarrisonsFund/status/583796245031858176,False,,1,https://pbs.twimg.com/media/CBoPi0aUIAAafOO.jpg,,,,,,,[],,,,
583245085640249344,583245085640249344,2015-04-01 18:00:39 IST,2015-04-01,18:00:39,+0530,274233761,bradloncar,Brad Loncar,,I can't say enough how refreshing it is to hear $SRPT's chairman answering these questions. Compare that to $ACAD's open ???'s.,en,[],[],[],1,2,11,[],"['srpt', 'acad']",https://twitter.com/bradloncar/status/583245085640249344,False,,0,,,,,,,,[],,,,
583096015370227712,583096015370227712,2015-04-01 08:08:18 IST,2015-04-01,08:08:18,+0530,44438256,matthewherper,Matthew Herper,,I spoke to $SRPT interim CEO Ed Kaye. Here's what he said.  http://t.co/mkTuvokhWA,en,[],['http://onforb.es/19B61Mt'],[],9,30,24,[],['srpt'],https://twitter.com/matthewherper/status/583096015370227712,False,,0,,,,,,,,[],,,,
583086313018138624,583086313018138624,2015-04-01 07:29:44 IST,2015-04-01,07:29:44,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Sudden Exit of $SRPT CEO Fuels Speculation Soured FDA Relationship to Blame  http://t.co/wUtV8YcbiU Insta-nalysis!,en,[],['http://www.thestreet.com/story/13097716/1/sudden-exit-of-sarepta-ceo-fuels-speculation-soured-fda-relationship-to-blame.html'],[],2,9,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/583086313018138624,False,,0,,,,,,,,[],,,,
583073379877523456,583073379877523456,2015-04-01 06:38:21 IST,2015-04-01,06:38:21,+0530,44438256,matthewherper,Matthew Herper,,"The last thing I wrote on $SRPT, from Oct.  27. CG ""seems to be in over his head.""   http://t.co/nhGuP09p9t",en,[],['http://onforb.es/1DkT15r'],[],0,0,5,[],['srpt'],https://twitter.com/matthewherper/status/583073379877523456,False,,0,,,,,,,,[],,,,
583066201317871616,583066201317871616,2015-04-01 06:09:49 IST,2015-04-01,06:09:49,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"A toast to CG with my last Grapefruit Sculpin. Always liked him personally, wish him the best. $SRPT  http://t.co/q16sNasBwB",en,[],[],['https://pbs.twimg.com/media/CBd3nelWEAAk8Y8.jpg'],3,1,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/583066201317871616,False,,1,https://pbs.twimg.com/media/CBd3nelWEAAk8Y8.jpg,,,,,,,[],,,,
583063597485563905,583063597485563905,2015-04-01 05:59:29 IST,2015-04-01,05:59:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Let‚Äôs spend the rest of the night on Twitter talking about $SRPT. With beer or your adult beverage of choice.,en,[],[],[],2,3,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/583063597485563905,False,,0,,,,,,,,[],,,,
583063297164845056,583063297164845056,2015-04-01 05:58:17 IST,2015-04-01,05:58:17,+0530,274233761,bradloncar,Brad Loncar,,What do you say we nominate @ianestepan for $SRPT CEO??,en,"[{'screen_name': 'ianestepan', 'name': 'ian estepan', 'id': '166711687'}]",[],[],4,4,13,[],['srpt'],https://twitter.com/bradloncar/status/583063297164845056,False,,0,,,,,,,,[],,,,
583063047368912896,583063047368912896,2015-04-01 05:57:17 IST,2015-04-01,05:57:17,+0530,14031032,adamsinger,Adam Singer,,"$SRPT should come up with a new tagline. Instead of ""developer of innovative RNA-targeted therapeutics"" I recommend ""we know drama.""",en,[],[],[],4,1,6,[],['srpt'],https://twitter.com/AdamSinger/status/583063047368912896,False,,0,,,,,,,,[],,,,
583060542417477632,583060542417477632,2015-04-01 05:47:20 IST,2015-04-01,05:47:20,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT never boring.,en,[],[],[],2,1,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/583060542417477632,False,,0,,,,,,,,[],,,,
583059146494210048,583059146494210048,2015-04-01 05:41:47 IST,2015-04-01,05:41:47,+0530,274233761,bradloncar,Brad Loncar,,Whoa Ed Kaye interim $SRPT CEO,in,[],[],[],3,3,8,[],['srpt'],https://twitter.com/bradloncar/status/583059146494210048,False,,0,,,,,,,,[],,,,
582650207768309760,582642375849353216,2015-03-31 02:36:49 IST,2015-03-31,02:36:49,+0530,102094857,adamfeuerstein,Adam Feuerstein,,. @BosBizDon Whether or not $SRPT measurement of that dystrophin is accurate will be focus of FDA review. Fri. panel doesn‚Äôt change that.,en,"[{'screen_name': 'bosbizdon', 'name': 'don seiffert', 'id': '15752608'}]",[],[],1,1,4,[],['srpt'],https://twitter.com/adamfeuerstein/status/582650207768309760,False,,0,,,,,,,,[],,,,
582649990503391233,582642375849353216,2015-03-31 02:35:57 IST,2015-03-31,02:35:57,+0530,102094857,adamfeuerstein,Adam Feuerstein,,". @BosBizDon If anything, reminded me (us) that $SRPT only DMD company with abundance of positive dystrophin data, more than $BMRN $PTCT",en,"[{'screen_name': 'bosbizdon', 'name': 'don seiffert', 'id': '15752608'}]",[],[],1,5,9,[],"['srpt', 'bmrn', 'ptct']",https://twitter.com/adamfeuerstein/status/582649990503391233,False,,0,,,,,,,,[],,,,
575767949010714625,575767949010714625,2015-03-12 02:49:10 IST,2015-03-12,02:49:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Am I the only person listening to this $ACAD call but thinking about $SRPT?,en,[],[],[],11,0,11,[],"['acad', 'srpt']",https://twitter.com/adamfeuerstein/status/575767949010714625,False,,0,,,,,,,,[],,,,
570969368495927296,570969368495927296,2015-02-26 21:01:20 IST,2015-02-26,21:01:20,+0530,14031032,adamsinger,Adam Singer,,@rushtonjdr listening to the conference call for $SRPT this morning ...this is Chris:  https://t.co/DssXP3H9lq,en,[],['https://www.youtube.com/watch?v=qd_zs8AwoTQ'],[],0,0,5,[],['srpt'],https://twitter.com/AdamSinger/status/570969368495927296,False,,0,,,,,,,,[],,,,
570917560817987584,570917560817987584,2015-02-26 17:35:28 IST,2015-02-26,17:35:28,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"The two most-dreaded words in any $SRPT press release: ‚ÄúFDA‚Äù and ‚Äúmeeting.""",en,[],[],[],0,2,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/570917560817987584,False,,0,,,,,,,,[],,,,
567732359802273792,567732359802273792,2015-02-17 22:38:37 IST,2015-02-17,22:38:37,+0530,274233761,bradloncar,Brad Loncar,,"The last time $SRPT had a 14%+ day was April 22nd of last year, the day after they announced plans to file the NDA. Stock closed $38.79.",en,[],[],[],2,2,6,[],['srpt'],https://twitter.com/bradloncar/status/567732359802273792,False,,0,,,,,,,,[],,,,
555885422425829378,555885422425829378,2015-01-16 06:03:07 IST,2015-01-16,06:03:07,+0530,274233761,bradloncar,Brad Loncar,,Here's a link to the full JJ Bienaim√© interview:  http://t.co/KtzvclJz3n $BMRN $SRPT cc: @BosBizDon,en,"[{'screen_name': 'bosbizdon', 'name': 'don seiffert', 'id': '15752608'}]",['http://video.cnbc.com/gallery/?video=3000346765&play=1'],[],3,0,4,[],"['bmrn', 'srpt']",https://twitter.com/bradloncar/status/555885422425829378,False,,0,,,,,,,,[],,,,
555875032161714176,555875032161714176,2015-01-16 05:21:49 IST,2015-01-16,05:21:49,+0530,274233761,bradloncar,Brad Loncar,,JJ Bienaim√© on why he did the Sarepta comparison:  https://t.co/hHvsDoqfN3 $SRPT $BMRN,en,[],['https://plus.google.com/110729939817396802862/posts/J6JfsimtsSF'],[],4,4,7,[],"['srpt', 'bmrn']",https://twitter.com/bradloncar/status/555875032161714176,False,,0,,,,,,,,[],,,,
555823055130198016,555823055130198016,2015-01-16 01:55:17 IST,2015-01-16,01:55:17,+0530,47678782,megtirrell,Meg Tirrell,,"""These drugs are markedly different,"" $SRPT's Garabedian says of eteplirsen, drisapersen",en,[],[],[],2,6,12,[],['srpt'],https://twitter.com/megtirrell/status/555823055130198016,False,,0,,,,,,,,[],,,,
555822101647880192,555822101647880192,2015-01-16 01:51:30 IST,2015-01-16,01:51:30,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Not sure if we‚Äôre seeing a forceful @ianestepan effect in CG‚Äôs #JPM15 presentation, but feels like it. $SRPT",en,"[{'screen_name': 'ianestepan', 'name': 'ian estepan', 'id': '166711687'}]",[],[],2,5,10,['jpm15'],['srpt'],https://twitter.com/adamfeuerstein/status/555822101647880192,False,,0,,,,,,,,[],,,,
555820148863819776,555820148863819776,2015-01-16 01:43:44 IST,2015-01-16,01:43:44,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT CG rebuttal/defense of eteplirsen data strikes right note. Will it matter? #JPM15,en,[],[],[],4,2,11,['jpm15'],['srpt'],https://twitter.com/adamfeuerstein/status/555820148863819776,False,,0,,,,,,,,[],,,,
555819530606239745,555819530606239745,2015-01-16 01:41:17 IST,2015-01-16,01:41:17,+0530,47678782,megtirrell,Meg Tirrell,,"""I was approached by researchers who felt this was inappropriate,"" $SRPT's Garabedian says of competitor comparing DMD studies at #JPM15",en,[],[],[],1,8,7,['jpm15'],['srpt'],https://twitter.com/megtirrell/status/555819530606239745,False,,0,,,,,,,,[],,,,
555356707514097666,555356707514097666,2015-01-14 19:02:11 IST,2015-01-14,19:02:11,+0530,274233761,bradloncar,Brad Loncar,,$SRPT announces first patient dosed in European phase I/II study of SRP-4053 in DMD (exon-53).,en,[],[],[],1,4,10,[],['srpt'],https://twitter.com/bradloncar/status/555356707514097666,False,,0,,,,,,,,[],,,,
554748916210479104,554748916210479104,2015-01-13 02:47:03 IST,2015-01-13,02:47:03,+0530,44438256,matthewherper,Matthew Herper,,Via @adamfeuerstein: I find this $BMRN argument against $SRPT compelling.  http://t.co/9wI66kyiTy,en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",['http://www.thestreet.com/story/13008055/1/biomarin-shows-up-rival-sarepta-during-jpm15-investor-presentation.html'],[],10,1,6,[],"['bmrn', 'srpt']",https://twitter.com/matthewherper/status/554748916210479104,False,,0,,,,,,,,[],,,,
554725073924263936,554725073924263936,2015-01-13 01:12:18 IST,2015-01-13,01:12:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BMRN Shows Up Rival $SRPT During #JPM15 Investor Presentation  http://t.co/mxpjEjHFJX via @TheStreet,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/13008055/1/biomarin-shows-up-rival-sarepta-during-jpm15-investor-presentation.html'],[],4,13,12,['jpm15'],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/554725073924263936,False,,0,,,,,,,,[],,,,
554718403311992833,554718403311992833,2015-01-13 00:45:48 IST,2015-01-13,00:45:48,+0530,102094857,adamfeuerstein,Adam Feuerstein,,The 2nd slide: $BMRN $SRPT #JPM15  http://t.co/hlqI5a68rN,en,[],[],['https://pbs.twimg.com/media/B7LBcnhCAAEgzbx.jpg'],7,7,9,['jpm15'],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/554718403311992833,False,,1,https://pbs.twimg.com/media/B7LBcnhCAAEgzbx.jpg,,,,,,,[],,,,
554717745284407298,554717745284407298,2015-01-13 00:43:11 IST,2015-01-13,00:43:11,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$BMRN #JPM15 presentation contain 2 slides comparing drisa w/ $SRPT eteplirsen. Don‚Äôt see this very often w/ unapproved drugs. Interesting.,en,[],[],[],1,3,6,['jpm15'],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/554717745284407298,False,,0,,,,,,,,[],,,,
553421151053938689,553421151053938689,2015-01-09 10:50:59 IST,2015-01-09,10:50:59,+0530,274233761,bradloncar,Brad Loncar,,There were 5 new additions to the breakout list today. 52 total now on board. #JPM15 $AGIO $BAX $BLUE $SRPT $WBMD  https://t.co/ik0mOfki5p,en,[],['https://plus.google.com/110729939817396802862/posts/SbEutB26vsW'],[],9,9,38,['jpm15'],"['agio', 'bax', 'blue', 'srpt', 'wbmd']",https://twitter.com/bradloncar/status/553421151053938689,False,,0,,,,,,,,[],,,,
551928294942056448,551928294942056448,2015-01-05 07:58:54 IST,2015-01-05,07:58:54,+0530,274233761,bradloncar,Brad Loncar,,"Wow $KITE was given the last presentation slot on Thursday at #JPM15. How did that happen? $SRPT was too, btw.",en,[],[],[],6,4,10,['jpm15'],"['kite', 'srpt']",https://twitter.com/bradloncar/status/551928294942056448,False,,0,,,,,,,,[],,,,
544504071927762944,544504071927762944,2014-12-15 20:17:41 IST,2014-12-15,20:17:41,+0530,14031032,adamsinger,Adam Singer,,"We need X-Files t-shirts that say ""I want to believe."" But instead of aliens it just has the $SRPT ticker. #sigh",en,[],[],[],1,1,7,['sigh'],['srpt'],https://twitter.com/AdamSinger/status/544504071927762944,False,,0,,,,,,,,[],,,,
540832402092720131,540832402092720131,2014-12-05 17:07:47 IST,2014-12-05,17:07:47,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta  http://t.co/3LLuTMSo3r via @TheStreet $AEMD $OXGN $SRPT",da,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/12974675/1/biotech-stock-mailbag-aethlon-medical-oxigene-sarepta.html'],[],9,4,8,[],"['aemd', 'oxgn', 'srpt']",https://twitter.com/adamfeuerstein/status/540832402092720131,False,,0,,,,,,,,[],,,,
539752058237497345,539752058237497345,2014-12-02 17:34:53 IST,2014-12-02,17:34:53,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"DB‚Äôs Robyn K dinner w/ $BMRN last night, says they may assert drisapersen IP rights in US to keep $SRPT etep off market, force royalties.",en,[],[],[],8,12,9,[],"['bmrn', 'srpt']",https://twitter.com/adamfeuerstein/status/539752058237497345,False,,0,,,,,,,,[],,,,
534712087088361472,534712087088361472,2014-11-18 19:47:50 IST,2014-11-18,19:47:50,+0530,274233761,bradloncar,Brad Loncar,,$SRPT Announces First Patient Dosed in Confirmatory Study of Eteplirsen in Ambulant Patients  http://t.co/lPe9BUfy5S,en,[],['http://finance.yahoo.com/news/sarepta-therapeutics-announces-first-patient-141500812.html?soc_src=mediacontentstory&soc_trk=tw'],[],1,6,10,[],['srpt'],https://twitter.com/bradloncar/status/534712087088361472,False,,0,,,,,,,,[],,,,
532661572741922816,532661572741922816,2014-11-13 03:59:49 IST,2014-11-13,03:59:49,+0530,47678782,megtirrell,Meg Tirrell,,$SRPT says first pt dosed in new 20-pt study,en,[],[],[],2,3,5,[],['srpt'],https://twitter.com/megtirrell/status/532661572741922816,False,,0,,,,,,,,[],,,,
528188509094703105,528188509094703105,2014-10-31 19:45:28 IST,2014-10-31,19:45:28,+0530,102754598,johncendpts,John Carroll,,FDA to $SRPT's CEO: You don't hear so well. And that's something you don't see much. Great piece by @DamianFierce   http://t.co/C5yEsmIAra,en,[],['http://www.fiercebiotech.com/story/fda-pulls-back-curtain-sareptas-latest-dmd-delay/2014-10-31'],[],1,5,5,[],['srpt'],https://twitter.com/JohnCendpts/status/528188509094703105,False,,0,,,,,,,,[],,,,
528157188817039360,528157188817039360,2014-10-31 17:41:01 IST,2014-10-31,17:41:01,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Forget about $SRPT for a moment. Consider $RNA and its straight shot to approval. Here‚Äôs one roadmap to get there ‚Äî&gt;  http://t.co/2j7ALGAPSo,en,[],['http://www.thestreet.com/story/12934441/1/biotech-stock-mailbag-prosensa-sarepta-arena-pharma-hemispherx.html'],[],5,5,9,[],"['srpt', 'rna']",https://twitter.com/adamfeuerstein/status/528157188817039360,False,,0,,,,,,,,[],,,,
527972846975217664,527952535823601664,2014-10-31 05:28:30 IST,2014-10-31,05:28:30,+0530,274233761,bradloncar,Brad Loncar,,"@chasingthealpha The moral is that if you want to push the FDA envelope, you need to have your sh*t together, and clearly $SRPT hasn't.",en,[],[],[],1,2,10,[],['srpt'],https://twitter.com/bradloncar/status/527972846975217664,False,,0,,,,,,,,[],,,,
527956960243908608,527956960243908608,2014-10-31 04:25:22 IST,2014-10-31,04:25:22,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"FDA know it‚Äôs partly to blame for this fucking mess, so it needs escape route. $SRPT shares blame, too.",en,[],[],[],10,2,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/527956960243908608,False,,0,,,,,,,,[],,,,
527956706605940736,527956706605940736,2014-10-31 04:24:22 IST,2014-10-31,04:24:22,+0530,102094857,adamfeuerstein,Adam Feuerstein,,The FDA wrote this placating letter because @jennmcnary &amp; the other $SRPT moms are threatening to handcuff themselves to FDA‚Äôs front door.,en,"[{'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}]",[],[],6,5,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/527956706605940736,False,,0,,,,,,,,[],,,,
527954832997756929,527954832997756929,2014-10-31 04:16:55 IST,2014-10-31,04:16:55,+0530,102094857,adamfeuerstein,Adam Feuerstein,,FDA statements on $SRPT eteplirsen regulatory timeline ‚Äî&gt;  http://t.co/89nnwyupN2,en,[],['http://www.fda.gov/Drugs/DrugSafety/ucm421270.htm'],[],4,5,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/527954832997756929,False,,0,,,,,,,,[],,,,
527947150605684738,527947150605684738,2014-10-31 03:46:24 IST,2014-10-31,03:46:24,+0530,44438256,matthewherper,Matthew Herper,,"From @FDA's perspective, I think they feel they have been very consistent w/ regards to $SRPT. I think company, advocates have misread FDA.",en,"[{'screen_name': 'fda', 'name': 'fda', 'id': '1255526396807561217'}]",[],[],3,0,4,[],['srpt'],https://twitter.com/matthewherper/status/527947150605684738,False,,0,,,,,,,,[],,,,
527782749277786112,527779806109507584,2014-10-30 16:53:07 IST,2014-10-30,16:53:07,+0530,44438256,matthewherper,Matthew Herper,,Balanced article on Sarepta. RT @jennmcnary $SRPT   http://t.co/Gy20LOAwbE,en,"[{'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}]",['http://mobile.businessweek.com/articles/2014-10-30/duchenne-muscular-dystrophy-moms-fight-for-fda-approval-of-sarepta-drug'],[],4,8,10,[],['srpt'],https://twitter.com/matthewherper/status/527782749277786112,False,,0,,,,,,,,[],,,,
526782576258609152,526782576258609152,2014-10-27 22:38:47 IST,2014-10-27,22:38:47,+0530,15971805,investorslive,Nathan Michaud,,$SRPT Stifel downgrade to BAGHOLD from buy,en,[],[],[],0,5,15,[],['srpt'],https://twitter.com/InvestorsLive/status/526782576258609152,False,,0,,,,,,,,[],,,,
526763373044961281,526763373044961281,2014-10-27 21:22:29 IST,2014-10-27,21:22:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I have many regrets &amp; ‚Äúshould haves‚Äù w/r/t $SRPT, but at top is my idiotic dismissal of really smart people who told me Art Krieg was right.",en,[],[],[],9,5,16,[],['srpt'],https://twitter.com/adamfeuerstein/status/526763373044961281,False,,0,,,,,,,,[],,,,
526755990599782400,526755990599782400,2014-10-27 20:53:09 IST,2014-10-27,20:53:09,+0530,274233761,bradloncar,Brad Loncar,,"This news is obviously very disappointing, and I think it is likely even worse than it sounds on the surface. Stinks all around. $SRPT",en,[],[],[],2,3,9,[],['srpt'],https://twitter.com/bradloncar/status/526755990599782400,False,,0,,,,,,,,[],,,,
526755598780473344,526755598780473344,2014-10-27 20:51:36 IST,2014-10-27,20:51:36,+0530,274233761,bradloncar,Brad Loncar,,Since people have asked on DM...I've sold 3/4 of my $SRPT position. Will hold 1/4 as a legacy in case they ever pull this off one day.,en,[],[],[],6,1,8,[],['srpt'],https://twitter.com/bradloncar/status/526755598780473344,False,,0,,,,,,,,[],,,,
526752441446825984,526752441446825984,2014-10-27 20:39:03 IST,2014-10-27,20:39:03,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Shares Falls on Duchenne Drug Approval Filing Delay  http://t.co/wSrdp2Lp9P via @TheStreet,en,"[{'screen_name': 'thestreet', 'name': 'thestreet', 'id': '15281391'}]",['http://www.thestreet.com/story/12927808/1/sarepta-shares-falls-on-duchenne-drug-approval-filing-delay.html'],[],1,8,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/526752441446825984,False,,0,,,,,,,,[],,,,
526699000955953152,526699000955953152,2014-10-27 17:06:42 IST,2014-10-27,17:06:42,+0530,873399943,jacobplieth,Jacob Plieth,,"A year ago I interviewed $RNA's CEO, Hans Schikan. What he said about $SRPT's dystrophin measurement is interesting  http://t.co/kEy2zdI3is",en,[],[],['https://pbs.twimg.com/media/B0818waIgAI-fL9.jpg'],1,10,12,[],"['rna', 'srpt']",https://twitter.com/JacobPlieth/status/526699000955953152,False,,1,https://pbs.twimg.com/media/B0818waIgAI-fL9.jpg,,,,,,,[],,,,
526698633446834177,526698633446834177,2014-10-27 17:05:14 IST,2014-10-27,17:05:14,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"That Ebola media strategy working GREAT for $SRPT right now. Awesome job, guys!",en,[],[],[],1,4,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/526698633446834177,False,,0,,,,,,,,[],,,,
526693692401520640,526693692401520640,2014-10-27 16:45:36 IST,2014-10-27,16:45:36,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT maybe the wrong guy was fired?,en,[],[],[],3,4,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/526693692401520640,False,,0,,,,,,,,[],,,,
522843624456060929,522843624456060929,2014-10-17 01:46:48 IST,2014-10-17,01:46:48,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Maybe DMD parents should move with their kids to W. Africa. $SRPT,en,[],[],[],4,1,5,[],['srpt'],https://twitter.com/adamfeuerstein/status/522843624456060929,False,,0,,,,,,,,[],,,,
522792185800839169,522792185800839169,2014-10-16 22:22:24 IST,2014-10-16,22:22:24,+0530,14031032,adamsinger,Adam Singer,,@bradloncar I am going to close my eyes and just believe everyone is suddenly buying $SRPT for Eteplirsen like they should be.,en,[],[],[],1,1,6,[],['srpt'],https://twitter.com/AdamSinger/status/522792185800839169,False,,0,,,,,,,,[],,,,
521701994776776705,521701994776776705,2014-10-13 22:10:22 IST,2014-10-13,22:10:22,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"A look at $SRPT and the new, 3-year natural history study of DMD patients ‚Äî&gt;  http://t.co/BwOsLaoEGl",en,[],['http://www.thestreet.com/story/12911313/1/sarepta-drug-could-benefit-from-duchenne-muscular-dystrophy-patient-study.html'],[],7,18,20,[],['srpt'],https://twitter.com/adamfeuerstein/status/521701994776776705,False,,0,,,,,,,,[],,,,
519259935067369474,519259935067369474,2014-10-07 04:26:30 IST,2014-10-07,04:26:30,+0530,274233761,bradloncar,Brad Loncar,,"The replay of today's $SRPT call can be heard at: 855-859-2056 passcode 14093167. But you didn't hear it from me, wink wink.",en,[],[],[],2,4,18,[],['srpt'],https://twitter.com/bradloncar/status/519259935067369474,False,,0,,,,,,,,[],,,,
517290713990828032,517290713990828032,2014-10-01 18:01:31 IST,2014-10-01,18:01:31,+0530,14886375,stocktwits,Stocktwits,,"Traders everywhere are watching $TKMR, $BCRX and $SRPT.  Why? They are each researching an Ebola cure. Trending:  http://t.co/8AWHyugojJ",en,[],['http://stks.co/r0q2Q'],[],1,9,9,[],"['tkmr', 'bcrx', 'srpt']",https://twitter.com/Stocktwits/status/517290713990828032,False,,0,,,,,,,,[],,,,
517062808669003776,517062808669003776,2014-10-01 02:55:54 IST,2014-10-01,02:55:54,+0530,1347071545,melissaleecnbc,Melissa Lee,,$SRPT POPS on news of first confirmed EBOLA case in US. CEO joins @CNBCFastMoney NEXT.,en,"[{'screen_name': 'cnbcfastmoney', 'name': ""cnbc's fast money"", 'id': '16732770'}]",[],[],5,9,5,[],['srpt'],https://twitter.com/MelissaLeeCNBC/status/517062808669003776,False,,0,,,,,,,,[],,,,
517058682946064385,517058682946064385,2014-10-01 02:39:31 IST,2014-10-01,02:39:31,+0530,16246929,danprimack,Dan Primack,,"See, it's all good news. RT @CNBC: ALERT: Ebola drug makers surge after first U.S. diagnosis.  http://t.co/xQa5lRxib5 ‚Ä¢ $TKMR $BCRX $SRPT",en,"[{'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}]",['http://www.cnbc.com/id/102046811'],[],0,7,8,[],"['tkmr', 'bcrx', 'srpt']",https://twitter.com/danprimack/status/517058682946064385,False,,0,,,,,,,,[],,,,
517058486728151041,517058486728151041,2014-10-01 02:38:44 IST,2014-10-01,02:38:44,+0530,20402945,cnbc,CNBC,,ALERT: Ebola drug makers surge after first U.S. diagnosis.  http://t.co/5MBH9FKSVe ‚Ä¢ $TKMR $BCRX $SRPT,en,[],['http://www.cnbc.com/id/102046811'],[],14,125,24,[],"['tkmr', 'bcrx', 'srpt']",https://twitter.com/CNBC/status/517058486728151041,False,,0,,,,,,,,[],,,,
514505619135791105,514505619135791105,2014-09-24 01:34:33 IST,2014-09-24,01:34:33,+0530,274233761,bradloncar,Brad Loncar,,Credit Suisse initiated $SRPT. $36PT,en,[],[],[],1,6,9,[],['srpt'],https://twitter.com/bradloncar/status/514505619135791105,False,,0,,,,,,,,[],,,,
513046739603828737,513046739603828737,2014-09-20 00:57:29 IST,2014-09-20,00:57:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT should hire @MartinShkreli as a timeline promise keeper consultant. Oh wait‚Ä¶,en,"[{'screen_name': 'martinshkreli', 'name': 'martin shkreli', 'id': '312653402'}]",[],[],1,0,5,[],['srpt'],https://twitter.com/adamfeuerstein/status/513046739603828737,False,,0,,,,,,,,[],,,,
513038210453471233,513038210453471233,2014-09-20 00:23:35 IST,2014-09-20,00:23:35,+0530,274233761,bradloncar,Brad Loncar,,"Not saying it's a reason for this, but still $SRPT needs to stop wasting time going to investment conferences. Time is too precious now.",en,[],[],[],2,1,10,[],['srpt'],https://twitter.com/bradloncar/status/513038210453471233,False,,0,,,,,,,,[],,,,
512314339236544512,512314339236544512,2014-09-18 00:27:11 IST,2014-09-18,00:27:11,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Say what you will about $RNA, but at least they‚Äôre dosing DMD patients. $SRPT‚Ä¶. ahem‚Ä¶.",en,[],[],[],5,4,10,[],['rna'],https://twitter.com/adamfeuerstein/status/512314339236544512,False,,0,,,,,,,,[],,,,
501491414048710658,501491249560293376,2014-08-19 03:40:45 IST,2014-08-19,03:40:45,+0530,274233761,bradloncar,Brad Loncar,,"RT @SmarterAnalyst: $SRPT Cowen Assumes Coverage Of Sarepta At Outperform, $44 Price Target  http://t.co/WDBd7ta3Cy",en,"[{'screen_name': 'smarteranalyst', 'name': 'smarter analyst', 'id': '2567518027'}]",['http://www.smarteranalyst.com/2014/08/18/cowen-assumes-coverage-of-sarepta-at-outperform-44-price-target/'],[],4,3,9,[],['srpt'],https://twitter.com/bradloncar/status/501491414048710658,False,,0,,,,,,,,[],,,,
497052585660936193,497052585660936193,2014-08-06 21:42:25 IST,2014-08-06,21:42:25,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT Should Shut Up About Ebola, Focus on Job No. 1  http://t.co/Mmme8NuG8W",en,[],['http://www.thestreet.com/story/12835746/1/sarepta-should-shut-up-about-ebola-focus-on-job-no-1.html'],[],14,9,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/497052585660936193,False,,0,,,,,,,,[],,,,
496976770630172672,496976770630172672,2014-08-06 16:41:10 IST,2014-08-06,16:41:10,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I‚Äôm sure DMD parents like @jennmcnary thrilled when they read this graph from @BostonGlobe $SRPT ebola story  http://t.co/v7gtftVTqe,en,"[{'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}, {'screen_name': 'bostonglobe', 'name': 'the boston globe', 'id': '95431448'}]",[],['https://pbs.twimg.com/media/BuWdvVjIgAApfWN.jpg'],8,8,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/496976770630172672,False,,1,https://pbs.twimg.com/media/BuWdvVjIgAApfWN.jpg,,,,,,,[],,,,
496494455294152704,496494455294152704,2014-08-05 08:44:37 IST,2014-08-05,08:44:37,+0530,274233761,bradloncar,Brad Loncar,,The parents who took an unusual step with the FDA to improve research on a rare disease  http://t.co/VOpacZZYz0 $SRPT $RNA,en,[],['http://on.wsj.com/1sop5D7'],[],0,3,7,[],"['srpt', 'rna']",https://twitter.com/bradloncar/status/496494455294152704,False,,0,,,,,,,,[],,,,
494957799223590913,494957799223590913,2014-08-01 02:58:29 IST,2014-08-01,02:58:29,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT Less talking, more doing. Please.",en,[],[],[],3,1,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/494957799223590913,False,,0,,,,,,,,[],,,,
494957312050987008,494957312050987008,2014-08-01 02:56:33 IST,2014-08-01,02:56:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Only $SRPT PR I‚Äôm interested in reading starts like this: ‚ÄúSarepta Therapeutics announces eteplirsen has been filed with the FDA‚Ä¶""",en,[],[],[],3,6,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/494957312050987008,False,,0,,,,,,,,[],,,,
494955205276864512,494955205276864512,2014-08-01 02:48:11 IST,2014-08-01,02:48:11,+0530,274233761,bradloncar,Brad Loncar,,"Okay, so we got what we asked for‚Ä¶some clarity in writing from the board so that we can move on. Good news. $SRPT",en,[],[],[],0,2,7,[],['srpt'],https://twitter.com/bradloncar/status/494955205276864512,False,,0,,,,,,,,[],,,,
494307303311437824,494201473329553408,2014-07-30 07:53:39 IST,2014-07-30,07:53:39,+0530,44438256,matthewherper,Matthew Herper,,Numbing. RT @adamfeuerstein The constant $SRPT drama is tiring.,en,"[{'screen_name': 'adamfeuerstein', 'name': 'adam feuerstein', 'id': '102094857'}]",[],[],0,0,4,[],['srpt'],https://twitter.com/matthewherper/status/494307303311437824,False,,0,,,,,,,,[],,,,
494210290607591425,494210290607591425,2014-07-30 01:28:09 IST,2014-07-30,01:28:09,+0530,274233761,bradloncar,Brad Loncar,,My last comment: I think the chairman of $SRPT needs to write something publicly that clears the air and moves on‚Ä¶whatever that might be.,en,[],[],[],2,4,11,[],['srpt'],https://twitter.com/bradloncar/status/494210290607591425,False,,0,,,,,,,,[],,,,
494201473329553408,494201473329553408,2014-07-30 00:53:07 IST,2014-07-30,00:53:07,+0530,102094857,adamfeuerstein,Adam Feuerstein,,The constant $SRPT drama is tiring.,en,[],[],[],2,3,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/494201473329553408,False,,0,,,,,,,,[],,,,
493845687571087360,493845687571087360,2014-07-29 01:19:21 IST,2014-07-29,01:19:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I totally endorse Dirk for $SRPT new CSO. Why the fuck not?  http://t.co/ac3Wmuu8sk @RNAiAnalyst,en,"[{'screen_name': 'rnaianalyst', 'name': 'multivalent dirk haussecker', 'id': '409194010'}]",['http://rnaitherapeutics.blogspot.de/2014/07/dear-chris-garabedian.html'],[],0,2,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/493845687571087360,False,,0,,,,,,,,[],,,,
492304143273316355,492304143273316355,2014-07-24 19:13:49 IST,2014-07-24,19:13:49,+0530,274233761,bradloncar,Brad Loncar,,"Sarpeta is sitting on the ten yard line right now, almost miraculously so. And 9 out of 10 CEOs would have never made it happen. $SRPT",en,[],[],[],1,3,8,[],['srpt'],https://twitter.com/bradloncar/status/492304143273316355,False,,0,,,,,,,,[],,,,
492298974624485377,492298974624485377,2014-07-24 18:53:16 IST,2014-07-24,18:53:16,+0530,102094857,adamfeuerstein,Adam Feuerstein,,The Story Behind $SRPT Firing of its Top Scientist ‚Äî&gt;  http://t.co/wz6UZBz1EE,en,[],['http://www.thestreet.com/story/12786982/1/the-story-behind-sareptas-firing-of-its-top-scientist.html'],[],7,12,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/492298974624485377,False,,0,,,,,,,,[],,,,
492275922079592448,492275922079592448,2014-07-24 17:21:40 IST,2014-07-24,17:21:40,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I have more info on $SRPT. Blog post later this morning.,en,[],[],[],2,5,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/492275922079592448,False,,0,,,,,,,,[],,,,
487685165922013184,486185317657899008,2014-07-12 01:19:38 IST,2014-07-12,01:19:38,+0530,274233761,bradloncar,Brad Loncar,,@arshavin_k No. For me $SRPT is like a venture investment. It's either going to pan out one day or not. Not doing any trading in between.,en,[],[],[],2,0,7,[],['srpt'],https://twitter.com/bradloncar/status/487685165922013184,False,,0,,,,,,,,[],,,,
487333478606721024,487333478606721024,2014-07-11 02:02:10 IST,2014-07-11,02:02:10,+0530,274233761,bradloncar,Brad Loncar,,"I sent this quick note to $SRPT IR. Setting aside your bull/bear opinion on the actual news, what do you think?  http://t.co/2wL6jH1lEY",en,[],[],['https://pbs.twimg.com/media/BsNbN3SCEAAy2R0.png'],9,3,18,[],['srpt'],https://twitter.com/bradloncar/status/487333478606721024,False,,1,https://pbs.twimg.com/media/BsNbN3SCEAAy2R0.png,,,,,,,[],,,,
487229857420832768,487229857420832768,2014-07-10 19:10:24 IST,2014-07-10,19:10:24,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Step back, people, and remember, drugs are approved on 1 yr benefit even w/ data showing benefit disappears at 2 yrs. $SRPT",en,[],[],[],7,16,13,[],['srpt'],https://twitter.com/adamfeuerstein/status/487229857420832768,False,,0,,,,,,,,[],,,,
487212647654653952,487212647654653952,2014-07-10 18:02:01 IST,2014-07-10,18:02:01,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Latest $SRPT Study Updates Shows Greater Decline in Walking Ability ‚Äî&gt;  http://t.co/hBh0do8X2U,en,[],['http://www.thestreet.com/story/12769742/1/latest-sarepta-study-update-shows-greater-decline-in-walking-ability.html'],[],2,4,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/487212647654653952,False,,0,,,,,,,,[],,,,
486220970567692288,486220970567692288,2014-07-08 00:21:27 IST,2014-07-08,00:21:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Monday Selloff on New (Old) Worries Addressed ‚Äî&gt;  http://t.co/sOciAdpdIw,en,[],['http://www.thestreet.com/story/12766397/1/sareptas-monday-selloff-on-new-old-worries-addressed.html'],[],4,12,12,[],['srpt'],https://twitter.com/adamfeuerstein/status/486220970567692288,False,,0,,,,,,,,[],,,,
481432191441076224,481432191441076224,2014-06-24 19:12:33 IST,2014-06-24,19:12:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"OK, enough with CF, now $VRTX needs to buy $SRPT.",en,[],[],[],5,5,14,[],"['vrtx', 'srpt']",https://twitter.com/adamfeuerstein/status/481432191441076224,False,,0,,,,,,,,[],,,,
473858563647868928,473858563647868928,2014-06-03 21:37:40 IST,2014-06-03,21:37:40,+0530,44438256,matthewherper,Matthew Herper,,$RNA and $SRPT: I'm skeptical this FDA process is going to end well.,en,[],[],[],9,2,6,[],"['rna', 'srpt']",https://twitter.com/matthewherper/status/473858563647868928,False,,0,,,,,,,,[],,,,
473838900843409410,473838900843409410,2014-06-03 20:19:32 IST,2014-06-03,20:19:32,+0530,274233761,bradloncar,Brad Loncar,,Just finished up with the $SRPT shareholder meeting in Cambridge. The main takeaway with that company is always what a solid team they have.,en,[],[],[],5,2,6,[],['srpt'],https://twitter.com/bradloncar/status/473838900843409410,False,,0,,,,,,,,[],,,,
471979390566289408,471979390566289408,2014-05-29 17:10:30 IST,2014-05-29,17:10:30,+0530,274233761,bradloncar,Brad Loncar,,Retweeting this WSJ piece on RNA companies in case you missed it:  http://t.co/B7wThnCsYF $ALNY $ISIS $SRPT,en,[],['http://online.wsj.com/articles/gene-technology-regains-some-of-its-luster-1401315623?cb=logged0.8267318950966001'],[],1,2,4,[],"['alny', 'isis', 'srpt']",https://twitter.com/bradloncar/status/471979390566289408,False,,0,,,,,,,,[],,,,
471331405868564480,471331405868564480,2014-05-27 22:15:38 IST,2014-05-27,22:15:38,+0530,14031032,adamsinger,Adam Singer,,"To anyone who cares, I added more $SRPT today. Fav stock / company of the year that is measurably improving the lives of people.",en,[],[],[],2,2,9,[],['srpt'],https://twitter.com/AdamSinger/status/471331405868564480,False,,0,,,,,,,,[],,,,
469859416154845184,469859416154845184,2014-05-23 20:46:29 IST,2014-05-23,20:46:29,+0530,873399943,jacobplieth,Jacob Plieth,,Winds of change and an elephant in the room. My take on today's #DMD developments $SANN $PTCT $SRPT $RNA  http://t.co/vAUrFpzIrv,en,[],['http://ow.ly/xbLWr'],[],0,5,6,['dmd'],"['sann', 'ptct', 'srpt', 'rna']",https://twitter.com/JacobPlieth/status/469859416154845184,False,,0,,,,,,,,[],,,,
459140359029661696,459140359029661696,2014-04-24 06:52:46 IST,2014-04-24,06:52:46,+0530,274233761,bradloncar,Brad Loncar,,"See, that didn't hurt at all. $SRPT",en,[],[],[],1,1,8,[],['srpt'],https://twitter.com/bradloncar/status/459140359029661696,False,,0,,,,,,,,[],,,,
458707682510139392,458707682510139392,2014-04-23 02:13:28 IST,2014-04-23,02:13:28,+0530,274233761,bradloncar,Brad Loncar,,"Raising money because you are now going full speed ahead is a good thing, not a bad one. $SRPT",en,[],[],[],7,7,13,[],['srpt'],https://twitter.com/bradloncar/status/458707682510139392,False,,0,,,,,,,,[],,,,
458308150769094656,458308150769094656,2014-04-21 23:45:52 IST,2014-04-21,23:45:52,+0530,274233761,bradloncar,Brad Loncar,,"Chris did a nice job on TV. Thanked the families, FDA, mentioned FDASIA, didn't over-promise, said the finish line is in sight. $SRPT",en,[],[],[],1,0,5,[],['srpt'],https://twitter.com/bradloncar/status/458308150769094656,False,,0,,,,,,,,[],,,,
458285682503741440,458285682503741440,2014-04-21 22:16:35 IST,2014-04-21,22:16:35,+0530,1347071545,melissaleecnbc,Melissa Lee,,Mover of the day: $SRPT +45%. CEO joins me and @SullyCNBC on @StreetSignsCNBC today at 2p! See you then!,en,"[{'screen_name': 'sullycnbc', 'name': 'brian sullivan', 'id': '24443284'}, {'screen_name': 'streetsignscnbc', 'name': ""cnbc's street signs"", 'id': '36074927'}]",[],[],7,4,8,[],['srpt'],https://twitter.com/MelissaLeeCNBC/status/458285682503741440,False,,0,,,,,,,,[],,,,
458243130014593024,458243130014593024,2014-04-21 19:27:30 IST,2014-04-21,19:27:30,+0530,14216123,jimcramer,Jim Cramer,,Couple things: I do not trust $SRPT's gains and i would sell it. I think $IBM is putting in a bottom --www.actionalertsplus.com,en,[],[],[],5,6,4,[],"['srpt', 'ibm']",https://twitter.com/jimcramer/status/458243130014593024,False,,0,,,,,,,,[],,,,
458221626564169728,458221626564169728,2014-04-21 18:02:03 IST,2014-04-21,18:02:03,+0530,274233761,bradloncar,Brad Loncar,,"Including eteplirsen, $SRPT currently has 8 drug candidates that might be applicable to about half of the DMD community.",en,[],[],[],1,5,6,[],['srpt'],https://twitter.com/bradloncar/status/458221626564169728,False,,0,,,,,,,,[],,,,
458207984389455872,458207984389455872,2014-04-21 17:07:51 IST,2014-04-21,17:07:51,+0530,360154668,harrisonsfund,Harrison's Fund,,"We did it! Took the FDA way too long, but it's here now! #epicDay $SRPT #justthestart  http://t.co/8wjTpOpyiV @jennmcnary @ianestepan",en,"[{'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}, {'screen_name': 'ianestepan', 'name': 'ian estepan', 'id': '166711687'}]",['http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&p=irol-newsArticle&ID=1920025&highlight='],[],0,5,14,"['epicday', 'justthestart']",['srpt'],https://twitter.com/HarrisonsFund/status/458207984389455872,False,,0,,,,,,,,[],,,,
458206789691912192,458206789691912192,2014-04-21 17:03:06 IST,2014-04-21,17:03:06,+0530,274233761,bradloncar,Brad Loncar,,Make sure you read @matthewherper's story on this. He's had the weekend to compose his thoughts about the news:  http://t.co/ui9jPKJtKs $SRPT,en,"[{'screen_name': 'matthewherper', 'name': 'matthew herper', 'id': '44438256'}]",['http://www.forbes.com/sites/matthewherper/2014/04/21/digging-in-to-sareptas-fda-victory/'],[],3,2,5,[],['srpt'],https://twitter.com/bradloncar/status/458206789691912192,False,,0,,,,,,,,[],,,,
458205316220743680,458205316220743680,2014-04-21 16:57:15 IST,2014-04-21,16:57:15,+0530,44438256,matthewherper,Matthew Herper,,$SRPT gave me time to think about their announcement. Here's a pretty deep dive into what the company needs to do...  http://t.co/srvf2bf4O4,en,[],['http://onforb.es/1njKmfX'],[],6,27,24,[],['srpt'],https://twitter.com/matthewherper/status/458205316220743680,False,,0,,,,,,,,[],,,,
458201985297436672,458201985297436672,2014-04-21 16:44:00 IST,2014-04-21,16:44:00,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Only $SRPT can interrupt my vacation. Wow! Amazing news. Hats off to @jennmcnary &amp; the other DMD parents.,en,"[{'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}]",[],[],3,15,25,[],['srpt'],https://twitter.com/adamfeuerstein/status/458201985297436672,False,,0,,,,,,,,[],,,,
458201567259525120,458201567259525120,2014-04-21 16:42:21 IST,2014-04-21,16:42:21,+0530,44438256,matthewherper,Matthew Herper,,A big day for muscular dystrophy patients: $SRPT will file an NDA late this year. Digging into the announcement:  http://t.co/OyVr65UYbO,en,[],['http://www.forbes.com/sites/matthewherper/2014/04/21/digging-in-to-sareptas-fda-victory/?partner=yahootix'],[],0,18,13,[],['srpt'],https://twitter.com/matthewherper/status/458201567259525120,False,,0,,,,,,,,[],,,,
458198059256524801,458198059256524801,2014-04-21 16:28:24 IST,2014-04-21,16:28:24,+0530,274233761,bradloncar,Brad Loncar,,Sarepta Therapeutics Announces Plans to Submit New Drug Application to FDA for Eteplirsen for the...  http://t.co/IIUafAWo0u $SRPT,en,[],['http://finance.yahoo.com/news/sarepta-therapeutics-announces-plans-submit-105500879.html?soc_src=mediacontentstory'],[],1,7,7,[],['srpt'],https://twitter.com/bradloncar/status/458198059256524801,False,,0,,,,,,,,[],,,,
457531138546741248,457531138546741248,2014-04-19 20:18:18 IST,2014-04-19,20:18:18,+0530,274233761,bradloncar,Brad Loncar,,The sad thing about the Barron's article on $SRPT is that they basically published the same thing a year ago. What is taking so darn long?,en,[],[],[],5,2,13,[],['srpt'],https://twitter.com/bradloncar/status/457531138546741248,False,,0,,,,,,,,[],,,,
453602867094753280,453602867094753280,2014-04-09 00:08:45 IST,2014-04-09,00:08:45,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT on Cusp of Huge Eteplirsen News ‚Äî&gt;  http://t.co/O6aoqYqqYa,en,[],['http://www.thestreet.com/story/12633133/1/sarepta-therapeutics-on-cusp-of-huge-eteplirsen-news.html'],[],8,10,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/453602867094753280,False,,0,,,,,,,,[],,,,
453575025879035904,453575025879035904,2014-04-08 22:18:07 IST,2014-04-08,22:18:07,+0530,274233761,bradloncar,Brad Loncar,,Well $SRPT would have wrapped up their Needham presentation a few minutes ago. Let's hope whatever else they are doing today is going well.,en,[],[],[],3,3,10,[],['srpt'],https://twitter.com/bradloncar/status/453575025879035904,False,,0,,,,,,,,[],,,,
452613829445165056,452613829445165056,2014-04-06 06:38:40 IST,2014-04-06,06:38:40,+0530,274233761,bradloncar,Brad Loncar,,"""The reason it doesn‚Äôt have one, however, is largely the fault of the agency itself."" &lt;‚ÄîAmen  http://t.co/sR1Nz9L1sV $SRPT h/t @ianestepan",en,"[{'screen_name': 'ianestepan', 'name': 'ian estepan', 'id': '166711687'}]",['http://m.bizjournals.com/boston/blog/bioflash/2014/04/fda-head-says-agency-s-work-has-helped-shorten.html?page=all&r=full'],[],2,8,9,[],['srpt'],https://twitter.com/bradloncar/status/452613829445165056,False,,0,,,,,,,,[],,,,
452291534348500992,452291534348500992,2014-04-05 09:17:59 IST,2014-04-05,09:17:59,+0530,274233761,bradloncar,Brad Loncar,,"I'm not sure if this video has been posted, but it has a few more comments from Comm. Hamburg and Sen. Warren.  http://t.co/4fyYNDVl4a $SRPT",en,[],['http://www.myfoxboston.com/story/25168179/fox-follow-up-fda-commissioner-responds-to-mothers-plea'],[],3,5,13,[],['srpt'],https://twitter.com/bradloncar/status/452291534348500992,False,,0,,,,,,,,[],,,,
452275300336799744,452228927000698880,2014-04-05 08:13:29 IST,2014-04-05,08:13:29,+0530,274233761,bradloncar,Brad Loncar,,@rushtonjdr I think we are going to hear very soon too. It has passed the point of being ridiculous. $SRPT,en,[],[],[],2,1,9,[],['srpt'],https://twitter.com/bradloncar/status/452275300336799744,False,,0,,,,,,,,[],,,,
445988863354634242,445988863354634242,2014-03-18 23:53:25 IST,2014-03-18,23:53:25,+0530,360154668,harrisonsfund,Harrison's Fund,"{'type': 'Point', 'coordinates': [51.3281917, -0.41051498]}",Tune in to The Willis Report on Fox at 5:30pm EST to hear from Jenn Mcnary &amp; Christine McSherry...  http://t.co/KXPstrWNbq‚Äù $SRPT,en,[],['http://fb.me/2Kys02pAK'],[],0,11,6,[],['srpt'],https://twitter.com/HarrisonsFund/status/445988863354634242,False,,0,,,,,,,,[],,,,
443702181397807104,443702181397807104,2014-03-12 16:26:58 IST,2014-03-12,16:26:58,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Is Josh Hardy more deserving than Austin LeClaire? @jennmcnary $SRPT $CMRX,en,"[{'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}]",[],[],4,9,10,[],"['srpt', 'cmrx']",https://twitter.com/adamfeuerstein/status/443702181397807104,False,,0,,,,,,,,[],,,,
438810118122405888,438810118122405888,2014-02-27 04:27:39 IST,2014-02-27,04:27:39,+0530,274233761,bradloncar,Brad Loncar,,Good luck tomorrow $SRPT!,en,[],[],[],2,2,14,[],['srpt'],https://twitter.com/bradloncar/status/438810118122405888,False,,0,,,,,,,,[],,,,
438020068019290112,438020068019290112,2014-02-25 00:08:16 IST,2014-02-25,00:08:16,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"For those asking me abt $SRPT short thesis: eteplirsen ‚Äútoo big‚Äù to get into cells, I recommend asking @MartinShkreli or @biotechtoreador",en,"[{'screen_name': 'martinshkreli', 'name': 'martin shkreli', 'id': '312653402'}, {'screen_name': 'biotechtoreador', 'name': 'dr. biotechtoreador', 'id': '376347156'}]",[],[],2,3,5,[],['srpt'],https://twitter.com/adamfeuerstein/status/438020068019290112,False,,0,,,,,,,,[],,,,
436380589218750465,436380589218750465,2014-02-20 11:33:34 IST,2014-02-20,11:33:34,+0530,274233761,bradloncar,Brad Loncar,,Dad Starts Biotech in Muscular Dystrophy Quest  http://t.co/bpUHen0O7A #DMD $SRPT $RNA,en,[],['http://bloom.bg/1feNHtz'],[],4,12,8,['dmd'],"['srpt', 'rna']",https://twitter.com/bradloncar/status/436380589218750465,False,,0,,,,,,,,[],,,,
433368197601845250,433368197601845250,2014-02-12 04:03:24 IST,2014-02-12,04:03:24,+0530,375980238,sassy_spy,"Rachel Shasha, MAüé≤",,Updated short interest on many names(@ bottom) $TSLA $SCTY $GMCR $SPY $SODA $ANGI $LULU $SRPT $EEM $FXI  http://t.co/mWGCteRqJx #SassyMusings,en,[],['http://stks.co/g0HEV'],[],4,5,10,['sassymusings'],"['tsla', 'scty', 'gmcr', 'spy', 'soda', 'angi', 'lulu', 'srpt', 'eem', 'fxi']",https://twitter.com/Sassy_SPY/status/433368197601845250,False,,0,,,,,,,,[],,,,
431903343867211776,431830373295996928,2014-02-08 03:02:36 IST,2014-02-08,03:02:36,+0530,274233761,bradloncar,Brad Loncar,,"Admiration, praise, respect, applause, props, and good luck to these amazing women ‚Äî&gt; @jennmcnary: #supermoms $srpt  http://t.co/Rr3Jx5E6qU",en,"[{'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}]",[],['https://pbs.twimg.com/media/Bf4rb7jIAAAzhHt.jpg'],1,10,27,['supermoms'],['srpt'],https://twitter.com/bradloncar/status/431903343867211776,False,,1,https://pbs.twimg.com/media/Bf4rb7jIAAAzhHt.jpg,,,,,,,[],,,,
423830154473795584,423830154473795584,2014-01-16 20:22:37 IST,2014-01-16,20:22:37,+0530,274233761,bradloncar,Brad Loncar,,"$SRPT came to play y'day. Put out a relevant press release, addressed the Drisa and natural history issues, talked broader platform. Solid.",en,[],[],[],3,5,8,[],['srpt'],https://twitter.com/bradloncar/status/423830154473795584,False,,0,,,,,,,,[],,,,
423625035085910016,423625035085910016,2014-01-16 06:47:33 IST,2014-01-16,06:47:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT will be talking to potential partners about morpholino chemistry. Promote it, CG!!!",en,[],[],[],1,5,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/423625035085910016,False,,0,,,,,,,,[],,,,
423624696697856002,423624696697856002,2014-01-16 06:46:12 IST,2014-01-16,06:46:12,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"$SRPT new CSO hire will accelerate ""platform"" expansion. Maybe investors will reward $SRPT like they do $ISIS $ALNY.",en,[],[],[],5,16,9,[],"['srpt', 'srpt', 'isis', 'alny']",https://twitter.com/adamfeuerstein/status/423624696697856002,False,,0,,,,,,,,[],,,,
423619647980584960,423619647980584960,2014-01-16 06:26:09 IST,2014-01-16,06:26:09,+0530,274233761,bradloncar,Brad Loncar,,That was insanely good. $SRPT #JPM14,en,[],[],[],0,0,10,['jpm14'],['srpt'],https://twitter.com/bradloncar/status/423619647980584960,False,,0,,,,,,,,[],,,,
423613250018627584,423613250018627584,2014-01-16 06:00:43 IST,2014-01-16,06:00:43,+0530,274233761,bradloncar,Brad Loncar,,$SRPT 2014 corporate milestones. #JPM14  http://t.co/CD5zrNGV5X,es,[],[],['https://pbs.twimg.com/media/BeD6AaECMAAU5AB.png'],0,5,6,['jpm14'],['srpt'],https://twitter.com/bradloncar/status/423613250018627584,False,,1,https://pbs.twimg.com/media/BeD6AaECMAAU5AB.png,,,,,,,[],,,,
422816461610954752,422816461610954752,2014-01-14 01:14:34 IST,2014-01-14,01:14:34,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Wall St. gives $ALNY platform benefit of doubt but does not for $SRPT platform. Interesting to me. #JPM14,en,[],[],[],3,4,6,['jpm14'],"['alny', 'srpt']",https://twitter.com/adamfeuerstein/status/422816461610954752,False,,0,,,,,,,,[],,,,
420248897257103361,420248897257103361,2014-01-06 23:11:59 IST,2014-01-06,23:11:59,+0530,102094857,adamfeuerstein,Adam Feuerstein,,This FDA Letter About $SRPT and Accelerated Approval for Eteplirsen Will Blow Your Mind ‚Äî&gt;  http://t.co/pOf2iXLXwA,en,[],['http://www.thestreet.com/story/12211040/1/this-fda-letter-about-sarepta-and-accelerated-approval-for-eteplirsen-will-blow-your-mind.html'],[],10,10,14,[],['srpt'],https://twitter.com/adamfeuerstein/status/420248897257103361,False,,0,,,,,,,,[],,,,
420170704697315328,420170704697315328,2014-01-06 18:01:17 IST,2014-01-06,18:01:17,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Do you care what Citi says about $SRPT? Here‚Äôs today‚Äôs downgrade blurb.  http://t.co/40O3qYajZS,en,[],[],['https://pbs.twimg.com/media/BdS_B5ICYAEfbQU.jpg'],7,7,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/420170704697315328,False,,1,https://pbs.twimg.com/media/BdS_B5ICYAEfbQU.jpg,,,,,,,[],,,,
418959682875576321,418959682875576321,2014-01-03 09:49:06 IST,2014-01-03,09:49:06,+0530,274233761,bradloncar,Brad Loncar,,"According to this schedule, both $SRPT &amp; $AEGR have chosen to webcast their breakout room Q&amp;A's. Huge thanks to both of them! #JPM14",en,[],[],[],0,5,6,['jpm14'],"['srpt', 'aegr']",https://twitter.com/bradloncar/status/418959682875576321,False,,0,,,,,,,,[],,,,
411204215566893056,411204215566893056,2013-12-13 00:11:39 IST,2013-12-13,00:11:39,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Apparently, ""the press"" is now to blame for the $SRPT FDA mess. Thanks, Janet. Get your own fucking house in order.",en,[],[],[],7,3,5,[],['srpt'],https://twitter.com/adamfeuerstein/status/411204215566893056,False,,0,,,,,,,,[],,,,
411202185003679744,411202185003679744,2013-12-13 00:03:35 IST,2013-12-13,00:03:35,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Liisa Bayko of JMP Securities on today's DMD Forum  http://t.co/OldiT8UDoN,tl,[],[],['https://pbs.twimg.com/media/BbTiNV6CcAARgLL.jpg'],1,12,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/411202185003679744,False,,1,https://pbs.twimg.com/media/BbTiNV6CcAARgLL.jpg,,,,,,,[],,,,
407700794805600257,407700794805600257,2013-12-03 08:10:18 IST,2013-12-03,08:10:18,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT: I just listened to end of Garabedian's chat with DB's Robyn K. He should have thanked DMD moms but he didn't throw them under bus.,en,[],[],[],8,2,11,[],['srpt'],https://twitter.com/adamfeuerstein/status/407700794805600257,False,,0,,,,,,,,[],,,,
400595386873548800,400595386873548800,2013-11-13 17:35:57 IST,2013-11-13,17:35:57,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"A Post-Mortem on $SRPT Epic Explosion, Mea Culpa Included --&gt;  http://t.co/GcSheyu7WY",en,[],['http://www.thestreet.com/story/12106960/1/a-post-mortem-on-sareptas-epic-explosion-mea-culpa-included.html?kval=dontmiss'],[],19,13,20,[],['srpt'],https://twitter.com/adamfeuerstein/status/400595386873548800,False,,0,,,,,,,,[],,,,
400346139259445248,400346139259445248,2013-11-13 01:05:32 IST,2013-11-13,01:05:32,+0530,274233761,bradloncar,Brad Loncar,,Here's Janney's latest newsletter. Their $SRPT report is in there if you want to read a sell-side take.  http://t.co/EEkPqHYdJz,en,[],['http://www.janney.com/institutions--corporations/investment-banking/industry-groups/healthcare/life-sciences-newsletter'],[],3,0,7,[],['srpt'],https://twitter.com/bradloncar/status/400346139259445248,False,,0,,,,,,,,[],,,,
400238407764307968,400238407764307968,2013-11-12 17:57:27 IST,2013-11-12,17:57:27,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Serious Setback: FDA Says No Early Approval Filing for Eteplirsen -&gt;  http://t.co/jbhiDatipk,en,[],['http://www.thestreet.com/story/12105293/1/sarepta-serious-setback-fda-says-no-early-approval-filing-for-eteplirsen.html'],[],5,18,10,[],['srpt'],https://twitter.com/adamfeuerstein/status/400238407764307968,False,,0,,,,,,,,[],,,,
397381000428544000,397381000428544000,2013-11-04 20:43:08 IST,2013-11-04,20:43:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Why I'm More Confident in $SRPT Than Ever Before --&gt;  http://t.co/J7oLkw1SMy New column by @sharkbiotech I wish he'd write more for me ;-),en,"[{'screen_name': 'sharkbiotech', 'name': 'dan rosenblum', 'id': '255996385'}]",['http://www.thestreet.com/story/12094287/1/why-im-more-confident-in-sarepta-than-ever-before.html'],[],2,7,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/397381000428544000,False,,0,,,,,,,,[],,,,
395893943860076544,395893943860076544,2013-10-31 18:14:06 IST,2013-10-31,18:14:06,+0530,102094857,adamfeuerstein,Adam Feuerstein,,A Rousing Rebuttal of the $SRPT Serial Short --&gt;  http://t.co/takjEuofG8 With alliteration!,en,[],['http://www.thestreet.com/story/12089371/1/a-rousing-rebuttal-of-the-sarepta-serial-short.html'],[],5,7,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/395893943860076544,False,,0,,,,,,,,[],,,,
395598053392257024,395598053392257024,2013-10-30 22:38:20 IST,2013-10-30,22:38:20,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I just read @Steven_BIP $SRPT story closely and there is so much wrong with it. I don't mind a good bear thesis but this is shoddy work.,en,[],[],[],5,5,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/395598053392257024,False,,0,,,,,,,,[],,,,
393696892158091264,393696892158091264,2013-10-25 16:43:48 IST,2013-10-25,16:43:48,+0530,102094857,adamfeuerstein,Adam Feuerstein,,This week's Biotech Stock Mailbag --&gt;  http://t.co/B18IJpy5lE $VNDA $ONTX $CPRX $SRPT + Hate Mail &amp; Nasty Tweets,nl,[],['http://www.thestreet.com/story/12081830/1/biotech-stock-mailbag-vanda-onconova-catalyst-pharma-sarepta.html?kval=dontmiss'],[],5,7,6,[],"['vnda', 'ontx', 'cprx', 'srpt']",https://twitter.com/adamfeuerstein/status/393696892158091264,False,,0,,,,,,,,[],,,,
393052276945723392,393052276945723392,2013-10-23 22:02:20 IST,2013-10-23,22:02:20,+0530,44438256,matthewherper,Matthew Herper,,So @jennmcnary spoke at our Forbes Healthcare Summit. This may be particularly interesting to $SRPT followers.  http://t.co/taT5Q8SpJ6,en,"[{'screen_name': 'jennmcnary', 'name': 'jenn mcnary', 'id': '26817296'}]",['http://onforb.es/16tnNi8'],[],2,9,10,[],['srpt'],https://twitter.com/matthewherper/status/393052276945723392,False,,0,,,,,,,,[],,,,
392327105876209664,392327105876209664,2013-10-21 22:00:45 IST,2013-10-21,22:00:45,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT bears should be very worried about the photos in this blog post --&gt;  http://t.co/6ajHfzCCkl,en,[],['http://jettfoundation.org/uncategorized/changing-the-climate-at-the-fda-2/'],[],7,16,19,[],['srpt'],https://twitter.com/adamfeuerstein/status/392327105876209664,False,,0,,,,,,,,[],,,,
387964852817244161,387964852817244161,2013-10-09 21:06:43 IST,2013-10-09,21:06:43,+0530,102094857,adamfeuerstein,Adam Feuerstein,,who wants me to tweet the rest of Favus' short report on $SRPT? Raise your hand...,en,[],[],[],14,1,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/387964852817244161,False,,0,,,,,,,,[],,,,
387963956687409153,387963956687409153,2013-10-09 21:03:09 IST,2013-10-09,21:03:09,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Here's a screen grab of Favus' $SRPT short report. First page --&gt;  http://t.co/0ksTkIB9Ep,en,[],[],['https://pbs.twimg.com/media/BWJTKbACcAAcPfW.jpg'],4,6,7,[],['srpt'],https://twitter.com/adamfeuerstein/status/387963956687409153,False,,1,https://pbs.twimg.com/media/BWJTKbACcAAcPfW.jpg,,,,,,,[],,,,
387195417122721792,387195417122721792,2013-10-07 18:09:15 IST,2013-10-07,18:09:15,+0530,102094857,adamfeuerstein,Adam Feuerstein,,This Slide Paints Grim Picture of $GSK $RNA DMD Drug --&gt;  http://t.co/aWkHM3LQ4U $SRPT,en,[],['http://www.thestreet.com/story/12060347/1/this-slide-paints-grim-picture-of-glaxo-prosensas-dmd-drug.html'],[],3,8,5,[],"['gsk', 'rna', 'srpt']",https://twitter.com/adamfeuerstein/status/387195417122721792,False,,0,,,,,,,,[],,,,
385850208052994048,385850208052994048,2013-10-04 01:03:53 IST,2013-10-04,01:03:53,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$RNA $SRPT $GSK Here's pic of full drisapersen dystrophin poster from DEMAND-2. Apologies if not legible.  http://t.co/d2vlqsD1i6,en,[],[],['https://pbs.twimg.com/media/BVrQuDkCAAAex_a.jpg'],3,2,6,[],"['rna', 'srpt', 'gsk']",https://twitter.com/adamfeuerstein/status/385850208052994048,False,,1,https://pbs.twimg.com/media/BVrQuDkCAAAex_a.jpg,,,,,,,[],,,,
385763081227218944,385763081227218944,2013-10-03 19:17:40 IST,2013-10-03,19:17:40,+0530,274233761,bradloncar,Brad Loncar,,Would be great if this is the start of $SRPT getting the $ALNY treatment. Otherwise known as the respect it deserves.,en,[],[],[],2,1,6,[],"['srpt', 'alny']",https://twitter.com/bradloncar/status/385763081227218944,False,,0,,,,,,,,[],,,,
381080732900139008,381080732900139008,2013-09-20 21:11:41 IST,2013-09-20,21:11:41,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"This story I wrote on drisa ph2 data from April reads prescient today --&gt;  http://t.co/SmWL68dFiN $RNA $SRPT Sorry, self-congratulatory.",en,[],['http://www.thestreet.com/story/11894391/2/sarepta-fans-a-single-data-slide-raises-questions-about-glaxos-dmd-drug.html'],[],1,1,6,[],"['rna', 'srpt']",https://twitter.com/adamfeuerstein/status/381080732900139008,False,,0,,,,,,,,[],,,,
369544304940683264,369544304940683264,2013-08-20 01:10:02 IST,2013-08-20,01:10:02,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT issued a statement to me re: dystrophin staining photos from Annals of Neurology paper. Here --&gt;  http://t.co/xN88UnIOaq,en,[],[],['https://pbs.twimg.com/media/BSDillyCEAECvOU.jpg'],4,14,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/369544304940683264,False,,1,https://pbs.twimg.com/media/BSDillyCEAECvOU.jpg,,,,,,,[],,,,
369473923278069760,369473923278069760,2013-08-19 20:30:22 IST,2013-08-19,20:30:22,+0530,274233761,bradloncar,Brad Loncar,,$SRPT sentiment lately is the investing equivalent to the supermodel who was never asked to the prom. A lot of shortsighted people out there,en,[],[],[],5,3,6,[],['srpt'],https://twitter.com/bradloncar/status/369473923278069760,False,,0,,,,,,,,[],,,,
360087886445551617,360087886445551617,2013-07-24 22:53:36 IST,2013-07-24,22:53:36,+0530,102094857,adamfeuerstein,Adam Feuerstein,,I updated my earlier $SRPT story w/ comments from CEO Chris Garabedian. I spoke w/ him --&gt;  http://t.co/VHC5aq39c3,en,[],['http://www.thestreet.com/story/11987227/1/sarepta-to-seek-early-us-approval-for-muscular-dystrophy-drug.html'],[],2,11,4,[],['srpt'],https://twitter.com/adamfeuerstein/status/360087886445551617,False,,0,,,,,,,,[],,,,
360029078557966336,360028342524715008,2013-07-24 18:59:56 IST,2013-07-24,18:59:56,+0530,274233761,bradloncar,Brad Loncar,,@redacre As Warren Buffet says‚Ä¶transfer of money from those who are impatient to those who are patient. $SRPT,en,[],[],[],2,0,3,[],['srpt'],https://twitter.com/bradloncar/status/360029078557966336,False,,0,,,,,,,,[],,,,
359978925566332930,359978925566332930,2013-07-24 15:40:38 IST,2013-07-24,15:40:38,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"I'm missing my morning run to wait for $SRPT news. Running -- something DMD kids aspire to, if we get good news today.",en,[],[],[],4,2,9,[],['srpt'],https://twitter.com/adamfeuerstein/status/359978925566332930,False,,0,,,,,,,,[],,,,
359825390891565057,359825390891565057,2013-07-24 05:30:33 IST,2013-07-24,05:30:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Let's keep the self-congratulatory back-slapping tweets to a minimum. We all know you either 1) bought $SRPT at $3; or 2) shorted at $45.,en,[],[],[],3,2,8,[],['srpt'],https://twitter.com/adamfeuerstein/status/359825390891565057,False,,0,,,,,,,,[],,,,
340194927193509888,340194927193509888,2013-05-31 01:26:05 IST,2013-05-31,01:26:05,+0530,274233761,bradloncar,Brad Loncar,,$SRPT - trading at levels not seen since yesterday.,en,[],[],[],1,6,7,[],['srpt'],https://twitter.com/bradloncar/status/340194927193509888,False,,0,,,,,,,,[],,,,
340190052237864960,340190052237864960,2013-05-31 01:06:43 IST,2013-05-31,01:06:43,+0530,274233761,bradloncar,Brad Loncar,,"As Warren Buffet says: ""stock market is a means for transferring money from the impatient to the patient."" Just hold the stock folks. $SRPT",en,[],[],[],2,4,6,[],['srpt'],https://twitter.com/bradloncar/status/340190052237864960,False,,0,,,,,,,,[],,,,
323911584407752706,323911584407752706,2013-04-16 03:01:54 IST,2013-04-16,03:01:54,+0530,102094857,adamfeuerstein,Adam Feuerstein,,A Proactive FDA is Already Reviewing $SRPT's Muscular Dystrophy Drug --&gt;  http://t.co/DRL6RumMCn,en,[],['http://www.thestreet.com/story/11896146/1/a-proactive-fda-is-already-reviewing-sareptas-muscular-dystrophy-drug.html'],[],4,6,5,[],['srpt'],https://twitter.com/adamfeuerstein/status/323911584407752706,False,,0,,,,,,,,[],,,,
322715028153303040,322715028153303040,2013-04-12 19:47:13 IST,2013-04-12,19:47:13,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Fans: A Single Data Slide Raises Questions About $GSK's DMD Drug --&gt;  http://t.co/kE9Uf6k2Uj,en,[],['http://www.thestreet.com/story/11894391/1/sarepta-fans-a-single-data-slide-raises-questions-about-glaxos-dmd-drug.html'],[],6,8,2,[],"['srpt', 'gsk']",https://twitter.com/adamfeuerstein/status/322715028153303040,False,,0,,,,,,,,[],,,,
313985764872552450,313985764872552450,2013-03-19 17:40:14 IST,2013-03-19,17:40:14,+0530,102094857,adamfeuerstein,Adam Feuerstein,,DB's Robyn K channels @sharkbiotech smart take on $SRPT. Accelerated approval? Who cares? Stock still undervalued.  http://t.co/MtrbAaAeRT,en,"[{'screen_name': 'sharkbiotech', 'name': 'dan rosenblum', 'id': '255996385'}]",['http://www.thestreet.com/story/11873301/1/db-analyst-gets-it-sarepta-is-a-winner-even-without-accelerated-approval.html'],[],2,4,4,[],['srpt'],https://twitter.com/adamfeuerstein/status/313985764872552450,False,,0,,,,,,,,[],,,,
310024184568897536,310024184568897536,2013-03-08 19:18:20 IST,2013-03-08,19:18:20,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Last night, I watched Max walk around room, helping his wheelchair-bound brother Austin. Lots love betwn those guys. Eteplirsen works. $SRPT",en,[],[],[],1,16,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/310024184568897536,False,,0,,,,,,,,[],,,,
306835176288309249,306835176288309249,2013-02-28 00:06:21 IST,2013-02-28,00:06:21,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"BREAKING: $GSK DMD Drug Tied To Serious Side Effects, Hospitalizations --&gt;  http://t.co/90ySaa6zHL $SRPT",en,[],['http://www.thestreet.com/story/11854354/1/glaxo-dmd-drug-tied-to-serious-side-effects-hospitalizations.html'],[],7,21,6,[],"['gsk', 'srpt']",https://twitter.com/adamfeuerstein/status/306835176288309249,False,,0,,,,,,,,[],,,,
304369622516391936,304369622516391936,2013-02-21 04:49:07 IST,2013-02-21,04:49:07,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Cure Duchenne call w/ FDA's Bob Temple made me feel incrementally more confident in $SRPT eteplirsen AA filing. Worth listening to replay.,en,[],[],[],5,7,6,[],['srpt'],https://twitter.com/adamfeuerstein/status/304369622516391936,False,,0,,,,,,,,[],,,,
301312244774498304,301312244774498304,2013-02-12 18:20:11 IST,2013-02-12,18:20:11,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT Will Defy Wall St. Consensus With Eteplirsen Early FDA Filing --&gt;  http://t.co/6T6RIgpU,en,[],['http://bit.ly/V33zX9'],[],5,4,4,[],['srpt'],https://twitter.com/adamfeuerstein/status/301312244774498304,False,,0,,,,,,,,[],,,,
273393264860749824,273393264860749824,2012-11-27 17:20:08 IST,2012-11-27,17:20:08,+0530,102094857,adamfeuerstein,Adam Feuerstein,,10 Best-Performing Biopharma Stocks And Their Outlook for 2013 --&gt;  http://t.co/rV1kJ0Wz $AFFY $PCYC $ARNA $SRPT $CLSN $THLD $BDSI $GALE,en,[],['http://bit.ly/RfHtP4'],[],3,4,7,[],"['affy', 'pcyc', 'arna', 'srpt', 'clsn', 'thld', 'bdsi', 'gale']",https://twitter.com/adamfeuerstein/status/273393264860749824,False,,0,,,,,,,,[],,,,
254246709843075072,254246709843075072,2012-10-05 21:18:33 IST,2012-10-05,21:18:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,$SRPT - A handy @appeering link to my summary of the Summer Street call --&gt;  http://t.co/apFpvBR9,en,"[{'screen_name': 'appeering', 'name': 'peerin', 'id': '352038416'}]",['http://bit.ly/T5AsKS'],[],1,4,3,[],['srpt'],https://twitter.com/adamfeuerstein/status/254246709843075072,False,,0,,,,,,,,[],,,,
243296128865562624,243296128865562624,2012-09-05 16:04:52 IST,2012-09-05,16:04:52,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Essential 2012 Biotech Fall Preview --&gt;  http://t.co/dCSNoeOQ My look at what to expect before year end. $ARIA $EXEL $CLSN $SRPT $AMRN et al,en,[],['http://bit.ly/RKkJjC'],[],3,12,7,[],"['aria', 'exel', 'clsn', 'srpt', 'amrn']",https://twitter.com/adamfeuerstein/status/243296128865562624,False,,0,,,,,,,,[],,,,
